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Abstract 
Short chain fatty acids (SCFA), including propionate, are produced by the bacterial 
fermentation of carbohydrates in the colon.  Propionate has many potential roles in health, 
including inhibiting cholesterol synthesis, de novo lipogenesis and increasing satiety.  The 
profile of SCFA produced is determined by both the substrate available and the bacteria 
present and may be influenced by environmental conditions within the lumen of the colon. 
 
Whilst it may be beneficial to increase colonic propionate production, dietary strategies to 
achieve this are unproven.  Adding propionate to food leads to poorer organoleptic 
properties, and oral propionate is absorbed in the small intestine.  The optimum way to 
selectively increase colonic propionate would be to select fermentable carbohydrates that 
selectively promote propionate production.  To date, few studies have undertaken a 
systematic assessment of the factors leading to increased colonic propionate production 
making the selection of propiogenic carbohydrates challenging.  
 
The aim of this thesis was to identify the best carbohydrates for selectively increasing 
propionate production, and to explore the factors which control propionate production.  
This work started with a systematic review of the literature for evidence of candidate 
carbohydrates, which led to a screen of ‘propiogenic’ substrates using in vitro batch 
fermentations and mechanistic analysis of the impact of pH, bond linkage and orientation 
using a range of sugars, polysaccharides and fibre sources.  
 
A new unit for SCFA production was developed to allow comparison of results from in 
vitro studies encompassing a range different methodologies found in the literature. The 
systematic review found that rhamnose yielded the highest rate and proportion of 
propionate production whereas, for polysaccharides, β-glucan ranked highest for rate and 
guar gum ranked highest for molar production, but this was not replicated across all 
studies.  Thus, no single NDC was established as highly propiogenic.  Some substrates 
appeared more propiogenic than others and when these were screened in vitro. Laminarin, 
and other β-glucans ranked highest for propionate production. Legume fibre and 
mycoprotein fibre were also propiogenic.  A full complement of glucose disaccharides was 
tested to examine the role glycosidic bond orientation and position on propionate 
production. Of the glucose disaccharides tested, β(1-4) bonding was associated with 
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increased proportion of propionate and α(1-1) and β(1-4) increased the rate and proportion 
of butyrate production.  
 
In conclusion, it appears that for fibre to affect satiety, high intakes of fibre are needed, and 
which a major mechanism is thought to occur via propionate. Within this thesis, it was 
identified that rather than selecting specific fibres, increasing overall intakes of highly 
fermentable carbohydrates is as effective at increasing propionate production. Selecting 
carbohydrates with beta-bonding, particularly laminarin and other β(1-4) fermentable 
carbohydrates leads to marginal increases in propionate production.  Compared with 
targeted delivery of propionate to the colon, fermentable carbohydrates examined in this 
thesis have lesser and variable effects on propionate production. A more complete 
understanding of the impact of bond configurations in polysaccharides, rather than 
disaccharides, may help selection or design of dietary carbohydrates which selectively 
promote colonic propionate production substrates for inclusion in functional foods. 
Overall, this study has concluded that few substrates are selectively propiogenic and the 
evidence suggests that similar changes in propionate production may be achieved by 
modest changes in dietary fibre intake. 
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 Background 
 
The considerable variety of foods in the human diet gives rise to a number of bioactive 
molecules which impact upon health.  One example of a food component that varies 
considerably between diets is dietary fibre which encompasses a range of different non 
digestible carbohydrates (NDC). Dietary fibres have been associated with reduction in the 
risk of type 2 diabetes (T2D), total cholesterol and body mass index (BMI) (de Munter et 
al., 2007, Consortium, 2015).  The mechanisms of these effects may differ between types 
of NDC and have not been fully elucidated.  The inability of the enzymes in the small 
intestine (SI) to digest NDC, and their fermentation by the colonic bacteria to produce 
short chain fatty acids (SCFA) indicate that bacterial products may play a crucial role.  
 
Comprehension of the complex colonic bacterial ecosystem, has accelerated in recent 
years, particularly with the shift away from culture dependent techniques to those that are 
more DNA/RNA based.  For example, Walker’s group considered the effects of pH on 
bacterial populations in vitro using FISH which is dependent on matching DNA or RNA 
with bacterial probes (Walker et al., 2005).  Qin and colleagues used metagenomics to 
investigate the variety of the bacteria in different people (Qin et al., 2010) and David et al 
considered the impact of short term dietary changes on the bacterial populations also using 
metagenomics (David et al., 2014).   
 
This transition in methodology has provided greatly improved knowledge of the types of 
bacteria and enzymes that are present in the colon, but more limited information on their 
active functionality.  Metagenomic analysis provides information on the capacity, but not 
the actual activity of the enzymes present, whereas transcriptomics provides information 
on mRNA expression.  However, as transcriptomics is often performed on stool samples, it 
may be misleading and not representative of events in the proximal colon, where most of 
the metabolism occurs (Kinross et al., 2011, David et al., 2014).  Metabolomics, which can 
be performed with range of possible techniques including NMR and GC-MS, scans the 
metabolites in samples of blood (Wikoff et al., 2009), urine or faeces (Yap et al., 2008) and 
can help unravel the overall impact of different diets on bacterial metabolism.  These 
methods generate large amounts of data which require complex bioinformatics and rely on 
metabolite pattern comparison rather than quantification of fermentation products (Kinross 
et al., 2011). 
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Another approach is targeted metabolomics where specific types of bacterial products are 
studied, a key example being short chain fatty acids (SCFA).  Acetate, propionate, and 
butyrate are the main SCFA produced in the colon.  These are key bacterial metabolites 
which have several possible down-stream roles in human health, including effects on 
colonic enterocytes, liver metabolism, inflammation and energy metabolism (den Besten et 
al., 2013b, Wong et al., 2006).  The main focus of this thesis is on the production of 
propionate.  Propionate has been reported to influence cholesterol production (Wolever et 
al., 1991, den Besten et al., 2013a), gluconeogenesis (De Vadder et al., 2015) and activates 
colonic free fatty acid receptors (FFAR) associated with increased expression of the satiety 
hormones; peptide YY (PYY) and glucagon like peptide-1 (GLP-1) (Le Poul et al., 2003, 
Lin et al., 2012).  Recently, direct administration of high levels of propionate into the colon 
using a synthetic ester vehicle produced many of these effects, and inhibited  body weight 
gain, and reduced plasma cholesterol levels (Chambers et al., 2014).  These studies will be 
discussed in detail later in this introduction. 
 
SCFA production can be differentially manipulated by feeding non-digestible 
carbohydrates (NDC) which differ in their physicochemical properties.  For example, 
glucans containing beta glycosidic bonds had higher propionate production compared with 
those with predominantly alpha bonds (Hughes et al., 2008, Laurentin and Edwards, 2004).  
Due to a lack of mechanistic analysis, the specific drivers leading to the production of 
propionate are not known, making selection of substrates for selectively increasing 
propionate production difficult.  Understanding the determinants of propionate production 
would enable the development of strategies to increase the amount of propionate produced 
in the colon or its release from synthetic vehicles such as that used by Chambers and 
colleagues.  This thesis describes a series of studies to elucidate the factors that increase 
propionate production and strategies for enhancing colonic propionate levels in humans. 
 
 The colonic ecosystem 
The colon was previously considered to be an organ solely used for the absorption of 
water, salts, and nutrients and the formation of stool to remove waste. The colon is 
however much more than this, it is a diverse ecosystem which is linked to many aspects of 
and disturbances in physiology ranging from obesity, (Ley et al., 2006) and immunological 
disorders (Maslowski et al., 2009b) to autism (Mulle et al., 2013). The colonic bacterial 
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ecosystem is also capable of a wide range of metabolic processes many of which remain to 
be fully explored. 
 
The activity and possible influences of the colonic bacterial ecosystem have been studied 
for several decades but research has been hampered by the difficulties in growing many 
fastidiously anaerobic bacteria with complex growth requirements.  However, the field has 
been revolutionised by the development of culture independent techniques with the rapid, 
and now affordable sequencing of bacteria using next generation sequencing (NGS) and 
complex bioinformatics.  This highly detailed analysis, which does not require growth and 
isolation of individual bacteria, has shed intense light onto the complexities of the human 
microbiome. For example, approximately 3 million bacterial genes being identified, (Qin 
et al., 2010) however the active functionality of these bacteria and how their metabolism 
can be modified remain relatively unclear. 
 
In the MetaHIT study of stool samples collected from individuals across Europe, it was 
reported that an individual colon contains approximately 160 out of over 1000 possible 
species of colonic microbiota, of which Bacteroidetes and Firmicutes were the most 
prevalent.  The functions of the genes identified were also assessed and after the 
housekeeping genes , the second key group encoded for enzymes involved in the utilisation 
of NDC (e.g. pectin and sorbitol and glycans) (Qin et al., 2010).  Bacteria differ greatly in 
the enzymes they express to ferment dietary components and their capabilities to use 
different substrates (discussed below) (Martens et al., 2011).  This is beneficial as humans 
are unable to digest NDC using their own enzymes.  Thus there is a symbiotic relationship 
between humans and their commensal bacteria.  The humans gain a range of bioactive 
molecules including SCFA, and extra energy from substrates they cannot salvage 
themselves; the bacteria gain a suitable living environment with a regular source of energy 
and nutrients.   As there are many possible variations in the composition of the microbiome 
of an individual, there are large differences in the composition of the colonic bacterial 
ecosystem between individuals.  Factors such as age, body mass index, and diet have all 
been associated with differences in the bacterial composition.  However, approximately 
90% of the ecosystem is made up of a core set of 57 different bacterial species, suggesting 
that the foundation of the gut microbiome is relatively conserved (Qin et al., 2010) with 
five dominant phyla of bacteria. Of these, the vast majority belong to the phyla 
Bacteroidetes or Firmicutes and the remaining are Actinobacteria, Proteobacteria and 
Verrucobacteria.  At genus level; Bacteroides, Prevotella, Ruminococcus, Lactobacillus, 
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and Bifidobacterium are also highly abundant within the colon and are associated with the 
increased production of SCFA (Eckburg et al., 2005, Arumugam et al., 2011, Qin et al., 
2010, Le Chatelier et al., 2013). 
 
 Fermentation and the production of SCFA 
The colonic microbiota obtains energy from substrates such as NDC and proteins by 
fermenting them to SCFA, branched chain fatty acids (BCFA, isovalerate, isocaproate, 
isoleucine), carbon dioxide, methane, and hydrogen, as well as secondary products such as 
ethanol, succinate, and lactate which can be further utilised by other bacteria for SCFA 
production (Reichardt et al., 2014, Wong et al., 2006). BCFA are isomers of SCFA formed 
by the fermentation of amino acids with valine fermentation producing isobutyrate, leucine 
forming isovalerate as well as isocaproate, and isoleucine forming 2-methylbutyrate 
(Windey et al., 2012). 
 
There are two main types of colonic fermentation; saccharolytic and proteolytic.  
Saccharolytic fermentation is the most common type occurring in the colon (particularly in 
the proximal region), and occurs when there is an abundance of sugars, mostly contained 
within NDC and produces mostly SCFA as reduced products.  Proteolytic fermentation 
occurs mainly in the distal colon when there is a scarcity of sugars for saccharolytic 
fermentation as they have been utilised in the proximal colon.  Proteolytic fermentation of 
proteins, peptides, and glycoproteins leads to the production of BCFA, phenols, and 
amines.  Proteolytic fermentation produces some SCFA, but the majority of acetate, 
propionate, and butyrate is produced by saccharolytic bacteria.  
 
Smith and Macfarlane., (1997) conduced in vitro fermentations of amino acids and 
observed that the fermentation of 10 mmol/l valine fermentation generated 2.9 mmol/l of 
isobutyrate whereas fermentation of 10 mmol/l leucine yielded 1.2 mmol/l of isovalerate 
(Smith and Macfarlane, 1997).  Mortensen et al., (1990) carried out similar analysis and 
found that the fermentation of valine alone (100 mmol/l) generated 23.2 mmol/l of 
isobutyrate, and leucine produced 15.6 mmol/l of isovalerate. In contrast, when 100 
mmol/l of lactulose was fermented low concentrations of BCFA were produced with 4.0 
mmol/l isobutyrate and 1.9 mmol/l of isovalerate which was lower than that of acetate, 
propionate and butyrate (679.2 mmol/l, 93.2 mmol/l, and 27.7 mmol/l). This demonstrates 
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that BCFA production by NDC fermentation is low or that the BCFA are rapidly used by 
the bacteria fermenting the carbohydrate. 
 
  Extent of SCFA production 
SCFA are carboxylic acids consisting of 1 to 6 carbons with acetate (C2), propionate (C3), 
and butyrate (C4) being produced in the highest concentrations by colonic fermentation 
(Figure 1-1).  Less prominent SCFA include; formate (C1), valerate (C5), caproate (C6) 
and the BCFA; isobutyrate (iC4), isovalerate (iC5), and isocaproate (iC6). 
 
 
 
 
 
 
 
 
 
 
 
The majority of SCFA production occurs in the proximal colon and decreases distally. As 
most of the SCFA are rapidly absorbed (95% of production) with absorption rate 
increasing as SCFA concentrations increase, quantification of colonic SCFA production is 
challenging (Wong et al., 2006, Fleming  et al., 1991, Hadjiagapiou et al., 2000, 
Rechkemmer and von Engelhardt, 1988).  The majority of SCFA in the colon (pH range of 
6.7 - 5.4) are in the deprotonated anionic form as SCFA have a pKa of 4.8 (Sellin, 1999, 
Fallingborg et al., 1989). Therefore they are absorbed either by the Na+/ H+ exchanger and 
SCFA-bicarbonate antiporters which can be Na+ dependent or independent (Tyagi et al., 
2002), or transporters, such as the monocarboxylate transporter 1 and SCL5A8 transporters 
(Hadjiagapiou et al., 2000).  In contrast, SCFA in the protonated form (acetic acid) enter 
the colonic epithelial cells by diffusion (Sellin, 1999).   
 
SCFA within the colon can also act as ligands for free fatty acid receptors (FFAR) located 
on the luminal epithelium of the colon, as well activating FFAR located in various sites 
around the body (see Section 1.6.3).  
CH3 – CH2 – CH2– C O O- CH3 – CH2 – C 
O 
O
- 
CH3 – C O 
O
- 
Acetate Propionate Butyrate 
Figure 1-1: The structure of the carboxylic acids; acetate, propionate, and butyrate 
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Direct estimation of the colonic production of SCFA is difficult due to the inaccessibility 
of the proximal colon and rapid absorption of the SCFA. Rectal infusion studies have 
shown that the rate of absorption increases as the chain length decreases so faecal 
concentrations of SCFA are unlikely to represent the actual SCFA produced  (Vogt and 
Wolever, 2003). 
 
This disparity in faecal and caecal SCFA has been shown in studies in rats, where faecal 
SCFA concentrations (umoles/g dry weight) were approximately 80% less than observed 
in the caecum (Edwards and Eastwood, 1992).  Investigations of colonic SCFA are often 
conducted in animals, and two studies have directly measured colonic SCFA in sudden 
death patients (Cummings et al., 1987, Macfarlane et al., 1992). The molar proportions of 
SCFA varied little between different colonic regions, however, SCFA concentration 
reduced along the colon with 26.7 mmol/kg in the proximal colon to 14.2 mmol/kg at the 
distal colon (Cummings et al., 1987).  In the later study from the same group (Macfarlane 
et al., 1992) the colonic SCFA were compared between a methanogenic sudden death 
victim and another who did not produce methane.  The SCFA in the caecum were 8 fold 
higher than in the distal colon.  In the methanogenic colon, the methanogenic bacteria 
increased towards the distal colon, and in the non-methanogenic colon, they were replaced 
with sulphate reducing bacteria.  Thus the faecal samples may have much less SCFA and a 
different bacterial profile to proximal colon even in humans, due to differences in 
absorption and substrate availability. 
 
Cummings et al., (1987) estimated that the colonic concentration of SCFA is 
approximately 80-150mmol/kg with acetate, propionate, and butyrate being produced in 
the approximate ratio; 60:20:20 although this can be altered with dietary modifications 
(Cummings et al., 1987).  Modifications in the ratio of SCFA have been observed in vitro 
by Laurentin and Edwards., (2004) where pyrodextrinised starch increased the proportion 
of propionate at the expense of acetate and the feeding trial by Vogt et al., (2004) where 
consumption of 25g rhamnose increased serum proportions of propionate.   
 
Recent measurements of faecal SCFA concentrations in adults confirm a similar mean 
ratio, but indicate significant variation between individuals and studies (Verbeke et al., 
2015).  After absorption in the colon, the SCFA are transported to the liver along the portal 
vein where portal blood concentrations of 262.8 μM acetate and 30 μM of propionate and 
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butyrate have been observed (Bloemen et al., 2009).  Acetate is not preferentially used in 
the gut or liver and is found at the highest concentrations in the peripheral blood of 70-
150μM (compared to propionate and butyrate).  In contrast, propionate is removed by the 
liver, where it is involved in functions such as gluconeogenesis (see below), resulting in 
approximately 4-6 μM in the peripheral blood.  Butyrate in comparison is largely utilised 
as a fuel at the colonic epithelium and also undergoes uptake in the liver, resulting in 
peripheral concentrations of approximately 2-4 μM (Cummings et al., 1987, Bloemen et 
al., 2009).   
 
 SCFA functionality 
 Luminal functions 
SCFA have a plethora of roles within the colonic lumen before undergoing rapid 
absorption. SCFA are weak acids with a pKa of ~4.8, and increased concentrations reduce 
the pH of the lumen. In a study where healthy volunteers ingested a pH measuring capsule  
the distal small intestine had a pH of ~7, the caecum, ascending and transverse colon had a 
pH of ~5.6, and the pH rose to 6.5 in the descending and sigmoid colon (Fallingborg et al., 
1989). However, these subjects were fasted and so this may not take into account SCFA 
production, which would promote more acidic colonic pH (Fallingborg et al., 1989).  A 
reduced luminal pH has been shown to be protective against pathogenic bacteria such as 
Clostridium perfringens which are unable to survive at a pH below pH 5.0 (Wang and 
Gibson, 1993). 
 
SCFA have also been shown to have potential beneficial roles in the inhibition of 
secondary bile acid formation.  Fadden et al., (1997), conducted batch fermentations with 
lactulose and wheat bran and assessed impact on concentrations of deoxycholic acid and 
lithocholic acids, both of which are formed by the 7α-dehydroxylation of primary bile 
acids. Fermentation of lactulose reduced the pH to less than 5.5 preventing the formation 
of the secondary bile acids, whereas this did not occur with wheat bran which was not well 
fermented (Fadden et al., 1997). Christl et al., (1995) assessed the effect of starch 
fermentation on the same secondary products, but controlled the pH at 6 or 7 (Christl et al., 
1995). Here, fermentation of starch at pH 6 led to reduced concentrations of deoxycholic 
(35%) and lithocholic acid (31%) compared with fermentation at pH 7 for 24 hours. 
During fermentation of starch, SCFA concentrations increased compared to the control 
9 
 
 
(Christl et al., 1995).  This suggests that the reduced pH occurring by starch fermentation 
prevented the production of secondary bile acids via the inhibition of the bacterial enzyme, 
7α-dehydroxylase, which is present in bacteria such as Clostridial cluster XVIa (Hofmann, 
1999).  Populations of Clostridial cluster XVIa have been shown to be affected by diet.  
For example, in a human feeding trial where African Americans consumed an ‘African’ 
diet (low fat- high fibre), and Africans consumed an ‘American’ diet (high fat- low fibre) 
for 2 weeks.  The switch from an African to an ‘American’ diet, was associated with 
increased prevalence of Clostridial cluster XVIa bacteria, a 400% increase in secondary 
bile acid formation and increases in bile acid conjugators, deoxycholic and lithocholic 
acid.  This high fibre diet, like in the study of Christl et al., (1995), was also associated 
with increased SCFA production.  This is further evidence that reductions in secondary 
bile acid synthesis are associated with increased SCFA production, thus indicating the 
impact of diet on bile acid production (O'Keefe et al., 2015). 
 
SCFA also alter colonic motility with acetate, propionate and butyrate having slightly 
different effects. Squires et al., (1992) used colonic explants from the rat and infused with 
them with 100 mM of a ‘SCFA cocktail’ of acetate, propionate and butyrate, or varying 
concentrations of each SCFA alone (10 mM and 100 mM). Contractile motility was 
reduced throughout the colon with the SCFA cocktail. Motility of the proximal and middle 
colon were also reduced when 100mM of the individual SCFA were infused, for example 
motility in the proximal and distal colon was 17.3 and 5.0 contractions per 20 minutes 
whereas for the control this was 37.2 and 25.8 contractions per 20 minutes.  These effects 
were dose dependent  and butyrate was more effective in the caecum whereas acetate and 
propionate had greater effects than butyrate in the more distal colon (Squires et al., 1992).  
 
A more recent investigation of guinea pig colon perfused with 0.1 ml / min buffer 
containing 10 to 30 mM of acetate, propionate or butyrate reported similar results. The 
SCFA had different effects of motility in the colon where butyrate dose dependently 
increased the number of contractile propagations (indicating propulsion), but reduced the 
number of non-propagating contractions (indicating mixing). In contrast propionate and to 
a lesser extent acetate reduced contractile propagations but increased the number of non-
propagating contractions. This indicates that butyrate may be associated with propulsion 
and propionate is involved in mixing within the colon (Hurst et al., 2014). SCFA also 
reduced motility in the electrically stimulated rat distal colon, and the guinea pig terminal 
ileum which was bathed in a solution of acetate, propionate or butyrate.  SCFA dose 
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dependently reduced the contractions of the rat distal colon (0.3 mM to 100 mM) and 
concentrations of 100 mM reduced peristalsis of the guinea pig ileum. To test if these 
effects were associated with the colonic receptors FFAR2, the distal colon of FFAR2 
knock out mice was electrically stimulated in the presence of SCFA.  Colonic motility was 
not altered in knock out mice, indicating that the role of SCFA on gut motility is 
independent of the receptor FFAR2 and reduces motility by other mechanisms within the 
colonic lumen (Dass et al., 2007).  
 
This is contradictory to the study by Jouët et al., (2013) in humans where the effect of 
SCFA infusion on motility in the colon was measured with 7 manometric channels 
connected to pressure transducers and a barostatic bag which was swallowed by healthy 
individuals.  Individuals were given an infusion containing 75 mM of acetate, propionate, 
and butyrate at pH 7 and pH 4.5 directly into the colon, as well as saline at both pHs and 
observed no effect on colonic motility. However, there was no reported preparation of the 
bowel, or prior fasting, therefore it is possible that there may have been existing colonic 
SCFA prior to infusion, masking any effects (Jouet et al., 2013).  This indicates that it may 
be difficult to extrapolate from the controlled in vitro animal gut assessment to the in vivo 
response in humans due to the high concentrations used in vitro and the reduced control of 
human studies. 
 
Individually, SCFA have an assortment of functions occurring in the lumen, within the 
colonic epithelial cell layer, as well as post absorption. The individual roles of the SCFA 
are discussed below. 
 
 Acetate 
Approximately 60% of SCFA produced is acetate, which has little uptake in the liver. The 
remainder of the acetate produced enters the periphery, and acetate is the only SCFA that 
reaches the systemic blood in easily measurable concentrations (Bloemen et al., 2009).  
 
When in the cell cytoplasm acetate, via acetyl- CoA, can be used for fatty acid (FA) and 
cholesterol synthesis.  Acetate is the preferential substrate for lipogenesis in the 
colonocytes (compared to butyrate) (Zambell et al., 2003). Rectal infusion studies in 
healthy adults have also observed inhibition of acetate incorporation into FA in the 
presence of propionate, where 6mM Na-propionate led to a 30% reduction in plasma FA 
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concentrations when compared to acetate without propionate infusion (Wolever et al., 
1995).  Wolever and colleagues used rectal infusion studies in healthy individuals and 
demonstrated that propionate mediated suppression of cholesterol synthesis occurs as a 
result of the inhibition of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA 
reductase) (Wolever et al., 1991, Wolever et al., 1995).  The ability of propionate to 
oppose the effect of acetate was also demonstrated in vitro using isolated rat hepatocytes, 
in which the effect of propionate dose (0.1-25 mM) on 14C acetate, 3H2O and 1-14C 
Mevalonate (marker of the HMG-CoA pathway) mediated production of FA and 
cholesterol. Cholesterol synthesis was dose dependently reduced from 2.5mM for all 
precursors tested. In contrast, FA synthesis via acetate was only dose dependently 
decreased by propionate (2.5 mM) FA synthesis by 3H2O and 1-14C Mevalonate were not 
altered (Wright et al., 1990).  These studies therefore indicate the potential importance of 
the acetate to propionate ratio on the regulation of FA and cholesterol synthesis. 
 
Acetate also has a selection of potential different tissue specific effects including being 
able to cross the blood-brain barrier to reach the hippocampus. This was seen in the 
investigation by Frost et al., (2014) where an intraperitoneal injection of 11C- acetate 
stimulated the arcuate nucleus and labelled acetate accumulated in the hypothalamus, but 
not in other areas of the brain. Within this study it was also observed that pro-
opiomelanocortin expression (anorectic hormone) increased and agouti-related peptide 
expression (orexigenic) decreased which would indicate that acetate could potentially have 
FFAR2 independent effects on satiety (see below)(Frost et al., 2014).   
 
Acetate is also involved in the inhibition of lipolysis in mouse adipocytes, and is possibly 
due to the activation of FFAR2 as this was attenuated in an FFAR3 knock out mouse 
model (Ge et al., 2008). This is interesting as FFAR3, which is closely related to FFAR2 
(see below), is also activated by acetate but has been shown to increase expression of 
leptin (Xiong et al., 2004) which is associated with increased lipolysis (Zeng et al., 2015).  
Acetate is also implicated in beta-cell function where in the recent study by Tang et al., 
(2015) acetate dose dependently (0.1-1 mM) inhibited insulin secretion occurring after 
GLP-1 exposure. These effects were not present with beta-cells from FFAR2-/-FFAR3-/- 
knockout mice, suggesting a role for these receptors in these acetate mediated roles in beta-
cell function (Tang et al., 2015). 
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 Propionate 
Approximately 90% or more of propionate reaching the liver via the portal vein is utilised 
in the liver, with the remainder reaching the peripheral tissues (Peters et al., 1992, 
Bloemen et al., 2009). As discussed previously, propionate inhibits the uptake into the liver 
of colonic acetate for the production of cholesterol, reducing the rate of cholesterol 
synthesis. Propionate and butyrate are also involved in the regulation of insulin-stimulated 
and basal lipogenesis. Heimann et al., (2015) demonstrated that propionate and butyrate 
inhibited basal, and insulin mediated lipogenesis, as well as increasing insulin sensitivity 
and basal glucose uptake in rat adipocytes. The insulin mediated effects were detected with 
1 mM of propionate whereas for basal effects 10 mM of propionate was required, 
suggesting increased sensitivity to propionate in the presence of insulin (Heimann et al., 
2015). 
 
Propionate, as well as regulating cholesterol and lipid production, can contribute carbon to 
the de novo synthesis of glucose - gluconeogenesis. Gluconeogenesis occurs once 
propionate enters the citric acid cycle as succinyl-CoA (Wiltrout and Satter, 1972, den 
Besten et al., 2013a) and is particularly important in ruminants that obtain a high 
proportion of glucose by hepatic gluconeogenesis. For example, in lactating cows 
approximately 45% of all glucose was produced directly from propionate (Wiltrout and 
Satter, 1972).  Hepatic and intestinal gluconeogenesis (IGN) are also important in man for 
generating glucose in the fasted state, or during diets that are low in carbohydrate, and 
occurs when propionate is converted to succinate (Nuttall et al., 2008, Veldhorst et al., 
2009).  Unlike hepatic gluconeogenesis, IGN is linked to the activation of FFAR3.  FFAR3 
activation generates the release of vasoactive intestinal peptide (VIP), a neurotransmitter 
involved in signalling from gut epithelial cells to the brain. This then leads to the activation 
of glucose-6-phosphatase, resulting in the de novo production of glucose (De Vadder et al., 
2015).  Colonic butyrate is also involved in gluconeogenesis by releasing cAMP, 
activating the expression of IGN genes, (propionate does this via FFAR3) which then leads 
to IGN, with propionate being utilised as a substrate (De Vadder et al., 2015). 
 
IGN and the downstream metabolic effects have also been investigated in IGN knockout 
mice (I-G6pc-/- mice).  De Vadder et al., (2015) fed these mice a variety of diets and 
observed a reduced tolerance of glucose and insulin compared to wild type controls, 
particularly after a propionate enriched diet. It was also observed that these knock-out mice 
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had increased weight gain compared to the wild type, although there was no change in 
food consumption (De Vadder et al., 2015).  IGN was also observed to have an effect on 
weight gain in an earlier investigation by De Vadder et al., (2014) where I-G6pc-/- and wild 
type mice were fed a high fat/high sugar diet with or without fructooligosaccharide (FOS, a 
fermentable carbohydrate). It was observed that the I-G6pc-/- mice had greater body weight 
gain and reduced glucose clearance compared to the wild type mice after feeding of both 
diets (De Vadder et al., 2014).  Similar effects were also observed by Penhoat et al., (2011) 
who fed the same knock-out mouse model (with IGN inhibition) a protein enriched diet, 
and observed increased food intake, and decreased body weight compared to wild type 
mice (Penhoat et al., 2011).  This indicates that IGN may play a role in the reduction of 
weight gain and increased glucose tolerance that has been identified after consumption of 
NDC and the down-stream fermentation metabolites that are produced (De Vadder et al., 
2014, De Vadder et al., 2015). 
 
Propionate has been shown to prevent tumorigenesis in vitro with BaF3 cancerous cells 
which are present in the liver. Propionate dose dependently reduced the proliferation of 
these cells (log-6 to log-2 M propionate).  This also occurred with butyrate and to a lesser 
extent acetate (Bindels et al., 2012).  Propionate also has roles in the regulation of the cell 
cycle acting as a histone deacetylate inhibitor (HDACi), but this occurs more with butyrate  
(Hinnebusch et al., 2002). This is discussed below in section 1.5.4. 
 
 Propionic acidaemia 
Although propionate is generally considered as advantageous, for some humans this is not 
the case as they are unable to metabolise propionate. This inability to metabolise 
propionate is caused by the disorder known as propionic acidaemia (PA).  PA is an 
autosomal recessive disorder where the enzyme propionyl-CoA carboxylase (PCC) is 
absent, or does not function.  PCC converts propionyl-CoA to methylmalonyl-CoA in the 
pathway leading to the citric acid cycle.  PCC deficiency prevents individuals with PA 
from utilising BCFA, cholesterol side chains, some amino acids, and odd chain fatty acids, 
such as propionate leading to accumulation of propionic acid in all organs (Baumgartner et 
al., 2014, Grunert et al., 2013).  Globally, PA effects 1:50000 to 1:100000 individuals, 
although this is higher in areas with a higher prevalence of incest (Zayed, 2015).  PA is 
often diagnosed within the first week of life and is associated with neurological deficits, 
such as low IQ and developmental delay, gastrointestinal issues, such as vomiting and 
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ketoacidosis, cardiomyopathy, anaemia, and failure to thrive.  Treatment for this disorder 
is the consumption of a low protein diet, L-carnitine, and antibiotics to reduce the gut 
bacteria activity (Zayed, 2015, Baumgartner et al., 2014, Grunert et al., 2013). 
 
 Butyrate 
Butyrate is the primary energy source in the colon, where in vitro assessment has 
demonstrated that butyrate provides up to 70-80% of the energy consumed by the 
colonocytes (Roediger, 1980).  Butyrate has several actions in the turnover of colonic cells, 
many of which are paradoxical.  The butyrate paradox was partially explained within the 
study by Belcheva et al., (2014) where mice predisposed to colonic polyps and cancer were 
fed a high or a low carbohydrate diet. Here, low concentrations of butyrate increased 
cellular proliferation, and at high concentrations, butyrate did not increase cell proliferation 
(Belcheva et al., 2014).  The regulatory effects of butyrate are likely due to the ability to 
act as an HDACi of which it has the highest propensity of all the SCFA (Waldecker et al., 
2008a).  Hinnebusch et al., (2002) observed anti-proliferative effects of propionate and 
butyrate by inducing cell cycle arrest via the activation of p21 in cells from the HT-29 
cancerous cell line, although this translated to increased apoptosis only after butyrate 
exposure, not propionate exposure (Hinnebusch et al., 2002).   
 
Butyrate has immunoregulatory functions analogous with its role as an HDACi, for 
example Aoyama et al., (2010) observed that 4 mM of butyrate caused neutrophil 
apoptosis (Aoyama et al., 2010).  Butyrate, as well as propionate is connected with 
regulation of the immune response where it induces the production of regulatory T-cells by 
upregulating FOXP3 from dendritic cells (Furusawa et al., 2013, Arpaia et al., 2013). This 
role of butyrate has also been observed where administration reduces inflammatory 
markers in mouse models of colitis and in the release of regulatory T-cells after the 
exposure to lipopolysaccharides (LPS) (Arpaia et al., 2013). 
 
Propionate and butyrate influence immunity and cellular proliferation independently of 
their role as an HDACi. When an inulin type fructan was fed to leukemic mice for 13 days, 
reduced expression of proinflammatory cytokines and chemokines such as IL-4, IL-8, and 
MCP-1 compared to the leukemic mouse on a standard diet was observed.  Leukemic cells 
from these mice were also exposed to varying concentrations of acetate, propionate, and 
butyrate. This led to a dose dependent decrease in hepatic cell proliferation occurred via 
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free fatty acid receptor 2 (FFAR2) activation by propionate and butyrate (Bindels et al., 
2012). These studies highlight the complexities regarding the regulatory roles of 
propionate and butyrate that occur based on their ability to function as a HDACi as well as 
their ability to activate FFAR2/3 (see below). 
 
 SCFA receptors in the colon 
SCFA have recently been shown to act as agonists of a selection of de-orphanized G 
Protein coupled receptors (GPCR). There are a variety of GPCR in the colon; these include 
GPR109A, GPR120, GPR40, GPR41, GPR43, and olfactory receptor 78 (Olfr78). This 
functionality of these receptors is discussed below. 
 
 Medium and long chain receptors 
Medium and long chain fatty acids are the natural ligands of free fatty acid receptor 1 
(FFAR1; also known as GPR40)  which potentially plays a role in satiety and glucose 
homeostasis via the expression of GLP-1 (Habib et al., 2013). 
 
FFAR4 (GPR120) is activated by long chain fatty acids (13-21 carbons) and is expressed 
on a variety of cell types including: adipose, lung, and the colonic epithelium (Hirasawa et 
al., 2005).  FFAR4 is observed to be up-regulated in obesity, high fat diets and may have 
an effect on appetite regulation and glucose homeostasis (Cornall et al., 2011, Habib et al., 
2013), as well as increasing GLP-1 expression in mice (Habib et al., 2013, Hirasawa et al., 
2005). 
 
 GPR109A 
GPR109A is located on the colonic epithelium, particularly in the distal regions of the 
colon, adipose tissue, macrophages, and dendritic cells.  This receptor is activated by 
niacin (Vitamin B3) and butyrate, and has effects within the colon (Thangaraju et al., 2009, 
Singh et al., 2014).  In colon cancer GPR109A is downregulated, although transfection of 
GPR109A to the human colon cancer cell line KM12L4 has shown that the activation of 
the receptor leads to apoptosis of these cancerous cells.  This occurred with activation by 
both niacin, and butyrate, although this was more apparent with butyrate.  Although 
butyrate is an HDACi, the observed apoptosis was postulated to be as a result of blockage 
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of the NFĸB pathway of inflammation and not due to changes in acetylation (Thangaraju et 
al., 2009).  GPR109A also has butyrate-mediated effects on inflammation where it has 
been identified as being protective during colonic inflammation (Singh et al., 2014). 
 
 GPR43 (FFAR2) and GPR41 (FFAR3) 
The SCFA receptors: GPR43 and GPR41 (FFAR2 and FFAR3) are of interest as they have 
roles in the mediation of satiety hormones, inflammation, and glucose homeostasis, all of 
which are associated with obesity.  SCFA are the natural ligands for these receptors, with 
propionate able to activated FFAR2 with an EC50 of 290 μM and FFAR3 with an EC50 of 
127 μM (Le Poul et al., 2003, Brown et al., 2003).  FFAR2 and FFAR3 are only 39% 
similar but differ in their modes of action by having different pathways of activation (Le 
Poul et al., 2003, Brown et al., 2003). 
 
All of the SCFA have the ability to activate these receptors with high ligand affinity 
however; the extent differs for each SCFA.  Propionate has the highest affinity for both, 
GPR43 (FFAR2) and GPR41 (FFAR3).  Ligand binding abilities of acetate, propionate, 
and butyrate for GPR43 (FFAR2) are in the order; propionate > acetate = butyrate, 
whereas for GPR41 (FFAR3) ligand binding affinities are in the order; propionate = 
butyrate > acetate (Le Poul et al., 2003, Nilsson et al., 2003, Brown et al., 2003). 
 
FFAR2 and FFAR3 are located on a large selection of cells and tissues but their tissue 
distribution around the body is not equal (Le Poul et al., 2003).  Both receptors are widely 
expressed throughout the body. They have been identified in the spleen, bone marrow, 
colon (Kaji et al., 2011), adipose, breast tissues (Le Poul et al., 2003) and pancreatic cells 
(Tang et al., 2015).  Interestingly, these receptors are also expressed on immune cells such 
as peripheral blood mononuclear cells ([PBMC], monocytes, macrophages, B-
lymphocytes) and polymorphonuclear cells ([PMN], mast cells, eosinophils, leukocytes 
and neutrophils) (Al-Lahham et al., 2012, Le Poul et al., 2003).  Both receptors are 
expressed on these cells, however FFAR2 is associated with greater expression on immune 
cells compared with FFAR3 (Brown et al., 2003, Nilsson et al., 2003, Kaji et al., 2011).  
As these receptors are expressed on the enteroendocrine L-cells of the colon, this allows 
the SCFA to have receptor mediated effects prior to being absorbed from the lumen (Fig 1-
2) (Karaki et al., 2008). 
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As well as activation by different ligands, in different locations within the body, the 
expression of these receptors can be manipulated by the diet and body mass. This occurs as 
dietary fibre consumption increases SCFA production, and different NDCs generate 
different proportions of SCFA.  For example, FOS consumption is associated with 
increased SCFA production, leading to increased FFAR2 expression. This was 
demonstrated in the ex vivo experiment by Kaji et al., (2011) where a 5% FOS diet was fed 
to mice for 28 days. The consumption of FOS increased the density of FFAR2 by 300% in 
the proximal colon and 50% in the distal colon of the mice compared to the control. This 
indicated that that increased consumption of NDC increases the number of cells not only in 
the proximal, but also distal colon leading to the release of GLP-1.  Assessment of the 
human colon also identified that the sigmoid colon had the highest densities of cells 
expressing FFAR2 and GLP-1 (Kaji et al., 2011).  This suggests that selecting slowly 
fermentable substrates may be advantageous for activation of the more distally located 
receptors.  It has also been observed that obese individuals have an increased expression of 
FFAR3 compared to lean controls. This is likely to be due to reduced methylation of the 
FFAR3 gene thus increasing gene expression, and as a result receptor expression (Remely 
et al., 2014).  These receptors are of particular interest due to their down-stream effects.  
The signalling and transduction pathways of FFAR2 are better understood than those of 
Figure 1-2: Simplistic diagram of a colonic crypt 
The majority of the cells in the colonic crypt are enterocytes, and butyrate is their source of energy. 
Entero-endocrine L cells are less common (~1% of the cells in the colon) and more sporadically 
located within the colonic crypt. Within these L –cells, the receptors FFAR2 and FFAR3 are located 
and are involved in the expression of satiety hormones such as; GLP-1 and PYY (Karaki et al., 2008, 
Tolhurst et al., 2012)  
Enterocyte 
 
Entero-endocrine L cells    
 
Intestinal stem cell 
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FFAR3 (Sleeth et al., 2010), and both receptors have a variety of actions.  In mouse 
models with FFAR2, FFAR3 or both receptor knockouts (Tang et al., 2015), different 
effects were seen.  For example FFAR2-/- had no effect on insulin secretion with 1M 
acetate and FFAR3-/-  showed slight attenuation in insulin secretion compared to the wild 
type, whereas the double knock out mice had no insulin secretion compared to wild type 
and similar effects were also seen with blood glucose (Tang et al., 2015).  This suggests 
that these receptors may have synergistic roles, at either a genetic or a protein level and 
that in single knock out models the other receptor may ‘compensate’ for the other (Lin et 
al., 2012, Tang et al., 2015).  Some of the functions of FFAR 2/3 activation are discussed 
below (Figure 1-3). 
 
 
 
 
Figure 1-3: Key roles of FFAR2 and FFAR3. 
Common and differential roles of stimulation of the FFAR. (Kaji et al., 2011, Lin et al., 2012, Maslowski et 
al., 2009b, De Vadder et al., 2014, Byrne et al., 2015, Xiong et al., 2004). 
 
 Inflammation 
FFAR2 and FFAR3 are involved in the regulation of inflammation and the immune 
response where much of the mechanistic insight has been derived from knockout mouse 
models.  Maslowski et al., (2009) determined in FFAR2-/- mice that after consumption of 
acetate, these mice had increased inflammatory markers with onset of allergic airway 
disease and inflammatory arthritis compared to the wild type group. These effects were 
attributed to FFAR2 located on neutrophils as there was a reduced effect of acetate on 
FFAR2/ GPR43
Neutrophil chemotaxis
Immune regulation
FFAR3/ GPR41
Stimulation of the 
sympathetic nervous
system
Intestinal gluconeogenesis
PYY 
GLP-1 
Leptin 
Inflammation 
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neutrophil count, cytokine, and chemokine response in response to an inflammatory 
challenge on FFAR2-/- neutrophils but not FFAR2+/+  neutrophils (Maslowski et al., 2009a). 
This role of these receptors in inflammation is also supported by the investigation by Kim 
et al., (2013) where feeding acetate to wild type mice increased neutrophil counts after 
inducing inflammatory stress compared to those without acetate.  An appropriate immune 
response (neutrophil infiltration, inflammatory cytokines) after exposure to the pathogenic 
bacteria Citrobacter rodentium and with an ethanol challenge occurred with wild type 
mice; however, this did not occur in FFAR2-/- and FFAR3-/- mice.  These effects indicate 
that the presence of SCFA and colonic receptors are required to deal with the initial onset 
of inflammation as reduced neutrophil frequency and cytokine presence was observed in 
the knock out mice post infection.  This suggests that the immune roles of these receptors 
are not restricted to immune cells but may be relevant during the onset of inflammation 
within the colon (Kim et al., 2013).  The activation of FFAR2 and FFAR3 by acetate and 
propionate may also have led to the onset of downstream inflammatory signalling 
pathways MEK/ERK, and p38 MAPK after infection by C. rodentium.  This is as these 
SCFA, and propionate to a greater extent, led to approximately 30% of colonic epithelial 
cells expressing p-ERK in wild type but not in knock out mice, indicating that the SCFAs 
and receptors may have immunoregulatory roles in the colon (Kim et al., 2013).  Exposure 
to propionate, butyrate, and to a lesser extent, acetate ex vivo in the colonic cells of mice 
with induced colonic inflammation has also been shown to reduce inflammation via 
inhibition of NFκB and reduced production of proinflammatory cytokines such as IL-6 and 
TNF-α by neutrophils. Within the same study the human colonic cell line COLO320DM 
was exposed to LPS where propionate and butyrate, and to a lesser extent acetate reduced 
TNF-α production and increased Il-8 production (Tedelind et al., 2007).  The observation 
that topical administration of butyrate in individuals with ulcerative colitis reduced 
inflammation (albeit mildly), suggests that SCFA via FFAR2 and FFAR3  may have 
immunoregulatory roles within the colon and have the ability to reduce generalised 
inflammation such as that caused by IBD (Vernia et al., 1995). 
 
 Anorexigenic gut hormones 
FFAR2 and FFAR3 may be involved in the satiety response,  and have been shown to be 
central to the release of PYY (Karaki et al., 2008), and GLP-1 in mouse models (Lin et al., 
2012).  Investigations using FFAR2-/- and FFAR3-/- mice (single knock out) showed that 
GLP-1 expression was reduced with stimulation of acetate (100%) and propionate (50%) 
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in FFAR3-/-  mice compared with wild type mice (Tolhurst et al., 2012).  This effect was 
more prevalent in FFAR2-/- mice than FFAR3-/- mice indicating that FFAR2 is the main 
receptor mediating GLP-1 release in the colon (Tolhurst et al., 2012).  These results are 
similar to those of Psichas et al., (2014) who observed that propionate injections dose 
dependently increased GLP-1 and PYY in wild type mice, but this was attenuated in 
FFAR2-/- mice (Psichas et al., 2014). Samuel et al., (2008) also identified reduced PYY 
expression in FFAR3-/- mice compared to wild type mice, although this required bacterial 
colonisation to occur.  Therefore, this indicates that these effects were likely as a result of 
SCFA produced by bacterial fermentation of their polysaccharide rich diet.  Paradoxically, 
FFAR3-/- mice had reduced expression of leptin and reduced weight gain compared to wild 
type mice (Samuel et al., 2008).  This also suggests that the production of SCFA by 
bacterial fermentation increases satiety via the receptor mediated release of PYY and GLP-
1. This is also supported by evidence from a study where propionate was directly 
administered to the colon in a human feeding trial using an inulin -propionate ester which 
also led to increased concentrations of PYY and GLP-1 (Chambers et al., 2014). 
 
 Olfr78 
Olfr78 is an olfactory receptor activated by acetate and propionate (Pluznick et al., 2013). 
Olfr78 is expressed in a number of different systems such as the brain, blood vessels, 
kidney and colon.  Within the colon, Olfr78 expression increases distally and is expressed 
on colonic enteroendocrine L-cells also expressing PYY, GLP-1, FFAR2, and FFAR3.  
For activation of these receptors high concentrations of propionate are required, for 
example the EC50 of FFAR3 is 11 μM and 900 μM for Olfr78.  This along with their 
expression on L-cells led to the hypothesis of Fleischer et al., (2015) that they may play a 
role in the regulation of satiety hormones, PYY and GLP-1, this however has not been 
tested (Fleischer et al., 2015). 
 
Olfr78 and FFAR3 have opposing effects. Using different knockout mice Pliznick et al., 
(2013) observed antagonistic effects of Olfr78 on FFAR3 mediated blood pressure 
reduction. In wild type mice, administration of 0-50 mM propionate dose dependently 
decreased blood pressure by 30 mmHg, and this effect remained in Olfr78-/- mice. 
However, when FFAR3-/- mice were exposed to 10 mM propionate, blood pressure 
increased significantly compared to the wild type (Pluznick et al., 2013).  Although little is 
known about Olfr78, this suggests that they may possibly have regulatory effects on the 
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actions of SCFA. It would however be interesting to assess how the release of PYY and 
GLP-1 is effected as a result of Olfr78 of which to my knowledge has not been tested. 
 
 Satiety 
Satiation is the feeling of fullness that results in the termination of a meal and satiety is the 
feeling of fullness experienced after a meal (postprandial feelings) which delay the 
consumption of the next meal (Duca and Covasa, 2012). Feelings of satiety are stimulated 
throughout the gut through receptor mediated monitoring of luminal and circulating 
nutrients, leading to production of anorexigenic (enhances feelings of satiety) or orexigenic 
(increase food intake) hormones. Figure 1-4 outlines the effects and process of food 
consumption throughout the gut. Table 1-1 outlines some of the effects of hormones 
produced during feeding or fasting on satiety and energy intake.  Some of these effects on 
feeding are short term, affecting gastric emptying and the initiation or termination of a 
meal, whereas others are long term, altering the intake of subsequent meals (Wren et al., 
2001, Batterham et al., 2003b, Edholm et al., 2010). 
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Mouth 
• Amylase, lipase 
• Chewing- particle size 
• Mechanoreceptors 
• Chemoreceptors 
• Solid or liquid 
Stomach 
• Pepsin (protein 
breakdown) 
• Low pH (1-4) 
• Grinding motility 
• Distension signals sent to 
brain via the vagus nerve 
• Controlled gastric 
emptying determined by 
consistency of meal/ liquid 
to solid proportions 
•  Satiety hormones: 
• Ghrelin 
• Leptin 
• Viscosity 
Small intestine (SI) 
Duodenum 
• Digestion by pancreatic 
enzymes (e.g amylase, 
lipase trypsin) 
• Viscosity- slows mixing/ 
digestion/ absorption  
• Absorption of nutrients  
• CCK 
Distal SI 
• PYY 
• GLP-1 
 
Colon 
• Bacterial 
fermentation – 
SCFA and gases 
• Distention  
• Low pH (4-7) 
• PYY 
Figure 1-4: Events in the gastrointestinal tract which may influence digestion and 
satiety. 
CCK – Cholecystokinin, PYY – Peptide YY, GLP-1- Glucagon- like peptide-1, OXM – Oxyntomodulin 
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Table 1-1- Gastrointestinal hormones associated with the regulation of energy intake 
Hormone Effects Location Reference 
Ghrelin x Increased under fasting conditions 
x Enhances food intake 
x Concentrations increase after calorie 
restricted weight loss but not after Roux-
En-Y gastric bypass 
x Concentrations reciprocal to those of leptin 
x Short term effects on satiety 
x Decreased by OXM 
Stomach (Wren et al., 
2001), 
 
(Cummings et 
al., 2002) 
Leptin x Increased by high body fat (obesity) 
x Weight loss by calorie restriction decreases 
concentrations 
x Increased with meal and insulin production 
x Concentrations are reciprocal to those of 
ghrelin 
x Long term effects on satiety 
x  
Adipose 
tissue,  
Stomach,  
(Xiong et al., 
2004, Lin et al., 
2012)  
 
(Weigle et al., 
2003) 
CCK x Increased 15 minutes after feeding, 
stimulates pancreatic secretion 
x Reduces energy intake and duration of 
feeding, stimulates gall bladder contraction 
x Slows on gastric emptying and also acts 
centrally in hypothalamus 
x Short term effects on satiety 
 
Small 
intestine 
(Mathus-
Vliegen and de 
Groot, 2013, 
Kissileff et al., 
1981). 
PP x Increased after feeding 
x Reduces energy intake and increases satiety 
short and longer term (12 hours) 
 
Pancreas (Batterham et 
al., 2003b) 
PYY x Reduces energy intake and enhances satiety 
x Short term, and long term effects 
x Reduces ghrelin concentrations 
x Basal concentrations are reduced in obesity 
 
Distal SI 
and colonic 
L-cells, Co-
located 
with GLP-1 
(Habib et al., 
2013, 
Batterham et 
al., 2003a) 
GLP-1 x Reduces energy intake 
x Enhances satiety 
x Reduced gastric emptying 
Distal SI 
and colonic 
L-cells, Co-
located 
with PYY 
(Habib et al., 
2013, Verdich 
et al., 2001, 
Edholm et al., 
2010) 
OXM x Reduces energy intake 
x Short term effects 
x Decreases concentrations of ghrelin 
Intestinal 
cells 
(Cohen et al., 
2003) 
CCK – Cholecystokinin, PP – Pancreatic polypeptide, PYY – Peptide YY, GLP-1- Glucagon- like 
peptide-1, OXM – Oxyntomodulin 
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 Dietary fibre 
One of the main influences on SCFA production is the colonic fermentation of NDC which 
are nearly all encompassed in the most recent definition of dietary fibre, agreed in the 
Codex Alimentarius in 2009 (Moller, 2011) is: 
“Dietary fibre denotes carbohydrate polymers1 with 10 or more monomeric Units2, 
which are not hydrolysed by the endogenous enzymes in the small intestine of humans 
and belong to the following categories: 
- Edible carbohydrate polymers naturally occurring in the food consumed.   
- Carbohydrate polymers, which have been obtained from food raw material by 
physical, enzymatic or chemical means and which have been shown to have a 
physiological benefit to health, as demonstrated by generally accepted scientific 
evidence to competent authorities. 
- Synthetic carbohydrate polymers that have been shown to have a physiological 
benefit to health, as demonstrated by generally accepted scientific evidence to 
competent authorities. 
NOTES: 
1 Includes also lignin and other compounds if quantified by AOAC 991.43. 
2 Decision on whether to include carbohydrates with a degree of polymerization from 
DP 3 to 9 should be left to national authorities”. 
 
Epidemiological evidence associates dietary fibre with improved health Table 1-2. The 
Scientific Advisory Committee on Nutrition (SACN) recommend that adults should 
consume 30 g of dietary fibre per day (SACN., 2015).  Consumption of fibre in the British 
diet is much lower than this, with the National Diet and Nutrition Survey identifying that 
approximately 13.7 g/day NSP (~17.8 g/ day of dietary fibre) is consumed within the 
British diet (Bates et al., 2014). Table 1-2 outlines epidemiological evidence highlighting 
the importance of dietary fibre in different ethnicities as well as different habitual diets 
(Eastern and Western).  Of importance is the association of increased dietary fibre and 
reduced weight, BMI, and waist circumference, particularly as current recommendations 
for fibre intake are not met, which may be related to the increased prevalence of obesity. 
Over the last 35 years the prevalence of obesity has doubled worldwide with 13% of all 
adults being obese and 39% of adults being overweight (WHO, 2015). Obesity is 
associated with the increased prevalence of type two diabetes (T2D) where 90% of the 
people affected are obese or overweight and 12.4% of all obese adults are affected (Public 
Health England., 2014).  As described in Table 1-2, T2D prevalence also decreases with 
increased dietary fibre consumption.  Obesity may also increase the risk of some cancers, 
for example, 20.3% of uterine and 11.1% of colon cancers were associated with obesity in 
a cohort study of the UK population (Bhaskaran et al., 2014). 
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Table 1-2: Epidemiological studies assessing association of dietary fibre intake and health. 
Reference Population Fibre 
consumption 
Impact of 
fibre 
Fibre type 
observations 
(Du et al., 
2010) 
89432, European 
individuals 
10 g/day increase ↓ weight 
change, ↓ 
waist 
circumference 
NE on BMI 
Cereal fibre 
beneficial 
compared to 
fruit and 
vegetable  
fibre 
(Consortium, 
2015) 
The InterAct 
Consortium 
28460, European 
individuals 
<18.9 g/day vs  > 
29.7 g/day 
↓ Total 
cholesterol 
↓ Risk of T2D 
NE on BMI 
Cereal fibre 
beneficial 
compared to 
fruit and 
vegetable  
fibre 
(Consortium, 
2015) 
The InterAct 
Consortium 
Meta-analysis of 20 
investigations of 
men and women, 
different diabetes 
status and a 
selection of 
different ethnicities 
(e.g European, 
Asian, Nauru) 
10 g/day increase ↓ Risk of T2D Cereal fibre 
beneficial 
compared to 
fruit and 
vegetable  
fibre 
(Jiang et al., 
2012) 
934, Chinese with 
T2D and 918 
Chinese healthy 
individuals 
 
≤9.1 g/day vs 
>9.1 g/day men 
and ≤8.4 g/day 
and >8.4 g/day 
women 
↓HbA1c 
↓ Total 
cholesterol 
↓LDL 
cholesterol 
 
(Larsson and 
Wolk, 2014) 
69677 Swedish 
individuals 
≤18.2 g/day vs 
≥28.3 g/day men 
and ≤20.4 g/day 
and ≥30.5 g/day 
women 
↓ Stroke 
↓Cerebral 
infarction 
NE on BMI 
Fruit and 
vegetable fibre 
are the most 
beneficial 
(Fujii et al., 
2013) 
4399 diabetic 
Japanese 
Associations 
based on diabetic 
and non-diabetic 
food diaries. 
Average fibre 
intake was 12.83 
g/day 
↓ Waist 
circumference 
↓HbA1c 
↓Total, LDL 
and HDL 
cholesterol 
↓BMI 
 
(de Munter 
et al., 2007) 
161737 American 
(USA) women 
 
~4.35 vs ~41.25 
g/ whole grain per 
day 
Whole grain ↓ 
T2D 
↓BMI 
Beneficial 
effects from 
the bran 
(de Munter 
et al., 2007) 
Meta-analysis of 6 
investigations 
(USA men and 
women, Finnish) 
Two servings a 
day of whole 
grain 
Whole grain ↓ 
T2D 
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(Kim and Je, 
2014) 
Meta-analysis of 7 
investigations 
including; Europe, 
USA, middle east 
10 g/day ↓ risk of 
mortality 
 
(Threapleton 
et al., 2013) 
Meta-analysis of 22  
investigations with 
men, women, 
smokers, and 
vegetarians from 
Europe, UK, 
Scandinavia, Japan, 
USA, and Australia 
7 g/ day ↓ risk of CHD 
↓risk of CVD 
 
(Liu et al., 
2003) 
74091 American 
(USA) women 
13 g/day vs 20 
g/day DF from 
whole grain and 
18 g/day and 15 
g/day. DF from 
refined grain 
↓BMI 
↓Weight gain 
Changes with 
whole grain 
fibre, not 
refined fibre 
(Thane et al., 
2009) 
3663 British adults 0- ≥48 g of whole 
grain /day 
NE on BMI 
but ↓ BMI in 
men when 
BMI is over 30 
NE on waist 
circumference 
 
 
(Wanders et 
al., 2011) 
Meta-analysis of 
188 investigations 
with long and short 
term consumption 
of different dietary 
fibres 
 
Energy intake: 
supplement of 17 
g/day 
Body weight: 
supplement of 
11.1 g/day 
↓ energy 
intake 
↓ body weight 
 
T2D = Type two diabetes, CHD = coronary heart disease, CVD = cardiovascular disease, BMI = body mass 
index, LDL = low-density lipoprotein. HbA1c is a marker of plasma glucose concentration 
 
 
The positive effects of dietary fibre have also been observed in acute and long term feeding 
trials on animals, healthy, and overweight adults (Table 1-4).  However, the results 
between studies are often conflicting even for the same dietary fibres. This may be due to 
different doses or comparing different cohorts of individuals/ animals. For example beta-
glucan consumption (10% w/w) in mice decreased body weight gain and food intake, after 
three weeks and increased production of acetate and propionate (Arora et al., 2012). 
However, consumption of 30 g of oat β-glucan by healthy individuals had no effect on 
satiety or desire to eat (Lyly et al., 2009).  This was in contrast to a human feeding trial by 
Vitaglione et al., (2009) where 3 g of barley β-glucan for a breakfast led to reduced hunger 
27 
 
 
and energy intake in a subsequent meal. It was also observed that plasma ghrelin decreased 
and PYY increased up to 180 minutes after the breakfast with β-glucan (Vitaglione et al., 
2009). Different effects were also observed in overweight individuals after consumption of 
guar gum, which contains beta, linked mannoses and galactoses (Adam and Westerterp-
Plantenga, 2005).  Here, a breakfast containing 2.5 g of guar gum increased plasma GLP-1, 
but no effect on satiety was observed (Adam and Westerterp-Plantenga, 2005) (Table 1-4). 
Similar differences were also seen with assessment of inulin (10%) where consumption in 
mice decreased body weight gain and food intake after 6 weeks (Arora et al., 2012).  
Effects differed in studies of healthy humans where 24 g of inulin had no effect on GLP-1 
or GIP but decreased ghrelin and increased SCFA production. Although a standard lunch 
was provided as part of the protocol, energy intake was not assessed and therefore it is 
difficult to assess whether the changes in hormone levels led to differences in energy 
intake (Table 1-4) (Tarini and Wolever 2010)  
Mixed effects of dietary fibre on satiety, energy intake and body weight were also evident 
in the systematic review of 188 human feeding studies of various type of dietary fibre 
(Table 1-3)(Wanders et al., 2011).  Both acute studies with a maximal duration of 7 hours, 
and long- term effects, (maximum mean duration, 20 weeks) were assessed.  Forty three 
percent of the acute studies observed an overall energy intake reduction after eating fibre.  
All included studies assessing viscous fibres such as pectin (74 individuals, average dose- 
14.2 g) and pectin rich fibres (33 individuals, average dose- 3.6 g) observed a reduction in 
overall subjective appetite (Table 1-3). In contrast, studies which fed β-glucan- rich fibres, 
dextrin, fructan, and resistant starch showed no overall effect on subjective appetite. The 
impact of physicochemical properties was also assessed and 59% of studies of the more 
viscous fibres showed reductions in subjective appetite compared to only 14% of studies 
using less viscous fibres although objective criteria for this division on viscosity were not 
provided.  When the energy intake (assessed with an ad libitum meal) of the short term 
studies was compared, 100% of studies assessing β-glucan- rich fibres, dextrin, resistant 
starch and pectin observed reductions in energy intake. Energy intake was also reduced in 
39% more studies using viscous fibres and 34% more studies with soluble fibre than non-
viscous and non-soluble fibres (Wanders et al., 2011). 
 
 
28 
 
 
Long-term studies (with an average duration of 8.4 weeks) observed less of an effect of 
fibre type on recalled or ad libitum energy intake, in which 63% of all studies observed 
decreased energy intake.  An advantage of the long-term studies is the ability to assess the 
effect of long-term fibre intake on bodyweight. Overall, 54% of studies assessed observed 
a reduction in body weight due to increased fibre intake (Table 1-3)(Wanders et al., 2011). 
 
This systematic review also identified only a weak correlation (slope = -0.014χ) between 
increased fibre dose and decreased body weight (per 4 week period).  Acute fibre doses 
were approximately 9 g/day and long-term doses were approximately 14 g/day (Wanders 
et al., 2011). The requirement of high doses of fibre has also been identified where the 
oligofructose consumption was dose dependently increased (Pedersen et al., 2013). Doses 
above 35 g/day of oligofructose were required to observe any effects on gut released 
satiety hormones. In comparison with the average fibre intake of adults of 13 g/day (NSP) 
doses equivalent to or higher than the UK daily intake of fibre to have an effect (Wanders 
et al., 2011, Pedersen et al., 2013, Bates et al., 2014). 
 
Wanders et al., (2011) concluded that all types of fibre had some effect on appetite and 
body weight (Table 1-3), however the extent depended on the physicochemical properties 
of the dietary fibre.  All fibre types reduced appetite and body weight; however, reduced 
appetite occurred more with more viscous fibres.  In contrast, acute energy intake was 
reduced only when the fibres were more viscous, soluble and fermentable.  All of the fibre 
types tested (except for more viscous fibre) reduced long-term energy intake (Wanders et 
al., 2011). Therefore, these data go towards explaining the mixed effects of dietary fibre on 
health in studies which use varied doses and physicochemical structures of dietary fibre 
(Table 1-6 – Table 1-6) (Wanders et al., 2011). 
 
Consumption of high doses of fibre are also associated with colonic effects which may 
alter hunger and satiety and differ with the physicochemical properties of fibre sources. 
For example, consumption of highly fermentable, non-viscous, soluble fibres such as 
oligofructose have been associated with increased flatulence and bloating in contrast to 
cellulose (Daud et al., 2014).  Consumption of the soluble, fermentable and viscous fibre, 
psyllium for two weeks in crackers (providing ~23 g/fibre a day) increased bloating, 
flatulence and abdominal pain, but did reduce ad libitum food intake (Table 1-5).  In 
contrast, wheat bran had no effect on any of these parameters (Stevens et al., 1987).  These 
studies indicate that factors other than the SCFA produced could alter energy intake.  This 
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is particularly true for highly fermentable and soluble fibres, which result in increased 
abdominal symptoms (Daud et al., 2014).  As a result replicating the doses of dietary fibre 
used in human feeding trials is likely to be unfeasible and difficult for the general 
population to maintain (Wanders et al., 2011). 
 
Table 1-3: Physicochemical properties of fibre and overall effects on appetite, energy intake 
and body weight from a systematic review of 188 studies (Wanders et al., 2011). 
Fibre type Subjective 
appetite 
Acute 
Energy 
intake 
Long term 
energy intake 
Body weight 
More viscous Strongly 
Reduced 
Reduced No effect Reduced 
Less viscous Reduced No effect Reduced Reduced 
More soluble Reduced Reduced Reduced Reduced 
Less soluble Reduced No effect Reduced Reduced 
More fermentable Reduced Reduced Reduced Reduced 
Less fermentable Reduced No effect Reduced Reduced 
Total fibre Reduced Reduced Reduced Reduced 
Table adapted from (Wanders et al., 2011). Reduced = 1-50% of studies observed an effect, 
strongly reduced 51-100% of studies observed an effect, No effect = 0% of studies observed an 
effect. 
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Table 1-4:  Intervention studies in animal models investigating the effect of fibres on satiety associated parameters. 
Study 
Fibres 
investigated 
Intervention Satiety and food intake Gut hormones SCFA production 
(Kaji et al., 
2011) 
Fructo-
oligosaccharide 
Rats fed ~16 g/day for 29 days Fructo-
oligosaccharide in diet 
 
↑ FFAR2, ↑ GLP-1 in 
proximal colon 
 
(Arora et 
al., 2012) 
Inulin 
Mice fed High fat diet + 100 g/kg inulin for 8 
weeks 
↓ Body weight gain from 3 
weeks, ↓ Food intake from 
6 weeks 
 
↑ Acetate 
↑ Propionate 
(Van den 
Abbeele et 
al., 2011) 
Inulin 
10% of feed (w/w%) was inulin for 21 days in 
humanised rats 
  
↑ SCFA production 
↓ Acetate % 
 
(Arora et 
al., 2012) 
β-glucan 
Mice fed High fat diet + 100 g/kg β-glucan for 8 
weeks 
↓ Body weight gain from 3 
weeks, ↓ Food intake from 
4 weeks 
 
↑ Acetate 
↑ Propionate 
(Zhou et al., 
2008) 
Resistant starch Rats fed  530.7g resistant starch for 10 days  
↑ GLP-1, ↑ PYY, ↑ Glucose 
↓ Insulin 
 
(Van den 
Abbeele et 
al., 2011) 
Long-chain 
arabinoxylan (LC-
AX) 
10% of feed (w/w%) was LC-AX for 21 days in 
humanised rats 
  
↑ SCFA production 
↓ Acetate % 
↑ Propionate % 
LC-AX - Long-chain arabinoxylan, MOS – Mannooligosaccharide, PDX – Polydextrose, HDL- high density lipoprotein. Blank space – it was not measured 
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Table 1-5: Human intervention studies investigating the effect of fibres on satiety associated parameters 
Study Fibres 
investigated 
Intervention Satiety and food intake Gut hormones SCFA production 
(Tarini and 
Wolever, 
2010) 
Inulin 
56 g High fructose corn syrup + 24 g inulin as a 
drink (compared with High fructose corn syrup) 
Single blind cross over design 
 
NE glucose, insulin, c-
peptide, GIP, GLP-1. 
↓ FFA at 4 hours 
↓ Ghrelin 4 – 6 hours 
↑ Acetate 
↑ Propionate 
↑ Butyrate 
(Lyly et al., 
2009) 
Oat β-glucan 
30 g oat β-glucan added to drink 
Crossover with 1day between sessions 
NE on feelings of satiety or 
desire to eat 
  
(Vitaglione 
et al., 2009) 
Barley β-glucan 
Consumed bread containing 3 g barley β-glucan for 
breakfast. 
Cross over randomised design with one week wash 
out 
↓ Hunger 
↑ Fullness 
↑ Satiety 
↓ Energy intake 
↓ Glucose 
↓ Ghrelin 
↑ PYY 
 
(Ellis et al., 
1991) 
Guar gum 
Breakfast of different molecular weight guar gum 
sandwiches containing 7.6 g 
Randomised blinded Cross-over, 3 days apart 
 
↓ Insulin 
NE glucose 
 
(Lyly et al., 
2009) 
Guar gum 
10 g guar gum added to drink 
Crossover with 1day between sessions 
↑ Feelings of satiety 
↓ Desire to eat 
  
(Adam and 
Westerterp-
Plantenga, 
2005) 
Galactose and guar 
50 g galactose + 2.5 g guar at breakfast in a drink 
Crossover design with placebo separated by 1 week 
 
↑ Plasma GLP-1, ↑insulin at 
120 mins, ↑feelings of 
satiety 
 
32 
 
 
(Stevens et 
al., 1987) 
Psyllium 
Consumed equivalent of 23 g/day for 2 weeks as a 
cracker. 
Double blinded cross-over study 
↑ Flatulence, ↑Bloating, ↑ 
Abdominal pain, 
NE nausea, ↓Energy intake 
  
(Vogt et al., 
2004a) 
Rhamnose 
Consumed 25 g rhamnose for 28 days 
Semi randomised crossover design, separated by 3 
months 
  
↑ Propionate 
(serum) 
NE faecal or 
urinary SCFA 
(Vogt et al., 
2004a) 
Lactulose 
Consumed 25 g Lactulose for 28 days 
Semi randomised crossover design , separated by 3 
months 
  
NE breath, faecal 
or urinary SCFA 
(Bodinham 
et al., 2013) 
High-amylose maize 
type 2 RS 
24 g dietary fibre at breakfast and lunch in 
Randomised single blind cross over study with 
placebo separated by 1 week 
 
Breakfast: ↓GLP-1, NE 
insulin 
Lunch: ↓ Insulin, NE GLP-1 
NE: Glucose, C-peptide 
 
(Cherbut et 
al., 1997) 
Maize fibre 
15 g fibre/ day of maize fibre for 4 weeks 
Cross-over, single blind randomised study with one 
month interval 
 
NE glucose, insulin 
↓ total cholesterol 
 
(Cherbut et 
al., 1997) 
Potato fibre 
15 g fibre/day of maize fibre for 4 weeks 
Cross-over, single blind randomised study with one 
month interval 
 
NE glucose, insulin, total 
cholesterol 
 
(Stevens et 
al., 1987) 
Wheat bran 
Consumed equivalent of 23 g/day for 2 weeks as a 
cracker. Double blinded cross-over study 
NE Flatulence, bloating, 
abdominal pain, nausea, or 
energy intake 
  
(Lyly et al., 
2009) 
Wheat bran 
21.8 g Wheat bran added to drink 
Crossover with 1day between sessions 
NE on feelings of satiety or 
desire to eat 
  
(Lyly et al., 
2009) 
Wheat bread 
50 g Wheat bread consumed 
Crossover with 1day between sessions 
↑ Feelings of satiety 
↓ Desire to eat 
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(Asano et al., 
2004) 
Manno-
oligosaccharide  
1 g/day or 3 g/day MOS each for 2 weeks, 
Crossover with a 2 week interval period 
  NE 
(Beards et 
al., 2010b) 
Maltilol 
50 g increasing to 100 g of chocolate over 6 weeks. 
Some of the chocolate replaces with maltilol. 
Randomised double blind and placebo controlled 
  
 
↑ Acetate 
↑ Propionate 
↑ Butyrate 
 (Beards et 
al., 2010b) 
Maltilol + 
polydextrin 
50 g increasing to 100 g of chocolate over 6 weeks. 
Some of the chocolate replaces with maltilol + 
polydextrin 
Randomised double blind and placebo controlled 
  
↑ Acetate 
↑ Propionate 
↑ Butyrate 
(Astbury et 
al., 2013) 
Polydextrose (PDX) 
 
 
Consumed a drink containing PDX ranging 6.3-25 g 
Cross-over, single blind randomised study with a 7 
day interval 
NE fullness, hunger or desire 
to eat 
↓ Energy intake at test meal 
NE on subsequent EI 
Total energy intake reduced 
with 25g PDX 
  
(Finley et al., 
2007) 
Pinto beans 
Consumed 130 g pinto beans per day for 12 weeks. 
Randomised parallel study 
 
↓ total cholesterol 
↓ HDL 
↓LDL 
 
LC-AX - Long-chain arabinoxylan, MOS – Mannooligosaccharide, PDX – Polydextrose, HDL- high-density lipoprotein. Grey space – it was not measured 
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Table 1-6: Intervention studies investigating the effect of fibres on satiety associated parameters in overweight subjects 
Study 
Fibres 
investigated 
Intervention Satiety and food intake Gut hormones SCFA production 
(Daud et al., 
2014) 
Oligofructose 
10 g of Oligofructose for 8 weeks 
Randomised, single blind parallel study 
 
↑ PYY, NE on GLP-1, 
insulin, and glucose 
↑ Breath hydrogen, 
↑ Acetate 
↑ Butyrate 
(Parnell and 
Reimer, 2009) 
Oligofructose 
21 g oligofructose/day for 12 weeks Randomised, 
double blind 
↓ Body weight 
↓ Fat mass 
↓ Energy intake 
↓ Insulin change 
↓ Glucose 
AUC = NE 
↓Ghrelin 
↑ PYY 
↑ GLP-1 
 
(Chambers et al., 
2014) 
Inulin 
10 g/day inulin consumed for 24 weeks 
Randomised, double blind, parallel design 
 
↓ Total cholesterol, ↓HDL 
Improved liver function 
 
(Adam and 
Westerterp-
Plantenga, 2005) 
Galactose and 
guar 
50 g galactose + 2.5 g guar at breakfast crossover 
design with placebo separated by 1 week 
NE on feelings of satiety 
↑ Plasma GLP-1, 
Delayed peak insulin,  
 
(Finley et al., 
2007) 
Pinto beans 
Consumed 130 g pinto beans per day for 12 
weeks 
Randomised parallel study 
 
↓ Total cholesterol 
↓ HDL 
↓ LDL 
 
LC-AX - Long-chain arabinoxylan, MOS – Mannooligosaccharide, PDX – Polydextrose, HDL- high-density lipoprotein. Grey space – it was not measured 
35 
 
 Propionate feeding trials 
 Oral propionate interventions 
It is difficult to carry out oral propionate feeding trials due to its low palatability.  
Propionate is commonly added to bread in the form of calcium propionate (Ca-Propionate) 
to prolong shelf life by preventing mould and bacterial growth (Liljeberg et al., 1995). 
However, concentrations of Na-propionate in bread are much lower than has been 
suggested to have an effect on satiety (~16 mmoles) (Liljeberg et al., 1995, Darzi et al., 
2012).  Details of investigations of the effects of oral propionate are shown in Table 1-7. 
Human consumption of approximately 50 mmoles propionate in a single meal had 
beneficial effects on glucose and insulin tolerance, as well as increasing satiety (Liljeberg 
and Bjorck, 1996). Similar effects were observed by Darwiche et al., (2001) where 50 
mmol propionate reduced gastric empting, blood glucose and plasma insulin 
concentrations.  
 
At high concentrations, poor organoleptic properties observed with Na-propionate may 
confuse the outcome. Thus, breads with palatable concentrations of Na-propionate were 
tested. A dose of 6 mmol was deemed palatable based on a visual analogue scales after 
ingestion, but consumption did not affect glucose, insulin, energy intake or feelings of 
fullness (Darzi et al., 2012).  In contrast, a propionate dose of 16 mmol within bread was 
palatable and increased feelings of satiety, decreased blood glucose and plasma insulin, 
indicating that 16 mmol is to lowest palatable dose of Na-propionate to exert beneficial 
effects (Liljeberg et al., 1995).  This also does not take into account the ‘standard loaf’ of 
each country tested. The investigation by Liljeberg et al., (1995) was conducted in Sweden, 
where sourdough bread is commonly consumed.  The study by Darzi et al., (2012) also 
used sourdough, however unlike in Sweden sourdough bread is not commonly consumed 
in the UK.  It is possible that different cultures may have had different tolerances for 
propionate within the bread, altering the perceived feelings of palatably with different 
propionate doses within the bread. Palatability on food intake and hunger have been 
measured using 25 mmol acetate (in the form of vinegar).  The dose of acetate was 
consumed in a single drink (unpalatable), or two drinks (palatable) during a breakfast meal. 
All treatments increased feelings of fullness, decreased appetite, but subsequent meal 
intake was significantly reduced in the unpalatable group compared to the palatable group, 
indicating that the palatability affects food intake (Darzi et al., 2011). 
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Many of these effects may be due to reduced gastric emptying observed after propionate 
consumption.  Delayed gastric empting is associated with increased feelings of satiety, as 
well as being better insulin and glucose sensitivity (Darwiche et al., 2001, Liljeberg and 
Bjorck, 1996).  These effects may be due to local mechanisms and differ from the effects  
of propionate produced from fermentation of carbohydrate in the colon (Darzi et al., 2012). 
  
 Effect of colonic propionate on satiety 
As discussed in Table 1-4 – Table 1-6 and Section 1.9, propionate is produced in the colon 
by the fermentation of NDC. Much of the information gained on the ability of a SCFA to 
be produced is by using in vitro analysis (discussed in Section 1.9), or as part of feeding 
studies. Feeding studies do not provide much insight into colonic propionate production, as 
SCFA concentrations are often measured using faecal or serum samples (Vogt et al., 
2004a). Faecal samples are representative only of the distal colon due to the rapid 
absorption of propionate in the gut, and as much of the propionate is used by the liver, little 
reaches the peripheral blood (Bloemen et al., 2009).  However, consumption of 3g oat 
beta- glucan (a substrate considered to be propiogenic [Hughes et al., 2008]) added to 
bread, has similar effects to propionate feeding studies (Vitaglione et al., 2009).  When this 
bread was consumed for breakfast there were increased feelings of satiety, reduced energy 
intake, and decreased blood glucose concentrations.  However, the SCFA were not 
measured so the mechanism of this effect is unclear (Vitaglione et al., 2009).  Rectal 
infusion containing propionate has been used to assess FA synthesis and plasma 
cholesterol, but effects of satiety were not measured (Wolever et al., 1995).  Therefore, 
there is a need to correlate health outcomes with SCFA produced from fermentation.  An 
estimation of the amount of propionate formed by colonic fermentation can be made with 
stable isotope analysis.  There are relatively few studies using isotopes to assess SCFA 
production; however, Pouteau et al., (1998) assessed acetate production from colonic 
lactulose fermentation by measuring the dilution of labelled acetate infused into the blood 
of healthy adults. Similar methods could be used could be used to assess propionate 
production (Pouteau et al., 1998).   
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Table 1-7: Outcomes of oral propionate consumption in human feeding trials 
Study Intervention+ Propionate dose* Palatability Effect of propionate Effect of propionate on 
energy intake 
(Darzi et al., 2012) Propionic acid bread 
consumed (n=20, 
healthy) 
6.1 mmol Palatable1 NE plasma glucose 
NE plasma insulin 
NE energy intake during 
subsequent ad libitum 
meal. 
NE fullness1 
(Ruijschop et al., 
2008) 
Milk based drink with 
calcium-propionate 
(N=43 healthy) 
10.4 mmol (~53 mM, 0.6% in 150  
ml) 
↓ Palatability1  NI ↑ Fullness1 
↓ Hunger1 
NE food intake in 
subsequent ad libitum 
meal 
(Frost et al., 2003) Consumed high fat diet 
with propionate (n=10, 
healthy) 
~31 mmol (3 g propionate in 50 g 
available CHO) 
Palatable amount used although 
participants complained of 
nausea 
↑ GLP-1 
↓ Gastric emptying 
NE glucose 
↑cMax insulin 
NE energy intake 
(Todesco et al., 
1991) 
Na-propionate bread 
(n=6, healthy)  
~34 mmol (3.3 g Na propionate in 
50 g CHO) 
NI ↓ Glucose   
(Liljeberg et al., 
1995) 
High and low 
concentration Na-
propionate bread 
consumed 
(n=11, healthy) 
Low ~ 16 mmol (21.3 g/100 g DW) 
High ~49 mmol (60.8 g/100 g DW) 
↓ Palatability of high 
concentration propionate bread. 
NE palatability low 
concentration (c.f. control)1  
Both breads ↓ Plasma 
glucose, insulin  more 
so in high 
concentration 
↑ Satiety1   
(Liljeberg and 
Bjorck, 1996) 
Na- propionate bread 
consumed (n=12, 
healthy) 
~49 mmol (60.8 g/ 100 g DW) Previous investigation found 
palatability to be poor 
(Liljeberg et al., 1995) 
↓ Blood glucose 
↓ Serum insulin 
↑ Satiety1  
(Darwiche et al., 
2001) 
Na- propionate bread 
consumed (n=9, healthy) 
~49 mmol NI ↓ Gastric emptying 
↓ Blood glucose 
↓ Serum insulin 
NI 
(Todesco et al., 
1991) 
Na-propionate bread 
(n=6, healthy) (1week 
duration) 
~ 103 mmol (9.9 g in 150 g CHO 
per day) 
NI ↓ Glucose  
NE cholesterol 
NE energy intake 
1= measured by visual analogue scale * When dose was not provided food consumed, by individuals, dose was calculated from information provided within the text when possible.  + one day acute study 
unless otherwise stated. NI = not included, NE = no effect, VAS = visual analogue scale Cmax = maximal concentration, NA= not available. 
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More recently, an inulin-propionate ester (IPE), delivering very high doses of propionate 
directly to the colon (31 mmol, 2.36 g in 10 g) has been developed. Overweight individuals 
consumed 10 g/day of IPE for 24 weeks, which led to a 13.8% decrease in energy intake, 
decreased weight gain and decreases in visceral and hepatic body fat percentage were 
observed. No effects on glucose, insulin, PYY or GLP-1 concentrations were observed 
with long-term supplementation, however acute supplementation of IPE (10g) by the same 
group has had mixed effects of PYY and GLP-1 release. For example, Chambers et al., 
(2014), observed increased hormone expression between 240 and 420 minutes and Byrne 
et al., (2016) at the same dose did not identify any effect in hormone expression. Both 
studies did observe a reduction in food intake, indicating that in the case of the IPE these 
effects are potentially occurring independently of the satiety hormones (Chambers et al., 
2014, Byrne et al., 2016).   
 
 Properties influencing selective SCFA production- the challenge of 
increasing propionate production 
In order to increase colonic production of propionate by manipulating the types and 
amounts of dietary fibres consumed, the key determinants of propionate production need to 
be identified. There are many different factors that can influence the production of 
propionate, or any other SCFA.  Table 1-8 outlines the properties that alter the production 
of SCFA, which are not only dependent on the dietary fibre consumed, but also other host 
factors such as the colonic pH and the profile of the colonic microbiota.  These factors are 
not independent of one another. As discussed earlier, increased bacterial fermentation 
reduces the colonic pH, resulting in differences in bacterial activity. On the other hand, the 
distal colon has a higher pH due to reduced fermentation of carbohydrate and increased 
BCFA production indicating proteolytic fermentation (Section 1.3). 
 
Table 1-8: Potential factors that influence the production of SCFA 
Substrate Factors Host Factors 
Substrate availability Colonic pH 
Saccharide composition 
Solubility 
Molecular weight 
Small bowel transit time 
Colonic residence time 
 
Chain length Gut microbiota composition 
Molecular bonding and branching  
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 Saccharide Structure 
To-date there are very few studies systematically examining the factors leading to colonic 
production of propionate (or any other SCFA).  Most studies on SCFA production use 
complex dietary fibres for analysis, and as a result little is known about the role of sugar 
composition and / or bonding.   
 
 Monosaccharide sugars 
Very few monosaccharides reach the colon, but they can be produced by bacterial 
catabolism of disaccharides and polysaccharides. Determining the sugars which increase 
individual SCFA production would enable more selective substrates to be used for 
propionate production. In vitro fermentation experiments have observed that the 
fermentation of different sugars is associated with different concentrations and patterns of 
individual SCFA.  Using a batch in vitro fermentation model Gietl et al., (2012) observed 
that fermentation of L-rhamnose (a pentose sugar) and D-mannose (hexose sugar) 
generated 60.74 and 52.20 mmol/l of total SCFA, whereas the pentose sugars; L-xylose 
and D-arabinose generated 24.9 mmol/l and 38.18 mmol/l total SCFA. Differences in 
propionate production were also identified with rhamnose which selectively increased 
propionate production (19.09 mmol/l) when compared with a selection of sugars, such as 
glucose (6.07 mmol/l), and L-xylose (2.87 mmol/l) (Gietl et al., 2012).  Differences in 
sugar composition and total SCFA production have also been observed by Mortensen et 
al., (1988) using 10 different sugars. D-xylose, D-ribose, D-glucose generated 
concentrations above 900 mmol/l, whereas D-mannose, L-rhamnose, and, D-arabinose 
generated between 280 and 520 mmol/l total SCFA.  Mortensen et al., (1988) used 10x 
more substrate than Gietl et al., (2012) but SCFA concentrations were approximately 5x 
higher than that of (Gietl et al., 2012). Here, rhamnose, like the investigation by Gietl et 
al., (2012) led to the most propionate production, and sorbitol produced the most butyrate 
(Mortensen et al., 1988). This shows that when considering the data, without further 
processing to account for volume and mass of substrate used, comparing SCFA production 
between studies can be challenging. 
 
Increased propionate production after rhamnose consumption has also been observed in 
human feeding studies. Vogt et al., (2004a), (2004b), and (2006) carried out a number of 
investigations on rhamnose consumption and propionate production. When healthy 
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subjects were fed 25g of rhamnose over the course of one day as part of a meal, serum 
propionate area under the curve (AUC) was increased compared to glucose and/or lactose 
(1.63 vs 2.4 and 3.0 μmol.h/l) (Vogt et al., 2004b). When the same group fed the same 
dose of rhamnose to healthy men for 28 days, once again, serum propionate was increased, 
but there was no observed difference in faecal or urinary SCFA concentrations (Vogt et al., 
2004a). Vogt et al., (2006) conducted further analysis on the previous investigations and 
observed that four weeks of rhamnose consumption led to reduced TAG production, but 
there was no effect on total cholesterol, glucose or insulin (Vogt et al., 2006).  In a more 
recent study, consumption of up to 25.5 g/day of rhamnose, over 7 days by healthy 
individuals had no effect on serum SCFA concentrations, fasting insulin or subjective 
appetite ratings, but did decrease plasma insulin concentrations (Darzi et al., 2015). 
 
The effect of isomeric configuration differs between sugars. D-glucose increased total 
SCFA production compared to L-glucose, but there was no effect of isomeric configuration 
on propionate production (Mortensen et al., 1988).  In contrast, D-arabinose increased 
propionate production compared to L- arabinose (16.91 mmol/l vs 6.19 mmol/l). The same 
trend was also observed for increased propionate from fermentation of the D isomer of 
xylose (Gietl et al., 2012). However, rhamnose is an L isomer suggesting that isomeric 
configuration is not the sole determinant of whether increased propionate is produced. 
 
 Disaccharide sugars 
Most disaccharides do not reach the colon (although there are exceptions to this, such as 
lactulose) and are normally digested and/or absorbed in the human small intestine.  
However, disaccharides in in vitro fermentation studies are useful for the assessment of the 
SCFA producing properties of both the sugars and their linkages.  Lactulose was utilised 
by Sayer et al., (2007), and Arrigoni et al., (2005) as a highly fermentable control yielded 
mainly acetate (Sayar et al., 2007, Arrigoni et al., 2005).  There is poor consensus between 
different investigations in determining whether a disaccharide sugar is propiogenic. For 
example, sucrose, a disaccharide consisting of glucose and fructose, has been identified as 
being highly acetogenic, propiogenic, and butyrogenic in different investigations, all of 
which used in vitro batch fermentation. Wang and Gibson., (1993), identified that sucrose 
yielded 82% acetate (of total SCFA), Gietl et al., (2012), observed 83% propionate and 
Ferguson and Jones., (2000) observed 50% butyrate (of total SCFA) after sucrose 
fermentation (Wang and Gibson, 1993, Gietl et al., 2012, Ferguson and Jones, 2000).  An 
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issue with the analysis of the properties of disaccharides is that investigations have not 
been systematic, i.e. different sugars and bonding have not been individually assessed.  
 
Few investigations have systematically fermented disaccharides to assess the impact of the 
glycosidic bond linkage on propionate production. Gietl et al., (2012) conducted batch 
fermentations on four different disaccharides consisting of 1-4, or 1-6 bonding in both the 
alpha and beta orientation, and observed no difference in the production of propionate 
(Gietl et al., 2012).  Sanz et al., (2005) did a small investigation, with a stool sample from 
only one donor, fermenting of all the possible glucose-glucose disaccharides for 12 hours. 
With glycosidic linkages (1-1), (1-2), (1-3), and (1-4) the beta orientation increased 
propionate, whereas for (1-6) linkages the alpha orientation increased production.  
Different linkages of galactobiose (galactose-galactose) and mannobiose (mannose- 
mannose) were amongst other disaccharides tested. It was observed that 3α (galactobiose) 
increased butyrate production compared to other galatobioses tested, and 2α (mannibiose) 
increased propionate compared to 3α, 4α, and 6α- mannobiose.  The bacterial 
compositional changes because of these disaccharides was investigated and no changes in 
the bacterial population were observed (Sanz et al., 2005a). This indicates that, in this one 
individual, changes because of glycosidic bond linkage altered SCFA production 
independently of changes in the microbiota; however, how this relates to the bacterial 
functionality was not measured. This does highlight the requirement of robust systematic 
investigations to assess the role of disaccharide structure and bonding as drivers for 
selective SCFA production. 
 
 Poly and Oligo-saccharide structure 
Few in vitro fermentations have been carried out to systematically assess how the sugar 
composition of a NDC affects SCFA production.  Karppinen et al., (2000) conducted in 
vitro fermentations and observed that for oat, rye, and wheat bran the more fermentable the 
substrate the more SCFA was produced. This was not the case for inulin, which was the 
most rapidly fermented of the substrates tested (within 4 hours) but did not produce the 
most SCFA at 24 hours. Of the sugars in oat bran, glucose was most highly fermented with 
78% being utilised over 24 hours of fermentation, compared with only 9% of arabinose. 
This differed from inulin where fructose then glucose were most highly utilised during 
fermentation with approximately 64% of glucose and 99% of fructose being utilised. This 
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difference in preference of sugar for fermentation may have altered SCFA production 
(Karppinen et al., 2000). 
 
The relationship between SCFA production and the constituent sugars has also been tested 
in the seaweed, ulvan. Differentiation of the sugars producing each SCFA showed that 
aldobiuronate producing acetate, propionate and butyrate in the ratio 55.5 : 21.3 : 15.7., 
rhamnose yielded the highest proportion of propionate (51%), and glucoronate yielded a 
high proportion of butyrate (23%) (Bobin-Dubigeon et al., 1997).  
 
Although little analysis has been carried out to determine what makes a substrate 
particularly propiogenic, different NDCs have been linked to the production of individual 
SCFA.  Acetate is consistently the most abundant SCFA produced.  Oligofructose is 
associated with increased acetate production (Khan and Edwards, 2005, Ferguson and 
Jones, 2000, Rycroft et al., 2001a).  Laminarin (a β glucan component of seaweed), and 
pyrodextrinised starch are associated with increased propionate production (Deville, 2007, 
Laurentin and Edwards, 2004).  Resistant starch is associated with increased production of 
butyrate (Laurentin and Edwards, 2004, Zhou et al., 2013) and as well as propionate, beta-
glucans are associated butyrate production (Kim and White, 2009, Kaur et al., 2011). The 
reason that these NDCs selectively increase production of acetate, propionate, or butyrate 
is unclear. Differences in SCFA production are difficult to predict because of the 
complexity and differences in physicochemical properties of different substrates, which 
likely alter the colonic bacteria required to utilise them. These differences include 
solubility, molecular weight, chain length, the bonds present and branching.  
 
 Solubility 
Solubility is thought to a play a role in the determination of SCFA production.  Soluble 
fibre is generally more fermentable than insoluble fibre.  Insoluble fibres are generally 
considered to act as a stool bulker and do not undergo extensive fermentation, however 
there are exceptions (e.g resistant starch) (Wong et al., 2006, Slavin, 2013). Dietary fibre 
sources usually consist of a combination of insoluble and soluble fibre with approximately 
65% being insoluble (Wong et al., 2006). 
 
Characterising a carbohydrate on the basis of whether it is soluble or not is simplistic, 
based on chemical analysis with solvents and carbohydrates are rarely 100% soluble or 
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insoluble (Mortensen and Nordgaard-Andersen, 1993).  The association between solubility 
and fermentation is likely due to the properties within the carbohydrate such as if it is 
viscous, interacting with water molecules like pectin, has a high molecular weight or 
remains solid like wheat bran. Cellulose is an insoluble fibre, which does is not viscous 
and is poorly fermented yielding low concentrations of SCFA (Mortensen et al., 1991, 
Mortensen and Nordgaard-Andersen, 1993, Yu et al., 2013).  Pectin, ispaghula, and guar 
are all examples of carbohydrates that are characterised as being soluble fibres and produce 
viscous solutions. They are also highly fermentable and yield high SCFA concentrations, 
particularly propionate and butyrate.  This may be due to a greater accessibility of the 
sugar bonds for fermentation.  This however does not take into account the differences in 
the sugar and bonding structure that these carbohydrates have (Khan and Edwards, 2002, 
Mortensen and Nordgaard-Andersen, 1993, Rycroft et al., 2001a).  However, oligofructose 
is very soluble but is not viscous and unlike pectin, guar, and ispaghula it is not associated 
with the increased production of propionate and butyrate but it is associated with the 
production of acetate (Rycroft et al., 2001a). 
 
Solubility is associated with the MW of a substrate.  Kim and White., et al (2010) found 
that a curvilinear relationship between MW and solubility, this did not translate to 
differences in individual SCFA production although total production was slightly higher 
for the low MW substrate (Kim and White, 2010).  This was contradicted by an 
investigation by Ramasamy et al., (2014) who fermented chicory root pulp (contains 
inulin), and as MW increased, so did solubility. The differences in solubility observed did 
not lead to down-stream differences in acetate, propionate, or butyrate production, but 
soluble fibre increased total SCFA production by 30%. Here, insoluble fibre was only 
fermented after all of the soluble fibre had been utilised by the bacteria (Ramasamy et al., 
2014). 
 
Solubility is likely to affect total SCFA production by increasing fermentation; however, it 
is unlikely to be the key determinant of individual SCFA production. The predominant 
physicochemical properties to determine acetate, propionate, or butyrate production, 
remain to be elucidated. 
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 Molecular weight (MW) 
The MW of a fermented carbohydrate is thought to influence the resultant SCFA 
production.  Kim and White have conducted several studies to assess the role of MW on 
SCFA production using in vitro batch fermentations with healthy stool donors (Kim and 
White, 2010, Kim and White, 2011a, Kim and White, 2011b). They identified mixed 
effects of MW on SCFA production when testing a selection of different MW oat β-
glucans (53-898 kDa). Both the highest and lowest MW resulted in the lowest total SCFA 
production, and to a lesser extent, reduced acetate production. Propionate and butyrate 
production were unaffected by MW (Kim and White, 2011b). Total SCFA production 
related to MW resulted in a curvilinear association (Figure 1-5). 
  
Figure 1-5: SCFA production and molecular weight of oat β-glucan. 
4- 24 hour data obtained from (Kim and White, 2011b). 0 and 2 hours was omitted due to no observable 
effects as a result of MW seen at these time points.  
 
This group also researched the effect of β-glucan of different MW added to wheat flour on 
the in vitro production of SCFA (Kim and White, 2011a).  Total SCFA production was not 
altered by MW, although propionate and butyrate proportions were significantly higher for 
the low MW compared to the high MW (66 vs 361 kDa) (Kim and White, 2011a).  This 
effect could be due to altered solubility, in the study by Kim and White., (2011) it was 
observed that solubility of the β -glucan showed a similar pattern with the extreme ends of 
the MW containing more soluble fibre, than the other MW β -glucans.  This however was 
not significant, and may explain the slight curvilinear response to different MW observed 
(Kim and White, 2011b).  The decrease in total SCFA production may also be due to steric 
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hindrance preventing the bacterial hydroxylases from accessing and utilising the sugars.  
This could occur as a result of increased number of bacterial enzymes utilising the 
substrate, preventing access (Valjamae et al., 1998). Steric hindrance,  physical 
inaccessibility due to the crowded molecular structure around the bond which the enzyme 
targets, could also occur due to the substrate structure, such as increased viscosity, making 
it less accessible to the bacterial hydrolases (Pickardt et al., 2004). This would then prevent 
fermentation occurring, and as a result reduce the production of SCFA. 
 
Similar effects were also seen after assessment of different MW of guar gum (15 kDa – 
1100 kDa) on SCFA production in vitro (Stewart and Slavin, 2006).  The 400 kDa guar 
gum generated the highest total SCFA, acetate, propionate, and butyrate production. Low 
MW guar gum (15 kDa) led to selectively less propionate production compared to the 
20kDa and 400 kDa, but not the 110 kDa guar gum. This, similar to the studies with oat β-
glucans, and suggests that there is a curvilinear response of SCFA production based on 
MW (Stewart and Slavin, 2006).  It was hypothesised in these studies that these differences 
in SCFA production were as a result of differences in the solubility of the β-glucans or due 
to the rapid fermentation of the lower MW β-glucans (Kim and White, 2011b, Kim and 
White, 2011a, Stewart and Slavin, 2006) .  Stewart and Slavin., (2006) also postulated that 
the differences in the capabilities of the bacteria to utilise the different MW substrates 
could possibly be altering the SCFA production (Stewart and Slavin, 2006). 
 
The effect of MW on bacterial composition, independently of any changes in SCFA 
production, has also been investigated.  Al-Tamimi et al., (2006) fermented varying 
fractions of sugar beet arabinoxylan and found no difference in SCFA production, but 
observed changes in the bacterial composition. A high MW increased numbers of 
lactobacilli and a low MW decreased Clostridium perfringens/ histolyticum sub group 
numbers (Al-Tamimi et al., 2006).  Although these differences in SCFA production due to 
MW have been seen, this does not take into account molecular structure such as the linear 
chain length or the branching of fibre.  Linear chain length has been shown to alter SCFA 
production when this was assessed with galacto-oligosaccharide (GOS).  For example in 
vitro investigations by Gietl et al., (2012) and Cardelle-Cobas et al., (2009) used GOS with 
different degrees of polymerisation (DP) found that DP did not alter SCFA production or 
bacterial composition (Gietl et al., 2012) (Cardelle-Cobas et al., 2009). In contrast, Ladirat 
et al., (2014) determined that a low DP GOS (DP of 2-3) resulted in low total SCFA, 
although they did note that a DP of 4, 5 or 6 did not generate any changes in SCFA 
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production compared with each other. The chain length has been shown to influence 
bacterial composition and SCFA production (Ladirat et al., 2014). Inulin with DP of 10 
and β(1-2) bonding reduced bifidobacteria numbers compared to lactulose β(1-4) as well as 
having a decreased acetate concentration compared to GOS (DP = 2).  GOS also increased 
Streptococci compared to FOS (DP [4-5], β1-2), but decreased propionate production 
compared to lactulose (Rycroft et al., 2001a).  DP has been shown to effect SCFA 
production, FOS and inulin with a DP between 10-20 yielded high total SCFA, a high 
proportion of propionate and low proportions of acetate and butyrate compared to inulin 
and FOS with lower DPs (Stewart et al., 2008).  These studies demonstrate that a specific 
chain length or branching is unlikely to determine individual SCFA production. 
 
Carbohydrate branching also had differing effects on SCFA production. Hopkins et al., 
(2003) fermented arabinoxylans crosslinked with ferulic acid and noted decreased total 
SCFA production with branching, but no difference on individual SCFA production 
(Hopkins et al., 2003). This difference in total production is attributed to different bacterial 
species being required to utilise the bonds that form the cross-links.  Decreased butyrate 
production has been detected when dextrans of various MW and branching are 
investigated. Unlike with arabinoxylans, there was no difference in total SCFA production 
with differences in branching or MW dextrans when they were tested in vitro (Sarbini et 
al., 2011). The pyrodextrinisation of starch which introduces branching as well as β-
linkages to starch has also been observed in vitro (Laurentin and Edwards., 2004). These 
low MW pyrodextrinised starches increased production of propionate and decreased 
acetate compared to the native starches of potato, lentil and cocoyam. The reason for this 
was unknown but it was postulated that the solubility might have had an effect. 
 
 Dietary intake and bacterial populations 
The NDC that reach the colon may alter the colonic microbial environment. This may be 
due to enriching the populations of bacteria that can utilise certain substrates or by 
changing pH or other inhibitory metabolites which affect some but not all bacteria.  The 
profound effect of a habitual diet on the colonic microbiota has been investigated in both 
children (De Filippo et al., 2010), and adults (Yatsunenko et al., 2012).  Children 
consuming a Western diet which was high in fat and protein and low in fibre were 
compared with those consuming a rural African ‘Neolithic’ diet consisting of low fat and 
protein and high fibre (De Filippo et al., 2010).  Children on the different diets had the 
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same core phyla of Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria, which 
covered 94.2% of the bacterial phyla present, demonstrating that the basic bacterial 
genome is relatively stable. Differences were apparent with the Western diet with 
Firmicutes and Proteobacteria prevailing and for the Neolithic diet Actinobacteria, 
Bacteroidetes (particularly Prevotella [53% of the bacteria] dominating) (De Filippo et al., 
2010). This was also corroborated by Yatsunenko et al., (2012) who found microbiome 
and enzyme activity of two different high carbohydrate diets; those of the Amerindians in 
the Amazon and rural Malawians to be similar, however they were distinct from the 
Western diet of US Americans, particularly in adulthood.  Interestingly, bacterial 
composition did not differ between Western children and children from more traditional 
and ‘Neolithic’ backgrounds during breast feeding, suggesting that these later differences 
are possibly due to diet and not environmental or genetic factors (De Filippo et al., 2010, 
Yatsunenko et al., 2012). 
 
 Modulation of the colonic bacterial profile 
Human feeding trials as well as in vitro investigations have demonstrated that different 
foods and increasing NDC consumption alter the bacterial profile. Fava et al., (2013) 
demonstrated in overweight individuals that increasing overall carbohydrate consumption 
for 24 weeks increased Bacteroides, and Bifidobacterium spp populations (Fava et al., 
2013). This was in contrast to a 18 week investigation of overweight and obese individuals 
where consuming 43 g/day of cereal fibre had no influence on bacterial profiles (Weickert 
et al., 2011). This discrepancy in the role of different foods on bacterial changes is also 
demonstrated in feeding studies, which have been assessed using different bacterial 
methods (Table 1-9).  The different results could also be due to the large quantities of food 
required to have an effect on the bacterial profile.  Martinez et al., (2010) investigated the 
effect of the consumption of type 2 and type 4 resistant starch by 13 healthy individuals.  
Type 4 resistant starch influenced the bacterial profile reducing Firmicutes and increasing 
Bacteroidetes, Actinobacteria and Bifidobacterium, whereas type 2 resistant starch had no 
effect (Table 1-9), suggesting the physicochemical properties may lead to different 
bacterial profiles. Within this investigation, it was also observed that these effects were 
short lived, and once consumption of the starches had ceased the bacterial population 
returned to its initial state (Martinez et al., 2010).  Investigations from the same group 
(Sanz et al., [2005, 2006]) found different effects of FOS on bacterial production in vitro. 
For example, bifidobacteria increased in some (Sanz et al., 2005b, Sanz et al., 2006b), but 
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not all investigations (Sanz et al., 2006a), although all studies did not find any effect on 
total bacteria or lactobacilli.  This along with Table 1-9 demonstrates that the modulation 
of the bacteria with diet is complex and in many cases, for profound effects on the bacterial 
profile, large quantities of individual fibres for prolonged periods are required to maintain 
these changes. 
 
Table 1-9: Carbohydrate consumption and the bacterial composition 
References Food Intervention Bacterial changes Bacterial analysis 
(Kruse et al., 
1999) 
Inulin 8 healthy individuals 
34 g/day 8 weeks 
↑ Bifidobacterium 
NE total 
FISH 
(Gibson et 
al., 1995) 
Inulin 4 healthy individuals 
15 g/day for 15 days 
NE Total bacteria 
↑bifidobacteria 
NE Bacteroides 
NE Clostridia 
NE Lactobacilli 
Selective media 
plating 
(Gibson et 
al., 1995) 
OF 8 healthy individuals 
15 g/day for 15 days 
NE Total bacteria 
↑ bifidobacteria 
↓ Bacteroides 
↓ Clostridia 
↓  Lactobacilli 
Selective media 
plating 
(Bouhnik et 
al., 1999) 
OF 40 healthy individuals 
dose response 0 – 
20g/day for 7 days  
↑ bifidobacteria 
(10 g/ day and 20g/ day 
were optimal) 
Selective media 
plating 
(Beards et 
al., 2010a) 
Maltitol 10 healthy individuals 
consumed 45.6 g in 
100g chocolate 
↑Bifidobacterium 
↑Bacteroides 
↑Lactobacilli / 
enterococci 
↑ F.prausnitzii 
↑Total bacteria 
FISH 
(Beards et 
al., 2010a) 
Resistant 
starch 
10 healthy individuals 
consumed 45.6 g in 
100 g chocolate 
↑Bifidobacterium 
↑Bacteroides 
↑Lactobacilli / 
enterococci 
↑Total bacteria 
FISH 
(Walker et 
al., 2011) 
Resistant 
starch 
6 overweight 
individuals consuming  
50-60 g/day 
↑Eubacterium retale 
↑Ruminococcus bromii 
↑Roseburia 
NE Bacteroidetes, 
Bifidobacterium or 
F.prausnitzii 
qPCR 
(Martinez et 
al., 2010) 
Type 2 
resistant 
starch 
10 healthy individuals 
33 g/day for 3 weeks 
NE Firmicutes 
NE Bacteroidetes 
NE Actinobacteria 
NE Bifidobacterium 
16s rRNA 
pyrosequencing 
(Martinez et 
al., 2010) 
Type 4 
resistant 
starch 
10 healthy individuals 
33 g/day for 3 weeks 
↓ Firmicutes 
↑ Bacteroidetes 
↑ Actinobacteria 
↑ Bifidobacterium 
16s rRNA 
pyrosequencing 
NE= no effect ↓ = decreased ↑ = increased, FISH – fluorescence in situ hybridisation. OF = oligofructose 
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 Gut transit time 
Whole gut transit time in healthy individuals is approximately 24 -72 hours although this is 
highly variable between individuals (Wang et al., 2015, Read et al., 1980).  Gut transit time 
is associated with alterations in SCFA production and bacterial populations, and is also 
associated with different pH along the colon.  In an investigation where transit time was 
altered by the intake of cisapride and loperamide, thus decreasing or increasing transit time 
in healthy individuals, it was found that reduced transit time (measured using radio-opaque 
pellets) increased total faecal SCFA production (El Oufir et al., 1996).   Residence time 
has also been evaluated in vitro with continuous culture systems that allow control of the 
system retention time by changing dilution rate (Child et al., 2006).  Child et al., (2006) 
used a retention time of 20 or 60 hours to mimic the role of gut transit time on SCFA 
production and bacterial populations. Differences in microbial composition and SCFA 
production were found to be related to different retention times.  A reduced transit time 
decreased the proportion of acetate, whilst increasing the proportion of butyrate, although 
it had little effect on propionate production, which is in agreement with El Oufur et al., 
(1996).  Although differences in total bacteria have not been identified as a consequence of 
altered transit time, differences in the bacterial compositions have been noted (Child et al., 
2006, El Oufir et al., 1996, Rodes et al., 2011).  El Oufir et al., (1996) observed altered 
bacterial populations due to increased transit times with the number of methanogens 
decreasing, and sulphate reducing bacteria increasing in prevalence, although total bacteria 
(measured using selective media) was not altered. This has also been demonstrated in vitro 
where transit time was reduced from 20 hours to 60 hours and FISH analysis was used to 
assess bacterial changes. The reduced transit time increased the proportion of 
Faecalibacterium prausnitzii (a butyrate producer), but reduced Eubacterium recale and 
Clostridium coccoides.  Bifidobacterium spp however were able to withstand changes in 
transit time, suggesting that not all bacterial species were affected by changes in transit 
time (Child et al., 2006). 
 
 Colonic pH 
Different locations in the colon have different pH with the proximal colon having a lower 
pH (as low as 4.5) than that of the distal colon (neutral)(Fallingborg et al., 1989).  Low pH 
was associated with increased in acetate production, possibly due to reductions in lactic 
acid bacteria such as Anaerosties caccae, and Eubacterium hallii. As the pH increased to 
50 
 
 
~6.5 propionate and butyrate concentrations increased, likely due to increased populations 
of lactic acid bacteria (Belenguer et al., 2007).  
 
 Effect of pH on SCFA production 
The distal colon frequently has a higher pH than the proximal colon because of a lack of 
fermentable substrate and improved colonic buffering. Slowly fermented substrates that 
reach the distal colon and undergo fermentation may be especially useful as most disease 
occurs in the distal colon (Edwards and Eastwood, 1995).  In vitro investigations of the 
effect of pH on SCFA production are often carried out with the use of pH-controlled in 
vitro systems. For example, continuous culture studies conducted fermentations at a variety 
of pHs and clearly demonstrated an effect pH in each study but no overall pattern was 
established (Table 1-10) this may be due to the different bacterial profiles in each study. 
Walker et al., (2005) observed that after 200 hours increasing the pH from 5.5 to 6.5 led to 
changes in the bacterial composition using FISH analysis. A higher pH increased numbers 
of bacteria within the Bacteroides- Prevotella group, yet decreased F.prausnitzii, and 
Roseburia spp both of which are butyrate producers. This is also supported by the changes 
in butyrate production where the low initial pH favoured butyrate production.  In contrast, 
at the lower pH Bacteroides, and Clostridial cluster XVIa strains were reduced. As these 
bacteria yield propionate, this is supported by the observation that the higher pH favoured 
propionate production (Walker et al., 2005).  
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Table 1-10: SCFA proportion at different pH in controlled continuous fermentation systems 
Reference pH Acetate % Propionate % Butyrate% 
(Edwards et al., 1985) 5.0 54.8 37.0 8.2 
(Edwards et al., 1985) 6.0 46.7 48.9 4.4 
(Edwards et al., 1985) 7.0 67.4 29.8 2.8 
     
(Walker et al., 2005) 5.5 70.0 4.8 25.3 
(Walker et al., 2005) 6.5 69.3 15.4 15.4 
     
(Belenguer et al., 2011) 5.5 50.7 23.0 19.3 
(Belenguer et al., 2011) 6.0 53.4 29.8 16.9 
     
(Child et al., 2006) 5.5 62.0 22.3 15.7 
(Child et al., 2006) 6.2 61.4 23.5 15.1 
(Child et al., 2006) 6.8 57.3 26.5 16.2 
     
(Jiang and Savaiano, 1997) 5.7 42.4 52.1 5.4 
(Jiang and Savaiano, 1997) 6.2 53.4 31.3 15.3 
(Jiang and Savaiano, 1997) 6.7 61.4 38.5 0.1 
Data presented are the molar percentage of the SCFA production  
 
 Enzymatic degradation of non-digestible carbohydrates 
Colonic bacteria are responsible for catabolising the carbohydrates that have evaded 
digestion in the small intestine due to a lack of appropriate enzymes (CAZymes). For this 
carbohydrate catabolism, the colonic bacteria have developed a repertoire of saccharolytic 
enzymes that are upregulated when required. This enables the catabolism of a plethora of 
fibres and their constituent bonds, highlighting the symbiotic relationship that has 
developed between host and the gut microbiome. Different bacterial species have the 
ability to degrade different carbohydrates. For example, Bacteroides thetaiotaomicrom and 
Bacteroides ovatus are able to utilise a variety of different carbohydrate sources, with 
some common substrates but not all. B.ovatus could utilise hemicelluloses and beta-
glucans, whereas B. thetaiotaomicrom could not (Martens et al., 2011).  The importance of 
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this is demonstrated by metagenomic and population studies which have identified that 
after the house keeping genes, genes encoding the enzymes for the catabolism and 
utilisation of fibres and their sugars are predominant within the bacterial genome (Qin et 
al., 2010, Yatsunenko et al., 2012).  To-date there are five classes of CAZymes; Glycoside 
hydrolases (GHs), Glycosyl Transferases (GTs), Polysaccharide Lyases (PLs), 
Carbohydrate esterases (CEs), Auxilary activities (AAs), and carbohydrate-binding 
molecules (CBMs), all of which are further described on the CAZyme database; CAZy 
(www.cazy.org)(Lombard et al., 2014).  These classes of CAZymes consist of a wide 
variety of subfamilies, allowing a several carbohydrate structures and their linkages to be 
utilised (Lombard et al., 2014).  CAZymes, along with other proteins are required for 
degrading polysaccharides and these genes are expressed on polysaccharide utilisation loci 
(PUL).  PULs enable the utilisation of various substrates; an example is the starch 
utilisation system (SUS) enabling the degradation of starch (Martens et al., 2011, Rogers et 
al., 2013). 
 
Due to the varied human diet, many different enzymes are required to utilise the different 
polysaccharides consumed. As it is metabolically expensive to express all the enzymes 
available, CAZyme expression is tightly regulated. The gut bacteria may be generalist or 
specialist, Bacteroidetes, a major phylum in the gut are generalists and able to utilise many 
different polysaccharides. However, B. thetaiotaomicron can catabolise pectin and starch, 
while B. ovatus utilises hemicelluloses and β-glucans. This difference even among 
generalists demonstrates the requirement for a selection of bacteria with different PULs 
and CAZymes (Martens et al., 2011, Rogers et al., 2013).  Catabolism of dietary fibre to 
SCFA is determined by the colonic bacteria and the PULs present. The bacteria available 
determine the pathways used and as a result the SCFA that are produced.  The bacteria 
may work in concert and crossfeed synergistically which means that changes in the 
population induced by dietary changes can alter SCFA pathways in complex interactions. 
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 Pathways of SCFA production 
Fermentation of fibres by colonic bacteria to acetate, propionate and butyrate requires a 
series of steps. The equation summarising SCFA production from glucose fermentation 
(Christian et al., 2003) is: 
34.5 C6H12O6 --> 48 CH3COOH + 11 CH3CH2COOH + 5 CH3CH2 CH2COOH 
+  23.75 CH4+ 34.2 CO2 + 10.5 H2O. 
 
 Acetate production 
The main pathways of acetate production are the Embden-Meyerhof-Parnas (EMP) 
pathway (glycolysis) and Wood-ljungdahl pathway (reductive acetyl-CoA pathway) 
(Wolin et al., 1999).  The EMP pathway produces acetate via pyruvate and acetyl-CoA 
using oxidative decarboxylation.  This pathway utilises glucose, where one molecule of 
glucose leads to three molecules of acetate (Figure 1-6) (Wolin et al., 1999).  The final step 
for acetate production requires acetate kinase and generates of one molecule of ATP 
(Munoz-Tamayo et al., 2011). 
 
The Wood-ljungdahl pathway (reductive acetyl-CoA pathway) mobilises two molecules of 
carbon dioxide for the production of acetate. This pathway has two streams leading to the 
production of acetyl-CoA, these are the methyl and carbonyl (Figure 1-7).  The methyl 
branch produces the methyl group of acetyl-CoA by forming a series of tetrahydrofolate 
molecules. The carbonyl end occurs by the reduction of carbon dioxide (CO2) to carbon 
monoxide, a process which has been shown to be carried out by Blautia 
hydrogenotrophica (Louis et al., 2014). 
 
For both pathways, acetyl-CoA is produced via acetyl-CoA synthetase, which then initiates 
a process leading to the production of acetate. Acetate then is either converted to butyrate 
or enters the colonic lumen and is then absorbed (Wolin et al., 1999). 
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Figure 1-6:  Embden-meyerhof-parnas pathway (glycolysis). 
Acetate is production from glucose with the use of acetate kinase, and interconversion of acetate to 
butyrate occurs via acetyl-CoA. Asterix (*) indicates acetate kinase. 
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Figure 1-7: Wood Ljungdahl pathway (reductive acetyl-CoA pathway) of acetate production. 
THF = tetrahydrofolate (FH4) 
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 Propionate production 
 Succinate pathway 
The majority of propionate is produced via the succinate pathway (Wolin et al., 1999). 
This occurs by the conversion of oxaloacetate to succinate, then to propionyl-CoA then 
leading to the generation of propionate (Figure 1-8). When succinate is converted to 
propionyl-CoA one molecule of CO2 is formed by the decarboxylation of methyl-malonyl-
CoA. This is then further recycled for the re-carboxylation of oxaloacetate. Due to its 
symmetrical structure succinate is unique, this structure results in either of the two 
carboxylic acid ends being decarboxylated  (Hosseini et al., 2011). Consequently, it is 
challenging to carry out pathway analysis of succinate.  Using the isotopically labelled 
carbon, 13C it was observed that after decarboxylation of succinate, 50% of the 13C label 
was identified in methyl end and 50% was at the carboxyl end of propionate due to 
succinate being symmetrical (Wolin et al., 1999). 
 
A variety of colonic bacteria produce propionate via the succinate pathway. Bacteroides 
strains such as B.thetaiotaomicron utilises methyl-malonyl-CoA in addition to a variety of 
polysaccharides and peptides to produce propionate (Reichardt et al., 2014). Bacteroidetes 
and Veillonella parvula (a type of negativicutes) produce succinate in the presence of 
lactate. Phascolarctobacterium succinatutens is a succinate utiliser and produces 
propionate from succinate (Reichardt et al., 2014). Other bacteria producing propionate via 
the succinate pathway include Firmicutes, Clostridial cluster IX (now called negativicutes) 
(which are present in high concentrations like Bacteroides) (Reichardt et al., 2014). 
 
 Acrylate pathway 
The acrylate pathway produces propionate by forming acryl-CoA via lactate ultimately 
leading to propionate (Figure 1-8). There is a variety of different bacteria, which utilise the 
lactate pathway to produce propionate. These include Eubcaterium hallii and Veillonella 
spp, with the lactate being produced from pyruvate (Louis et al., 2014, Reichardt et al., 
2014).  Coprococcus cactus and Megasphaera elsdenii (negativicutes) also produce 
propionate via lactate (Louis et al., 2014, Reichardt et al., 2014). 
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 Propane-diol pathway 
The propane-diol pathway leads to the production of propionate with propanal being 
produced as a bi-product.  Salmonella enterica typhimurium is an example of a bacterial 
species that has the ability to produce propionate via this pathway (Reichardt et al., 2014). 
Roseburia inulinvorans is also associated with propionate production when grown on 
fucose.  R.inulinvorans it is associated with increased butyrate production when grown on 
glucose, demonstrating the role of substrate on the preference of SCFA production.  Other 
ruminococcus species such as Ruminococcus obeum is also associated with producing 
propionate via this pathway, but also leads to butyrate production (Reichardt et al., 2014). 
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Figure 1-8: Pathways of propionate production,. 
Left: Succinate pathway, Centre: Acrylate pathway, Right: Propane-diol-pathway based on (Reichardt et al., 
2014). 
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 Butyrate production 
Approximately 85% of all butyrate production occurs from the interconversion of acetate 
(Duncan et al., 2004) (Figure 1-6). Duncan et al., (2004) identified using Roseburia 
intestinalis and F.prausntizii that up to 90% of butyrate was produced from acetate, 
although this was not possible by all acetate producers (Duncan et al., 2004). For 
interconversion of acetate to butyrate to occur Butyryl CoA: Acetate CoA transferase is 
required and has been shown to be present in F.prausnitzii, Eubacterium rectale,  
Roseburia faecis, and R.intestinalis (Duncan et al., 2004, Reichardt et al., 2014, Louis et 
al., 2010). 
 
About 15% of all butyrate is produced directly via the intermediates, butyryl-CoA and 
butyrate phosphate (Figure 1-9). For this to occur the bacteria possessing the enzyme, 
butyrate kinase is required. B. thetaiotaomicron, B.fragilis, B. vulgatis, Coprococcus 
eutactus as well as Clostridium difficile have the genes for butyrate kinase for direct 
butyrate production. Often bacteria that directly produce butyrate are unable to produce 
propionate suggesting that these bacteria only have the enzymes to allow for butyrate, or 
propionate production, but not both. There are exceptions to this rule, for example 
C.eutactus can produce propionate and butyrate, this occurs as it utilises lactate for 
propionate production and acetate for butyrate production (Reichardt et al., 2014). 
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Figure 1-9: Direct Butyrate production and butyrate production by interconversion. 
(*) indicates butyryl CoA: Acetate CoA transferase 
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This review of the potential roles of NDC and the production of propionate has highlighted 
many of the gaps in our knowledge, and in particular, the lack of a systematic approach in 
determining which physicochemical properties drive propionate production.  Generally 
accepted assumptions about which substrates are propiogenic are not necessarily supported 
by the evidence and differences in methodology make comparisons of studies difficult. It is 
not yet fully understood if the type of NDC is the most important factor, or indeed what it 
is about an NDC that promotes different profiles of SCFA.  It is not clear if the pH, 
bacterial profile or transit times are more influential.    
 Aims and objectives 
What has been highlighted is the lack of a systematic approach for the assessment of which 
carbohydrates are best suited for the production of propionate.  This PhD sought to 
elucidate some of the mechanisms that promote propionate production. This led to the 
following aims and objectives: 
 
1. To carry out a systematic review of the investigations that have conducted in vitro 
batch fermentations of carbohydrate sources to identify propiogenic substrates. 
2. To generate a new term to quantify SCFA production in cultures of faecal bacteria 
with different volumes and substrate concentrations. 
3. To screen a selection of potentially propiogenic substrates identified within the 
systematic review, as well as other sources in vitro batch cultures using human 
faecal bacteria. 
4. To explore the factors that increase propionate production such as the carbohydrate 
source, the role of bond anomer configuration and position using glucose-glucose 
disaccharides, initial culture pH.  
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  Materials and Methods 
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This chapter contains a discussion of the choice of model for the in vitro fermentation 
studies.  It also describes the methods used in the experimental chapters but the rationale 
and overall design for each study are explained in the relevant chapters (Figure 2-1). 
 
 Experimental models for assessment of the SCFA production of different 
substrates 
The SCFA producing capabilities of different NDCs can be tested in a number of different 
ways in humans and animals. In vitro analysis has also been used to provide the 
information for in silico prediction of SCFA production (Kettle et al., 2015). 
 
 Human studies of SCFA production 
Assessment of SCFA production in humans is difficult due to rapid absorption, and 
inaccessibility of the proximal colon. Few studies have adequately assessed the production 
in humans.  Cummings et al., (1987) and Macfarlane et al., (1992)  used samples from 
different parts of the colon of sudden death patients to assess SCFA concentrations as 
material moves along the large intestine.  The same group also used sudden death victims 
to assess SCFA concentrations in the liver, and peripheral blood (Cummings et al., 1987). 
Systematic review 
 (Chapter 3) 
Screening 
(Chapter 5) 
Miniaturisation    
(Chapter 4) 
Mycoprotein 
(Chapter 7) 
Disaccharides 
(Chapter 6) 
Figure 2-1: Flow chart of the experimental chapters within this thesis 
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Very few studies have assessed production itself.  Bloemen et al., (2009) assessed 
production in surgery patients, but these were in the fasted state.  
 
Assessing human SCFA production after consumption of a certain fibre is difficult as the 
proximal colon is so inaccessible. The impact of different foods on faecal SCFA (which is 
often presumed to be associated with production in the colon [Edwards and Eastwood., 
1992]) has been estimated in human feeding studies (Table 1-5).  These includes long term 
studies e.g. 28 days (Beards et al., 2010b) or for several months (Chambers et al., 2014) or 
acutely where the effect of a single meal is assessed (Tarini and Wolever, 2010). One of 
the main issues with these types of study is that it is difficult to control the habitual diet of 
the individuals tested.   
 
The fermentability of a substrate can be estimated by measuring breath hydrogen, or 
measuring SCFA in blood samples (mostly acetate), urine (Verbeke et al., 2010) or in a 
faecal samples (Beards et al., 2010b).  These methods have several issues when used as an 
index of SCFA production in the colon. For example, breath hydrogen is only an indicator 
of fermentation and does not give any information about the amount or types of SCFA 
production. Breath hydrogen can also be reduced if colonic hydrogen is used by 
methanogens in the colon, which are present in about one third to half of the population 
(Fernandes et al., 2000). Measuring SCFA in blood plasma is also fraught with difficulties 
as butyrate is extensively metabolised by the colonic enterocytes.  The remainder of the 
butyrate and propionate are removed in the liver, and it is mainly acetate which reaches the 
peripheral blood (Bloemen et al., 2009).  However, acetate is also made by human cells 
and fasting levels are likely to be of human rather than bacterial origin. Urinary SCFA are 
often at low concentrations and mostly consist of acetate with very low amounts of 
propionate and butyrate. Faecal SCFA can be misleading as 95% of the SCFA produced in 
the colonic lumen are absorbed (den Besten et al., 2013b). Assessment of colonic SCFA by 
measuring  faecal samples is further hindered as each SCFA has been shown in a rectal 
infusion study, to be absorbed at different rates, with butyrate being preferentially 
absorbed over acetate (Vogt and Wolever, 2003). 
 
An alternative is to use stable isotopes which could be employed as a direct measure of 
SCFA production by feeding a labelled NDC and measuring labelled SCFA, or indirectly 
by infusing labelled SCFA and noting the dilution by exogenous production. This method 
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was employed by Boets et al., (2015), by feeding 15g of 14C-carboxylic acid inulin to 
healthy adults. This provided both assessment of breath hydrogen and breath 14CO2 to 
provide a marker of fermentation and transit time (Boets et al., 2015). Assessment of 
acetate production, also used a similar method, where unlabelled lactulose was consumed 
and an infusion of 13C- acetate given only.  This enabled the analysis of breath hydrogen 
production and acetate concentrations in the peripheral blood, which enabled colonic 
acetate production to be calculated (Pouteau et al., 1998). An issues this this methodology 
is that to quantify SCFA production the concentration of splanchnic uptake of SCFA is 
required, which is variable between individuals, thus making it an unreliable method of 
assessing SCFA production. 
 
 Animal studies of SCFA production 
Animal models are another way to assess the SCFA produced from different substrates. 
Animal models allow better regulation of the environment, food consumption and other 
aspects of control than is possible in human trials. The main advantage of animal studies is 
that the caecum and different regions of the colon can be accessed, which is not possible in 
healthy free-living humans.  Animal studies can also provide direct access to the tissues 
and allow more mechanistic studies to be carried out.  For example  mouse models have 
shown an effect of diet on the bacterial profile (Ridaura et al., 2013), the effect of SCFA 
on induced pathologies, e.g. inflammation (Trompette et al., 2014), and the mechanisms by 
which some of the down-stream effects of SCFA such as food intake, body weight and 
hormone release (Lin et al., 2012). 
 
There are also disadvantages in using animals to assess the production of SCFA by 
different substrates.  Animal studies can be very expensive and different species have 
different physiological systems to humans, making it difficult translate findings. For 
example rats are coprophagic but are often used.  Coprophagy may alter gut bacterial 
profiles and SCFA produced, causing further difficulties in the translation to the human gut 
but coprophagy can be reduced with suitable housing (Ridaura et al., 2013).  Edwards and 
Eastwood (1992) fed rats ispaghula or wheat bran for 28 days.  After sacrifice, the colon 
and cecum was removed and SCFA production within these regions, as well as in the 
faeces was measured. This led to the observation that SCFA concentrations reduced from 
the cecum to the faeces with a standard diet. It also showed that ispaghula consumption 
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increased SCFA concentrations in the whole of the large intestine (Edwards and Eastwood, 
1992).   
 
Assessment of SCFA production from different substrates has also been carried out in pigs 
that were cannulated via the cecum, giving access to the caecal contents. This model was 
used to assess the effect of 2 weeks of chicory or sugarbeet pulp in the animal diet on 
SCFA production.  It showed that propionate increased by 28% with the diet containing 
sugarbeet pulp compared with chicory (Ivarsson et al., 2012).  Animal models should be 
validated against human physiology where possible and any extrapolation of results should 
be made with caution (Sunvold et al., 1995, Edwards et al., 1992).  
 
  In vitro models of fermentation 
Much of the assessment of the SCFA production from a dietary fibre is carried out using in 
vitro methodologies. Due to the location of the colon and the rapid absorption of SCFA 
from the colon, it is impractical to investigate colonic SCFA production directly in 
humans. Many different in vitro models mimicking the gut have been developed. These 
systems range from simple batch fermenters modelling only the large intestine, to those 
that aim to model the whole gut such as the simulator of the human intestinal microbial 
system (SHIME)(Molly et al., 1993), these are discussed below. 
 
In vitro models can be inoculated by human or animal gut bacteria and from animals this 
can be from caecum or colonic contents as well as faeces. These are discussed below and 
Table 2-1 and are also reviewed in (Williams et al., 2015), (Payne et al., 2012) and (COST 
Action FA1005, 2015 ). 
 
 Batch fermentations   
Batch fermentations are static fermenter systems that can provide different levels of 
control depending on the user’s needs.  At a basic level, these systems require a source of 
bacteria, often from a faecal slurry, some liquid such as phosphate buffer or a nutrient 
containing buffer a substrate to ferment (although a substrate free control is also needed), 
all within an anaerobic vessel.  Additional controls can include temperature control (with a 
water bath or incubator) and movement (by a stirrer or shaking water bath).  These systems 
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are effective for approximately 48 hours but have been used for up to 72 hours (Rasmussen 
et al., 1988).  This method has been used on numerous occasions (Chapter 3) and various 
attempts have been made to standardise the protocol between different institutions (Barry 
et al., 1995, Edwards et al., 1996) (COST Action FA1005., 2015).  A more controlled form 
of batch fermentation is also available where the pH is maintained at a chosen level for the 
duration of the fermentation by the addition of an acid or a base.   
 
Batch fermentations were utilised by Sunvold et al., (1995) to assess the SCFA producing 
capabilities of four NDCs (cellulose, beet pulp, citrus pulp and citrus pectin) using faecal 
samples from humans, dogs, cats, pigs, horses and ruminal fluid of cattle for 48 hours. 
Patterns of SCFA production were similar for all (although concentrations were not), and 
that the substrate composition (e.g solubility) and fermentability was important in 
determining SCFA production in all of the inoculum tested (Sunvold et al., 1995). 
 
Variations of batch systems 
 
As these batch systems are quite simple and there are many ways to alter the system.  For 
example, different investigations use different media. Adiotomre et al., (1990)  used a 
media that comprised of a selection of trypticase, minerals and a carbonate-phosphate 
buffer, whereas Barry et al., (1995) utilised the same buffer but without the trypticase. In 
contrast, Edwards et al., (1996) did not use a complex media but carried out fermentations 
of starch with phosphate buffer and faecal inoculum alone.  Other modifications of the 
media include the addition of  an amino acid source such as yeast extract (Deville, 2007), 
casein hydrolysate (Belenguer et al., 2007), or brain heart infusion (Cherbut et al., 1991).  
Although complex media are not required per se for batch fermentations, complex media 
can be used in an attempt to promote bacterial growth by providing all of the substrates 
required. These media can also contain low concentrations of carbohydrate sugars for 
fermentation (e.g 0.015% w/vol arabinoxylan), and low concentrations of SCFA (35 
mmol/l) (Belenguer et al., 2007). Additional bacteria, such as B.thetaiotaomicron, and 
E.coli  have previously been added to the media to assess their role in SCFA production 
(Dongowski et al., 2000). 
 
Fermentation systems are made anaerobic in a number of ways such as with the use of 
carbon dioxide, reducing agents (e.g sodium sulphide, cysteine hydrochloride) (Adiotomre 
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et al., 1990), oxygen free nitrogen (Edwards et al., 1996), anaerobic chamber (Cardelle-
Cobas et al., 2009) and oxyrase for broth (Rumpagaporn et al., 2012). When the 
fermentation system is not in an anaerobic chamber, anaerobic conditions are maintained 
by sealing the bottle so it is airtight. 
 
Fermentations inoculums can also consist of a single stool sample (non-pooled), or with 
multiple samples that have been combined and used as the inoculum (pooled) (Aguirre et 
al., 2014).  
 
Substrates within the fermentation system can also differ where different quantities of 
substrates are added to the vials. For example, Khan and Edwards., (2002) increased the 
amount of substrate in the fermentation vials from 2.5 mg/ml to 10.0 mg/ml in 2.5 mg/ ml 
increments and found that higher substrate concentrations were inhibitory for SCFA 
production after 24 hours of fermentation. This was likely as a result of product inhibition 
due to increased SCFA in the fermentation vials, reducing further SCFA production (Khan 
and Edwards, 2002).  As well as different substrate quantities differences in fermenter 
volume are used, for example Sanz., et al (2005) used a final volume of 1 ml, Edwards et 
al., (1996) conducted fermentations in 10 ml, and Adiotomore et al., (1990) had a final 
volume of 50 ml.  
 
The fluid surface area to fluid volume ratio (SA:V) of the fermenter vial has also been 
demonstrated in vitro to alter total SCFA production after 24 hours (Stevenson et al., 
1997).  The SA:V from 1:1 to 1:4, was reduced by changing the position of  the 
fermentation bottle within the incubator, which reduced the accessibility of the bacteria to 
the substrate. Pectin, starch and ispaghula were fermented and total SCFA production was 
reduced with SA:V  ratio of 1:4 for pectin and starch, but not ispaghula and only at high 
substrate concentrations (10 g / L-1).  Given that the effect of SA:V was inconsistent across 
the substrates tested, it remains unclear whether variations in SA:V truly alters the rate and 
amount of substrate fermentation or whether this phenomenon is restricted to selected 
substrates.  
 
Sampling time points also differ between studies.  The ability to take samples can be 
limited by the volume in the fermentation vessel.  Sanz et al., (2005)  used one time point 
for SCFA analysis (12 hours) as fermentations were conducted with a final volume of 1ml.  
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Kaur et al., (2011) had four time points (4, 8, 24, and 48 hours) and removed the 
fermentation vial at each time point for analysis and Khan and Edwards., (2002) took 
samples from the same fermenter vial after 4, 8, and 24 hours. Therefore, SCFA 
production could seem to be different at each time point as different fibres are utilised at 
different rates.  Pylkas et al., (2005) sampled at 0, 2, 4, 8, 12 and 24 hours and showed that 
SCFA production from cellulose was complete by 8 hours, production from polydextrose 
was complete by 12 hours and guar gum was not fully fermented after 24 hours (Pylkas et 
al., 2005).  Batch cultures change in growth characteristics with time.  They have an initial 
lag phase followed by exponential growth, a stationary phase and then death.  In contrast, 
continuous or semi-continuous cultures are maintained at steady state, which better reflects 
conditions in the human colon. 
 
  Continuous culture fermentations 
Continuous fermentations enable the in vitro assessment of different substrates at steady 
state but with more control, dilution of fermentation products, which reduces product 
inhibition, and often for a longer duration, and increases the complexity as the amount of 
regulation from the single stage to the multistage models increases. These systems vary in 
complexity with some having only one chamber and others mimicking the whole gut but 
also have pros and cons.  These systems all generate data that can be easily compared to 
the human system, and can assess changes in bacterial profiles, without the requirement of 
metagenomic analysis such as those conducted by De Filippo et al., (2010) and David et 
al., (2014). 
 
 Single stage fermenters 
These systems mimic the proximal colon only, and maintain the volume, pH, temperature, 
and mass of substrate within the system.  These models can be used and sampled for a 
period of up to approximately 3 weeks. 
 
This system has been adopted by Walker et al., (2005) and Edwards et al., (1985) where 
the ability to modify the pH during the fermentation was used to assess the effect of a shift 
in pH on the bacterial populations as well as SCFA production.  For fermentation studies 
of food, a pre-digestion stage is often needed to remove material that would normally be 
digested and absorbed in the upper gut.  This can be performed with in vitro models of 
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upper gut digestion but could also be done after consumption of foods by ileostomy 
patients and then their effluent used as a fermentation substrate. For example, this 
methodology was used by Fassler et al., (2007) who used the ileostomy effluent of 
ileostomy patients who consumed 40 g/day of resistant starch type 3 for three days, this 
pre-digestion step provided substrate to be fermented with batch and continuous culture 
(Fassler et al., 2007). 
 
 Multi stage fermenters -Colonic systems 
The fermentation systems become much more complex with the multi-chamber systems. 
These systems can model different areas of the colon, such as the proximal, transverse, 
distal, and sigmoid colon/ rectum. These systems have a variety of different uses in 
studying the metabolism of substrates in the large intestine. For example, the three- stage 
continuous model, which has three vessels at different pH (proximal, transverse, and distal) 
can undergo the control that occurs with single stage fermenters but also allows the 
contents of each vessel to move into a different vessel, i.e. modelling the movement along 
the colon. The investigation by Child et al., (2006) used this system to assess the changes 
in bacterial and SCFA composition at different colonic pH for a period of 60 hours (Child 
et al., 2006). 
 
 Multi stage fermenters –Gastrointestinal tract systems 
Gastrointestinal tract systems that mimic the whole gut have also been developed, 
examples include, the SHIME system (Molly et al., 1993) and the Toegepast 
Natuurwetenschappelijk Onderzoek (TNO) intestinal model (TIM) (Minekus et al., 1999) 
and are controlled via a computer.  A further advantage of these systems is that they are 
both able to mimic ‘absorption’ by dialysis, in which the dialysate contains metabolites 
such as SCFA. The SHIME system models the stomach, SI, ascending, transverse and 
descending colon, this system can be maintained for many days and is highly controlled. 
Unlike other continuous models this also enables ‘digestion’ to be part of the assessment 
with the use of digestive enzymes and the absorption of the metabolites produced in the 
upper GI tract. This model requires approximately 14 days for stabilisation (Molly et al., 
1993). There are two different TIM models, TIM-1 and TIM-2. TIM-1 models the upper 
gut whereas TIM-2 models the colon. TIM-2 consists of a loop of four different containers 
that are able to mimic peristaltic mixing and is able to function alongside the TIM-1 
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model, and enables the assessment of the absorption of metabolites up to 50kDa in size by 
dialysis (Minekus et al., 1999). Both of these systems have been utilised and compared in 
the investigation by Van den Abbeele et al., (2013) where the SHIME and the TIM-2 
model were compared in terms of fermentation of long chain arabinoxylan and inulin. Both 
models demonstrated similar effects of the NDC on SCFA production and bacterial 
composition (Van den Abbeele et al., 2013).  
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Table 2-1: In vitro models for investigating SCFA production by different substrates 
Table based on 1. (Edwards et al., 1996),(Khan and Edwards, 2005), 2. (Edwards et al., 1985), 3. 
(Macfarlane et al., 1998), 4. (Makivuokko et al., 2005), 5. (Molly et al., 1993), 6. (Minekus et al., 1995), 7. 
(Minekus et al., 1999, Williams et al., 2015, Payne et al., 2012)(COST Action FA1005., 2015 ).  
Abbreviations: SHIME- Simulator of the human intestinal microbial ecosystem, TIM- TNO intestinal model, 
SI- Small intestine.  
 
 
Model Description Advantages Disadvantages  
Batch1 Static fermenter 
system 
x pH can be controlled 
x Temperature control 
x Allows screening of many 
samples 
x Inexpensive and does not 
require high level skills 
 
x pH may change 
rapidly when not 
controlled 
x Build-up of potentially 
inhibitory products 
x Simplistic model of 
the colon 
x Short term 
Single- chamber 
continuous2 
Semi-continuous 
x Steady state 
x Pulses of new media 
mimic ileal delivery  
x Provide pH, temperature, 
stirring control 
x Can use for longer 
durations 
x Effective for assessment 
of bacterial changes 
x More expensive than 
batch techniques 
x Simplistic model of 
the colon 
x Low throughput 
 
Three-stage 
continuous 3 
Three chambers at 
pH 5.5 (proximal), 
6.2 (transverse) and 
6.8 (distal) 
x Allows different parts of 
the colon to be 
investigated 
x Can be long term 
x Provide pH control 
x Reliable  
x Inexpensive 
x Does not account for 
absorption, or other 
secretions 
x Low throughput 
x Short term <1 week 
 
EnteroMix® 
semicontinuous 
culture4 
Four chambers at 
pH 5.0 (proximal), 
6.0 (transverse), 6.5 
(distal), and 7.0 
(sigmoid 
colon/rectum) 
x Allows different parts of 
the colon to be 
investigated 
x Many experiments can be 
conducted at the same 
time 
x Expensive 
x Only short term 
experiments  
SHIME5 
5 reactors; 
Stomach, Small 
intestine, proximal, 
transverse and 
distal colon 
x  Digestion 
x Continuously stirred 
x Computer controlled, 
increasing reliability 
controlled 
x Continuous stirring 
x Expensive 
x Requires 2 weeks of 
stabilisation. 
x Low through put  
 
TIM-16 
8 reactors; stomach, 
Small intestine 
(duodenum, 
jejunum, ileum) 
x Digestion 
x Computer controlled 
x SI peristaltic pump 
moving contents 
x Can alter gut transit time 
x Absorption  
x Allow dialysis of 5 kDa 
x Expensive 
x Low throughput 
x Expertise required 
 
TIM-27 4 looping reactors 
as proximal colon 
x Peristaltic pump for 
mixing  
x Membrane allows nutrient 
absorption  
x Allow dialysis of 50 kDa 
x Expensive 
x Low throughput 
x Expertise required 
x Limited to three days 
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 Methods used in this thesis 
Due to the cost effectiveness and the ability to screen a large number of samples the in 
vitro batch system, without continuous pH control were used. These systems were 
inoculated with stool samples from healthy individuals in a system adapted from that of 
Adiotomre et al., (1990) and Laurentin and Edwards., (2004). 
 
 Batch fermentations 
 Faecal sample collection and preparation 
Stool samples were obtained from healthy Caucasian individuals and prepared within 2 
hours of passage. The samples were stored with an anaerobic sachet (Oxoid, Basingstoke, 
UK) within an airtight bag to facilitate an anaerobic environment, and placed within a bag 
containing a frozen icepack. Participants had not taken antibiotics within the previous 6 
months and had no GI disease.  Details of the number, and age and gender of individuals 
who provided stool samples are provided within each chapter.  
 
Ethical permission was granted by the University of Glasgow, College of Medical, 
Veterinary and Life Sciences (MVLS) Ethics Committee, with the faecal donors giving 
informed written consent (information sheet in appendix 1 and 2).  
 
Faecal samples were homogenised initially with a wooden tongue depressor, until the 
sample was uniform.  An aliquot was combined with sodium phosphate buffer (Sorenson’s 
buffer (0.133 M) 36 parts 0.066 M KH2PO4 and 61 parts 0.066 M Na2HPO4 at pH 7), to 
form a 32% faecal slurry and mixed with a blender until the sample was fully 
homogenised. Once homogenised, the faecal slurry was strained through a nylon stocking 
and immediately injected into the airtight fermentation vials.  The bottle was then flushed 
with oxygen free nitrogen (OFN) to create an anaerobic environment. 
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 Fermentation Media 
Standard fermentation media 
 
The fermentation medium as described in Adiotomre et al., (1990) was prepared 24 hours 
(or less) prior to the fermentation experiment and stored at 4oC. To produce 1 L of 
fermentation medium; 2.25 g tryptone, 450 ml dH2O, 112.5 μl micromineral solution, 225 
ml bicarbonate buffer solution, 225 ml macromineral solution (Table 2-2) and 1.125 ml 
0.1% resazurin to indicate anaerobic conditions.  This then boiled on a heat pad for five 
minutes to sterilise and remove any dissolved oxygen and cooled under OFN until 37oC.  
The fermentation medium was adjusted to pH 7 with 6 M HCl, added to the sterile, airtight 
fermentation vessels (no faecal slurry was present) and these were gassed with OFN until 
the vessel contents were anaerobic (based on the colour of resazurin). From this point 
onwards, the vessels remained airtight (further discussed below). Any alterations to this 
media are detailed in the chapter in which the relevant modification was introduced. 
 
Impact of initial pH studies.  
 
The experiments were based on the standard fermentation media method. The only 
modifications were the medium composition and the pH adjustment. All other processes 
were the same. 
pH 6.8: Per 1 L of fermentation medium; 2.25 g tryptone, 112.5 μl micromineral solution, 
225 ml bicarbonate buffer solution, 675ml macromineral solution (pH 6.8) (Table 
2-2) and 1.125 ml 0.1% resazurin to indicate anaerobic conditions. pH was 
adjusted to 6.8 after boiling. 
 
pH 5.4: Per 1 L of fermentation medium; 2.25 g tryptone, 112.5 μl micromineral solution, 
225 ml bicarbonate buffer solution, 675 ml macromineral solution (pH 5.4) (Table 
2-2) and 1.125 ml 0.1% resazurin to indicate anaerobic conditions. pH was 
adjusted to 5.4 after boiling. 
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Table 2-2: Composition of the solutions required to make 100ml of micromineral medium, 
bicarbonate butter and the standard, pH 6.8 and pH 5.4 macromedia media 
Micromineral 
Medium 
Bicarbonate 
Buffer 
Macromineral 
Solution - 
Standard 
Macromineral 
Solution - pH 6.8  
Macromineral 
Solution - pH 
5.4  
13.2 g CaCl2.2H2O  0.4 g NH4HCO3 0.57 g Na2HPO4 0.3 g   Na2HPO4  1.59 g  Na2HPO4  
10 g MnCl2.4H2O 3.5 g NaHCO3 0.62 g  KH2PO4 0.28 g  Na2PO4  0.85 g  C6H8O7 
1 g CoCl2.6H2O 100 ml dH2O 0.06 g 
MgSO4.7H2O 
0.06 g  
MgSO4.7H2O 
0.06 g  
MgSO4.7H2O 
8 g FeCl3.6H2O 
 
100 ml dH2O 100 ml dH2O 100 ml dH2O 
100 ml dH2O 
    
All reagents were made prior to fermentation, dH2O = distilled water 
 
Table 2-3: Composition of the reducing solution per 100ml 
Per 100ml Reducing solution reagents 
0.623g HSCH2CH(NH2)COOH HCl (Cysteine hydrochloride) 
0.623g Na2SO4.9H2O (Sodium sulphide non anhydrate) 
4ml     1M NaOH 
96ml  dH2O 
Solution was made just before use, dH2O = distilled water 
 
 Fermentation method 
Fermentations experiments were conducted with substrate sample sizes of 1g, 0.2g, 0.1g, 
and 0.05g. For all investigations the method was scaled proportionately (Table 2-4, Figure 
2-2). 
 
Table 2-4: Differences in quantities used between different vial sizes 
  Standard Mid-sized Medium Small  
Vial Size 100ml 27ml 10ml 6ml 
Substrate added 1g 0.2g 0.1g 0.05g 
Fermentation medium 42ml 8.4ml 4.2ml 2.1ml 
Reducing solution 2ml 400μl 200μl 100μl 
Faecal slurry 5ml 1ml 500μl 250μl 
Samples taken at each 
time point 3ml 1.6ml 800μl 400μl 
NaOH 1ml  600μl 300μl 150μl 
 
76 
 
 
 
 
Figure 2-2: Vials used for the different sized fermentation systems: 
Standard: Minaturisation (Chapter 4), Midsized: pH change, propiogenic substrates, starch fractions (Chapter 
5), Medium: Miniaturisation (Chapter 4) beta glucans, legumes, starch fractions (Chapter 5), mycoptrotein 
(Chapter 7), Small: Miniaturisation (Chapter 4), Disaccharides (Chapter 6)  
 
The ‘standard’ fermentation method is discussed here. On the day of the incubations the 
fermentation media was boiled for 5 minutes and cooled in OFN to 37○C, ensuring that all 
oxygen was removed from the medium, based on the colour change of resazurin (purple to 
clear). The pH was then readjusted to give a final pH of 7.0.   
 
To each 100 ml bottle containing 1 g of each test substrate (Figure 2-2), 42 ml of reduced 
fermentation medium (Table 2-2) and 2 ml of reducing solution (Table 2-3) were added.  
Bottles were crimp sealed with silicon septa and aluminium caps (so gas tight) and 
degassed with OFN for one minute with the use of a needle (one for the OFN, another to 
allow oxygen to be displaced) ensuring media was clear/ pale pink, demonstrating the lack 
of oxygen in the vial. A 5 ml aliquot of filtered faecal slurry was injected into the bottles 
and degassed with OFN for a further minute.  At 0 hours an aliquot of fermentation sample 
was obtained with a needle and syringe bottles were then incubated at 37oC at 60 
strokes/min. Aliquots of 3 ml were obtained with a needle and syringe at each time point 
and the pH measured with a (Mettler Toledo) pH meter, when required a semi-micro pH 
probe (Mettler Toledo) was used. To preserve and store the SCFAs, 1 ml of 1 M NaOH 
was added and then frozen at -20oC until extraction. All investigations had aliquots taken 
at 0 and 24 hours, other time points used are discussed within each relevant chapter. The 
sample volume taken and therefore the amount of 1 M NaOH required was dependent on 
the size of fermentation vial, volumes are in shown in (Table 2-4, Figure 2-2).  
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 SCFA Analysis 
SCFAs were extracted from fermentation slurries at each time point and underwent 
analysis by GC:FID. 
 
 SCFA extraction 
To allow quantitation of each SCFA, an external standard curve and internal standard were 
used to calculate SCFA concentrations within each sample. The external standard 
contained known concentrations of acetic acid (C2, 183.51 mM), propionic acid (C3, 
132.52 mM), butyric acid (C4, 107.06 mM), valeric acid (C5, 88.63 mM), caproic acid 
(C6, 74.36 mM), enanthic acid (C7, 66.25 mM), caprylic acid (C8, 57.84 mM), isobutyric 
acid (iC3, 104.13 mM), isovaleric acid (iC5, 86.59 mM), and isocarpoic acid (iC6, 50.93 
mM) all of which were contained in 2 M NaOH to prevent loss of SCFA. To account for 
losses of SCFA in the standards and samples an internal standard of 2-Ethyl butyric acid 
(73.8 mM, also in 2 M NaOH) was also added to all samples. SCFA were extracted from 
the external standard with the following method. Standards extracted by adding different 
concentrations of standard which was made up to 800 μl with distilled water, 100 μl 
internal standard, 100 μl orthophosphoric acid (OPA), and 3 ml diethyl-ether, per sample 
Table 2-5. This was then vortexed for 1 minute, the ether layer removed and 1 ml of 
diethyl-ether added and vortexed for 1 minute again, for a total of 3 times. For the samples, 
the same process was used with 800μl of slurry used in lieu of the 800 μl standard/water 
mix.   
 
Due to a minimum volume of available slurry from the reduced size fermentation systems, 
this extraction method was reduced to 200 μl of sample. Here, 50 μl or 25 μl of OPA and 
50 μl or 25 μl internal standard were added, and 1 ml of diethyl-ether was used (Table 
2-5).  This was then vortexed for 1 minute, the ether layer removed and 1ml of diethyl-
ether added and vortexed for 1 minute again, for a total of 3 times. The external standards 
were also reduced so the final volume of standard/ water was 200 μl. 
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Table 2-5: Production of standards for a standard curve for a final volume of 1000μl or 
(300μl) 
External 
standard 
volume (μl) 
Water  
(μl) 
Internal 
standard 
(μl) 
OPA 
(μl) 
Final volume 
(μl) 
0 800 (200) 100 (50,25) 100 (50,25) 1000 (300,250) 
10 790 (190) 100 (50,25) 100 (50,25) 1000 (300,250) 
25 775 (175) 100 (50,25) 100 (50,25) 1000 (300,250) 
50 750 (150) 100 (50,25) 100 (50,25) 1000 (300,250) 
100 700 (100) 100 (50,25) 100 (50,25) 1000 (300,250) 
200 600 (0) 100 (50,25) 100 (50,25) 1000 (300,250) 
External standard volume of 100 μl discussed as the ‘standard 100’. Values in brackets show the 
reduced volumes required for the miniaturised systems. 
 
 Gas chromatography with flame ionising detector (GC:FID) 
A TRACE 2000 chromatograph (ThermoFisher Scientific, Loughborough, UK) was used 
to measure SCFA production. Peaks were identified and measured using Chrom-Card 22 
bit data system (ThermoFisher Scientific) where the data was processed in Microsoft Excel 
2013. The GC:FID measurement parameters and system are described in Table 2-6 and  
Figure 2-3.  
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Table 2-6: GC:FID measurement parameters used 
Oven  
Initial temperature 80oC for 1 minute 
Ramp 1 Temp increasing by 15oC/minute to 210oC, held 
for 1 minute 
Maximum oven temperature 260oC for 10 minutes 
Equilibration time  0.25 minutes 
Total oven run time  10.67 minutes 
Column Details  
Zebron ZB- Wax capillary 
column 
(catalogue no. 7EK-G007-22) 
15 m (length) x 0.53 mm diameter (ID) x 1.0 μM 
film thickness. Polythene glycol phase. 
Manufactured by Phenomenex (Cheshire) 
Splitless column  
Inlet Temperature 230oC  
Inlet Split Flow 36 ml/minute 
Split-less time 0.5 minutes 
Detector Details  
Base temperature 250 oC 
Air 350 ml/minute 
Hydrogen  25 ml/minute 
Nitrogen (carrier gas) 30 ml/minute 
Injection parameters  
Sample injection 1 μl (hand injection 2 μl) 
Air  1 μl 
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Figure 2-3: A schematic diagram of GC:FID 
A sample is injected via the injector and becomes vaporised where they then reach the column. 
Samples encounter the mobile phase where it reaches the column and then the stationary phase, 
where the sample are separated based on volatility, boiling and polarity.  The more volatile and less 
polar the sample is, the faster it travels through the column where they then reach the FID detector.  
The retention time is the time to reach the detector and the amount reaching the detector is 
expressed as millivolts to produce a chromatogram.  FID – Flame ionisation detector 
 
 Calculations used to measure SCFA produced 
When processing the data from the GC: FID, a number of quality controls were included. 
An initial quality control was carried out by assessing coefficient of variance (CV%) of the 
internal standard of all samples tested ensuring it was less than 10%.  This enabled the 
identification of any samples which needed further attention as the peaks may not have 
been identified properly, the injection was poor, or it was erroneously extracted. A second 
quality control was a curve of the external standards to assess if they were properly 
extracted, by ensuring an R2 value (minimum 0.95). A further control used to monitor the 
CV% of acetate observed by periodic injections of the ‘standard 100’ through the run of 
samples was less than 1%, as analysis of the SCFA produced by the samples fermented 
was based on the standard 100 (the sample containing 100 μl of external standard, Table 
2-5).   
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To calculate the concentration of the unknown samples the response factor was identified 
by equation 1:  
Response Factor= (External Standard AUC 
Internal Standard AUC )  x (
Internal Standard Concentation (mM) 
External Standard Concentration (mM) )       Equation 
2.1 
 
The response factor was then used to calculate the sample concentration using the sample 
area ratio (sample AUC/ Internal standard AUC):. 
 
Sample Concentration (mM) =
Sample Area ratio 
Response Factor
x  Internal standard concentration   Equation 
2.2 
 
This information was used to present SCFA data as a concentration (mmol/l), ratio 
proportion (%), a rate term was also developed (equations 2.3 and 2.4). 
 
SCFA production per hour= 
Concentration (mM) * Volume (L)
Mass (g) * Time (Hours)          Equation 2.3 
Or  
SCFA production per day= 
Concentration (mM) * Volume (L)
Mass (g)  Equation 2.4   
 
 
 Data handling and analysis 
All statistical analysis and data handling was conducted using IBM SPSS Statistics version 
22 and Microsoft Excel 2013. Total SCFA production was the sum of acetate, propionate 
and butyrate. Further information on statistical analysis used is located within each 
chapter. 
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 Introduction 
As discussed in chapter one, increasing colonic propionate may have a role to play in the 
reduction of weight gain (Chambers et al., 2014). Propionate is beneficial as it has a 
several potential effects on satiety and metabolism (den Besten et al., 2013b) thought to be 
mediated by:  
x Activation of FFAR2 and FFAR3, leading to the production of the anorexigenic gut 
hormones PYY and GLP-1 
x Regulation of lipid and cholesterol synthesis  
x Acting as a precursor for hepatic and intestinal gluconeogenesis, which in turn may 
influence energy balance 
 
Therefore increasing colonic propionate should be beneficial for long-term health.  It is 
believed that some carbohydrates are more propiogenic than others. Evaluating NDCs for 
their ability to increase propionate production could provide new opportunities for 
developing functional foods.  
 
Individual investigations and reviews articles have identified a number of substrates that 
appear to selectively increase SCFA production, particularly propionate and butyrate. 
None of these assessments have been carried out as a systematic review.  
 
Acetate, the most abundant SCFA produced, has been reported to be selectively increased 
by oligofructose fermentation (Macfarlane and Macfarlane, 2003, Wang and Gibson, 1993, 
Khan and Edwards, 2005).  Several substrates including psyllium (Wong et al., 2006, Kaur 
et al., 2011, Edwards and Eastwood, 1992), rhamnose (Gietl et al., 2012, Vogt et al., 
2004b), and β-glucans (Hosseini et al., 2011, Hughes et al., 2008, Queenan et al., 2007) 
have been associated with selectively increased propionate. Proportional increases in 
butyrate have also been linked with the fermentation of resistant starch, inulin, (Kolida et 
al., 2002, Hosseini et al., 2011, Laurentin and Edwards, 2004) and β-glucans (Kaur et al., 
2011). These associations were not reproducible in all studies, however, and have not been 
established on the basis of a systematic review of the evidence, making substrate selection 
to increase propionate or butyrate rather subjective. 
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Moreover, the available evidence does not identify the main drivers of propionate 
production or whether a single substrate is preferential.  From these papers, it is not clear if 
simply increasing the dietary fibre content is more effective at increasing propionate 
production than using a supposedly propiogenic NDC.  
  
Epidemiological evidence, such as that summarised in Table 1-2 and in the systematic 
review by Wanders et al., (2011) on dietary fibre feeding studies, suggest that increasing 
dietary fibre intake is beneficial to health.  It is still unclear if the type of fibre consumed is 
important in terms of increasing propionate production. 
 
Assessment of the ability of NDCs to selectively increase propionate in vivo is problematic 
and impractical due a lack of appropriate methods providing access to the proximal colon.  
Approximately 95% of colonic SCFA formed are absorbed (Verbeke et al., 2015, Bloemen 
et al., 2009) and so faecal SCFA may be misleading.  Studies evaluating SCFA production 
are further hindered by differential SCFA uptake in tissues which may alter the molar 
proportions excreted (Vogt and Wolever, 2003).  
 
The most relevant measurements of SCFA production are those using stable isotopes as 
described in Chapter 2 (Pouteau et al., 1998), but currently this methodology is not well 
validated nor in widespread use.  Instead, assessment of SCFA production is often 
undertaken using in vitro techniques. As discussed in Chapter 2 there are a variety of in 
vitro techniques including continuous and batch culture experiments with some modelling 
the whole GI tract and others modelling only the colon. Batch fermentation techniques are 
very simple and can provide high throughput screening of SCFA production from different 
carbohydrates (Williams et al., 2015) (Chapter 2).  A drawback of most of these batch 
fermentation techniques is that they lack several of the physiological activities in the colon 
including pH control (beyond simple buffers) and removal of bacterial products by 
absorption.  pH control is possible with the right equipment but is not often used.  The 
exact models used vary considerably in different studies which makes direct comparison 
difficult.  These differences include the amount of substrate added, culture volume, and the 
composition of inoculum used in the system.  Differences in sampling times and 
presentation of the SCFA data can also limit comparisons. For example, across a selection 
of studies, SCFA data were presented in units including; mmol/l (Laurentin and Edwards, 
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2004), mmol per 50mg CHO (Kaur et al., 2011), mmol/g substrate (Bourquin et al., 1992), 
and as a ratio of SCFA produced (Wang and Gibson, 1993).  
 
As a result, it is challenging to select substrates which preferentially produce propionate. 
This is particularly apparent for substrate mass as increased substrate dose is not linearly 
associated with increased SCFA production (Khan and Edwards, 2002), making 
assessment of SCFA production between studies using different methods onerous. This 
lack of consistency in methods used also compounds the lack of reproducibility and 
consistency when assessing SCFA production.  When comparing the fermentation of 
ispaghula in different studies, propionate production was shown to range from 0.72 
mmol/g substrate (Bliss et al., 2013), to 26.67 mmol/l (Mortensen et al., 1991). This, along 
with a lack of a systematic approach in determining SCFA production, hinders the 
development of functional foods that could be used to increase propionate production.  It is 
further very difficult to translate these results to the human colon as there is so little 
understanding of the determinants and influences in vivo. 
 
As there is an apparent lack of reproducible evidence in the literature, the aim of the study 
discussed in this chapter was to: 
1. Conduct a systematic review to identify and evaluate articles using in vitro batch 
fermentations to assess the SCFA producing capabilities of different substrates. 
2. Develop a unit quantifying the rate of individual SCFA production which 
normalises for substrate quantity and fermenter volume in order to compare the 
different batch fermentation methods used.  
3. To use both the systematic review, and the rate unit to identify substrates that are 
propiogenic i.e. selectively increase the amount of propionate produced. 
 
 Methods 
 Information sources 
Search engines used to identify publications were; PubMed, SCOPUS, Web Of Science 
and Medline Ovid. Searches were carried out to include investigations from the earliest 
possible year (1900, 1960, 1864 and 1947 for each database respectively), to 14-05-2014.  
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 Data collection 
The search terms used were ‘in vitro colonic fermentation’, ‘in vitro batch fermentation’, 
‘in vitro human fermentation’, ‘in vitro carbohydrate fermentation’, ‘human carbohydrate 
fermentation’, ‘faecal fibre fermentation’, ‘in vitro fibre fermentation’, ‘in vitro short chain 
fatty acid production’, ‘in vitro faecal fibre fermentation’, ‘short chain fatty acid 
fermentation’ and, ‘in vitro volatile fatty acid production’. All variations of spelling 
(British, and American English) and truncations of words using Boolean Operators where 
appropriate were used. Journal articles selected were limited to those using human adults 
in the English language. Reference lists from identified articles and reviews were used to 
gain additional articles. The process of elimination of articles was based on the PRISMA 
guidelines described in (Moher et al., 2009). To reduce potential bias predetermined 
inclusion and exclusion criteria (Table 3-1) were used to evaluate the quality of studies to 
be included for further analysis. 
 
Table 3-1: Inclusion and exclusion criteria for analysis of articles identified from abstracts 
Inclusion Criteria Exclusion criteria 
x Batch fermentation x Not a batch fermentation (i.e. 
continuous culture) 
x Initial pH 6 ≤ 8 x  pH stat controlled experiment1 
x 24 hour time point x Initial pH <6, >8 
x Use of a fresh faecal slurry 
only 
x additional bacteria added (i.e. use 
of bacterial pellet, probiotic) 
x Samples from healthy adults  x Samples from children, infants, 
disease states or animals 
x Data on acetate, propionate and 
butyrate4 
x Gastrointestinal disorders 
x Volume of fermentation system  
provided4 
x Use of antibiotics (within the 
study or participants within the 
previous fortnight) 
x Mass of substrate fermented 
given4 
x Manipulation of the diet3 
1. Articles where the fermentation system is conducted with the use of an acid or a base to keep it at a constant pH 
2. If SCFA production was presented as a ratio only, total SCFA concentration must be provided 
3. Includes; supplements provided to the donor, no exclusion or inclusion of foods from the diet of the sample donor 
4. To produce a rate term of SCFA production, the minimum information required was: mass of substrate fermented, 
final volume and amount of each SCFA produced  
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 Criteria for analysis 
The data from each paper required standardisation to properly compare the SCFA 
production between studies. Each selected paper required a minimum information set 
including fermentation volume, substrate mass and SCFA production (Table 3-1).  Papers 
were further excluded if insufficient methodological information was provided and the 
authors were not contactable. Of four authors approached, only one (for two papers) 
answered to provide more data when approached.  Examples of insufficient details 
included; not providing details of the amount of substrate added to each vial, the presence 
of a pre-digestion step without providing the mass of fibre undergoing fermentation, and 
no information on the volumes in each fermenter vial. 
 
 Data Analysis 
Initially, SCFA production data were grouped by substrate type fermented. The studies fell 
into two separate groups; those that used pooled faecal samples (more than one individual 
donor) and those that used a single donor (non-pooled) for the inoculum. These two types 
of study were considered separately. Many of the authors presented their SCFA production 
using different units of measurement, such as mmol/l, and mmol/100 mg carbohydrate, as 
well as a molar ratio. Production of SCFA is dependent of the quantity of substrate in the 
vial and the culture volume.  To correct for these incongruities, a rate term was developed 
(see section 3.3.2) with 24-hour SCFA production data presented as mmol/g carbohydrate/ 
day and to normalise the variability in sampling time points as mmol/g carbohydrate/ time 
fermented (hours). Other time points were grouped as follows: 1-5 hours early 
fermentation, 6-9 hours mid fermentation, and 10-23 hours mid/late fermentation, which 
took into account the sigmoid pattern of SCFA production by fermentation. 
Once the data obtained with the different methods were standardised using the rate term, 
the mean and standard deviations (SD) of the rates of production and the molar ratios of 
SCFA were calculated and compared between papers.  For inclusion of a substrate, three 
separate mean values for fermentation were needed.  This could have been from three 
separate studies but if more than one very similar substrate was used in one study this 
could be used as a second mean value.  However, at least two independent studies were 
required for each substrate.  
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 Grouping substrates 
For comparison of substrates from the different studies, substrates were grouped based on 
similar chemistry, similar physicochemical properties and the same sources.  Thus, data on 
the fermentation of sugars and disaccharides were grouped based on what they were; i.e 
glucoses were grouped together, and different studies fermenting lactulose were grouped 
together.  The grouping became more complex with the dietary fibres. Substrates were 
initially grouped broadly, e.g. β-glucans, pectin, guar gum, starch, and derivatives of 
seaweed.  If it became apparent that there were subgroups with sufficient replicate data, e.g 
raw starch and pre-digested starch, oligofructose and inulin, they were separated and 
assessed independently.  Different celluloses have different SCFA producing capabilities, 
often only the manufacturer (which produce different celluloses) was provided.  Due to 
this, celluloses were grouped together.  If multiple fibres were assessed in the same 
fermentation bottle (e.g. guar and oligofructose together), these were grouped separately to 
the individual components. If the substrate identified did not fit into a group of substrates, 
it was set as its own group where it then had to fulfil the criteria to be included for analysis 
(Section 3.2.3). 
 
 Assumptions made in the development of the rate term 
Although the rate term allowed the standardisation of the unit of SCFA production from 
different studies, two assumptions were required.  
 
Assumption 1: SCFA production is linear 
This is not the case, in the study by Aura et al., (2005) who carried out in vitro batch 
fermentations of various fractions of rye brans with multiple time points (0, 1, 2, 4, 6, 8, 
and 24 hours). The majority of SCFA production occurred between 1 and 8 hours of 
fermentation, and only minor increases in total SCFA production occurred between 8 and 
24 hours for some substrates indicating that the substrate was rapidly fermented, and 
exhausted within 8 hours (Aura et al., 2005). Another observation with this study was that 
SCFA production for all substrates tested plateaued between 6 and 8 hours (Aura et al., 
2005, Bliss et al., 2013, Khan and Edwards, 2005). The plateau value for 24 hours was not 
used but was included for the time point at which the plateau was achieved.  
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Not all the individual SCFA were produced at the same rate, for example butyrate 
production with xylanase treated rye bran and rye bran extract increased no further after 8 
hours whereas for rye bran, rye bran residue and extruded rye bran the butyrate production 
continued to increase after 8 hours (Aura et al., 2005).   
 
When studies used different actual time points they were grouped into early, mid, mid late 
fermentation and per day. This had less of an effect when the system was compared per 
day as this only took the production after 24 hours into account, at which point many of the 
sugars within the substrate being tested had been used, and no further SCFA production 
occurred (Khan and Edwards, 2002, Aura et al., 2005, Salvador et al., 1993) 
 
Assumption 2: Altering the substrate concentration in the incubation proportionally 
increases SCFA production. 
A number of studies have assessed the role of substrate dose on in vitro SCFA production. 
It was found that production was not linear and doubling the substrate mass did not double 
the total SCFA produced (Mortensen et al., 1991, Stevenson et al., 1997, Khan and 
Edwards, 2002). Mortensen et al., (1991) fermented different masses of substrates (Figure 
3-1) and found a non linear relationship with SCFA (Mortensen et al., 1991).  Similar 
effects were also identified in fermentations by Khan and Edwards, (2002) where 
increasing lactulose dose from 2.5 to 10 mg/ml in 2.5 increments was also not associated 
with a dose dependent increase in total SCFA production, but when the actual production 
was compared with predicted production, there was a non-linear dose dependent decrease 
in total SCFA production. 
 
Figure 3-1: The effect of increasing substrate mass in fermentation vial on total SCFA production. 
Data from in vitro batch fermentations performed by (Mortensen et al., 1991) with a selection of substrates 
total SCFA production after 24 hours of fermentation with the pooled inoculum of three individuals is 
shown. 
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 Results 
 Identification of articles for the systematic review. 
Figure 3-1 shows the PRISMA flowchart selection process for assessing papers fulfilling 
the inclusion/ exclusion criteria (Table 3-1, Section 3.2.2). Search terms and checking 
reference lists generated 15,541 abstracts for screening, 14,226 articles did not undergo 
further assessment and were rejected based on the information within the title and abstract, 
1315 articles had their full texts assessed. Texts were scrutinised to identify studies 
fulfilling the criteria required for inclusion, resulting in 114 articles in this systematic 
review. 
 
During evaluation of the articles it became apparent that the in vitro batch fermentation 
methodologies and the presentation of SCFA production by different substrates varied 
substantially, making direct comparison challenging.  A rate term was developed to 
overcome this (Section 3.3.2). One of the main differences in experimental design was 
whether the faecal inoculum used to seed the cultures was from one donor, or was pooled 
from several donors.  Fifty-one papers used pooled faecal samples and 65 used single 
faecal samples (two papers conducted fermentations using both pooled and non-pooled 
stool samples). 
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Figure 3-2: Flow diagram based on PRISMA guidelines outlining the process of elimination 
of articles identified   
The process of elimination adapted from PRISMA resulted in 114 articles undergoing further 
scrutiny. Two articles reported both, pooled and non-pooled data. 
 
 Rate unit  
A rate term was developed for inter-study comparison. This rate term required four pieces 
of information: 
1. Time (hours) at which the sample was taken for SCFA analysis  
2. Mass of substrate (grams) added to the fermentation vessels 
3. Total inoculum volume (L) added to the fermentation vessels  
4. Measured SCFA concentration (mmol/l) 
Equation 3.1 outlines the formula to calculate SCFA production as mmol/g 
carbohydrate/hour.  This equation was most commonly used for intermediary time points; 
a simple modification allowed it to be utilised for 24-hour data, Equation 3.2.    
SCFA Production (mmol/g CHO/hr) =
Concentration (mM) × Fermenter Volume (L)
Substrate amount (grams) × Time (hours)       Equation 3.1 
 
SCFA Production (mmol/g CHO/day)=
Concentration (mM) × Fermenter Volume (L)
Substrate amount (grams)      Equation 3.2 
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 Reduction in SCFA variability with the rate unit 
The use of the rate term enabled comparison of different investigations and reduced the 
inter-study variability in measured SCFA production (Table 3-2, Figure 3-3). However, 
this worked better for some substrates than others. The coefficient of variance (CV %) of 
propionate production increased by 13% for inulin when presented as a rate term (93.33% 
vs 106.47%), but it decreased for glucose (176.63% vs 101.08%), pectin (285.91% vs 
46.34%), control (blank) (150.81% vs 121.15%) and cellulose (7793% vs 144.74%) (Table 
3-2).  Figure 3-3 also highlights that when the data was transformed to the rate unit, the 
data was less variable.  Therefore, the rate allows comparison of investigations with more 
accuracy, making them more comparable. 
  Pooled vs non-pooled 
A key methodological difference observed was the decision to seed the fermenters with 
stool samples from a single donor (non-pooled) or from combined stools from multiple 
donors (pooled).  Variability of SCFA production was compared for a selection of the 
substrates identified during paper analysis (Table 3-3, Table 3-4). The interquartile range 
(IQR) of the rate of SCFA production was generally lower, or there was little effect when 
stools in non-pooled faeces studies were compared to those using pooled samples (Table 
3-3). For example, variation in propionate and butyrate production for cellulose were 
similar, but for the non-pooled samples was higher for acetate. The IQR however was 
lower for all of the non-pooled samples when compared to the pooled samples for guar. 
This suggests that the inter-study variability was not equal between substrates, however 
differences due to study methodology may have had an effect on the measured SCFA 
production (Table 3-3). 
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Table 3-2: Coefficient of variance (CV %) of acetate, propionate, butyrate, and total SCFA production after comparison of data provided within the articles 
and when converted to a rate  
CV% Inulin n=20 Glucose n=22 Pectin n=20 Cellulose n=13 Control (blank) n=34 
 
Given As rate Given As rate Given As rate Given As rate Given As rate 
Acetate  74.98 80.14 176.58  80.14 279.86 42.85 20480.3 463.24 169.22  97.83 
Propionate 93.33 106.47 176.63 101.08 285.91 46.34   7793 144.74 150.81 121.15 
Butyrate 89.42 81.39 194.56 166.53 254.88 41.12  7529.41 235.82 153.32 130.46 
Total 68.45 79.38 169.67  91.39 276.59 38.61 15361.23 330.76 155.71 100.45 
Both pooled and non-pooled data were included. N= number of studies providing data. CV% is the variation of all of the studies together as given within text and as the 
rate term (mmol/g CHO/day), n= number of investigations.
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Figure 3-3: Variability observed between individual investigations SCFA observations 
presented as a box plot.  
A, C, E provides information on control (blank), glucose and pectin when compared from the value given in 
the publication. B, D, F provides information on control (blank), glucose and pectin when compared as a rate.  
This demonstrates that when the data was transformed into a rate, the variability was reduced. 
 
Differences in the IQR between pooled and non-pooled samples were less clear when 
comparing the proportions of acetate, propionate, and butyrate.  For example, the IQR for 
cellulose (n=13) was equal for acetate production (~17.5%); non-pooled data had a larger 
IQR for propionate but a smaller IQR for butyrate production. In contrast, for ispaghula 
95 
 
 
 
(n=15) and pectin (n=20) the IQRs were similar for all SCFA for pooled and non-pooled 
studies (Table 3-4). 
 
These findings are in contrast to previous studies which found that pooling (or not pooling) 
of the stool samples did not affect the overall production of SCFA (Aguirre et al., 2014, 
Mortensen et al., 1991). These investigations like those of others such as Stewart and 
Slavin., (2006) and Ferguson and Jones., (2000) who pooled the stool samples only did one 
technical repeat. The lack of technical repeats may mask experimental variability as well 
as potential actual variability in SCFA production that can occur with and between 
individuals.  
 
Pooling samples may alter the sample bacteria, as the bacteria may interact/ compete in the 
lag phase of the culture, as one dominant/ established microbiota ecosystem tries to 
integrate with another. This was seen in mice (coprophagic animals) where combining two 
different bacterial profiles, led to one dominating over the other (Ridaura et al., 2013).  
Faecal transplants in humans have been shown to alter the bacterial population with the 
population of the recipient becoming that of the donor for 10 weeks (Fuentes et al., 2014). 
Based on this, pooling samples in vitro could well affect the bacterial population, which 
may also affect SCFA production, and may negate the effect of inter-individual variation. 
As a result, the decision was made to assess SCFA production from the pooled and non-
pooled studies separately.  
Table 3-3: IQR of rate data from pooled and non-pooled stool samples  
 Number of 
studies Acetate Propionate Butyrate 
 non-
pooled 
pooled non-
pooled 
pooled non-
pooled 
pooled non-
pooled 
pooled 
Cellulose 6 7 1.1 0.2 0.3 0.2 0.2 0.2 
Pectin 10 10 1.7 3.0 0.8 0.3 0.8 0.3 
Glucose 13 9 3.0 5.6 1.1 1.1 1.4 0.6 
Ispaghula 7 8 3.7 5.2 0.6 2.2 0.8 0.3 
Inulin 8 12 4.1 2.4 1.5 1.0 0.7 1.7 
Guar 6 6 1.2 2.4 0.5 1.0 0.3 0.5 
Control 19 15 1.1 2.6 0.3 0.7 0.3 0.6 
Rate data was calculated to mmol/g carbohydrate/ day  
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Table 3-4: IQR of molar ratios from pooled and non-pooled stool samples 
 
Number of 
studies 
Acetate Propionate Butyrate 
 
non-
pooled 
pooled 
non-
pooled 
pooled 
non-
pooled 
pooled 
non-
pooled 
pooled 
Cellulose 6 7 17.7 17.4 12.4 4.2 5.2 10.5 
Pectin 10 10 6.3 8.7 4.0 3.5 5.3 7.3 
Glucose 13 9 13.2 17.0 9.4 8.5 8.9 9.7 
Ispaghula 7 8 7.6 5.7 7.3 8.0 4.9 6.4 
Inulin 8 12 6.2 0.6 6.2 7.6 9.8 14.3 
Guar 6 6 2.3 3.4 5.0 1.4 3.5 1.7 
Control 19 15 19.9 7.1 8.0 6.7 10.6 2.4 
 
 Analysis of Non-pooled SCFA data 
SCFA production was grouped by early, mid, late and 24 hours of fermentation. This was 
to reduce the effect of the assumption of the rate term that production is linear, as well as 
for comparison of the substrates at different stages within the fermentation system.  
 
 SCFA production from 1-9 hours (early to mid-fermentation) 
Between 1 and 5 hours of fermentation, three substrates were identified, and not included 
for analysis.  
 
Between 6 and 9 hours of fermentation, 13 substrates had sufficient data for further 
analysis (Table 3-5, Table 3-6).  Lactulose fermentation generated the highest rate of total 
SCFA (1.17 [0.6] mmol/g CHO/hour) and acetate production (0.97 [0.5] mmol/ g CHO/ 
hour), as well as high butyrate production (0.93 [0.1] mmol/ g CHO/ hour). Highest rates 
of propionate and butyrate production occurred with guar gum yielding 0.18 (0.1) and 0.12 
(0.0) mmol/g CHO/ hour respectively.  Glucose, guar gum, and raw starch ranked in the 
top five for acetate, propionate, butyrate and total SCFA production.  Cellulose, and heat-
treated sugarbeet fibre both ranked in the bottom 5 for production of all SCFA (Table 3-5). 
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Proportions of SCFA production did not always reflect the rate of production. Cellulose 
fermentation led to the lowest rate (0.04 [0.0] mmol/g CHO/ hour), but the highest 
proportion of propionate (25.9 [5.5] %, Table 3-6).  Resistant starch followed a similar 
pattern in which fermentation produced low rates, but high proportions of butyrate (0.64 
[0.1] mmol/g CHO/ hour, 15.2 [8.2] %, Table 3-6). 
 
On occasion, rates did translate to proportions of SCFA production. This is exemplified 
with guar gum and ispaghula which both had high rates and ratios of propionate production 
(Guar: 0.18 [0.1] mmol/g CHO/ hour, 22.6 [6.8] %, ispaghula: 0.12 [0.0] mmol/g CHO/ 
hour, 24.3 [7.1] %). This was also seen with FOS and oat fibre, both of which produced 
low rates and proportions of propionate. 
 
 Mid to late fermentation - SCFA production between 10 and 23 hours 
Nine substrates were compared between 10 and 23 hours of fermentation, and as a result, 
the top and bottom 4 substrate identified are presented in Table 3-7.  
Acetate and total rates of production were the highest with pectin, generating 0.37 (0.2) 
and 0.47 (0.3) mmol/g CHO/ hour. In contrast, pectin produced low rates of propionate and 
butyrate yielding 0.06 (0.1) and 0.04 (0.1) mmol/ g CHO/ hour. This was also translated to 
molar proportions of SCFA production with pectin leading to the highest ratio of acetate 
(83.3 [7.7] %) and the lowest of propionate (10.6 [2.6] %) and butyrate (6.2 [5.1] %).  
Sugarbeet fibre gave rise to high rates of production, ranking first for propionate (0.10 
[0.1], mmol/g CHO/hour) and ranking second for acetate (0.28 [0.1] mmol/g CHO/ hour) 
and total production (0.44 [0.2] mmol/ g CHO/ hour, Table 3-7). This was translated to 
increased proportions of acetate but not propionate (Table 3-8). Butyrate production 
occurred the most with both, raw and resistant starch yielding 0.09 (0.1) and 0.09 (0.0) 
mmol/g CHO/hour respectively. High butyrate proportions were also associated with 
resistant starch, which led to 29.3 (8.0) % of total SCFA produced forming butyrate (Table 
3-7, Table 3-8).  
 
Pea and maize fibre consistently had the lowest rates of SCFA production, but differed in 
the proportions of acetate, propionate and butyrate formed. Pea fibre generated high ratios 
of acetate (71.5 [16.1] %), whereas maize fibre produced high proportions of propionate 
(27 [0.7] %), and butyrate (16.6 [1.9] %, Table 3-8)  
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Table 3-5: The top and bottom five ranked producers of acetate, propionate, butyrate, and total SCFA at 6-9 hours of fermentation (mmol/g carbohydrate/hour) 
Top 5 Ranked on Acetate Ranked on propionate Ranked on butyrate Ranked on total 
1 Lactulose (1-3)** 0.97 (0.5)* Guar gum (7, 10, 11) 0.18 (0.1) 
Guar gum (8, 10, 
11) 0.12 (0.0) 
Lactulose       
(1-3) 1.17 (0.6) 
2 Glucose (1,3-7) 0.84 (0.6) Glucose (1,3-7) 0.14 (0.1) Lactulose (1-3) 0.93 (0.1) Glucose        (1,3-7) 1.01 (0.7) 
3 Pectin (6-9) 0.52 (0.3) Sugarbeet fibre  (9, 14-17) 0.12 (0.1) Glucose (1,3-7) 0.86 (0.1) 
Guar gum (8, 
10, 11) 0.78 (0.1) 
4 Guar gum (7, 10, 11) 0.48 (0.2) Ispaghula (6-8) 0.12 (0.0) Raw starch  (12-13) 0.85 (0.1) Pectin (6-90 0.66 (0.5) 
5 Raw starch (12-13) 0.44 (0.4) Raw starch  (12-13) 0.11 (0.1) Oligofructose (18-22) 0.83 (0.1) 
Raw starch  (12-
13) 0.64 (0.4) 
Bottom 5         
5 Ispaghula (6-8) 0.34 (0.2) Wheat bran (8, 6, 23, 24) 0.08 (0.0) 
Sugarbeet  fibre (9, 
14-17) 0.06 (0.1) 
Wheat bran (8, 
6, 23, 24) 0.50 (0.3) 
4 Oat fibre (9,23, 24) 0.27 (0.2) Oat fibre  (9,23, 24) 0.08(0.1) Ispaghula (6-8) 0.06 (0.0) Oat fibre (9,23, 24) 0.42 (0.3) 
3 
Heat-treated 
sugarbeet fibre (14, 
25) 
0.22 (0.4) 
Heat-treated 
sugarbeet fibre (14, 
25) 
0.07 (0.1) Pectin (6-9) 0.06 (0.1) Resistant starch (5,6,26,27) 0.37 (0.2) 
2 Resistant starch (5,6,26,27) 0.21 (0.1) 
Oligofructose 1(8-
22) 0.06 (0.1) 
Heat-treated 
sugarbeet fibre 
(14,25) 
0.04 (0.1) 
Heat-treated 
sugarbeet fibre 
(14,25) 
0.32 (0.5) 
1 Cellulose (2,6-8) 0.11 (0.1) Cellulose (2,6-8) 0.04 (0.0) Cellulose (2,6-8) 0.02 (0.0) Cellulose (2,6-8) 0.18 (0.1) 
Mean *(standard deviation) of the data obtained within articles fulfilling the inclusion criteria.. Top 5, 1-5 = high to low, Bottom 5, 1-5 low to high . **References:1- (Mortensen et al., 
1988) 2- (Mortensen et al., 1990), 3- (Cardelle-Cobas et al., 2009), 4- (Olano-Martin et al., 2000), 5- (Zhu et al., 2013), 6- (Mortensen and Nordgaard-Andersen, 1993), 7-(McBurney, 
1989), 8- (Mortensen et al., 1991), 9-(Titgemeyer et al., 1991), 10-(Khan and Edwards, 2005), 11- (McBurney and Thompson, 1989), 12-(McBurney et al., 1990), 13- (Weaver et al., 1989), 
14- (Guillon et al., 1992), 15- (Oufir et al., 2000), 16- (Fardet et al., 1997), 17- (Barry et al., 1995), 18- (Yang et al., 2014), 19- (Stewart et al., 2008), 20- (Chen et al., 2013),21, (Kaur et al., 
2011), 22- (Rumpagaporn et al., 2012), 23- (Bourquin et al., 1992), 24- (McBurney and Thompson, 1990), 25- (Cherbut et al., 1991), 26- (Zhao and Lin, 2009), 27- (Thompson et al., 2011) 
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Table 3-6:  The top and bottom five ranked producers of acetate, propionate, and butyrate at 6-9 hours of fermentation based on the molar proportion (%) 
Top 5 Ranked  on acetate Ranked on propionate Ranked on butyrate 
1 Lactulose (1-3)** 83.0 (3.4)* Cellulose (2, 6-8)* 25.9 (5.5) Resistant starch (5, 6, 26, 27) 18.3 (8.2) 
2 Pectin (6-9) 81.8 (7.0) Ispaghula (6-8) 24.3 (7.1) Oligofructose (8-22) 16.8 (2.2) 
3 Glucose (1, 3-7) 77.0 (13.9) Resistant starch (5,6,26,27) 23.0 (10.6) Guar gum (8, 10, 11) 16.2 (8.8) 
4 Oat fibre (9, 23, 24) 74.5 (13.0) Heat-treated sugarbeet fibre (14, 25) 22.7 (2.0) Raw starch  (11-12) 15.2 (10.5) 
5 Oligofructose  (8-22) 73.04 (11.3) Guar gum (8, 10, 11) 22.6 (6.8) Wheat bran (8, 6, 23, 24) 14.2 (5.4) 
Bottom 5      
5 Heat-treated sugarbeet fibre (14, 25) 66.2 (3.2) Glucose (1, 3-7) 15.3 (11.9) Ispaghula (6-8) 10.4 (3.7) 
4 Ispaghula (6-8) 65.3 (5.8) Oat fibre (9, 23, 24) 14.0 (5.8) Sugarbeet fibre  (9, 14-17) 10.2 (7.7) 
3 Cellulose (2, 6-8) 63.5 (4.3) Pectin (6-9) 11.7 (3.6) Glucose (1, 3-7) 7.7 (5.6) 
2 Guar gum (8, 10, 11) 61.2 (10.6) Oligofructose (8-22) 10.2 (9.4) Lactulose (1-3) 7.30 (2.2) 
1 Resistant starch (5, 6, 26, 27) 58.7 (18.5) Lactulose (1-3) 9.5 (2.2) Pectin (6-9) 6.5 (4.3) 
 
Mean *(standard deviation) of the data obtained within articles fulfilling the inclusion criteria. Top 5, 1-5 = high to low, Bottom 5, 1-5 low to high. **Reference numbers 
correspond to those in the legend of Table 3-5
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Table 3-7: The top and bottom four producers of acetate, propionate, butyrate and total SCFA from 10-23 hours of fermentation (mmol/g carbohydrate/hour) 
Top 5 Ranked  on acetate Ranked  on propionate Ranked  on butyrate Ranked on total 
1 Pectin (7, 9)** 0.37 (0.2)* Sugarbeet fibre (9, 14- 17, 28) 0.10 (0.1) 
Resistant starch (26, 
27) 0.09 (0.0) Pectin (7, 9) 0.47 (0.3) 
2 Sugarbeet fibre (9, 14- 17, 28) 0.28 (0.1) 
Resistant starch (26, 
27) 0.08 (0.1) Raw  starch (5, 12, 13) 0.08 (0.1) 
Sugarbeet fibre (9, 
14- 17, 28) 0.44 (0.2) 
3 Raw starch (5, 12, 13)   0.21 (0.1) Raw starch (5, 12, 13)  0.08 (0.1) 
Wheat bran (24-25, 
28)  0.07 (0.1) 
Raw starch (5, 12, 
13) 0.37 (0.2) 
4 Heat treated sugarbeet fibre (14, 25) 0.20 (0.1) 
Heat-treated 
sugarbeet fibre  (14, 
25) 
0.07 (0.0) Oat fibre (9, 23, 24) 0.07 (0.1) Resistant starch (26, 27) 0.33 (0.2) 
Bottom 5        
4 Oat fibre (9, 23, 24) 0.18 (0.1) Oat fibre (9, 23, 24) 0.06 (0.0) Pectin (7, 9) 0.04 (0.1) Oat fibre (9, 23, 24) 0.31 (0.2) 
3 Resistant starch (26, 27) 0.17 (0.1) Pectin  (7, 9) 0.06 (0.1) 
Heat-treated sugarbeet 
fibre (14, 25) 0.04 (0.0) 
Heat-treated 
sugarbeet fibre (14, 
25) 
0.31 (0.1) 
2 Maize fibre (25, 28, 29) 0.09 (0.0) 
Maize fibre (25, 28, 
29) 0.04 (0.0) 
Maize fibre (25, 28, 
29) 0.03 (0.0) 
Maize fibre (25, 28, 
29) 0.16 (0.0) 
1 Pea fibre (9, 25, 28) 0.08 (0.0) Pea fibre (9, 25, 28) 0.03 (0.0) Pea fibre (9, 25, 28) 0.02 (0.0) Pea fibre (9, 25, 28) 0.13 (0.1) 
Mean *(standard deviation) of the data obtained within articles fulfilling the inclusion criteria. Top 5, 1-4 = high to low, Bottom 5, 1-4 low to high.  ** References: (number order follows 
that of Table 3-6: 5- (Zhu et al., 2013), 7- (McBurney, 1989), 9-(Titgemeyer et al., 1991), 12-(McBurney et al., 1990), 13- (Weaver et al., 1989), 14- (Guillon et al., 1992), 15- (Oufir et al., 
2000), 16- (Fardet et al., 1997), 17- (Barry et al., 1995),23- (Bourquin et al., 1992), 24- (McBurney and Thompson, 1990), 25- (Cherbut et al., 1991), 26- (Zhao and Lin, 2009), 27- 
(Thompson et al., 2011), 28-(Salvador et al., 1993), 29- (Cherbut et al., 1997)  
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Table 3-8: The ranked molar proportion (%) of acetate, propionate, and butyrate after 10-23 hours of fermentation 
Top 5 Ranked on acetate Ranked on propionate Ranked of butyrate 
1 Pectin (7, 9)** 83.3 (7.7)* Maize fibre (25, 28, 29) 27.0 (0.7) Resistant starch (26, 
27) 
29.3 (8.0) 
2 Pea fibre (9, 25, 28) 71.5 (16.1) Resistant starch (26, 27) 25.9 (6.3) Wheat bran (24-25, 28) 20.6 (3.0) 
3 Sugarbeet fibre (9, 14- 
17, 28) 
69.8 (14.5) Heat treated sugarbeet fibre 
(14, 25) 
22.7 (1.62) Raw starch (5,12,13) 18.4 (9.1) 
4 Oat fibre (9,23, 24) 66.3 (11.2) Wheat bran (24-25, 28) 21.1 (4.8) Maize fibre (25, 28, 
29) 
16.6 (1.9) 
Bottom 5 
     
4 Raw starch (5,12,13) 63.4 (16.0) Oat fibre (9,23, 24) 18.8 (3.2) Heat treated sugarbeet 
fibre (14, 25) 
13.5 (1.97) 
3 Wheat bran (24-25, 28) 58.3 (5.9) Pea fibre (9, 25, 28) 18.5 (9.4) Sugarbeet fibre (9, 14- 
17, 28) 
10.8 (6.3) 
2 Maize fibre (25, 28, 29) 56.4 (2.3) Raw starch (5, 12, 13) 18.2 (8.1) Pea fibre (9, 25, 28) 10.0 (7.1) 
1 Resistant starch (26, 27) 44.8 (13.9) Pectin (7,9) 10.6 (2.6) Pectin (7,9) 6.2 (5.1) 
Mean *(standard deviation) of the data obtained within articles fulfilling the inclusion criteria. Top 5, 1-4 = high to low, Bottom 5, 1-4 low to high. **Reference numbers 
correspond to those in the legend of Table 3-8. 
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 SCFA Production per day (24 hour SCFA production)  
A total of 27 different fermentable substrates were compared for analysis at 24 hours of 
fermentation. 
 
Lactulose generated the highest rate of total, acetate and butyrate generating 19.70 (22.5), 
13.68 (13.3) and 2.49 (4.0) mmol/g CHO/ day, and ranked second for propionate 
production yielding 3.49 (5.5) mmol/g CHO/ day.  GOS ranked second for the rate of 
acetate, butyrate and total, but did not rank in the top five for propionate production (Table 
3-9 - Table 3-11, Figure 3-4 - Figure 3-7).  Rhamnose was ranked highest for propionate 
production and proportion, producing 4.51 (0.5) mmol/ g CHO/ day and 40.1(8.3) % 
(Table 3-9, Table 3-10). Interestingly, rhamnose was the only substrate that did not rank in 
the top 5 for acetate production, but ranked in the top 5 for total SCFA production 
generating a total SCFA production rate of 11.76 (2.3) mmol/ g CHO/ day. The lowest 
production for all SCFA occurred with green kiwi fibre fermentation which yielded 0.76 
(0.0) mmol/g CHO/ day of total SCFA (Table 3-9, Figure 3-4 - Figure 3-7 ). 
 
Proportionally, β- glucan led to the highest percentage of butyrate (34.3 [0.6] %), and 
consequently this led to the lowest proportion of acetate (42.3[0.3] %, Table 3-10, Figure 
3-4).  Rate and ratio of production was similar in few of the substrates tested. Both, 
proportion and rate of propionate production ranked highest with rhamnose fermentation.  
Pectin, lactulose, xylose and lactose were all in the top 5 for acetate rate and ratio. 
Similarities in rate and ratio of butyrate production were only seen for inulin (top 5) and 
xylose (bottom 5).  The opposite of this also occurred, such as with green kiwi fibre and 
cellulose where the ratio of production ranked in the top five but the proportion ranked in 
the bottom 5 (Table 3-9, Table 3-10, Table 3-11, Figure 3-5).  
 
It can be seen from Figure 3-7, Table 3-11 that there was little difference between the top 
and bottom propionate producers, with approximately a 5.0 mmol/ g CHO/ day difference 
between substrates were observed, similar effects were also seen for total production 
(Table 3-11, Figure 3-4 - Figure 3-7 ). This indicates that the type of fibre may not be the 
most influential factor when determining individual SCFA production.  
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Table 3-9: Top and bottom five ranked producers of acetate, propionate, butyrate and total SCFA at 24 hours fermentation (mmol/g carbohydrate/day)  
Top 5 Ranked  on acetate Ranked  on propionate Ranked  on butyrate Ranked on total 
1 Lactulose (1-3)**  13.68 (13.3)* Rhamnose (1, 30, 43) 4.51 (0.5) Lactulose (1-3) 2.49 (4.0) Lactulose (1-3) 19.7 (22.5) 
2 GOS (3, 30-32) 10.0 (6.9) Lactulose (1-3) 3.49 (5.5) GOS (3, 30-32) 1.74 (1.2) GOS (3, 30-32) 13.77 (8.3) 
3 Xylose  (1, 30) 8.71   (6.8) Arabinose (1, 30, 33) 3.01 (1.2) Sugarbeet fibre (9, 15- 17, 28,45) 1.53 (1.4) Rhamnose (1, 30, 43) 11.76 (2.3) 
4 Lactose (1, 3, 30, 33) 8.55   (3.9) 
Guar gum (7, 10, 23, 
24, 35, 43) 2.78 (0.5) 
Inulin (31, 33, 42, 46-
48) 1.29 (1.5) Xylose (1, 30) 11.29 (7.6) 
5 Pectin (6,-9, 33-37) 6.54   (2.8) Xylose (1,30) 2.22 (1.2) Rhamnose (1, 30, 43) 1.16 (0.7) Lactose (1, 3, 30, 33) 10.75 (4.5) 
Bottom 5 
       
5 Maize fibre  (25, 28, 29) 1.53 (0.04) 
Oat bran (9, 23, 24, 
44) 0.55 (0.6) Maize fibre (25, 28, 29) 0.40 (0.1) 
Maize fibre (25, 28, 
29) 2.58 (0.3) 
4 Corn bran (9, 23, 24) 1.34 (0.7) Pea fibre (9, 25, 28)  0.46 (0.3) Xylose (1,30) 0.35 (0.4) Pea fibre (9, 25, 28) 2.35 (1.3) 
3 Beta-glucan (38, 39) 1.30 (0.0) 
Corn bran  (9, 23, 
24) 0.43 (0.2) Pea fibre (9, 25, 28) 0.34 (0.3) 
Corn bran  (9, 23, 
24) 2.22 (1.1) 
2 Cellulose (6,8, 23, 24, 35, 40)  0.87 (0.7) 
Cellulose (6, 8, 23, 
24, 35, 40) 0.38 (0.3) 
Cellulose (6, 8, 23, 24, 
35, 40) 0.25 (0.2) 
Cellulose (6,8 , 
23,24, 35, 40) 1.50 (1.1) 
1 Green kiwi fibre (41, 42) 0.49 (0.0) 
Green kiwi fibre (41, 
42) 0.13 (0.0) 
Green kiwi fibre (41, 
42) 0.14 (0.0)) 
Green kiwi fibre (41, 
42) 0.76 (0.0) 
Mean *(standard deviation) of data obtained within articles fulfilling inclusion criteria. GOS: Galactoooligosaccharide. Top 5, 1-5 = high to low, Bottom 5, 1-5 low to high:  **References   
1 (numbers follow on from Table 3-8)- (Mortensen et al., 1988) 2- (Mortensen et al., 1990), 3- (Cardelle-Cobas et al., 2009), 6-(Mortensen and Nordgaard-Andersen, 1993) , 8- (Mortensen 
et al., 1991), 9-(Titgemeyer et al., 1991), 10-(Khan and Edwards, 2005), 15- (Oufir et al., 2000), 16- (Fardet et al., 1997), 17- (Barry et al., 1995),  23- (Bourquin et al., 1992), 24- 
(McBurney and Thompson, 1990), 25- (Cherbut et al., 1991), 26- (Zhao and Lin, 2009), 27- (Thomson et al., 2011), 28-(Salvador et al., 1993), 29- (Cherbut et al., 1997), 30- (Gietl et al., 
2012), 31- (Rycroft et al., 2001a), 32- (Rycroft et al., 2001b), 33- (Wang and Gibson, 1993), 34-(Gelissen and Eastwood, 1995), 35- (Adiotomre et al., 1990), 36- (Waldecker et al., 2008b), 
37- (Bourquin et al., 1996), 38- (Kim and White, 2009), 39- (Kim and White, 2010), 40-(Yu et al., 2013), 41- (Rosendale et al., 2012). 42- (Parkar et al., 2012), 43- (Fernandes et al., 2000), 
44-(Kedia et al., 2009), 45-(Michel et al., 1996), 46- (Parkar et al., 2013), 47- (Salazar et al., 2008), 48- (Hughes et al., 2007) 
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Table 3-10:  Top and bottom five ranked acetate, propionate, butyrate and total SCFA producers based on molar proportion (%) at 24 hours of fermentation  
Top 5 Ranked on acetate Ranked on propionate  Ranked on butyrate  
1 Lactose (1, 3, 30, 33)** 78.0 (10.1)* Rhamnose (1, 30, 43) 40.1 (8.3) Beta-glucan (38, 39) 34.3 (0.64) 
2 Pectin (6,-9, 33-37) 77.5 (5.8) Modified pectin (48, 49) 36.0 (25.6) Inulin (31, 33, 42,46-48) 24.2 (5.3) 
3 Lactulose (1-3) 75.6 (12.6) Guar gum (7, 10, 23, 24, 35, 43) 32.5 (3.2) Green kiwi fibre (41, 42) 18.9 (0.1) 
4 Glucose (1-6, 8, 13, 30, 33, 34, 44, 47) 73.9 (31.4) Arabinose (1, 30, 33) 30.6 (9.8) 
Raw starch (5, 12, 13, 
33, 43, 52)  18.2 (5.6) 
5 Xylose (1,30) 73.7 (13.9) Cellulose (6,8, 23, 24, 35, 40) 27.9 (8.6) Oat bran (9, 23, 24, 44) 17.4 (5.3) 
Bottom 5  
    
5 Modified pectin (48, 49) 55.2 (22.6) 
Oligofructose (4, 10, 31-33, 44, 
50)  15.9 (7.3)  
Gum Arabic (9, 23, 
35) 9.4 (1.7) 
4 Guar gum (7, 10,23,24, 35, 43) 55.1 (3.6) 
Glucose  (1-6, 8, 13, 30, 33, 34, 
44, 47) 15.5 (15.6) 
Laminarin/ seaweed 
derivatives (45, 55) 9.2 (4.7) 
3 Cellulose (6,8, 23, 24, 35, 40) 54.9 (13.4) Lactulose (1-3) 13.3 (5.1) 
Modified pectin  (48, 
49) 8.8 (2.3) 
2 Rhamnose (1, 30, 43) 50.2 (8.0) Pectin (6,-9, 33-37) 11.3 (3.3) Arabinose 1, 30, 33) 4.1 (4.1) 
1 Beta- glucan (38, 39) 42.3 (0.3) Lactose (1,3,30, 33) 10.2 (2.9) Xylose (1,30) 2.7 (1.9) 
Mean *(standard deviation) of the data obtained within articles fulfilling the inclusion criteria. Top 5, 1-5 = high to low, Bottom 5, 1-5 low to high. References (based on above): 
**References 1- (Mortensen et al., 1988) 2- (Mortensen et al., 1990), 3- (Cardelle-Cobas et al., 2009), 4- (Olano-Martin et al., 2000), 5- (Zhu et al., 2013), 6- (Mortensen and Nordgaard-
Andersen, 1993), 7-(McBurney, 1989), 8- (Mortensen et al., 1991), 9-(Titgemeyer et al., 1991), 10-(Khan and Edwards, 2005), 12-(McBurney et al., 1990), 13- (Weaver et al., 1989), 23- 
(Bourquin et al., 1992), 24- (McBurney and Thompson, 1990), 30- (Gietl et al., 2012), 31- (Rycroft et al., 2001a), 32- (Rycroft et al., 2001b), 33- (Wang and Gibson, 1993), 34-(Gelissen 
and Eastwood, 1995), 35- (Adiotomre et al., 1990), 36- (Waldecker et al., 2008b), 37- (Bourquin et al., 1996), 38- (Kim and White, 2009), 39- (Kim and White, 2010), 40-(Yu et al., 2013), 
41- (Rosendale et al., 2012), 42-{Parkar, 2012 #297} 43- (Fernandes et al., 2000), 44-(Kedia et al., 2009), 45-(Michel et al., 1996), 46- (Parkar et al., 2013), 47- (Salazar et al., 2008), 48- 
(Hughes et al., 2007), 48-(Dongowski and Lorenz, 1998), 49- (Gulfi et al., 2007), 50- (Zhang et al., 2013), 51- (Michel et al., 1998), 52-(Khalil et al., 2014),53- (Weaver et al., 1992), 54-
(Christian et al., 2003), 55- (Kuda et al., 2005) 
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Table 3-11: Comparison of ranked acetate, propionate, and butyrate at 24 hours of fermentation 
  Ranked  on acetate Ranked  on propionate Ranked  on butyrate 
Top 5 Rate % Rate % Rate % 
1 Lactulose Lactose Rhamnose Rhamnose Lactulose Beta-glucan 
2 GOS Pectin Lactulose Modified pectin GOS Inulin 
3 Xylose Lactulose Arabinose Guar gum Sugarbeet fibre Green kiwi fibre 
4 Lactose Glucose Guar gum Arabinose Inulin Raw starch 
5 Pectin Xylose Xylose Cellulose Rhamnose Oat bran 
Bottom 5 
     
5 Maize fibre Modified pectin Oat bran Oligofructose Maize fibre Gum arabic 
4 Corn bran Guar gum Pea fibre Glucose Xylose Laminarin/ seaweed derivatives 
3 Beta-glucan Cellulose Corn bran Lactulose Pea fibre Modified pectin 
2 Cellulose Rhamnose Cellulose Pectin Cellulose Arabinose 
1 Green kiwi fibre Beta-glucan Green kiwi fibre Lactose Green kiwi fibre Xylose 
Top 5, 1-5 = high to low, Bottom 5, 1-5 low to high 
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Figure 3-4: Box plots to show the 24-hour acetate production of all of the substrates assessed within the systematic review (mmol/g CHO/ day).  
FOS= oligofructose, GOS= galactooligosaccharide. Outliers are signified by a circle, and extreme outliers with a * 
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Figure 3-5: Box plots show the 24-hour propionate production of all of the substrates assessed within the systematic review (mmol/g CHO/ day). 
FOS= oligofructose, GOS= Galactoooligosaccharide. Outliers signified by a circle, extreme outliers with a * 
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Figure 3-6: Box plots to show the 24-hour butyrate production of all of the substrates assessed within the systematic review (mmol/g CHO/ day) 
FOS= oligofructose, GOS= Galactoooligosaccharide. Outliers are signified by a circle, and extreme outliers with a * 
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Figure 3-7: Box plots show the 24-hour total SCFA production of all substrates assessed within the systematic review (mmol/g CHO/ day) 
FOS= oligofructose, GOS= Galactoooligosaccharide. Outliers signified by a circle, and extreme outliers with a * 
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 Pooled SCFA production per day (24 hour SCFA production) 
After screening the studies with a 24 hour time point, sufficient data were available for 
comparison of 18 substrates.  There was no substrate which selectively increased a specific 
SCFA (Table 3-13). Beta-glucan and lactulose fermentation generated the highest rate of 
acetate, propionate and butyrate.  
Fermentation of cellulose consistently resulted in low production of SCFAs generating a 
total rate of 0.9 mmol/g CHO/ day. Proportionally, the ability of different substrates to 
selectively produce SCFA was more varied. For example, pectin resulted in the highest 
proportion of acetate (90 [3.20 %) and the lowest proportion of propionate (8.0 [0.4] %) 
and butyrate (2.2 [0.5] %).  Guar gum generated the highest proportions of propionate with 
39.0 (6.2) % of total SCFA (Table 3-13, Table 3-14). 
 Additional articles which are not attached to tables 
 Table 3-12: Articles fulfilling all criteria but information was not provided in the tables as 
they are not in the top or bottom ten at any stage. 
Non-pooled (Lei et al., 2012, Rasmussen et al., 1988, Kotchariana, 2004, Pickardt et 
al., 2004, Trinidad et al., 1996, De Preter et al., 2010, McBurney et al., 
1988, Casiraghi et al., 2011, Bourquin et al., 1993, Gullón et al., 2011) 
Pooled (Granito et al., 2001, Amrein et al., 2003, Rose et al., 2010, Stewart and 
Slavin, 2009, Lebet et al., 1998, Kim and White, 2011a, Niemi et al., 
2013, Mallillin et al., 2008, Veeriah et al., 2007, Nordlund et al., 2013) 
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Table 3-13: The top and bottom five ranked producers of acetate, propionate, butyrate and total SCFA at 24 hours based on rate of production when samples are 
pooled (mmol/g carbohydrate/day) 
Top 5 Ranked on acetate Ranked on propionate Ranked on butyrate Ranked on total 
1 β-glucan (1-6)** 22.04 (30.5)* β-glucan  (1-6) 8.95 (13.7) β-glucan (1-6) 12.95 (18.9) β-glucan (1-6) 43.94 (62.2) 
2 Lactulose (1, 4- 9) 16.92 (34.9) Lactulose (1, 4- 9) 3.68 (8.7) Lactulose (1, 4- 9) 7.81 (18.1) Lactulose (1, 4- 9) 28.45 (61.7) 
3 Glucose (10-14) 7.05 (6.5) Resistant starch (3-5, 15-18) 2.46 (7.7) 
Oligofructose (3,10,19-
25) 2.46 (3.8) 
Resistant starch  (3-5, 
15-18) 11.92 (35.5) 
4 Resistant starch (3-5, 15-18) 6.92 (20.7) Guar gum (2, 22, 37) 2.42 (0.8) 
Resistant starch  (3-5, 
15-18) 2.53 (7.3) Glucose (10-14) 11.06 (11.9) 
5 Oligofructose  (3, 10, 19-25) 5.84 (6.7) 
Arabinoxylan (23, 
33, 38) 2.30 (2.5) Glucose (10-14) 2.3 (3.6) 
Oligofructose (3, 10, 
19-25) 9.50 (11.6) 
Bottom 5 
       
5 Ispaghula (3, 13, 14, 26) 2.34 (1.5) 
Inulin (2, 3, 8, 10, 
21, 29, 30, 39, 40) 0.81 (0.8) 
Arabinoxylan (23, 33, 
38) 0.61 (0.6) 
Ispaghula (3, 13, 14, 
26) 4.31 (2.1) 
4 
laminarin/ seaweed 
derivatives (12, 27, 
28) 
2.32 (1.9) Raw starch (15, 22, 11) 0.72 (0.4) Ispaghula (3,13, 14, 26) 0.55 (0.4) 
Laminarin/ seaweed 
derivatives (12, 27, 
28) 
3.56 (2.5) 
3 
Partially hydrolysed 
guar gum (13, 29, 
30) 
1.25 (1.1) Pectin (11, 14, 20, 22) 0.65 (0.3) 
Laminarin/ seaweed 
derivatives (12, 27, 28) 0.38 (0.1) 
Partially hydrolysed 
guar gum (13, 29, 30) 3.49 (3.3) 
2 Rye bran (31-35) 1.14 (2.1) Rye bran  (31-35) 0.40 (0.7) Rye bran  (31-35) 0.36 (0.7) Rye bran (31-35) 1.90 (3.5) 
1 Cellulose (14,22, 36) 0.57 (0.3) Cellulose  (14, 22, 36) 0.19 (0.1) Cellulose  (14,22, 36) 0.16 (0.1) Cellulose  (14, 22, 36) 0.92 (0.6) 
Mean *(standard deviation) of the data obtained in articles fulfilling the inclusion criteria. Top 5, 1-5 = high to low, Bottom 5, 1-5 low to high **References1: 1-(Kim and White, 2011c), 2- 
(Queenan et al., 2007), 3(Kaur et al., 2011), 4- (Sayar et al., 2007), 5 (Kim and White, 2010),  6-(Wood et al., 2002), , 7-(Arrigoni et al., 2005), 8-(Arrigoni et al., 2002), 9- (Gulfi et al., 
2005), 10- (Jenkins et al., 2011), 11-(Nordgaard et al., 1995), 12- (Deville, 2007), 13-(Pylkas et al., 2005), 14-(Mortensen et al., 1991), 15- (Martín Bernabé et al., 2011), 16-(Fassler et al., 
2007), 17-(Zhou et al., 2013), 18- (Zhang et al., 2012), 19-(Yu et al., 2013), 20-(Chen et al., 2013), 21- (Queenan et al., 2007), 22-(Ferguson and Jones, 2000), 23-(Rumpagaporn et al., 
2012), 24- (Munjal et al., 2009), 25- (Yang et al., 2014), 26-(Bliss et al., 2013), 27- (Bobin-Dubigeon et al., 1997), 28-(Lahaye et al., 1993), 29 - (Noack et al., 2013), 30- (Ohashi Y, 2012),  
31-(Karppinen et al., 2000), 32-(Nordlund et al., 2012), 33- (Karppinen et al., 2001), 34- (Aura et al., 2005), 35-(Aura et al., 2006), 36- (Wong et al., 2005), 37- (Stewart and Slavin, 2006), 
38- (Glei et al., 2006), 39- (Hartzell et al., 2013), 40-(Beyer-Sehlmeyer et al., 2003), 41 - (Barry et al., 1995). 
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Table 3-14: The top and bottom five ranked SCFA producers based on molar proportion (%) at 24 hours when samples are pooled 
Top 5 Ranked on acetate Ranked on propionate Ranked on butyrate 
1 Pectin (11, 14, 20, 22)** 75.0  (6.7)* Guar gum (2, 22, 37) 39.0  (6.2) Partially hydrolysed guar gum  
(13, 29, 30) 
46.0     (25.3) 
2 Glucose (10-14) 71.9 (13.7) Ispaghula (3, 13, 14, 26) 31.5  (12.5) β-glucan (1-6) 30.6    (5.4) 
3 Raw starch (15, 22, 11) 64.1 (19.8) Arabinoxylan  (23, 33, 38) 28.6   (11.4) Inulin (2, 3, 8, 10, 21, 29, 30, 
39, 40) 
30.0  (13.7) 
4 Cellulose  (14, 22, 36) 63.3 (12.5) Laminarin/ seaweed 
derivatives (12, 27, 28) 
26.5 (2.8) Oligofructose (3, 10, 19-25) 27.0  (7.5) 
5 Lactulose (1, 4- 9) 63.1 (13.5) Resistant  starch (3-5, 15-18) 23.9 (11.6) Lactulose (1, 4- 9) 25.1  (10.0) 
Bottom 5  
     
5 Ispaghula (3, 13, 14, 26) 56.2 (22.4) Raw starch (15, 22, 11) 13.1  (11.0) Glucose (10-14) 15.1 (9.2) 
4 Resistant starch  (3-5, 15-18) 54.6 (14.7) Glucose (10-14) 13.0  (5.4) Arabinoxylan  (23, 33, 38) 14.5    (5.8) 
3 β-glucan (1-6) 50.18 (6.8) Inulin (2, 3, 8, 10, 21, 29, 30, 
39, 40) 
13.0 (8.3) Laminarin/ seaweed derivatives 
(12, 27, 28) 
14.1       (5.0) 
2 Guar gum (2, 22, 37) 49.1   (3.2) Lactulose (1, 4- 9) 11.4   (4.1) Ispaghula (3,13, 14, 26) 12.3      (11.2) 
1 Partially hydrolysed guar 
gum  (13, 29, 30) 
35.8 (17.2) Pectin (11, 14, 20, 22) 9.6   (3.0) Guar gum (2, 22, 37) 11.9     (8.0) 
Mean (standard deviation)* of the data obtained within articles fulfilling the inclusion criteria.  Top 5, 1-5 = high to low, Bottom 5, 1-5 low to high: **References- numbers are based on 
those in the legend of Table 3-13 
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 Discussion 
The factors influencing the propensity of a particular NDC to selectively increase the 
production of a specific SCFA is not fully understood.  This gives rise to challenges in 
decision making when selecting NDCs for intervention studies designed to test the effects 
of increased propionate production.  To identify potential propiogenic substrates a 
systematic review was conducted to evaluate the SCFA producing capabilities of a variety 
of different substrates, determined using in vitro batch fermentations.  Searches generated 
114 acceptable articles and permitted comprehensive analysis of the role of NDC on 
propionate production in vitro to be carried out (Figure 3-2). 
 
Many issues were identified when comparing the studies for example a lack of a 
standardised methodology for in vitro batch fermentation setup and analysis. 
Unfortunately, attempts to agree a standardised model to reduce inter-study method 
variations have been unsuccessful and are not standard practice (Edwards et al., 1996, 
Barry et al., 1995),(COST Action FA1005, 2015).  The published literature therefore is 
based on a range of methodologies, with variability in substrate quantity, inoculum volume 
and composition, and fermenter size which made direct comparisons difficult. Different 
fermentation protocols may alter the rate, ratio and extent of SCFA produced. The amount 
of substrate added to the fermentation vial has been shown to alter SCFA production with 
10 mg/ml lactulose producing less total SCFA than 7.5 mg/ml lactulose.  This was 
probably due to end product inhibition occurring through a lack of absorption which would 
naturally occur in the colon  (Khan and Edwards, 2002).   
 
Another major issue identified when processing the data was the variety of units used to 
present the SCFA production. On some occasions, inadequate information on the unit used 
to present SCFA production was given. For example, Jonathan et al., (2012) presented 
SCFA production as mmol/g organic matter, without providing information on the 
substrate (e.g water content), so the fibre content could not be calculated (Jonathan et al., 
2012). This prevented calculation of the rate term, so the study was not included within the 
review  
 
Units used to describe SCFA production ranged from mmol/l, (Laurentin and Edwards, 
2004, Adiotomre et al., 1990) μmol/ g substrate, (Titgemeyer et al., 1991) and μmol per 
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50mg carbohydrate (Kaur et al., 2011).  A rate unit for the standardisation of SCFA data, 
was therefore developed to enable direct comparisons. This rate term (mmol/g CHO/day, 
or mmol/g CHO/ hour) took into account the mass of substrate, volume added, 
concentration of SCFA produced, and the duration of fermentation.  It became clear 
although using the molar ratios of SCFA production reduced the variation between 
investigations it was potentially misleading. Molar proportions did not take into account 
the total production, and therefore a substrate with a high percentage of an individual 
SCFA, may have not resulted in the highest final concentrations of each SCFA. This was 
demonstrated by green kiwi fruit fibre at 24 hours (Table 3-9, Table 3-10), which was 
ranked fourth for butyrate proportion (19 [0.1] %), but yielded the lowest production (0.14 
[0.0] mmol/g CHO/ day).  In addition, maize fibre produced the highest proportion of 
propionate (27 [0.7] %), but was the fourth lowest for rate (0.04 [0.0] mmol/ g CHO/ hour) 
between 10 and 23 hours (Table 3-7, Table 3-8). 
 
There was also substantial inter-individual variation in SCFA within investigations, which 
is supported by previous in vitro studies (Salazar et al., 2008, Casiraghi et al., 2011, 
McBurney and Thompson, 1989, Carlson et al., 2016).  However this inter-individual 
variation was shown not to inhibit the assessment of effects of dietary fibre on SCFA 
production in studies comparing pooled (inter-individual variation is negated by mixing 
samples) and non-pooled samples (Mortensen et al., 1991, Aguirre et al., 2014).  
Mortensen et al., (1991) concluded that variation was the same on all occasions whereas 
(Aguirre et al., 2014) concluded that pooling the stool samples reduced overall variability. 
Pooling of the stool samples however does not take into account the fact that not all 
individuals have the same colonic microbiota, and cannot ferment all NDCs equally.  
Differences in the bacterial composition of cultures with pooling have also been identified 
by Aguirre et al., (2014) where fermentation by pooled bacteria were different to that of 
each  individual donor, in some cases but not others. For example, for one of the 
individual’s faecal samples, which was later pooled, had a 35 fold increase in Prevotella, 
and a 19 fold increase in Roseburia compared to the final pooled inoculum. It was also 
identified that the response of the bacteria to pooling was not equal for all individuals and 
that some form of competition for bacterial dominance was occurring (Aguirre et al., 
2014).  The ability of some bacteria to dominate over existing bacterial populations has 
also been seen in faecal transplants of patients with Clostridium difficile infection. For 
these recipients, the bacterial population of the donor becomes that of the recipient, and 
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this remained at day 70 post-transplant (Fuentes et al., 2014).  Animal studies have also 
shown the dominance of a bacterial population using mouse models.  Ridaura et al., (2013) 
demonstrated that when obese mice were housed with lean mice that the obese mice 
became lean, and had the ‘lean’ bacterial profile, whereas the lean mice remained lean, 
suggesting a dominant set of bacteria. The obese mice housed with the lean bacteria also 
produced comparable SCFA to the lean mice, but not the obese mice with the obese 
bacteria, suggesting that pooling the bacteria may alter the SCFA production capabilities.  
However, housing mice with different bacteria, albeit with coprophagy to aid mixing, does 
not really mimic mixing different faecal samples in incubations (Ridaura et al., 2013).  
 
As the strategy to pool or not pool stool samples was one of the main technical differences 
in papers used for the systematic review, later analysis was split into pooled and non-
pooled data. After separating papers based on methodology, 51 articles were found to pool 
the faecal samples and 65 articles did not pool stool samples, (two articles (Barry et al., 
1995, Mortensen et al., 1991) reported both pooled and non-pooled investigations. An 
observation with the pooled samples was that although multiple stool donors were used, 
only one biological repeat was carried out. This occurred with 32 of 51 (63%) articles 
using one biological repeat, which was higher than that of the non-pooled samples 12 of 
the 65 (32%), indicating that the non-pooled experiments had increased statistical power.  
 
Studies not pooling the samples often conducted fermentations on three separate occasions; 
this is more appropriate as this means there are three biological repeats as opposed to one, 
further increasing statistical power. Although pooling stool samples is likely to reduce the 
variability within an investigation, it led to increased inter-study variation on some 
occasions (Table 3-3, Table 3-4).  This may be due to individuals having different levels of 
colonic microbiota diversity.  Greater diversity may aid rapid adaptation to the NDC 
present, producing different SCFA profiles.  However, this may vary when stool samples 
are pooled and a dominant ecosystem is not established.  
 
SCFA production during the intermediary time points, such as 10 - 23 hours were also 
considered (Table 3-5 - Table 3-8).  This later phase of the batch culture indicates if the 
NDC is no longer being fermented (for a rapidly fermented NDC) or for slowly fermented 
NDC this may be the fastest period of SCFA production.  Moreover, some SCFA are not 
greatly produced until later in the fermentation.  Butyrate is often produced in greater 
116 
 
 
 
amounts after 8 hours as it may be formed by conversion from other SCFA (Morrison et 
al., 2006, Khan and Edwards, 2005).  In the studies from the systematic review, between 6 
and 9 hours, cellulose generated the highest proportion of propionate and was the lowest 
producer of all the SCFA, further demonstrating how using a simple ratio can be 
misleading when evaluating SCFA production by NDC.  This increased proportion of 
propionate from cellulose may be attributed to the presence of glycosidic β-bonding which 
is associated with increased propionate production (Arora et al., 2012).  SCFA production 
from glucose was the highest of the substrates between 6 and 9 hours.  This may be 
because glucose is the most easily fermented. Between 10 and 23 hours, pea and maize 
fibre resulted in the lowest SCFA production; unfortunately, the data describing the SCFA 
production of these fibres prior to 10 hours did not fulfil the criteria for consideration in 
this review. When SCFA were compared as daily production, pea and maize fibre also 
ranked in the bottom 5 suggesting that they are poorly fermented substrates.  Maize fibre 
between 10 and 23 hours led to a high proportion of propionate (27%), but ranked second 
from bottom for rate of production yielding 0.03 (0.0) mmol/g CHO/ hour further 
demonstrating how the ratio can be misleading.  
 
After 24 hours of fermentation (Table 3-9, Table 3-10), it was found that rhamnose 
generated the highest proportion and rate of propionate production in the studies with 
individual faecal samples.  Rhamnose has also been associated with increased propionate 
in vivo, where consumption as part of a meal increased levels of serum propionate (Vogt et 
al., 2004a, Vogt et al., 2004b).  
 
Lactulose yielded high rates of SCFA production for the pooled and non-pooled samples 
This was demonstrated when 20g of lactulose was consumed by healthy individuals along 
with an infusion of labelled acetate where the fermentation of lactulose increased 
concentrations of exogenous acetate (Pouteau et al., 1998).  At 24 hours cellulose yielded 
low rates of SCFA production for the pooled and non-pooled, this is supported by in vivo 
studies that did not identify cellulose as producing high faecal SCFA concentrations 
(Spiller et al., 1980). 
 
When comparing the 24 hour non-pooled data with the pooled data, there were differences 
in the top and bottom SCFA producers. Pooled analysis identified that β-glucans generated 
the highest rate total SCFA, acetate, propionate and butyrate, whereas in the non-pooled 
117 
 
 
 
studies production from β-glucan was unremarkable; ranking 20th, 24th, 19th and 9th (out of 
27) for total, acetate, propionate, and butyrate production.  
 
One issue that affected the differences in the ranks of the NDC for SCFA between studies 
that pooled or did not pool faecal samples was that some of the substrates were not 
included due to lack of studies which met the inclusion criteria. Thus, the ranking of the 
substrates should not be directly compared between studies with these two methodologies. 
 
The main key finding of this review was that there was no substrate which particularly 
stood out in terms of propionate production, although rhamnose and β-glucan showed 
promise. This also indicates that if a fibre is proportionally propiogenic but does not have 
high total SCFA production it may not always be the best option for selection. Therefore it 
may be beneficial to maximise the total intake of dietary fibre as increasing total SCFA 
production also increases propionate production. The quantity of propionate in the colon is 
likely to be more important than the proportion of SCFA when considering the 
physiological effects.  
 
The differences between propionate production from different NDCs were relatively 
limited and increasing propionate production in the colon, on the basis of this data, could 
easily be achieved by increasing intake of almost any fibre studied.  When comparing guar 
gum and pre-digested starch (i.e. resistant starch), increasing the dose of resistant starch by 
60% could yield a similar amount of propionate as guar although guar has the higher molar 
proportion of propionate.  However, the ratio may be important for some physiological 
functions where SCFA compete for effects.  Wolever and colleagues found that the 
acetate/ propionate ratio determined impact on lipogenesis (Wolever et al., 1995, Wolever 
et al., 1991).    
Also highlighted within this review was the lack of a systematic approach to screen the 
drivers of propionate production. The following chapters within this thesis aim to do this. 
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 Miniaturisation Validation 
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Some substrates tested within this thesis were too expensive to run in the standard large 
(1g) scale fermentation system. Therefore, a study was undertaken to miniaturise and 
validate reduced volume systems to enable increased numbers of both, biological and 
technical replicates. Miniaturised systems could potentially enable fermentations with 20x 
less substrate than previously required. The substrates oligofructose, pectin, guar and a 
blank (control) were used for this validation, as they are commonly used as control 
substrates in the laboratory. 
 
 Materials and Methods 
Miniaturisation systems requiring 1 g, 100 mg, or 50 mg of substrate were compared 
(Table 4-1). These systems were used to ferment a selection of different substrates using 
the standard fermentation method in anaerobic conditions as described in Capter 2- Section 
2.2.  
 
Table 4-1: Changes to the fermentation composition because of the reduction in the 
fermentation size 
 
 
  Standard Medium Small  
Vial Size 100 ml 10 ml 6 ml 
Substrate added 1 g 0.1 g 0.05 g 
Fermentation medium 42 ml 4.2 ml 2.1 ml 
Reducing solution 2000 μl 200 μl 100 μl 
Faecal slurry 5000 μl 500 μl 250 μl 
Final volume of 
fermentation 49 ml 4.9 ml 2.45 ml 
Sample taken per time 
point 3000 μl 800 μl 400 μl 
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 Stool donors 
  Standard fermentation system 
M/F 3/2, aged 22-52, mean age 33.4 years (median age 25 years), n= 5 
These fermentations were conducted independently of the medium and small fermentation 
systems.  
 
 Medium and small fermentation system 
M/F 2/2, aged 22-52, mean age 35.5 years (median age 34 years), n= 4.  
These fermentations were conducted the same faecal samples.  The majority of donors 
provided a second sample for these systems, only one individual did not provide a second 
sample (male, 25 years). 
  
 Substrates tested 
x Oligofructose (Beneo 95, Mannheim, Germany) 
x Pectin (from apple, Sigma, Poole, UK) 
x Guar gum (Sigma, Poole, UK) 
A substrate free control was also used 
 
 
 Time points 
x 1g fermentation system – 0, 2, 4, 8, and 24 hours 
x 100 mg and 50 mg system – 0, 8, and 24 hours. Sampling was limited to three time 
points due to a reduced fermenter volume. 
 SCFA assessment 
The SCFA in the fermenter supernatant were measured as described in Chapter 2- Section 
2.2.1 with 100 μl (for standard system) and 25 μl (for medium and small systems) of 73.8 
mM 2-ethyl-butyric acid as internal standard.  
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 Statistical analysis and data presentation 
Production of SCFA was made comparable by the use of the rate term μmol/g CHO/ hour. 
This rate unit is further discussed in Chapter 3- section 3.3.2.  Molar proportions were also 
used to compare SCFA production. Data is presented as Mean (SEM). 
 
All comparisons of the different vial sizes were conducted using ANOVA with post hoc 
Bonferroni analysis using SPSS version 22 (IBM, New York, USA). Graphs were 
produced on Microsoft Excel 2013. 
 
 Results 
 Process of ‘miniaturisation’ 
A series of issues were identified whilst miniaturising the fermentation system.  At each 
time point with the ‘large’ 1 g system 3000 μl of sample was taken.  This was not possible 
in the smaller vessel sizes as this is 61% and more than the total of the fermentation 
volume of the medium and small systems. If 3000 μl of the fermentation slurry was 
required for the medium and small systems, a single fermentation vessel containing 100mg 
or 50 mg of substrate could be used and the vial removed at each time point, i.e. three time 
points = three vials per substrate.  Due to this, the amount of slurry that was taken at each 
time point was reduced, and the number of time points used was limited to three (including 
the final time point).  This had subsequent down-stream effects such as the requirement of 
a pH meter that was narrower, and able to measure the pH of smaller volumes. SCFA 
extraction was also modified due to the requirement of 800 μl of slurry with the standard 
‘in house’ fermentation system, which was reduced requiring only 200 μl of slurry per 
extraction (Chapter 2 – Section 2.2.1). In essence, the process of fermentation and 
subsequent SCFA analysis was proportionally decreased by a factor of 20, achieving 
similar final concentrations in all vessels used. 
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 Comparison of fermentations 
 The rate of SCFA production of the different models were compared to observe whether 
the volume had any impact.  There were no significant differences in each SCFA produced 
for any of the substrates tested or for the blank control at 8 or 24 hours (Figure 4-1, Figure 
4-2).  The fermentation systems all resulted in the same pattern of SCFA production.  At 8 
and 24 hours the propionate production was in the order: control < oligofructose < pectin < 
guar for all vial sizes (Figure 4-1, Figure 4-2).  Similar effects to the concentration were 
also seen when the variability of the molar proportion of propionate were assessed.  
Decreasing vial size, increased variability in propionate proportion this was clear for guar 
where the SEM for percentage propionate the large vial was 3.6%, the medium vial, 
4.48%, and the small vial was 7.71% (Figure 4-4). 
 
Although no significant differences in SCFA production between the vial sizes were 
observed, the variability for total SCFA production differed between vessel.  As the 
amount of substrate used was decreased, the more variable the total SCFA production 
became.  This was likely due to the propagation of errors, occurring when reducing the 
fermentation volume.  In most cases, the equipment used could be reduced to 
accommodate the difference in volumes, but not all errors in equipment were the same 
(Table 4-2).  This did not take into account difficulties encountered when adding the faecal 
slurries, which were increasingly difficult to measure as the volume reduced. The weighing 
scale also had an error of 1 mg resulting in the error in mass of substrate for the small 
system being 20x that of the large system (Table 4-2).  This propagation of effects likely 
occurred and each time point, where the viscosity could have also played a role in the 
increasing error, particularly with the 50 mg system.  The reduced fermentation size was 
challenging with use of the viscous fibres, such as guar, which produce a viscous 
supernatant, which reduced the volume of fermentation slurry available for sampling. 
Increased errors were also observed for oligofructose, as the propagation of errors could 
possibly have non-significantly altered the production of SCFA, which would be more 
apparent in a highly propiogenic substrate (Figure 4-3). 
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Table 4-2: Experimental error of different fermentation vessels used 
  Standard Error Medium Error Small  Error 
Scales error    
(1 mg)  1 g 0.1% 100 mg 1% 50 mg 2% 
Fermentation 
medium 42 ml 1.84% 4.2 ml 1.45% 2.1 ml 0.6% 
Reducing 
solution 2000 μl 1.92% 200 μl 1.9% 100 μl 2.4% 
Faecal slurry 5000 μl 0.64% 500 μl 3.08% 250 μl 0.48% 
Error % per 
vessel  
4.50%  7.43%  5.48% 
Errors were calculated by the average of five weighed measurements of water for each volume 
required. 
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Figure 4-1: Rate of SCFA production after 8 hours of fermentation (μmol/ g carbohydrate/ hour). 
Miniaturised fermenters containing 50 mg, 100mg (n=4) and 1000 mg (n=5), of guar gum, oligofructose or pectin were compared. Presented are mean + SEM. No significant 
differences as a result of vial size were observed. 
 
 
125 
 
 
 
   
Figure 4-2: Rate of SCFA production after 24 hours of fermentation (μmol/ g carbohydrate/ hour). 
Miniaturised fermenters containing 50 mg, 100mg (n=4) and 1000 mg (n=5), of guar gum, oligofructose or pectin were compared. Presented are mean + SEM. No significant 
differences as a result of vial size were observed.. 
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Figure 4-3 : Total rate of SCFA production after 24 hours of fermentation. 
Fermentation with miniaturised fermenters containing 1000 mg (n=5), 100 mg and 50 mg (n=4) of 
guar gum, oligofructose or pectin. No significant differences were observed because of substrate 
amount. 
 
 
Figure 4-4: Propionate proportion after 24 hours of fermentation  
Fermentation with miniaturised fermenters containing 1000 mg (n=5), 100 mg and 50 mg (n=4) of 
guar gum, oligofructose or pectin. No significant differences were observed because of substrate 
amount. 
.
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  Discussion 
It was possible to miniaturise the fermentation system without detrimental effects to the 
production of SCFA. This paves the way for screening expensive and less abundant 
substrates in a way that is more commercially viable, and enabled more biological 
replicates of costly substrates, as less substrate is required for each vessel. This provides 
increased power for the assessment of the SCFA producing capabilities of different 
substrates.  Although the systems were reduced, proportions of the components of each 
fermenter were maintained, i.e. 2.0% w/v of substrate, the less substrate added to the vial, 
the less SCFA and increased variability in the SCFA production occurred.  
 
Some of this variability would likely have occurred due to inter-individual variability in 
the SCFA production, as seen in previous studies (Carlson et al., 2016). The effect of this 
variability was limited in this miniaturisation by using stool samples from the same 
individuals. As different stool samples were used to seed the large vessels compared to the 
medium and small fermentation vials intra-individual variability in SCFA production may 
have occurred. This is as the diets were not controlled or replicated, and diet has been 
shown quickly alters the gut bacteria (David et al., 2014). For the medium and small vessel 
sizes, where the same stool sample was used to seed the vessels, the natural biological 
inter-donor variability would have also occurred, but to a similar extent for both sample 
sizes (Figure 4-1, and Figure 4-2). 
 
This suggests that some of the differences variability occurring between the medium and 
small vessel sizes may have been because of experimental error. This was particularly 
likely in the small system, during the setup of the fermentation and with the subsequent 
time points.  For example, the medium and small systems, each sampling removed 16% of 
the slurry (for further SCFA analysis). This was greater that the large system (6.0%), but 
does not explain the difference in the variability between the medium and small systems. 
Differences between the medium and small systems, in particular may have been because 
of propagation of error occurring during the miniaturisation of the system.  These errors 
were reduced by using different equipment where the sizes used were reduced accordingly, 
but was not always possible and may have resulted in the differences seen. This was 
apparent, in particular when weighing out the initial mass of substrate. The scale used had 
an error of 1 mg, which for the large fermentation system translates to 0.1% of mass added, 
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but when considering the small fermentation system this is a 2.0% difference in the mass 
added, thus leading to the further error, when reducing the fermentation system (Table 
4-2).  
 
Based on this the ‘small system’ was only subsequently used when many biological 
replicates of an expensive substrate was required, such as those within Chapter 6. Other 
studies have used similar fermentation systems that have been reduced to have a total 
volume of 700 μl, and limited sampling to one time point only (Sanz et al., 2005c, 
Hernandez-Hernandez et al., 2011) Small-scale fermenters with a 5 ml working volume 
and 50 mg of substrate can also be used in a pH-controlled system (Hernandez-Hernandez 
et al., 2011).  An advantage of the system within this chapter is that the reduction in 
substrate quantity, along with a reduced volume, did not alter the SCFA production 
profiles of the substrates tested. It has been previously demonstrated in the in vitro 
investigation by Khan and Edwards., (2002) where the amount of substrate was reduced 
from 10 mg/ml to 2.5 mg/ml, differences in SCFA production of lactulose were observed 
(Khan and Edwards, 2002).  
 
Another advantage of this system was that a smaller amount of stool sample was required 
to provide sufficient slurry for multiple fermentations. This was particularly beneficial 
when there was many different substrates for fermentation, or many different types of 
analysis conducted with one stool sample. A disadvantage of these miniaturised systems is 
that the number of sampling times and volumes taken needs to be reduced for enough 
fermentation media to remain for the whole duration of the experiment. This required 
down-stream analysis to be modified and was taken into account when planning 
experiments that required slurry for different forms of analysis.  
 
Overall, it has been demonstrated that the 1g in house system could be reduced without 
detrimental effects to SCFA production. However, although not significant, differences in 
the variability were seen, this was likely due to the increased experimental error, occurring 
when reducing the size of the fermentation vessel. This indicates that due to this error, the 
main benefit of the small system is when there the substrate being tested is scarce, and that 
the using the medium and large systems are more beneficial for screening of substrates in 
which are more abundant or less costly.  
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 Identification of substrates that 
selectively increase propionate production in vitro 
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 Introduction 
The potential importance of colonic propionate and its role in contributing to the health-
benefits of non-digestible carbohydrates (NDC) were discussed in Chapter 1. Increasing 
the amount and proportion of propionate produced from the fermentation of carbohydrates 
by colonic bacteria may affect: satiety and therefore eating behaviour (Chambers et al., 
2014, Byrne et al., 2016), liver metabolism of lipids and carbohydrates improving 
lipoprotein and cholesterol levels in the plasma (Berggren et al., 1996, Heimann et al., 
2015).  An understanding of which carbohydrates preferentially increase propionate 
production would enable selection of NDCs for dietary manipulation to improve health. 
 
In Chapter 3 (systematic review) which considered which substrates promote the 
generation of propionate it was concluded that the evidence predicting NDCs that are 
‘propionate’ producers was not clear-cut. This was despite perceived evidence of some 
carbohydrates (such as β-glucans) being more propiogenic than others.  The systematic 
review showed that carbohydrates yielding high proportions of propionate did not 
necessarily produce greater amounts of propionate when compared in vitro.  Comparisons 
between carbohydrates were also hampered by the vast variation in the methodologies used 
between studies.  Therefore, a more thorough and standardised comparison of 
carbohydrates is required to identify which NDC selectively increase propionate 
production in the human colon.  In this chapter, a selection of potentially propiogenic 
substrates were considered and screened in vitro for their propiogenic potential.  The 
substrates were chosen based on the data acquired within the systematic review and other 
sources.  The substrates tested are discussed below: 
 
 B-glucans 
Beta (β) – glucans are polymers of glucose linked with beta glycosidic bonding and are 
associated with the increased production of propionate. Queenan et al., (2007) showed in 
vitro that oat and barley β-glucans (consisting of β[1-3] and β[1-4] linkages) increased 
propionate production compared to controls (Queenan et al., 2007). Increased in vitro 
propionate production has also been seen with more uncommon β-glucans such as those in 
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seaweeds such as laminarin (brown algae, β[1-3], β[1-6] bonding) and Gelidium (red 
algae, β [1-4] bonding) (Ramnani et al., 2012, Deville, 2007).  
 
Beta glucans have also been shown to increase colonic propionate and have beneficial 
health outcomes after consumption.  When hypercholesteraemic individuals consumed 6 g/ 
day of oat β-glucan by for 6 weeks benefits such as reduced total and LDL cholesterol 
were observed (Queenan et al., 2007). Kuda et al., (2005) fed rats a diet containing 2% 
laminarin for 14 days, and observed a 66% increase in caecal propionate compared to 
controls and high molecular weight alginate (Kuda et al., 2005).  Feeding of laminarin 
(from laminara hyperborea) to pigs for 14 days also altered propionate production and 
bacterial composition. There was a dose dependent increased in the proportion of 
propionate, and decrease in caecal Enterobacterium spp (6.94- 6.7cfu /g digesta), and 
Bifidobacterium spp (8.33- 7.86 cfu /g digesta) numbers with β-glucan dose.  These effects 
however were not associated with differences in caecal pH (Lynch et al., 2010).   
 
 Legumes 
The fibre content of legumes is between 8 and 32% dietary fibre with, 30-75% being 
insoluble.  Colonic fermentation of legumes may have beneficial down-stream effects on 
satiety (McCrory et al., 2010, Guillon and Champ, 2002). In vitro fermentation, using 
human faecal bacteria, of the dietary fibre content of a selection of  legumes and root crops 
including kidney bean, mung bean, lima bean, and peanut (as extracted  using the (AOAC) 
991.43 method) was assessed by Mallillin et al., (2008).  It was identified that legumes 
produced high concentrations and proportions of propionate (Mallillin et al., 2008).  For 
example, 65% of the total SCFA production was formed as propionate from kidney bean 
fibre fermentation.  Data from this investigation was difficult to extrapolate to the general 
population as only a single fermentation consisting of one stool donor was used (Mallillin 
et al., 2008).  In another in vitro investigation, fermentation of lentil and chickpea fibre, 
pre-digested using an in vitro digestion model, resulted in SCFA with 26% and 19% 
propionate and 7% and 16% of butyrate respectively.  This suggested that legumes may be 
candidates for propionate production (Hernandez-Salazar et al., 2010). 
 
The impact of legumes on satiety and weight management has been previously reviewed 
(Guillon and Champ, 2002, McCrory et al., 2010, Barrett and Udani, 2011).  Consumption 
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of a low dose (2.6 g per day) or a high dose (5.8 g per day) of peanut sprout extract via a 
capsule for 4 weeks by 15 overweight and obese individuals showed several beneficial 
effects.  The low dose decreased waist circumference and plasma TAG concentrations.  
The high dose also decreased waist circumference, had no effect of TAG concentrations 
but decreased blood LDL cholesterol compared to dextrin (control) (Ha et al., 2015).  
Consumption of Phaseolus vulgaris (kidney bean, Beanblock®) extract by 12 individuals 
as a tablet before a meal decreased postprandial insulin, and a reduced change in glucose 
compared to the placebo. The experimental group also experienced greater feelings of 
satiety, and a reduced desire to eat compared to the placebo. Along with changes in 
perceived satiety, the experimental group also had significantly reduced plasma ghrelin 
production compared to the placebo group, which were associated by decreased β-cell 
activity (Spadafranca et al., 2013). 
 
Propionate is associated with improved insulin sensitivity, and β cell function (Tang et al., 
2015) and in vitro increases in propionate demonstrate that the soluble fibre of legumes 
may yield high concentrations of propionate. 
 
 Resistant starch and starch derivatives 
Starch is a glucose polymer consisting of amylose (α[1-4] bonds) and amylopectin (α[1-4] 
and α[1-6] bonds). These bonds are broken in the upper gut by salivary and pancreatic 
amylase and brush border enzymes.  Approximately 10% of dietary starch resists digestion 
in the SI and reaches the colon; this is termed resistant starch (RS).  RS is fermented in the 
colon, and has been subcategorised to RS1-RS5, each of which has different chemical and 
physical properties.  RS1 is inaccessible to digestion enzymes, such as within a grain, and 
is heat resistant.  RS2 is starch is tightly stored in granules, is often found in bananas and is 
comparatively dehydrated compared to other RS types.  RS3 (retrograded) has undergone 
some form of processing, often cooked, then cooled like cooked and cooled potatoes in 
potato salad.  RS4 is starch that has been chemically modified, such as by esterification 
(Topping and Clifton, 2001).  RS5 is starch formed of an amylose-lipid complex 
(Thompson et al., 2011). 
 
RS increases SCFA production in in vitro fermentation investigations and increased faecal 
SCFA in feeding trials.  In batch cultures of faecal bacteria RS selectively increased the 
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production of butyrate (Kaur et al., 2011, Weaver et al., 1989)(Chapter 3).  Pyrodextrinised 
(RS4) forms of potato, lentil and cocoyam starch generated significantly higher amounts of 
propionate (at the cost of acetate) compared to the native forms of these starches, in vitro 
(Laurentin and Edwards, 2004).  Ye et al., (2015) fed 19 individuals up to 10 g of Fibersol-
2 (pyrodextrinised corn starch) in a test drink (peach flavoured ice tea, 0, 5 or 10 g) along 
with a meal.  Feelings of satiety were increased, and hunger was decreased for up to two 
hours postprandially after the 10 g dose of Fibersol-2.  This was related to increased 
concentrations of PYY and GLP-1 (Ye et al., 2015), both of which have been associated 
with SCFA production (Lin et al., 2012).  
 
Altered eating behaviour has also been seen with other types of RS. Willis et al., (2009) 
observed when feeding 20 individuals a muffin containing approximately 8 g of fibre 
(muffin total weight - 92 g), including Hi-Maize (RS2) that there was decreased hunger 
and food intake (Willis et al., 2009).  The Hi-maize muffins were associated with low 
palatability compared to other muffins tested, which may have altered feelings of hunger 
and satiety.  Differences in satiety hormones by Hi-maize were also observed by 
Bodinham et al., (2013) where individuals (n= 30) were fed 80 g of Hi-maize (48 g of 
resistant starch), spread over breakfast and lunch.  After breakfast, there was a reduction in 
GLP-1, and after lunch, there was no difference in GLP-1, however feelings of hunger and 
satiety were not measured.  This was thought to be a result of the lack of change in 
concentration of GLP-1 from that produced at the breakfast, not necessarily the base-line 
(Bodinham et al., 2013).  
 
 Objectives 
The aim of the work in this chapter was to identify substrates which may increase the 
production or proportion of propionate.  This would enable further mechanistic analysis of 
why they increase yields of propionate, as opposed to other dietary fibres.   
 
The objective was to screen a range of potential substrates using in vitro batch cultures and 
to assess SCFA production.  Along with the substrate, the role of initial pH and its effects 
on propionate production were also assessed. 
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 Materials and Methods 
The screening of a selection of substrates to identify those that are propiogenic were 
grouped into a series of different experiments. These experiments were grouped based on 
substrate type or methodology. These experimental groups were: 
 
Experiment 1: Beta glucans 
Experiment 2: Legumes 
Experiment 3: Starch (and modified starch) 
Experiment 4: Modified barley starches 
Experiment 5: Starch fermentation at two initial pHs (6.8 & 5.4) 
Experiment 6: Guar, Trehalose dihydrate, Cellobiose and Glucagel fermentation at two 
initial pHs (6.8 & 5.4) 
 
 In vitro fermentation of the different substrates 
Section 2.1.3 outlines the protocols used for the in vitro fermentations used for the 
screening of the substrates. This in vitro method is similar to those compared within the 
systematic review (Chapter 3) and is high throughput, enabling a number of different 
substrates to be screened. 
 
Chapter 2 and Chapter 4 outline the differences, and the validation of the fermentation 
models utilised for the screening of substrates.  Two different fermentation sizes were used 
within this chapter, these were:  
 
1. Medium sized vessel: Substrate added 100 mg; total volume 4.9 ml 
2. Mid-sized vessel: Substrate added; 200 mg, total volume 9.8 ml 
As shown in Chapter 2- Section 2.2.1 there were three different fermentation buffers used 
all of which differed in composition: 
 
1. Standard – has an initial pH of 7.0 
2. pH 6.8 buffer – has an initial pH of 6.8 
3. pH 5.4 buffer – has an initial pH of 5.4 
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 Experimental Controls 
All fermentation experiments included a positive control. Positive controls for each 
experiment were: 
x High performance inulin (HPI, Beneo HP, Mannheim, Germany) 
x Oligofructose (OF, Beneo P95, Mannheim, Germany). 
A negative control (blank) was also included 
 
 Individual experiment details 
 Experiment 1: Beta-glucans 
Substrates: The substrates were commercially available from different sources, with 
variable levels of purity and variations in β-glucan bonding. 
x Oatwell 22: 22%  oat β-glucan, bonding β(1-3), β(1-4) (DSM, Heerlen, 
Netherlands) 
x Oatwell 28: 28% oat β-glucan, bonding β(1-3), β(1-4) (DSM; Heerlen, 
Netherlands) 
x Promoat oat β-glucans 35% β-glucan, bonding β(1-3), β(1-4) (Tate and Lyle; 
Kimstad, Sweden 
x Glucagel: a barley β-glucan consisting of 75% β-glucan, bonding β(1-3), β(1-4) 
(DKSH; London, UK) 
x Laminarin:  a polysaccharide extracted from Laminaria digitata  consisting only of 
glucoses bonding β(1-3), β(1-6) i.e. 100% β-glucan (Sigma; Poole, UK) 
Positive control: High performance inulin (Beneo; Mannheim, Germany) 
Fermentation model used: 100 mg substrate in medium sized vial. Standard media 
Stool donors: M/F, 2/1, aged 23-26 years, mean: 25 years, (median: 25 years), n = 3 
Sampling time points: 0 and 24 hours (the 6 hour time point was omitted due to culture 
viscosity which would result in sampling difficulties) 
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 Experiment 2: Legumes 
Substrates: The soluble fibre fraction of the legumes was extracted by Dr Douglas 
Morrison by hot water extraction and air dried (50°C). Native dried beans were purchased 
from a local supermarket (Sainsbury’s). Legumes tested were: 
x Peanut 
x Mung bean 
x Kidney bean 
Positive control:  Oligofructose (Beneo P95; Mannheim, Germany) 
Fermentation model used: 100 mg substrate medium sized vial. Standard media 
Stool donors:  M/F, 2/1, aged 23-52 years, mean: 33 years, (median: 24 years), n = 3 
(duplicate vials) 
Time points: 0, 6, and 24 hours 
 
 Experiment 3: Starch (and modified starch) fermentation 
Substrates: A selection of different starches were fermented, to identify any potential role 
in the selective production of propionate. These were: 
x Potato starch (Sigma; Poole, UK), 
x Hi-Maize starch, resistant starch (Ingredion; Manchester, UK), 
x Fibersol-2, resistant maltodextrin (Matsutani Chemical Industry Co., Ltd; Hyogo, 
Japan) 
Positive control:  Oligofructose (OF, Beneo P95, Mannheim, Germany) 
Fermentation model used: 100 mg substrate, medium sized vessel, pH 6.8 media 
Stool donors M/F, 2/1, aged 23-25 years, mean: 24 years (median: 24 years), n = 3 
(duplicate vials) 
Time points: 0, 6, and 24 hours 
 
 Experiment 4: Modified barley starches 
Substrates: Barley derived starches outlined by (Carciofi et al., 2012) were fermented.  
The starches used were; Amylose only (AO) and wild type (WT) starch. The starches were 
processed resulting in: 
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x Whole grain 
x Milled 
x Pure starch (Starch that has been purified) 
Fermentation model used: Whole-grain and milled - 200mg (mid-sized) vessel.  Pure 
starch – 100 mg (medium) vessel. All fermentations used pH 6.8 media 
Positive control:  Oligofructose (OF, Beneo P95; Mannheim, Germany) 
Stool donors: M/F, 2/1, aged 23-25 years, mean: 24 years, (median: 24 years), n = 3 
(duplicate vials) 
Time points: 0, 6, and 24 hours 
 
 Experiment 5: Starch fermentation at two initial pHs (6.8 & 5.4) 
Substrates: A selection of different starches previously tested in Experiment 3: Starch 
(and modified starch) fermentation, Experiment 4: Modified barley starches 
were fermented with two different initial pHs. This was used to identify any potential role 
of initial in the production of propionate. These were: 
x From Experiment 3 
o Potato starch 
o Hi-maize starch 
o Fibersol-2 
x From Experiment 4 
o Pure starch (of amylose only and wild type barley) 
 
Positive control:  Oligofructose (OF, Beneo P95, Mannheim, Germany) 
Fermentation model used: 100 mg substrate, medium vessel, pH 6.8 and pH 5.4 media 
Stool donors: M/F, 2/1, aged 23-25 years, mean 24 years, (median: 24 years), n = 3 
(duplicate vials) 
Time points: 0, 6, and 24 hours 
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 Experiment 6: Guar, Trehalose dihydrate, Cellobiose and Glucagel fermentation at 
two initial pHs (6.8 & 5.4) 
Substrates: A selection of different substrates associated with increased propionate were 
fermented at different pHs to identify any potential role in the production of propionate. 
These were: 
x Guar gum (Sigma, Poole, UK) 
x Glucagel (DKSH, London, UK) 
x Trehalose dihydrate (Carbosynth, Berkshire, UK) 
x Cellobiose (Carbosynth, Berkshire, UK ) 
Positive control:  Oligofructose (OF, Beneo P95, Mannheim, Germany)  
Fermentation model used: 200 mg (mid- sized) vessel, pH 6.8 and pH 5.4 media 
Stool donors: M/F 1/2, aged 23-24 years, mean: 23.7 years (median: 24 years), n = 3 
Time points: 0, 6, and 24 hours 
 
 pH measurements 
At each sampling time point, the pH was measured with 
 the use of a pH meter (HANNA). This was carried out before the addition of NaOH. 
 
 SCFA analysis 
The SCFA production was analysed by GC: FID, after undergoing ether extractions. This 
was conducted as described in Chapter2- Section 2.3. 
 
 Data presentation and statistical analysis 
Statistical analysis was conducted using IBM SPSS version 22. Tests of normality was 
analysed by the Shapiro Wilk test. Statistical analysis was as follows. Data for pH, SCFA 
concentration, ratio and rate unit between fibres or initial pH cultures were compared using 
ANOVA and post hoc Bonferroni.  Where data were not normally distributed, log 
transformation was used before statistical analysis.  Data comparing two time points (6 and 
24 hours) were compared by Mann Whitney U test.  
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 Specific details of statistical analysis for each experiment 
Experiment 1: Beta- glucans 
 
SCFA concentration: ANOVA and post hoc Bonferroni 
pH and SCFA ratio: Data was log(10) transformed and then analysed with ANOVA and 
post hoc Bonferroni 
Experiment 2: Legumes 
 
All data was log(10) transformed and then analysed with ANOVA and post hoc Bonferroni. 
Differences between times were measured with Mann Whitney U test. 
Experiment 3: Starch (and modified starch) fermentation 
 
pH: data was log(10) transformed and then analysed with ANOVA and post hoc Bonferroni. 
SCFA concentration and ratio: ANOVA and post hoc Bonferroni. 
Experiment 4: Modified barley starches 
 
All data was log(10) transformed and then analysed with ANOVA and post hoc Bonferroni. 
Experiment 5: Starch fermentation at two initial pHs (6.8 & 5.4) 
 
pH and SCFA ratio: data was log(10) transformed and then analysed with ANOVA and 
post hoc Bonferroni 
Rate:  ANOVA and post hoc Bonferroni. 
Experiment 6: Guar, Trehalose dihydrate, Cellobiose and Glucagel fermentation at 
two initial pHs (6.8 & 5.4) 
 
pH and rate: Data was log(10) transformed and an ANOVA was conducted with post hoc 
Bonferroni 
Ratio: ANOVA and post hoc Bonferroni 
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 Results 
 Experiment 1: Beta- glucans 
The β-glucans tested were fermented and produced significant amounts SCFA.  Due to 
fermentation being a closed system, the pH reduced for all substrates from pH 7.0 to a pH 
between 4.0 and 5.0.  For the blank the pH reduced by only 0.03 units.  The greatest 
reduction in pH was identified with Laminarin and Promoat fermentation falling from pH 
7.06 (0.35) to 4.15 (0.08), and pH 7.08 (0.27) vs 4.28 (0.26) and were significantly lower 
that all other substrates and the blank tested p<0.05. As well as having the lowest pH, 
Promoat and Laminarin also generated the highest concentrations of total SCFA (91.7 
[15.4] mmol/l and 147.9 [31.4] mmol/l, Figure 5-1). 
 
 
Figure 5-1: SCFA production (mmol/l) after 24 hours of fermentation. 
Substrates fermented were the β-glucans: Promoat, Glucagel, Laminarin, Oatwell 22, and Oatwell 
28.   Presented are mean (+ SEM), n=3, * = p<0.05 vs all β-glucans 
* * 
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Figure 5-2: SCFA molar proportion (%) after 24 hours of fermentation. 
Substrates fermented were the β-glucans: Promoat, Glucagel, Laminarin, Oatwell 22, and Oatwell 
28.  Median (+IQR), n=3 
 
Laminarin fermentation led to non-significant increases in acetate, propionate and total 
SCFA production compared to the other substrates used. Although non-significant, total 
SCFA production with laminarin fermentation was 56.2 mmol/l higher than that of 
Promoat, the second highest β-glucan for total SCFA production (Figure 5-1).  
 
There was also no significant effect (or trend) of β-glucan on the proportion of SCFA 
produced, however, Promoat resulted in the highest proportion of acetate (86.0 [13.4] %) 
and the lowest proportion of propionate (6.4 [5.5] %). Oatwell 28 and Glucagel generated 
the highest proportion of propionate (10.7 [10.4] % and 10.1 [5.6] %). Glucagel also 
yielded the highest proportion of butyrate with 25.7 (12.5) % of the total SCFA generating 
butyrate (Figure 5-2). This indicated that the increased fermentability of laminarin, 
increased all of the SCFA produced, and did not change the proportion. 
 
The order of magnitude of SCFA production was ranked for each individual set of cultures 
(individual donors, Table 5-1). Acetate production by the different β-glucans varied by 
individual. On all occasions, Laminarin resulted in the highest propionate production, and 
that propionate production from Glucagel was consistently high.  Ranking of butyrate 
production was more variable for the top producers, whereas it was clear that Promoat and 
the blank generated the lowest amount of butyrate for all donors (Table 5-1).  
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Table 5-1: Ranking of acetate, propionate and butyrate production from each stool donor after 24 hours of fermentation. 
 Acetate Propionate Butyrate 
Rank P1 P2 P3 P1 P2 P3 P1 P2 P3 
1 Laminarin Laminarin Promoat Laminarin Laminarin Laminarin Glucagel Oatwell 28 Laminarin 
2 Promoat Promoat Oatwell 22 Glucagel Glucagel Oatwell 28 Laminarin Glucagel Glucagel 
3 Oatwell 22 Oatwell 28 Glucagel Oatwell 22 Oatwell 28 Glucagel Oatwell 28 Laminarin Oatwell 22 
4 Oatwell 28 Glucagel Oatwell 28 Oatwell 28 Control Oatwell 22 Oatwell 22 Oatwell 22 Oatwell 28 
5 Glucagel Oatwell 22 Laminarin Promoat Oatwell 22 Promoat Promoat Promoat Promoat 
6 Control Control Control Control Promoat Control Control Control Control 
NDC with a ranking of 1 is the top producers, 6 is the lowest produced. 
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 Experiment 2: Legumes 
Fermentations were conducted using the soluble fractions of peanut, kidney bean, and 
mung bean fibre.  The pH for all legumes reduced compared to the control within 6 
hours (Table 5-2).  Oligofructose fermentation resulted in the lowest pH after 24 hours.  
The soluble fibre fraction of peanut had the smallest reduction in pH (0.9 units) after 24 
hours compared to the other legumes tested.  It was also observed that at 24 hours all 
substrates had significantly different pH from each other (Table 5-2). 
 
Table 5-2: pH at 0, 6 and 24 hours of fermentation of the soluble fibre of legumes,  
Time 
(hours) 
Control 
(Blank) 
Peanut Kidney 
Bean 
Mung Bean Oligofructose 
 
0 7.09 (0.18)a 6.98 (0.2) 6.92 (0.21)b 6.90 (0.18) 7.0 (0.22) p<0.05 
6 7.04 (0.07)a 5.77 (0.28)b 5.13 (0.18)c 4.71 (0.66)d 4.36 (0.51)d p<0.01 
24 7.04 (0.08)a 6.0 (0.11)b 5.4 (0.48)c 4.32 (0.5)d 3.98 (0.35)e p<0.01 
Median (IQR), different letters within rows indicate significant differences. 
 
 
 
 Figure 5-3: SCFA production with the soluble fibre from the legumes; mung bean, 
peanut and kidney bean (mmol/l) after 6 hours of fermentation.  
Median + IQR, n=3. Significant differences from peanut are denoted as a: p<0.01 
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Figure 5-4: SCFA production with the soluble fibre of the legumes; mung bean, peanut 
and kidney bean (mmol/l) after 24 hours of fermentation.  
Presented are median + IQR, n=3. Significant differences from peanut are denoted as a: p<0.05, 
and from oligofructose b: p<0.05, *; p= 0.081 vs Peanut, †; p=0.062,  
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Table 5-3: Ranking of the production of SCFA by the soluble fibre of legumes. 
 
Ranking from highest (1) to lowest (5) Control = blank/ negative control. P1-P3 indicates stool donors 1, 2, and 3. 
 
 
Rank Acetate Propionate Butyrate 
 P1 P2 P3 P1 P2 P3 P1 P2 P3 
1 Mung bean Oligofructose Oligofructose Peanut Peanut Oligofructose Mung bean Kidney bean Mung bean 
2 Oligofructose Mung bean Kidney bean Kidney bean Kidney bean Mung bean Oligofructose Peanut Oligofructose 
3 Kidney bean Kidney bean Mung bean Oligofructose Mung bean Kidney bean Kidney bean Oligofructose Kidney bean 
4 Peanut Peanut Peanut Mung bean Control Peanut Peanut Mung bean Peanut 
5 Control Control Control Control Oligofructose Control Control Control Control 
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Fermentation of all the soluble fraction legumes increased acetate production compared to 
the control at 6 hours (Figure 5-3).  For the legumes, mung bean fibre fermentation 
generated the most acetate, producing 37.1 (9.2) mmol/l, and peanut fibre resulted in the 
lowest acetate (19.0 [5.5] mmol/l).  The lowest producer of propionate and butyrate at 6 
hours was the control (blank) which generated 1.4 (0.7) mmol/l and 0.9 (1.6) mmol/l of 
propionate and butyrate.  Butyrate was produced in high quantities after fermentation with 
peanut and kidney bean soluble fibre fractions, which yielded 5.5 (7.3) mmol/l and 6.6 
(10.9) mmol/l of butyrate (Figure 5-3). 
 
Within 24 hours of fermentation all of the legume fibres had significantly more acetate 
production than the control (p<0.001), with oligofructose leading to the highest acetate 
production (48.5 [8.8] mmol/l).  Peanut fibre produced the most propionate by 24 hours 
yielding 9.8 (1.7) mmol/l, however this only reached statistical significance compared to 
the control (p<0.05, Figure 5-4). This was also seen when the SCFA production was 
ranked per individual, with two of the three donors ranking peanut fibre as a top producer 
(Table 5-3).  Butyrate production was the highest with kidney bean and mung bean fibres 
Figure 5-5: Ratios of SCFA production with the soluble fibre of legumes mung bean, 
peanut and kidney bean at 6 and 24 hours.  
Substrates with same letter are significantly different from each other; A, p = 0.047 for 
acetate, B, p= 0.013 for propionate at 24 hours.  Symbols indicate changes in proportion 
between 6 and 24 hours; O indicates changes in proportion of all SCFA p<0.05 with peanut, ◊, 
indicates a change in butyrate p<0.001 with kidney bean between 6 and 24 hours. Presented 
are median + IQR, n=3  
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resulting in 18.4 (1.2) mmol/l and 23.5 (19.6) mmol/l of butyrate respectively, this was 
significantly higher than the control (2.4 [0.43] mmol/l, p<0.05, Figure 5-4).  As suggested 
by the pH data, total production was similar for oligofructose, mung bean, and kidney bean 
soluble fibre fractions, all of which produced approximately 61.0 (26.1) mmol/l and was 
significantly higher than the control (p<0.001).  Total production indicated trends when 
compared with the soluble peanut fibre fraction vs oligofructose, p= 0.032, vs mung bean 
p= 0.062 and vs kidney p= 0.081 bean (Figure 5-4). 
 
When the molar proportions were measured, acetate was predominant on all occasions. 
The proportion of SCFA forming acetate was significantly less than oligofructose after 24 
hours for peanut (85.7 [33.6] % vs 56.5 [11.7] %, p<0.05).  At 6 hours, propionate was 
produced in the highest proportion for the control (20.2 [2.7] %) and the lowest for mung 
bean (4.0 [12.4] %, p<0.05).  Peanut fibre fermentation had the largest change in the 
proportion of propionate, significantly increasing by 8.3% between 6 and 24 to 19.6 (2.2) 
%, p<0.01.  Peanut also had the highest proportion of propionate after the control, which 
was significantly higher than mung bean, which had the lowest proportion of propionate 
(19.6 [2.2] % vs 5.4 [15.4] %; p<0.05). The proportion of butyrate was highest at 6 hours 
for peanut (21.7 [15.5] %).  At 24 hours, production of butyrate was significantly higher 
than at 6 hours for peanut, and kidney bean (p<0.01).  At 24 hours, more than 25% of total 
SCFA was being produced as butyrate by mung bean, peanut and kidney bean fibre (Figure 
5-5). 
 
 Experiment 3: Starch (and modified starch) fermentation 
Of the starches tested, potato starch resulted in the lowest pH at 24 hours at 3.94 (0.26).  At 
6 hours, all of the starches had a significantly lower pH than the control, but were also 
significantly higher than oligofructose.  After 24 hours of fermentation, the pH of the 
control had significantly less of a reduction in pH than that of all other substrates tested, 
p<0.01.  Fibersol also had less of a reduction in pH than oligofructose and potato starch 
p<0.05, Table 5-4). 
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Table 5-4: Change in pH at 0, 6, and 24 hours of fibersol, potato starch, and hi-maize starch. 
Time 
(hours) 
Control Oligofructose Fibersol Potato Hi-Maize 
0 6.74 (0.23) 6.63 (0.3) 6.66 (0.32) 6.75 (0.25) 6.65 (0.32) 
6 6.8 (0.32)a 4.17(0.45)b 4.62 (0.44)c 4.76 (1.01)c 5.49 (1.95)c 
24 6.84 (0.28)a 3.7 (0.72)b 4.34 (0.15)c 3.94 (0.26)b 4.02 (0.51)b,c 
Median (IQR), n=3, Different letters within rows indicate significant differences p<0.05. 
 
 
Figure 5-6: 24 hour SCFA production by potato starch, hi-maize and fibersol. 
Presented are Mean (+ SEM), n=3. Significant differences denoted as a: vs potato starch, b: vs 
fibersol, c: vs high maize p<0.05. † indicated p= 0.05 vs Oligofructose 
 
 
 
Figure 5-7: Molar ratios of 24 hour SCFA production of a selection of starches. 
Mean +SEM, n=3. Different letters denote significant differences in acetate, different symbols 
denote significant differences in propionate, and different numbers denote differences in 
butyrate production 
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Potato starch produced significantly higher total SCFA compared to all other substrates 
tested (77.5 [3.8] mmol/l, p<0.05). Potato starch also yielded significantly more acetate 
than the other substrates (oligofructose, p=0.05), however this did not translate into a 
higher proportion of acetate production (69.9 [1.6] %).  Oligofructose significantly 
increased the proportion of acetate compared to all other substrates (89.6 (0.27) %, 
p<0.001).  Fibersol yielded the highest concentration of propionate (6.06 [0.65] mmol/l) 
which was significantly higher than oligofructose (1.91 [0.15] mmol/l p<0.001), and high 
maize (2.99 [0.33] mmol/l, p<0.001). Fibersol also generated a significantly higher 
proportion of propionate than all substrates except the control (19.0 [1.9] %, p<0.001, 
Figure 5-6, Figure 5-7).  All starches increased butyrate production and molar proportions 
with potato starch, high maize, and, fibersol (Figure 5-6, Figure 5-7). This, along with the 
starch fraction indicates that the starches are butyrogenic. 
 
 Experiment 4 : Modified barley starches 
Table 5-5 shows the change in pH of different fractions of the modified barley starches.  
The control and the whole grain fractions did not decrease in pH, but increased slightly (< 
0.1 pH units) by 24 hours.  For amylose only and wild type barley grains, at 6, and 24 
hours, the pure starch and milled fraction gave rise to a significantly reduced pH compared 
to the other fractions.  For example, at 24 hours, amylose only pure starch had a lower pH 
than the whole grain which was higher than the pH of the milled fraction (Table 5-5). 
 
Table 5-5: pH after 0, 6, and 24 hours of fermentation of different fractions of amylose only 
and wild type barley.   
Amylose Only Wild type  
Time 
(hours) 
Control Whole 
Grain 
Milled Pure 
Starch 
Whole 
Grain 
Milled Pure 
Starch 
 
0 6.74 
(0.23) 
6.68 
(0.64) 
6.54 
(0.62) 
6.6   
(0.35) 
6.75 
(0.53) 
6.61 
(0.85) 
6.59 
(0.45) 
 
6 6.8 
(0.32) 
6.7    
(0.79)b 
5.69 
(0.91)a 
4.86 
(1.34)a,b,c 
6.79 
(0.54)b 
4.76 
(0.42)a,c 
4.5 
(0.71)a,b, 
P<0.001 
24 6.84 
(0.28) 
6.74 
(0.66)b 
4.67 
(0.39)a,c 
3.89 
(0.27)a,b,c 
6.81 
(0.72)b 
4.2  
(0.4)a,c 
3.57 
(0.26)a,b,c 
P<0.01 
Median (IQR), n=3 (control and oligofructose n=6).  a, different from whole grain of individual 
starch type, b different from milled fraction of individual starch, c is different from control 
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Figure 5-9: SCFA production rate per day at 24 hours of fermentation (mmol/g 
carbohydrate/day).  
Median (+ IQR), n=3 (control and oligofructose n=6). Data is presented as a rate to enable 
comparison of fermentations conducted using different fermenter sizes (see Chapter 2). Significant 
differences are denoted by: a = different from whole grain of each barley, b = different from milled 
fraction of each starch/grain,  * = difference between starch type for each SCFA. 
 
 
Figure 5-8: SCFA production after 6 hours of fermentation (μmol/ carbohydrate/ hour) 
Median (+ IQR), n=3 (control and oligofructose n=6). Data is presented as a rate to enable 
comparison of fermentations conducted using different fermenter sizes (see Chapter 2). 
Significant differences are denoted by: a = different from whole grain of each starch/grain  
 
(p<0.05), b = different from milled fraction of each starch/grain p<0.05, * = difference 
between the starch type (p<0.05), for each SCFA. 
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Information on the SCFA production by the starches was presented in the rate form, 
allowing comparison of all the starch fractions. For both barleys, the whole grain fraction 
did not result in higher SCFA than the control.  This suggested that whole grain was poorly 
fermented (24 hour total: control vs AO- whole grain 0.5 [0.1] vs 0.5 [0.1] mmol/g CHO/ 
day, p= 1.0, control vs WT- whole grain 0.5 [0.1] vs 0.5 [0.1] mmol/g CHO/ day, p= 1.0, 
Figure 5-9). 
 
After 6 hours of fermentation, the pure starch fraction led to the highest SCFA production 
of all the fractions tested. Pure starch for the wild type barley generated the highest rate of 
acetate production at 6 hours (218.8 [96.6] μmol/g CHO/hour), this however was less than 
that of the oligofructose (279.7 [113.9] μmol/g CHO /hour).  At 24 hours the milled 
fraction of the wild type starch generated the highest rate of acetate production with 106.0 
(38.6) μmol/g CHO/hour and 2.5 (0.9) mmol/g CHO/day.  As well as for the pure starch, 
the milled fraction for both amylose only and wild type barley also increased rates of 
acetate production compared to the whole grains and the control at 6 and 24 hours, 
demonstrating that these fractions are fermentable (Figure 5-8, Figure 5-9).  The 
Figure 5-10: 24 hour SCFA molar proportion (%) of fractions of amylose only and wild type 
starch 
Median (+ IQR), n=3 (control and oligofructose n=6). Significant differences are denoted by: a = 
different from whole grain of each starch/grain, b = different from milled fraction of each 
starch/grain, * = difference between the starch type, for each SCFA. 
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proportion of acetate was also highest with the starches, all of which had a SCFA 
proportion above 80% (Figure 5-10). 
 
The milled and pure starch fraction for both starch types also led to increased propionate 
and butyrate production.  The increase in propionate was not statistically significant at 6 
hours, however, at 24 hours the milled fraction of amylose only starch increased 
propionate compared to the control (13.9 [9.8] μmol/g CHO/hour vs 3.7 [3.4] mmol/g 
CHO/hour).  The rate of butyrate production of the milled fraction of amylose only barley 
did not differ between 6 and 24 hours (38.6 [34.5] vs 40.3 [23.9] μmol/g CHO/hour).  The 
milled fraction of amylose only also generated increased butyrate compared to the other 
substrates at 24 hours.  For example, the milled fraction of amylose only starch led to 
significantly higher rates and proportions of butyrate production (40.3 [23.9] μmol/g 
CHO/hour and 45.2 [19.8] %) compared to the wild type starch, which was at the cost of 
acetate (Figure 5-8 - Figure 5-10) suggesting that this is butyrogenic.  Generally, the rate of 
production, per hour was also reduced at 24 hours, suggesting that for most of the 
substrates tested the majority of the SCFA production occurred at between 0 and 6 hours. 
 
 Comparison of all substrates screened 
Table 5-6 shows the top 10 propionate producers from all substrates screened within this 
chapter (n=3 for all except oligofructose n=18).  When ranked, laminarin led to the highest 
rate of propionate production. The legumes and the β–glucans generated increased 
propionate production after 24 hours with all (except mung bean, 12th) ranking in the top 
10 of propionate producers. 
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Table 5-6: Ranking of the top 10 producers of propionate μmol/g CHO /hour at 24 hours 
Rank 
 
Acetate Propionate Butyrate Total 
1 Laminarin 198.7 (42.9) 53.1 (32.1) 50.2 (24.2) 302.0 (64.1) 
2 Guar 64.9(10.0) 26.7 (9.3) 28.7 (8.5) 120.3 (20.9) 
3 Glucagel 113.7 (14.8) 24.8 (8.1) 39.5 (9.6) 178.0 (15.0) 
4 Oatwell 28 117.6 (13.5) 20.9 (40.6) 42.8 (3.1) 181.3 (12.4) 
5 Pectin 136.7 (9.9) 20.5 (4.2) 32.4 (6.5) 185.1 (13.8) 
6 Cellobiose 63.8 (13.1) 20.5 (10.5) 33.7 (7.9) 118.0 (27.9) 
7 Peanut 54.8 (4.1) 19.7 (0.73) 25.8 (1.2) 98.2 (3.9) 
8 Oatwell 22 128.4 (11.0) 18.9 (5.0) 27.2 (10.6) 174.4 (22.4) 
9 Oligofructose 103.42 (4.5) 18.2 (7.7) 30.2 (6.0) 139.1 (17.55) 
10 Kidney bean 78.3 (4.6) 17.4 (2.8) 37.9 (0.6) 131.0 (8.1) 
Data presented are the mean (SEM) of the SCFA produced 
For comparison, samples from fermentations were ranked and compared. If two sets of experiments 
used the same substrates, the lower ranking value was removed, this prevented the comparison of 
production by the same donor. 
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 Comparisons of oligofructose 
 
Figure 5-11: Histogram of SCFA after the fermentation of oligofructose.  
A: Acetate production, B: Propionate production, C: Butyrate production, D: Total production. 
Unit: mmol/g CHO/ day, n=18 
 
Oligofructose was often used as a control during fermentations, and as a result has been 
fermented many times, providing a high number of technical replicates (n=18). 
Fermentation of oligofructose was plotted for each individual (Figure 5-11). It became 
apparent that although the majority of individuals had similar propionate production (0.0- 
0.25 mmol/g CHO /day), two datasets had high rates of propionate production (Figure 
5-11- B). These were from the same donor, but in other cases where they provided a stool 
sample, propionate production was not considered an outlier. 
A B 
C D 
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 Experiment 5: Starch fermentation at two initial pHs (6.8 & 5.4) 
A selection of substrates were fermented at two initial pHs (6.8 and 5.4), with the pH being 
controlled by buffer in the medium only (Section 2.2.1.2).  Sometimes the pH of the 
negative control rose instead of fell, this was possibly due to the buffering capacity of the 
media used for the fermentations, particularly for the initial pH of 5.4.  It could have also 
been associated with production of ammonia or hydrogen sulphide due to the fermentation 
of tryptone in the media with a lack of fermentable carbohydrate, which could have 
buffered against the decreasing pH (Walker et al., 2005, Magee et al., 2000).  Increases in 
the pH of the 6.8 media could also be as a result of variability where there was an IQR of 
0.5 after 24 hours of fermentation. 
 
Starch fermentations were conducted with an initial pH of 6.8 and 5.4.  Within the non-pH 
controlled fermentation systems, after 6 hours of fermentations the pH of all vessels did 
not differ regardless of initial pH, i.e. the initial pH of a substrate had no effect on the pH 
at 6 or 24 hours (Table 5-7).  This was not the case for hi-maize where the pH was 
significantly higher (p<0.001) at 24 hours with the initial media with a pH of 5.4 (pH 4.66 
[1.27]) compared to the 6.8 media (pH 4.02 [0.37]).  Interestingly, once again the pH of the 
control resulted in an increased pH (Table 5-7).  It was also observed that in all cases the 
pH was significantly lower than the control at both 6 and 24 hours. 
 
Table 5-7: pH change after fermentation of a selection of starches and starch derivatives with 
different starting pHs. 
Time 0 hours 6 hours 24 hours 
Initial pH 6.8 5.4 6.8 5.4 6.8 5.4 
Control 6.70  (0.2) 5.55 (0.11)* 6.71 (0.18)a 5.59 (0.14)a 6.76 (0.09)a 6.17 (0.07)a 
Oligofructose 6.65 (0.25) 5.49 (0.11)* 3.79 (0.3)b 4.03 (0.51)b 3.42 (0.34)d 3.74 (0.2)c 
Potato 6.75 (0.18) 5.56 (0.12)* 4.76 (0.73)c 4.57 (0.26)bc 3.94 (0.17)de 3.75 (0.04)c 
Hi- maize 6.65 (0.24) 5.53 (0.16)* 5.49 (1.51)c 4.82 (0.67)bc 4.02 (0.37)ce 4.66 (1.27)b* 
Fibersol 6.66 (0.24) 5.52  (0.1)* 4.62 (0.31)d 4.55 (0.15)bc 4.34   (0.1)b 4.53 (0.05)b 
Amylose only 6.6  (0.25) 5.55  (0.1)* 4.86 (0.94)c 4.83 (0.68)c 3.89 (0.19)e 4.06 (0.15)c 
Wild Type 6.59 (0.34) 5.51 (0.08)* 4.5 (0.51)bc 4.58 (0.56)bc 3.57 (0.21)d 3.79 (0.05)c 
Non pH-controlled (apart from buffer) batch fermentations were conducted with initial pHs of 6.8 
and 5.4. Amylose only and wild type are the pure starch fractions, median (IQR), n=3. Different 
letters within columns indicate significant differences between substrates, * indicates significant 
differences between substrates at different initial pHs (e.g 5.4 vs 6.8). 
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Table 5-8, and Figure 5-12 show the proportions of SCFA production after 24 hours of 
fermentation. There were significant differences in the proportion of each SCFA as a result 
of the starting pH. For example, with an initial fermentation pH of 5.4, acetate was the 
predominant SCFA, and was increased compared to substrates with an initial pH of 6.8. 
Acetate proportion was in the range of 71.6 (24.7) % -98.2 (2.6) % with and initial pH of 
5.4, compared to a range of 64.3 (12.6) - 89.9 (1.0) % or 6.8 (Table 5-8).  This difference 
was significant for the control (83.09 [6.7] % vs 66.7 [21.2] %, p<0.001), potato starch 
(93.4 [5.4] % vs 69.6 [7.3] %, p<0.001), hi-maize starch (83.8 [18.9] % vs 64.2 [19.9] %, 
p<0.026), and fibersol (71.6 [24.7] % vs 64.3 [12.6] %, p=0.006). It was, however, 
observed that oligofructose generated the highest proportion of acetate, and lowest of 
propionate and butyrate regardless of initial pH.  
 
An initial pH of 5.4 resulted in a significantly lower proportion of propionate for all 
substrates except high maize, and the control. After the control, fibersol resulted in the 
highest proportion of propionate with and initial pH of both 6.8 and 5.4 (12.1 [3.5] % and 
3.6 [1.2] %).  This increase was only significant with the fermentations of an initial pH of 
6.8 (p=0.013) against the control (p<0.001 against all other substrates, Table 5-8).   
 
Butyrate proportion was also altered by the different starting pHs, with the fermentations 
with the initial pH of 5.4 having significantly reduced butyrate compared to those with an 
initial pH of 6.8.  Figure 5-12 demonstrates the differences in propionate proportion at all 
measured occasions.  Here it was found that after 6 hours of fermentation for all starches 
tested there was a reduced proportion of propionate with the initial pH of 5.4 for fibersol 
(5.4 vs 6.8: 3.0 [3.2] % vs 10.2 [0.7], p = 0.001) and wild type (5.4 vs 6.8: 2.5 [3.5] % vs 
7.3 [3.7] %, p=0.004).  By 24 hours all starches tested (except high maize) resulted in the 
initial pH of 6.8 yielding increased proportions of propionate compared to the initial pH of 
5.4 (p<0.01). 
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Table 5-8: Molar proportion of acetate, propionate and butyrate after 24 hours of fermentation 
 
Acetate Propionate Butyrate 
Initial pH 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 
Control 66.74 (21.2)b 83.07 (6.7)a p<0.001 17.89 (9.4) c 7.93 (7.8)c p=0.07 15.37 (11.0)bc 8.91 (0.5)bc NS 
Oligofructose 89.90 (1.0)a 98.15 (2.6)b NS 3.43 (0.4)bd 0.88 (1.3)d p<0.001 6.81 (1.2)a 0.89 (1.9)a p<0.001 
Potato 69.6 (7.3)bc 93.36 (5.4)b p<0.001 6.21 (1.9)b 1.66 (0.6)ab p<0.001 24.09 (7.5)b 4.97 (4.8)abc p<0.001 
Hi- Maize 64.17 (19.9)b 83.77 (18.9)a p=0.026 5.79 (1.8)b 3.24 (1.0)a NS 30.86 (20.1)b 12.71 (19.7)c NS 
Fibersol 64.25 (12.6)b 71.63 (24.7)a p=0.006 12.08 (3.5)a 3.61 (1.2)abc p<0.001 21.98 (14.0)b 24.39 (24.8)b NS 
Amylose only 81.94 (7.0)c 94.60 (1.8)b NS 5.75 (1.74) b 1.8 (3.3)ab p=0.006 12.17 (5.3)c 2.79 (2.3)ab p=0.005 
Wild Type 86.28 (6.6)a 97.74 (2.3)b NS 4.40 (2.2)bd 1.55 (1.6)b p<0.001 9.34 (5.8)ac 1.07 (1.5)a p<0.001 
Date presented are the median (IQR) of the molar proportions of SCFA after fermentations of a selection of starches. Different letters within columns 
indicate significant differences between substrates. 
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Figure 5-12: Molar proportion (%) of propionate production at both 6, and 24 hours with initial pHs of 6.8 and 5.4. Data presented are 
median + IQR. N=3, and the pH was not maintained during the fermentation. Symbols indicates different proportions of propionate between 
fermentations starting at pH 5.4 and 6.8 at 6 hours (†) and 24 hours (*).Wild type and amylose only are the pure starch fractions. 
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Table 5-9: Rate of acetate, propionate, butyrate, and total production after fermentation with an initial pH of 5.4 or 6.8 mmol/g CHO/ day 
 
Acetate Propionate Butyrate Total 
Initial pH 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 
Control 0.33 
(0.01)ac 
1.78 
(0.05)abc P=0.002 
0.10 
(0.02)b 
0.19 
(0.03)a NS 
0.09 
(0.02)b 
0.19 
(0.01)ab NS 
0.52 
(0.05)a 
2.16 
(0.04)ab p=0.003 
Oligofructose 2.51 
(0.16)bc 
2.84 
(0.09)b NS 
0.09 
(0.03)b 
0.02 
(0.0)b NS 
0.18 
(0.06)b 
0.03  
(0.02)b NS 
2.78 
(0.19)b 
2.89 
(0.09)a NS 
Potato 2.66 
(0.1)b 
2.40 
(0.16)bc NS 
0.22 
(0.02)c 
0.04 
(0.01)b p<0.001 
0.92 
(0.16)ac 
0.10 
(0.12)ab p<0.001 
3.80 
(0.26)c 
2.54 
(0.27)ab NS 
Hi-Maize 1.82 
(0.02)bc 
1.60 
(0.05)c NS 
0.15 
(0.02)bc 
0.06 
(0.02)b NS 
0.76 
(0.02)cd 
0.34 
(0.02)a p=0.002 
2.73 
(0.04)bc 
2.0 
(0.07)ab NS 
Fibersol 1.58 
(0.15)c 
1.13 
(0.09)ac NS 
0.3 
(0.03)a 
0.05 
(0.01)b p<0.001 
0.56 
(0.04)bcd 
0.29 
(0.08)ab NS 
2.44 
(0.15)b 
1.47 
(0.15)b NS 
Wild type 2.49 
(0.26)bc 
2.42 
(0.5)bc NS 
0.15 
(0.01)bc 
0.03 
(0.0)b p=0.006 
0.31 
(0.02)bd 
0.03 
(0.01)b NS 
2.94 
(0.29)bc 
2.48 
(0.5)ab NS 
Amylose only 2.10 
(2.57)bc 
1.85 
(0.24)abc NS 
0.15 
(0.03)bc 
0.05 
(0.01)b p=0.074 
0.32 
(0.05)bd 
0.05 
(0.01)b NS 
2.57 
(0.38)b 
1.95 
(0.24)ab NS 
Mean (SEM) of the molar proportions of SCFA after fermentations of a selection of starches. Different letters within columns indicate significant 
differences between substrates. N=3. Wild type and amylose only are the pure starch fractions. Data presented as a rate to enable comparisons with the 
other rate changing data 
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Differences in acetate production at the two initial pHs were less apparent when presented 
as a rate, as opposed to a ratio.  The negative control led to differences in acetate 
production, with the lower initial pH resulting in significantly more acetate (1.8 [0.1] vs 
0.3 [0.0] mmol/g CHO/ day, p=0.002).  Interestingly the lower initial pH favoured SCFA 
production for the control, but not for the substrates fermented, although this was not 
significant (Table 5-9). 
 
Propionate production from fermentation of the starches tested was reduced with an initial 
pH of 5.4 compared to 6.8.  This occurred to the greatest extent with fibersol and potato 
starch, in which the lower initial pH led to ~82% less production (p<0.001) for both 
substrates. It was also identified that like the ratio, fibersol fermentation generated the most 
propionate with an initial fermentation pH of 6.8 (0.3 [0.0] mmol/g CHO/day).  This was 
not the case for the lower initial pH which resulted in high maize being the substrate 
generating the highest rate of propionate production (0.1 [0.0] mmol/g CHO/day).  High 
maize also led to high rates of butyrate production with both initial pHs (pH 6.8: 0.8 [0.0] 
and pH 5.4: 0.3 [0.0] mmol/g CHO/ day).  Potato starch generated the most butyrate with 
an initial pH of 6.8 (0.9 [0.2] mmol/g CHO/day).  Both high maize and potato starch led to 
increased butyrate production when initiated at pH6.8 compared to pH5.4 (55%, p =0.002 
and 89%, p<0.001).  Oligofructose and wild type starch resulted in the lowest rate of 
production of butyrate compared to all other substrates tested (pH6.8; 0.2 [0.1] and 0.3 
[0.0] mmol/g CHO/day, pH5.4; 0.03 [0.0] and 0.03 [0.0] mmol/g CHO/day, Table 5-9). 
 
Initial pH did not affect the total rate of production with the fermentation of substrates, 
however, the lower initial pH increased total SCFA compared to the initial pH for the 
control (6.8 vs 5.4: 0.5 [0.1] vs 2.2 [0.0] mmol/g CHO/day, p<0.001).  Fibersol was the 
substrate generating the lowest rate of total SCFA (pH6.8: 2.1 [0.1] and pH5.4: 1.5 [0.2] 
mmol/g CHO/day).  Total production with an initial pH of 5.4 was similar for 
oligofructose, potato starch and wild type starch (2.9 [0.1], 2.5 [0.3], 2.5 [0.5] mmol/ g 
CHO/ day, Table 5-9). 
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 Experiment 6: Guar, Trehalose dihydrate, Cellobiose and Glucagel 
fermentation at two initial pHs (6.8 & 5.4) 
For all the substrates, except the control, there was no significant difference between the 
pH of both systems by 6 hours, and by 24 hours was also the case for the control.  For all 
other substrates, except guar gum, where the pH was 5.0, the pH reduced to approximately 
pH 4.0 (Table 5-10). 
 
When the molar proportions were considered at each pH the increase in acetate was more 
apparent with an initial pH of 5.4 compared to the 6.8 starting pH, although this was not 
significant.  Molar percentages did not differ between the two initial pHs with the majority 
of the SCFA forming acetate.  Cellobiose with an initial pH of 5.4 led to 92.1 (2.8) % of 
SCFA production yielding acetate whereas this was only 55.2 (7.2) % with an initial pH of 
6.8 (Table 5-11).  Acetate molar percentage was however the highest for oligofructose with 
both starting pHs, with 80.0 (10.7) % and 95.8 (2.2) % of SCFA producing acetate. 
 
The proportion of propionate at pH 5.4 was lower than that at pH 6.8, although this was 
not significant.  Propionate proportion at pH 5.4 varied between oligofructose (1.6 [0.6] %) 
and guar gum (7.7 [2.6] %).  At an initial pH of 5.4; the control, trehalose dihydrate, and 
guar gum generated the highest proportions of propionate (7.1 [1.1] %, 7.6 [2.9] %, and 7.7 
[2.6] %).  Interestingly, the proportion of propionate yielded as a result of trehalose 
dihydrate did not significantly differ between the different pHs.  Trehalose dihydrate did 
yield the lowest proportion of propionate with an initial pH of 6.8 (6.8 vs 5.4: 7.3 [3.5] % 
vs 7.6 [2.9] %).  Like with the initial pH of 5.4, the initial pH of 6.8 resulted in guar gum 
and the control having the highest percentage yields of propionate (21.45 [3.0] % and 20.8 
[4.2] %). 
 
Generally, the proportion of butyrate was higher with an initial pH of 6.8, with trehalose 
dihydrate and glucagel resulting in the highest proportions (32.9 [16.2] % and 37.8 [3.2] 
%).  Trehalose dihydrate also led to the highest percentage of butyrate production 
compared to the other substrates (28.4 [8.1] %), although non-significant.  It was also 
observed that oligofructose resulted in the lowest proportion of butyrate at both initial pHs 
(9.2 [4.6] % and 3.2 [1.6] %). 
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Table 5-10: pH change in cultures with initial pHs of 6.8 and 5.4 at 0, 6 and 24 hours of fermentation. 
pH 
0 hours 6 hours 24 hours 
6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 
Control 6.65 (0.18) 5.38 (0.11) p<0.001 6.83 (0.6) a 5.44 (0.07) p = 0.011 6.93 (0.49)a 6.01 (0.19) NS 
Trehalose Dihydrate 6.64 (0.08) 5.38 (0.12) p<0.001 5.34 (1.21) b 5.01 (0.36) NS 4.46 (0.12)b 4.6 (0.62) NS 
Cellobiose 6.6 (0.06) 5.42 (0.11) p<0.001 4.58 (0.56) bc 4.9 (0.52) NS 4.11 (0.09)b 4.2 (0.29) NS 
Guar gum 6.54 (0.18) 5.54 p<0.001 4.86 (1.56) bc 5.04 NS 4.43 (0.51)b 5.04 NS 
Glucagel 6.5 (0.2) 5.45 (0.11) p<0.001 4.86 (0.23) bc 4.65 (0.17) NS 4.57 (0.25)b 4.58 (0.12) NS 
Oligofructose 6.61 (0.1) 5.37 (0.11) p<0.001 4.24 (0.06) c 4.59 (0.21) NS 4.01 (0.36)b 4.09 (0.36) NS 
Median (IQR). n=3 for all except guar gum where n=2 with an initial pH of 5.4. . Letters indicated differences between substrates with the same pH media. Data presented 
as a rate to enable comparisons with the other rate changing data. NS= non-significant 
Table 5-11 Molar SCFA production after 24 hours of fementation 
 
Acetate % Propionate % Butyrate % 
pH 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 
Control 57.62 (1.8) 85.52 (0.4) NS 21.46 (3.0) 7.12 (1.1) NS 20.92 (2.6) 7.36 (1.4) NS 
Trehalose Dihydrate 59.81 (19.4) 63.94 (8.8) NS 7.26 (3.5) 7.58 (2.9) NS 32.94 (16.2) 28.48 (8.1) NS 
Cellobiose 55.16 (7.2) 92.07 (2.8) NS 15.52 (4.4) 2.59 (0.6) NS 29.32 (5.2) 5.34 (2.3) NS 
Guar gum 55.05 (5.3) 76.54  (3.8) NS 20.84 (4.2) 7.68 (2.6) NS 24.11 (5.8) 15.78 (6.4) NS 
Glucagel 44.88 (3.0) 81.14 (12.8) NS 17.33 (5.3) 4.05 (1.5) NS 37.79 (3.2) 14.8 (11.3) NS 
Oligofructose 80.09 (10.7) 95.76 (2.2) NS 10.72 (6.9) 1.64 (0.6) NS 9.19  (4.6) 3.20 (1.6) NS 
Presented are mean (SEM).  N=3 except for guar, n=2. NS = non significant 
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Table 5-12 SCFA production as a result of fermentation of a variety of 'propiogenic substrates'-24 hours mmol/g CHO/day 
 
Acetate Propionate Butyrate Total 
pH 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 5.4 6.8 5.4 6.8 vs 
5.4 
Control 0.32 (0.1)a 1.86 (0.3) p<0.001 0.14  (0.1) 0.11 (0.0) NS 0.12 (0.0) 0.11 (0.1) NS 0.59 (0.1)a 2.17 (0.3) p<0.01 
Trehalose 
Dihydrate 
1.11 (0.6)b 1.08 (0.6) NS 0.18 (0.18) 0.07 (0.2) NS 1.07 (0.8) 0.75 (0.6) NS 2.26 (0.4)b 1.90 (1.4) NS 
Cellobiose 1.68 (0.8)b 2.49 (0.6) NS 0.26  (0.4) 0.07 (0.0) NS 0.76 (0.3) 0.14 (0.1) NS 2.41 (0.4)b 2.54 (1.4) NS 
Guar gum 1.41 (0.4)b 1.99 (0.1) NS 0.59  (0.4) 0.19 (0.1) NS 0.56 (0.3) 0.43 (0.2) NS 3.09 (1.1)b 2.61 (0.2) NS 
Glucagel 1.40 (0.4)b 1.16 (0.7) NS 0.29  (0.3) 0.07 (0.1) NS 1.07 (0.2) 0.16 (0.4) NS 3.00 (0.8)b 2.08 (0.8) NS 
Oligofructose 2.17 (0.6)b 2.62 (0.7) NS 0.12  (0.4) 0.05 (0.1) NS 0.16 (0.3) 0.11 (0.1) NS 3.20 (0.5)b 2.72 (0.9) NS 
Median (IQR).  N=3 except for guar, n=2 different letters within column = significant differences. Data presented as a rate to enable comparisons with the other pH change 
data. NS = non significant
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The rate of acetate and total SCFA production was significantly lower for the control with 
an initial pH of 6.8 (Table 5-12).  It was also found that acetate production was 
significantly lower than all other substrates measured with an initial pH of 6.8.  The rate of 
acetate production did not differ with the different pHs, where oligofructose resulted in the 
highest rate of production (2.2 [0.6] and 2.6 [0.7] mmol/g CHO /day).  No significant 
differences in propionate or butyrate production were observed, however an initial pH of 
5.4 did lead to decreased production compared to the pH 6.8 counterpart, although this was 
not significant.  An example of this was shown by cellobiose where with an initial pH of 
6.8, 0.3 (0.4) and 0.8 (0.3) mmol/g CHO/day of propionate and butyrate were produced, 
which was higher than in 0.1 (0.0) and 0.1 (0.1) mmol/g CHO /day of propionate and 
butyrate production at an initial pH of 5.4.  Total SCFA production also did not vary 
between the substrates with the initial pH of 5.4.  For example, trehalose dihydrate had the 
lowest rate of production (1.9 [1.4] mmol/g CHO /day) and oligofructose had the highest 
rate (2.72 [0.9] mmol/g CHO/ day).  Oligofructose also resulted in the highest rate of total 
production with an initial fermentation pH of 6.8 (3.2 [0.5] mmol/g CHO/ day, Table 
5-12). 
 
 Discussion 
 Beta-glucans 
A selection of commercial β-glucans containing different proportions of β-glucan, were 
fermented to determine their propionate producing capacity. Oatwell 22, Oatwell 28, 
Promoat, and Glucagel consisted of 22%, 28%, 35%, and 75% β-glucan respectively. 
All β-glucans tested resulted in a decreased pH and SCFA production.  There was no 
significant differences in the production or proportion of SCFA between the β-glucans.  
Thus indicating that the percentage of β-glucan within a substrate has no effect on the 
production of SCFA in vitro. 
 
This is supported by the investigation by Kim and White., (2011) who conducted in vitro 
batch fermentations of different molecular weight β-glucans and found no significant 
differences in the production of the individual SCFA (Kim and White, 2011b).  No effect 
of different molecular weights β-glucan on feelings of satiety were observed in a feeding 
trial of 23 healthy males (Clegg and Thondre, 2014).  Although there was no difference in 
SCFA production between the β-glucans, barley β –glucan has been previously shown to 
165 
 
 
 
alter individual SCFA production in vitro.  Kaur et al., (2011) fermented a selection of 
substrates and identified that barley β-glucan resulted in significantly higher total acetate 
and butyrate production compared to the other substrates tested (e.g. inulin and psyllium). 
The barley β-glucan also produced significantly more propionate than inulin, FOS and 
resistant starch (Kaur et al., 2011).  Although no significant increases in SCFA production 
by laminarin were observed, there was a trend for increased total and propionate 
production.  This was supported by the in vitro study by Deville et al, (2007) where 
increased proportions of propionate were identified after 24 hours of fermentation (Deville, 
2007).  The role of laminarin in the production of propionate has also been demonstrated in 
a feeding trial in which consumption selectively increased in propionate production, at the 
cost of acetate (Lynch et al., 2010). 
 
Increasing propionate to the detriment of acetate (by altering the acetate to propionate 
ratio) has been demonstrated to be beneficial for the regulation of cholesterol synthesis 
(Wolever et al., 1991). This indicates that β-glucan (and laminarin) consumption is 
beneficial but the type has little effect on SCFA production. 
 
 Legumes 
Legume consumption is associated with a healthy diet, and has been shown to lead to 
positive roles in health that could be attributed to the colonic fermentation of these 
substrates (McCrory et al., 2010). 
 
The legumes investigated here are formed of fat, protein, carbohydrates and dietary fibre. 
Based on the AOAC method 991.43 of assessment of the dietary fibre of freeze dried 
legumes, total fibre content of peanut, mung bean and kidney bean were 46.9%, 71.7%, 
and 60.4% and protein content was 22.1%, 14.6% and 28.3%  (Mallillin et al., 2008). 
When the AOAC method 991.43 was used to assess fibre content of mung bean and kidney 
bean as consumed (e.g hydrated) total fibre content was 4.43% ,and 11.22% respectively 
(Aldwairji et al., 2014).  Brummer et al., (2015) assessed the composition of the soluble 
fibre of a selection of legumes (not including those used within this thesis) and identified 
that the main sugars included galacturonic acid (also in pectin), arabinoxylose, 
galactobiose, and glucose (Brummer et al., 2015), all of which can lead to the production 
of SCFA (Mortensen et al., 1988).  
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This study showed that the soluble fibre of legumes is fermentable leading to a reduced pH 
and an increase in SCFA production. At 24 hours mung bean led to the lowest pH within 
the in vitro batch system. Peanut fibre increased propionate and butyrate proportion 
compared to controls (propionate: 19.59 [2.2] % vs 23.18 [11.4] %, butyrate: 25.30 [5.3] % 
vs 22.54 (4.7) %.  Peanut fermentation reduced production of acetate, demonstrating that it 
may be an effective substrate in reducing the acetate: propionate ratio, which may be 
important for the regulation of cholesterol (Wolever et al., 1991).  Consumption of 
2.6g/day of peanut by overweight and obese women for 4 weeks was shown to reduce 
waist circumference and plasma TAG concentrations (Ha et al., 2015).  
 
The in vitro SCFA producing capabilities of legumes have also been measured previously 
in batch fermenter systems, but with a sample from single subject, and also utilised total 
fibre (not the soluble fibre used in this thesis) (Mallillin et al., 2008).  Mallillin et al., 
(2008) observed that propionate proportions by peanut, mung bean and kidney bean were 
19.8%, 17.9% and 64.3%.  This supports our findings with the proportion of propionate by 
peanut being 19.59 (2.2) %, but propionate proportions with mung bean and kidney bean 
were lower with 5.4 (15.4) % and 14.0 (7.7) %.  This may be due to increased variability 
within this investigation due to using three different donors.  For example, one donor 
yielded 18.6% propionate, whereas the two other donors yielded approximately 3.8% 
propionate with mung bean resulting in an overall IQR of 15.4%.  Peanut production was 
less variable (IQR 2.2%), indicating that different individuals had different capabilities of 
utilising the legumes to produce SCFA. 
 
Proportions of butyrate with mung bean (26.32%) were similar to our observation of 30.3 
(29.5) %, whereas Mallillin et al., (2008) observed greater proportions of butyrate with of 
peanut fibre compared to this thesis (Mallillin et al., (2008) 54.0% vs this chapter  25.3 
(5.3) %). Like propionate, butyrate production by peanut was similar for all individuals. 
The butyrate proportion for mung bean was approximately 1/3rd less than the other two 
individuals (~35 vs 9%), as Mallillin et al., (2008) only used one stool donor, this would 
not have been observed. 
 
Although some differences were observed in the proportion of propionate and butyrate 
after 24 hours of fermentation, there was very little difference in the production of the 
SCFA between the legume fibres tested, whereas Mallillin et al., (2008) did find 
167 
 
 
 
differences.  What was also observed was that the legumes yielded total SCFA 
concentrations that did not differ from oligofructose, the highly fermentable control 
(Rycroft et al., 2001a, Stewart et al., 2008).  Consumption of oligofructose in rats has also 
been able to increased cellular FFAR2 densities as well as the satiety hormones PYY and 
GLP-1, this effect was attributed to the SCFA produced (Kaji et al., 2011).  As these 
legumes yielded similar concentrations of SCFA to oligofructose, it could be proposed as 
one of the possible mechanisms for increased feelings of satiety identified after legume 
consumption (Spadafranca et al., 2013).  Therefore, it would be interesting to assess the 
effects of commonly consumed legumes on propionate production, and to identify whether 
the feelings of satiety observed after consuming different legumes are related to the source 
of legume and type of fibre. 
 
 Starch 
As expected, all of the starches were fermentable which was initially demonstrated by the 
observed reduction in pH.  Potato starch resulted in the lowest pH of the individual 
starches tested, and generated the greatest increase in SCFA, particularly acetate. As 
expected, all of the individual starches tested led to increased butyrate production 
compared to oligofructose.  Fibersol also significantly increased propionate production 
compared to the other starches tested.  This observation is supported by in vitro trials by 
Laurentin and Edwards., (2004), who observed increased propionate after fibersol 
fermentation compared to native starch (Laurentin and Edwards, 2004).  In contrast, 
consumption of up to 15 g/ day of fibersol by healthy individuals for 7 weeks did not alter 
faecal propionate production, and increased butyrate production (Fastinger et al., 2008). 
 
After 24 hours of fermentation of both barley grains and purified starch fractions, the 
purified starch resulted in the lowest pH after 24 hours whereas whole grain had the lowest 
reduction in pH.  This was also associated with increased total SCFA production for the 
pure and milled fractions compared to the whole grain.  The whole grain fractions were not 
well fermented, yielding little SCFA production, independently of type of barley.  This is 
likely due to the lack of processing on the barley grains, resulting in the starch being 
physically inaccessible to the colonic bacteria, preventing fermentation.  It was also noted 
that the rate of SCFA production (μmol/g CHO/ hour) was greater at 6 hours compared to 
24 hours, suggesting that the barley starches were rapidly fermented.  Independently of 
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wild type barley or amylose only barley, total SCFA was similar for each level of 
processing.  An exception to this was the milled fraction in which the acetate and butyrate 
production differed between amylose only and wild type.  For example, the amylose only 
had a decreased acetate concentration, and an increased butyrate concentration compared 
to the wild type (Figure 5-9).  Similar findings were also observed as the butyrate 
proportion was 45.2 (19.8) % (of total) after fermentation of the milled fraction of amylose 
only barley bran compared to 15.25 (16.2) % (of total) for the milled fraction of wild type 
barley (p<0.05).  Unexpectedly butyrate production within the pure starch fraction did not 
differ between the amylose only and wild type barley. 
 
Although the starches increased butyrate production, butyrate was higher in all commercial 
starch products compared with the modified barley.  Increased butyrate production due to 
starch fermentation has been demonstrated in a variety of investigations (Sayar et al., 2007, 
Kaur et al., 2011).  Surprisingly the amylose only starch was not more butyrogenic than the 
wild type starch as previously high-amylose starch has been associated with increased 
butyrate production when consumed (Bird et al., 2008) and in vitro (Christl et al., 1997). 
 
 Initial pH on SCFA production. 
The initial pH of the fermentation vessel was successfully reduced to different initial pHs, 
which correspond to the proximal and distal colon.  By 6 hours, there was no difference in 
the pH of the vessels; except for controls.  Therefore, it was difficult to identify the role of 
pH on SCFA production.  For example, for the potentially propiogenic substrates there was 
no significant difference in SCFA production or proportion by the different initial pHs.  It 
was observed that for all substrates tested that acetate and total production was 
significantly higher than the control.  The control also led to significantly lower acetate and 
total production with an initial pH of 6.8 compared to that of pH 5.4.  This also occurred 
when a selection of different starches were fermented in the same conditions.  Belenguer et 
al., (2007) assessed the impact of different pH’s (5.2, 5.9, and 6.4) on the fermentation of 
lactate. Here it was also observed that after fermentation of a mix of carbohydrates with 
and without lactate, the lower pH favoured the production of acetate over propionate and 
butyrate.  This was attributed to a reduction in Eubacterium hallii (a lactate utiliser) and 
the accumulation of lactate at this low pH altering the SCFA produced.  Acetate can be 
formed independently of lactate in the Wood-ljundahl pathway, whereas propionate 
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requires lactate for production, and butyrate is formed by the interconversion of acetate, 
which likely explains the increased acetate production seen with the lower pH (Belenguer 
et al., 2007). 
 
This was also identified when the pH was switched from 5.5 to 6.5 where the lower pH 
favoured acetate and butyrate production, and the higher pH favoured propionate 
production. These changes in SCFA production were also attributed to changes in the 
bacterial composition, with the lower pH increasing numbers of F.prausnitzii and 
Roseburia spp, both of which are considered butyrogenic bacteria (Walker et al., 2005). 
These increases in butyrate production were not observed within this thesis; this is likely 
due to the pH not being continuously controlled, and the pH of the two systems not 
differing after 6 hours. 
 
Unlike for the ‘propiogenic substrates’, fermentations with different initial pHs led to 
differences in SCFA production and proportion after the fermentation of a variety of 
starches, even though the pH of the systems converged by 6 hours.  An initial pH of 6.8 
increased propionate production compared to the initial pH of 5.5 for potato starch, fibersol 
and wild type barley.  Propionate production was increased proportionally for all substrates 
tested except hi-maize, which was not significantly higher at pH 6.8 versus the initial pH 
of 5.4.  It was also observed that the starches led to increased butyrate production with an 
initial pH of 6.8 compared to an initial pH of 5.4 which was contradictory to that of 
(Walker et al., 2005).  However, to further elucidate the impact of pH on SCFA production 
pH controlled systems would be required. 
 
 Conclusion 
The SCFA production by different individuals was not always the same, with differences 
in production being observed. This was demonstrated in Figure 5-11, where production of 
propionate by the oligofructose was higher on some occasions.  This was from a single 
donor, whom also provided stool samples not differing from the other donors.  This 
variability has been observed previously, where two fold differences in SCFA production 
were observed between individuals (Carlson et al., 2016), and variation in SCFA 
production was also observed when the same donor provided two samples 30 days apart 
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(Mortensen et al., 1991).  This further exemplifies the difficulties faced when comparing 
the SCFA production of different substrates by different donors. 
Overall laminarin was identified as being the most propiogenic substrate in terms of rate of 
production yielding 53.1 (32.1) μmol/g CHO/ hour. The substrate which ranked second 
(guar) yielded approximately 50% less propionate than laminarin.  After this, the ranking 
of the substrates did not differ, i.e. second vs third had approximately a 7% difference in 
propionate production and guar (2nd) vs kidney bean (10th) had a 35% difference in 
propionate production.  This indicates that there were not large differences between top 
and bottom producers.  This is also supported by a consistent lack of significant changes in 
propionate production observed throughout this chapter.  Any differences may have been 
masked by inter-individual variability.  The top propionate producers also had high total 
SCFA production, leading to increased propionate production. This indicates that in terms 
of actual propionate production, increasing total SCFA production is beneficial, not 
necessarily changing the proportion of propionate. As described in Chapter 3 the ratio can 
be misleading in terms of predicting propionate production.  For example within this 
chapter after the controls (blank) the whole grain fractions of the wild type and amylose 
only starch led to 22.2 (1.3) % and 20.9 (2.4) % (of total SCFA) being propionate, and 
ranked highest for propionate proportion. The inaccuracy of the ratio in predicting 
propionate production is exemplified with these substrates ranking 30th and 33rd out of 37 
for total propionate production. 
 
This indicates that laminarin, which yielded high total production as well as propionate 
production was the best substrate tested.   
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 Investigation of the influence of 
glycosidic bond anomer configuration on 
production of propionate in vitro. 
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 Introduction 
As discussed in Chapter 1, the main determinants of propionate production remain 
unknown.  The properties of NDC thought to be involved in determining the amount and 
pattern of SCFA production include solubility (and therefore chain length), sugar 
composition, and bond configuration.  To-date there has been little systematic analysis of 
these factors and their impact on the production of propionate in vitro. 
 
It is difficult to characterise the fermentation properties of NDC based on their MW/ 
solubility.  This is because the solubility and MW do not take into account other 
physicochemical properties such as branching, bonding, or sugar composition, which can 
alter SCFA production (Salvador et al., 1993, Laurentin and Edwards, 2004).  Another 
issue is that not all NDC are 100% soluble or insoluble, such as ispaghula consisting of 
63% insoluble and 42% soluble fibre (Mortensen and Nordgaard-Andersen, 1993).  
Solubility is an indicator of fermentability, and is predictive of total SCFA production, not 
individual SCFA production.  Associations between SCFA production and carbohydrate 
solubility were observed after analysis of eight different NDC sources; glucose, sorbitol 
free ispaghula (Vi-siblin), ispaghula (Lunelax), pectin, resistant starch, sterculia (Inolaxol), 
wheat bran (Fiberform) and cellulose.  Each of the NDC tested had different solubilities 
and were fermented in vitro.  It was identified that the greater the solubility of the NDC the 
more SCFA produced (Mortensen and Nordgaard-Andersen, 1993).  Although increased 
solubility increases fermentability, insoluble fibre can also be fermentable, for example 
when equal amounts of the insoluble fibre of sugar beet and barley bran were fermented, 
SCFA were produced, but to different extents.  The insoluble fibre of sugar beet produced 
more total SCFA than the insoluble fibre of barley bran.  These differences in total SCFA 
production were attributed to differences in the sugar composition and bonding structure, 
not the solubility further demonstrating that solubility alone cannot determine SCFA 
production for all NDCs (Fardet et al., 1997). 
 
It has recently been shown that the influence of carbohydrate solubility on fermentability 
and SCFA production is more complex. Stewart and Slavin., (2006) fermented guar gum at 
a range of different MW (15-1100 kDa) and observed that guar gum of 400 kDa MW had 
the fastest rate of SCFA production between 4 and 8 hours (9.5 μmol/ml/hr).  In contrast, 
the rate of SCFA production for guar with MW of 15kDa (5.4 μmol/ml/hr) and 1100 kDa 
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(5.6 μmol/ml/hour) did not differ (Stewart and Slavin, 2006).  Moreover, total SCFA 
production has not been previously seen to have a significant linear association with MW 
in a study of oat beta glucans (Kim and White, 2011b) (Figure 6-1, Figure 1-5).  Between 0 
and 12 hours oat β-glucan MW had little effect on SCFA production where there was no 
significant differences in the total SCFA production between all the different MW β-
glucans.  It was also seen that the lowest MW oat β-glucan (0.5 kDa), and the highest MW 
oat β-glucan (9 kDa) produced comparable total production which was less than the 
reminder of the MW of β-glucan tested.  These different MW did not translate into 
differences in the production of propionate (Kim and White, 2011b).  
 
This reduction of SCFA production with the different MW could be due to a number of 
factors.  Such as the high MW altering the ability of different bacteria to adhere to the 
polysaccharides, thus preventing their utilisation.  For example, for the utilisation of 
cellulose by Ruminococcus flavefaciens dockerin-cohesin pairs are required to allow the 
glucosidases to break down the cellulose (Flint et al., 2008).  This could also occur as a 
result of steric hindrance due to differences in the outer structure preventing access to the 
carbohydrate (Valjamae et al., 1998).  Differences in utilisation could also occur as a result 
of the requirement of different glycoside hydroxylases (GH) which are found in the colonic 
bacteria.  This could result in a number of  different bacteria utilising the substrate 
including generalist species such as B.thetaiotaomicron can express many different 
CAZymes and utilise a variety of substrates, although it is not efficient to activate them all 
concurrently. However, B.thetaiotaomicron did not grow on β-glucans or galactomannan 
as used in the investigation by Martens et al., (2014) indicating that a different bacterial 
populations such as Bacteroides ovatus which has the appropriate CAZymes utilise these 
substrates (Martens et al., 2014). 
 
With the low MW, substrates reduced total SCFA production could have occurred; there 
may have been a lag period in the bacterial response.  This is as the low MW were di and 
tetra saccharides not commonly encountered within the diet (due to the consumption of 
complex polysaccharides).  Due to this different bacteria or the upregulation of different 
enzymes were likely to be required to catabolise these simple sugars, further highlighting 
the complexity of identifying drivers of SCFA production (Martens et al., 2014). 
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Figure 6-1: Total SCFA production over 24 hours after fermentation of different molecular 
weight oat β-glucans. 
Time points plotted are 0, 2, 4, 6, 12, and 24 hours. Data plotted from that presented by (Kim and 
White, 2011b).  Mean + SD, n=3. * indicates p<0.05 0.53 KDa vs  2.79 kDa and † = p<0.05 
0.53kDa and 8.98 vs 4.87, 2.79, 1.8 and 0.91 kDa. 
 
Although the systematic review conducted in Chapter 3 suggested that there was little 
difference in the ability of different NDC to produce propionate, few in vitro investigations 
have systematically considered the impact of the sugar composition of oligosaccharides on 
individual SCFA production - particularly propionate.  The fermentability and the SCFA 
producing capability of the individual sugars within a substrate has been previously studied 
by Salvador et al., (1993) using the in vitro fermentation technique. Salvador et al., (1993) 
assessed the composition of wheat bran, sugar beet, cocoa, maize and pea hull fibre and 
these were fermented to assess how well the sugars were utilised by the colonic bacteria. It 
was observed that uronic acids were the most fermentable sugars in wheat bran, cocoa, 
maize and sugar beet. For pea and cocoa, glucose was the most poorly fermented sugar, 
whilst xylose for sugarbeet, and arabinose for wheat bran were also poorly fermented. 
Sugar beet, which consisted of high arabinose (17.8%) and uronic acid (19.4%) content 
which as a whole, as well as the individuals sugars were highly fermentable, and led to the 
highest concentration of propionate after 24 hours of fermentation (~35 mmol).  In 
contrast, maize (10.7% arabinose) and pea fibre (14.7% uronic acid) did not lead to 
remarkable amounts of propionate production (~15 mmol) (Salvador et al., 1993). This 
suggests that within an NDC the fermentability of the different constituent sugars is not 
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uniform, and that the amount of SCFA produced is not only a sum of the SCFA production 
by each sugar within the NDC. This is likely as a selection of different CAZymes are 
required to utilise all of these sugars and bonds, which may or may not be produced by the 
same bacteria. For example the colonic bacteria are highly adaptable with sugars tested 
within this study can be utilised by the bacteria B. thetaiotaomicron and B.ovatus. This 
however does not take into account competition of the bacteria utilising these substrates or 
other properties of the substrates.  For example, B.ovatus preferentially acts on less soluble 
carbohydrates whereas B. thetaiotaomicron acts on more soluble substrates (Martens et al., 
2011).  In contrast, Firmicutes bacteria preferentially act on insoluble fibre indicating that 
there may be competition as well as reduced access to the bonding resulting in altered 
SCFA production profiles (Martens et al., 2014, Ze et al., 2012). 
 
Although not all monosaccharides and disaccharides reach the colon, the glucose 
disaccharides used are likely to be absorbed in the colon after breakdown by brush border 
hydrolases in the small intestine.  However, in vitro fermentation studies of these sugars 
allow a more mechanistic approach to the identification of components determining 
propionate production.  Monosaccharide analysis by in vitro batch fermentation 
investigations demonstrated that rhamnose, a sugar that can avoid digestion, selectively 
increased the generation of propionate (Gietl et al., 2012, Fernandes et al., 2000).  Human 
feeding studies have also found varied effects of rhamnose on serum propionate 
concentration when approximately 25 g/day was consumed by healthy individuals.  Vogt et 
al., (2004) observed that a drink containing rhamnose ingested for 4 weeks and in a single 
dose trial increased concentrations of serum propionate.  In contrast, Darzi et al., (2015) 
found no effect on serum propionate after consumption of a rhamnose containing jelly for 
a week (Vogt et al., 2004b, Vogt et al., 2004a, Darzi et al., 2015). 
 
Few studies have also investigated the role of disaccharides on propionate production. 
Sanz et al., (2005) conducted in vitro fermentation experiments with a selection of 
different disaccharides, including glucose disaccharides.  This study appears to have used 
only one stool sample and sampled only at 12 hours of fermentation making extrapolation 
to the population difficult. Here, a few differences were observed, where beta-glycosidic 
bonding of glucoses generally increased propionate production compared to glycosidic 
bonding in the alpha anomeric form.  Increased propionate with specific glycosidic bonds 
were identified with the fermentation of sophorose (β-1-2- glucose-glucose), β-β- trehalose 
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(β-1-1-β- glucose-glucose), laminaribiose (β-1-3- glucose-glucose), cellobiose (β-1-4- 
glucose-glucose), whereas isomaltose (α-1-2- glucose-glucose) and mannobiose (2α 
mannose – mannose) which also have alpha bonds also increased propionate production 
(Sanz et al., 2005a).  In contrast when a small selection of disaccharides (isomaltose, 
maltose cellobiose and gentiobiose) underwent in vitro fermentation (n=3), after 24 hours 
there was no significant differences in the production of propionate (Gietl et al., 2012). 
 
Changes as a result of alterations in bonding have also been observed when comparing 
pyrodextrinised starches which have increased solubility and water holding capacity 
compared to their native forms.  Pyrodextrinisation does not alter the sugar composition, 
but pyrodextrinised forms have increased beta glycosidic bonding compared to native 
forms (Laurentin and Edwards, 2004, Campechano-Carrera et al., 2007).  When 
pyrodextrinised forms of native starches were fermented in vitro, it was found that 
pyrodextrinised starch generated significantly more SCFA per kg of carbohydrate than 
native starch.  Propionate proportions also increased with pyrodextrinised starches by an 
average of 50% and acetate proportions decreased by an average of 22.7% (Laurentin and 
Edwards, 2004), suggesting that the bond anomer may be a major player in the production 
of propionate. 
 
Investigations of oligosaccharide structures with different types of bonds, structures, and 
sugars conducted in vitro also observed that bonding in the beta anomeric form was 
associated with increasing propionate production.  For example, in vitro incubations and 
human feeding trials of dietary fibres consisting of bonding with the beta anomer such as 
laminarin (β[1-3] β[1-6] glucose bonding).  After in vitro fermentation of laminarin, and 
when laminarin consisted of 2% of the diet in rats for 2 weeks resulted in approximately 
double the caecal concentration of propionate compared to a low MW form of alginate 
(7.49 [1.33] vs 4.51 [1.32] μmol/g content)(Deville, 2007, Kuda et al., 2005).  Cereal β-
glucans which are formed of linked glucoses (β[1-3] β[1-4] glucose bonding) have also 
been demonstrated in vitro and in feeding trials to increase production of propionate 
(Queenan et al., 2007).  Feeding trials where 3% of the diet was barley β-glucan and was 
consumed for 2 weeks by rats produced significantly more propionate than the control diet 
and the low β-glucan diet (0.02% of the diet). 
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Guar gum, differing in sugar composition compared to cereal β-glucans and laminarin is 
also considered propiogenic.  Guar gum is formed of a β-linked mannose back bone with 
α- linked galatobiose side chains where increased propionate has been demonstrated in 
vitro and after guar gum formed 8% of the diet in rats for 3 weeks.  Guar gum consumption 
led to the production of double the amount of cecal propionate compared to resistant starch 
(50 [6.0] mM vs 27 [7.0] mM) (Khan and Edwards, 2005, Levrat et al., 1996).  Pectin, also 
differing in structural composition (α[1-4] linked galactouronic acid) has been shown in 
vitro and in feeding trails where it formed 5% of the diet of rats diet for 3 weeks and caecal 
propionate production was higher than that of the control (88.1 vs 53.0 μmol/g) 
(Titgemeyer et al., 1991, Knapp et al., 2013). 
 
As these all have different structures and bonding, the question of which factor in the most 
influential in determining propionate production remains.  This demonstrates that although 
changes in propionate production have been observed as a result of different 
monosaccharides, disaccharides, and oligosaccharide structure, there have been no studies 
which have systematically considered the impact of individual glycosidic bonds on SCFA 
profiles.  Using disaccharides of glucose covering the full range of glycosidic bond 
configuration available would allow analysis of the impact of the bond configuration, 
without the confounding effects of different monomer composition, MW or solubility. 
 
 Aim 
 
To identify which glycosidic bond configurations selectively increase SCFA production 
during fermentation of all commercially available glucose-glucose disaccharides. 
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 Methods 
 Substrates 
All possible glucose-glucose disaccharides (diglucoses), except for β, β-trehalose 
(diglucose β[1-1]β) which was not a commercially viable option to study in a usable 
amount, were used to model the effect of glycosidic bonding on SCFA production (Figure 
6-2). 
Bond linkages (both anomers and all positional isomers) investigated were; α,α-D-
Trehalose Dihydrate (diglucose α[1-1]), α,β,- Trehalose (diglucose β[1-1]), Kojibiose 
(diglucose α[1-2]), Sophorose (diglucose β[1-2]), Nigerose (diglucose α[1-3]), 
Laminaribiose (diglucose β[1-3]), D-Maltose Monohydrate (diglucose α[1-4]), D-
cellobiose (diglucose β[1-4]), Isomaltose (diglucose α[1-6]), β-D-gentiobiose (diglucose 
β[1-6]). All disaccharide substrates were purchased from Carbosynth (Berkshire, UK). 
A blank (no-substrate) control was also used to adjust for background SCFA production.  
 
 
 
 
Figure 6-2: Bond linkages used in this investigation.   
All linkes in the α and β anomer with all positional isomers were fermented. The β(1-1)β, 
which was not included due to cost is indicated by the red box. Adapted from (Peric-Hassler et 
al., 2010). Trehalose = trehalose dihydrate, Isotrehalse = Trehalose.  Nb Iso and neotrehalose 
are annotated the wrong way around 
179 
 
 
 
 In vitro batch Fermentations 
Batch fermentations were performed as outlined in Section 2.2.1 and in Chapter 4. The 
fermentations were carried out in the validated 50mg ‘small vessel size’ due to the high 
cost of the substrates, therefore enabling a sufficient number of repeats. SCFA and pH 
were measured in samples from the fermentation vessels at 0, 8, and 24 hours. The SCFA 
were extracted and analysed by GC: FID as described in Section 2.3. 
 
 Sample donors 
All sample donors were healthy Caucasians. No information on prior or habitual diet or 
weight were obtained. An initial power calculation using G.Power 3.1 ([Heine et al., 2016] 
University of Dusseldorf) was calculated using data generated during the miniaturisation  
(see Chapter 4).  It indicated that differences in propionate production could be observed 
with approximately 12 fermentations would yield 80% statistical power. Due to a lack of 
substrate availability, 10 fermentations were conducted.  Initially, stool samples were 
obtained from 10 individuals (4 males and 6 females) aged 20-52 (median age 26.5 years, 
mean age, 31 years).  Due to a lack of substrate, diglucose β(1-1)α was n=9 (4 males and 5 
females, aged 20-52, median age 28 years, mean age 31.9 years).  A post hoc power 
calculation was also conducted and it was identified that for α(1-1) and β(1-4) an 
additional five fermentations should achieve sufficient statistical power. As it was feasible 
and affordable, five additional fermentations for these substrates were performed along 
with the blank. The additional five donors (three males and two females) were aged 23-52 
(median age 30, mean age 35.4).  This resulted in the final 15 stool samples being obtained 
from seven males and eight females, aged 20-52 (median age = 28 years, mean age 32.5 
years). 
 
 Statistics 
Statistical power was measured by post hoc power analysis using G.Power 3.1 ([Heine et 
al., 2016] University of Dusseldorf).   The distribution of the data was assessed using the 
Shapiro Wilk test of normality.  The effect of pH was tested by the Kruskal Wallis test 
with post-hoc pairwise comparisons with the Dunn-Bonferroni test.  Analysis of the rate 
and ratio were conducted using one-way ANOVA with post hoc Bonferroni analysis on 
log(10) transformed data.  Statistical significance was considered at p<0.05.  
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 Results 
All substrates were easily dissolved enabling ease of sampling, with no substrates being 
viscous.  The majority of gases were produced after 8 hours of fermentation.  These gases 
were removed (but not measured) to allow for the sampling.  Gas was also produced at 24 
hours, indicating fermentation resumed and that the vessel remained anaerobic. 
 
 Statistical power 
As indicated in Section 6.3.2.1 an initial power calculation using G.Power 3.1 identified 
that 12 fermentations would provide 80% power.  Once the initial 10 fermentations were 
conducted, a post hoc power calculation was performed.  Here it became apparent that an 
additional five fermentations could provide a statistical power that was >90%. Power at 8 
and 24 hours differed with α(1-1), β(1-2), β(1-4), β(1-6) have >90% power for propionate 
production.  All other disaccharides had >40% power after 8 hours of fermentation.  
Diglucoses α(1-1) and β(1-4) had power of; 98% and 93%, β(1-2) and β(1-6) had 70% 
power, the remainder of diglucoses had a power <20% after 24 hours of fermentation. 
 
 pH 
All diglucoses were utilised by the bacteria within the slurry, as demonstrated by a 
reduction in pH (Table 6-1).  Within 8 and 24 hours of fermentation, all of the diglucoses 
had a significantly reduced pH compared to the control and the initial pH.  Diglucose α(1-
4) had the lowest pH at both time points (pH 3.85 [0.15] and pH 3.57 [0.33], Table 6-1).   
 
When comparing the effect of linkage on pH, diglucose α(1-1) had a significantly lower 
reduction in pH compared to all other linkages in the alpha anomer, after both 8 and 24 
hours of fermentation (pH 5.07 [0.52] and pH 4.55 [0.13], p< 0.05).  The pH did not differ 
between the disaccharide bonding positions with the beta anomer at 8 or 24 hours (Table 
6-1). 
 
When considering the effect of bond anomer on pH, few selective effects were seen across 
or between different types of glycosidic bond linkages.  Differences in anomer were 
observed for the 1-4 position with the alpha anomer having a significantly lower pH than 
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the beta anomer at both 8 (pH =3.85 [0.15], vs 4.44 [0.32], p= 0.001) and 24 hours (pH= 
3.57 [0.12] vs 3.99 (0.44), p< 0.002).  Diglucoses with 1-1 bond positions had differences 
in pH with the alpha anomer having a significantly higher pH at both time points (8 hours 
5.07 [0.52] vs 4.12 [0.40], p=0.002, 24 hours 4.55 [0.13] vs 3.80 [0.39], p = 0.003, Table 
6-1). 
 
Table 6-1: pH after fermentation of all possible diglucoses at 0, 8 and 24 hours 
 
0h 8h 24h 
 
α β α β α β 
Diglucose 
(1-1) 
7.15 
(0.62) 
6.99 
(1.11) 
5.07 
(0.52)a* 
4.12 
(0.40) 
4.55 
(0.13)a* 
3.80 
(0.39) 
Diglucose 
(1-2) 
6.81 
(0.98) 
7.06 
(0.93) 
4.23 
(0.49)b 
4.16 
(0.35) 
3.85 
(0.33)b 
3.81 
(0.19) 
Diglucose 
(1-3) 
6.91 
(0.83) 
6.76 
(0.84) 
4.05 
(0.34)b 
4.42 
(0.25) 
3.84 
(0.34)b 
3.89 
(0.39) 
Diglucose 
(1-4) 
6.95 
(0.89) 
7.15 
(0.63) 
3.85 
(0.15)b* 
4.44 
(0.32) 
3.57 
(0.12)b* 
3.99 
(0.44) 
Diglucose 
(1-6) 
6.93 
(0.83) 
7.21 
(0.37) 
4.05 
(0.18)b 
4.14 
(0.37) 
3.72 
(0.20)b 
3.77 
(0.40)+ 
Median (IQR) n= 15 for blank, α(1-1), and β(1-4), n= 9, β(1-1) all other diglucoses n=10. All 
diglucoses except α(1-1) had a pH significantly lower than the blank control at 8 and 24 hours 
(p<0.0001) .  Different letters indicate significant differences between diglucoses with the same 
anomer, p<0.05, + indicated p=0.066 vs. β(1-1). * indicated significant differences as a result of 
bond anomer, p<0.05. 
 
 SCFA production after 8 hours of fermentation 
SCFA production at 8 hours was not significantly affected by the disaccharide linkage.  
Trends were observed with the α(1-1) linkage, which generated the lowest amount of 
acetate, 107.38 (72.74) μmol/g carbohydrate/ hour where, p= 0.075 vs α(1-6) (261.08 
[78.70] μmol/g carbohydrate/ hour) and p=0.056 vs β(1-6) (230.18 [148.87] μmol/ g 
carbohydrate/ hour, Table 6-2).  Also observed at 8 hours was the lack of effect of 
anomeric orientation on acetate, propionate, or butyrate.  Unlike for bonding position, no 
trends were observed due to the different anomers. 
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Table 6-2: SCFA production after 8 hours of diglucose fermentation μmol/g carbohydrate/ 
hour 
 
Acetate Propionate Butyrate Total 
 
α β α β α β α β 
Diglucose 
(1-1) 
107.38 
(72.74) 
187.17 
(59.69) 
19.00 
(21.63) 
12.58 
(10.2) 
28.10 
(26.66) 
9.92 
(4.86) 
182.07 
(173.45) 
247.22 
(63.46) 
Diglucose 
(1-2) 
174.03 
(97.55) 
225.28 
(109.71) 
16.68 
(17.62) 
18.44 
(4.29) 
10.34 
(13.21) 
34.01 
(36.78) 
250.85 
(97.63) 
265.62 
(98.89) 
Diglucose 
(1-3) 
224.36 
(151.90) 
119.85 
(98.42) 
14.21 
(12.14) 
15.49 
(7.42) 
8.66 
(24.24) 
14.14 
(20.21) 
278.73 
(129.24) 
189.71 
(113.86) 
Diglucose 
(1-4) 
224.91 
(93.05) 
130.73 
(85.95) 
13.63 
(13.80) 
21.55 
(21.88) 
7.57   
(7.54) 
31.66 
(85.83) 
260.02 
(104.41) 
223.37 
(182.97) 
Diglucose 
(1-6) 
261.08 
(78.70)a 
230.18 
(148.87)b 
16.46 
(14.81) 
13.99 
(21.56) 
10.08 
(15.27) 
32.30 
(34.40) 
304.04 
(90.76) 
290.66 
(220.07) 
Median (IQR) n = 15 for α(1-1), and  β(1-4), n= 9 β(1-1) all other diglucoses n=10. 
Letters indicate trends vs α(1-1) a; p = 0.075, b; p = 0.056 
 
 SCFA production after 24 hours of fermentation 
 Influence of bond position on SCFA production 
After 24 hours of fermentation, there was no significant difference in the production of 
propionate or total SCFA as a result of bond anomer. In contrast, significant differences in 
acetate and butyrate production were observed (Table 6-3,Table 6-4, Figure 6-3).  When 
considering bonding with an alpha anomer, diglucose α(1-1) led to the lowest rate of 
production and molar proportion of acetate and were significantly less than the values for 
diglucoses α(1-6) (57.05 [46.58] vs 125.51 [48.45] μmol/g carbohydrate/ hour, p= 0.001), 
and α(1-4) (57.05 [46.58] vs 108.97 [48.50] μmol/g carbohydrate/ hour, p= 0.006). 
 
Acetate proportion for diglucose α(1-1) was significantly less than all other linkages in the 
alpha anomer yielding 61.47 (21.44) % compared all other linkages in the alpha anomeric 
form with 1-2= 90.8 (18.90) %, 1-3 = 92.2 (17.52) %, 1-4 = 93.94 (8.82) %, 1-6 = 92.16 
(8.45) %, p<0.01. 
 
Diglucose α(1-1) generated significantly more butyrate production (29.17 [36.74] μmol/g 
carbohydrate / hour) and molar proportion of butyrate (26.45 [32.40] %, p<0.01) than all 
other linkages with alpha anomer. Statistical p values for the rate were; α(1-1) vs α(1-2), p 
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= 0.057, α(1-1) vs α(1-3), p = 0.019 , α(1-1) vs α(1-4), p = 0.001, α(1-1) vs α(1-6), p= 
0.006. This indicates that the bacteria were preferentially producing butyrate over acetate.  
The other diglucoses with alpha anomer did not differ in butyrate production from one and 
other (Table 6-3).  
 
The diglucose with α(1-1) bonding position also had the highest rate and proportion of 
propionate production but this was not statistically significant (Table 6-3, Table 6-4).  With 
propionate production from α(1-1) being 11.14 (15.51) μmol/g carbohydrate/ hour 
compared to α(1-4) yielding the least propionate with 4.3 (3.53) μmol/g carbohydrate 
(Table 6-3).  Similar observations were also seen with the proportion of propionate with 
α(1-1) yielding 9.10 (9.38) % and the lowest proportion of propionate was from α(1-4) 
producing 3.89 (7.71) %Table 6-4). 
 
When considering the beta anomer effects on the rate of acetate production were observed. 
Diglucose β(1-6) produced the highest rate of acetate which was significantly more than 
β(1-1); 191.47 (191.09) vs 95.62 (30.05) μmol/g carbohydrate/ hour, p = 0.004 and β(1-2); 
191.47 (191.09) vs 125.32 (48.45) μmol/g carbohydrate/ hour, p = 0.036.  For linkages in 
the beta anomer there was no difference in propionate, butyrate, or total production (Table 
6-3, Figure 6-2, Figure 6-3).  Proportionally, a trend for increased butyrate production with 
diglucose β(1-4) compared to β(1-1) was observed 19.2 (28.39) % vs 2.68 (8.27) %, 
p<0.051.  The proportion of acetate production was significantly reduced for diglucose 
β(1-4) compared to diglucoses β(1-1); 68.56 (37.89) % vs  92.18 (12.74) %, p= 0.016 and 
β(1-6); 68.56 (37.89) % vs 85.27 (10.82) %, p = 0.023 (Table 6-4). 
 
 Influence of bond anomer on SCFA production (alpha vs beta) 
Differences in butyrate production due to anomer were seen with the 1-1 diglucose linkage 
(α: 29.17 [36.74] vs β: 3.69 [2.54] μmol/g carbohydrate/ hour, p = 0.009), and 1-4 (α: 2.75 
[2.60] vs β: 26.43 [35.80] μmol/g carbohydrate/ hour; p = 0.033, Table 6-3, Figure 6-3) 
Contrasting proportions of acetate, propionate, and butyrate were seen in diglucoses with 
1-1 and 1-4 linkages.  Diglucoses with the 1-4 linkages in the alpha anomer observed a 
significantly higher proportion of acetate (α: 93.94 [8.82] % vs β: (68.56 [37.89] %, 
p=0.001) and a lower proportion of propionate (α: 3.89 [7.71] % vs β: 9.29 [7.22] %, p = 
0.037) and butyrate (α: 2.86 [2.63] % vs β: 19.20 [28.39] %, p = 0.001) compared to the 
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beta anomer.  A similar effect in the molar proportions of acetate and butyrate as a result of 
differing bond anomer were observed for diglucose 1-1 where the alpha anomer had a 
significantly lower proportion of acetate (61.47 [21.44] % vs 92.18 [12.74] %, p<0.001), 
and higher proportion of butyrate (26.45 [32.4] % vs 2.68 [8.27] %; p= 0.001, Table 6-4). 
 
Table 6-3: SCFA production after 24 hours of diglucose fermentation μmol/g carbohydrate/ 
hour 
 
 
Acetate Propionate Butyrate Total 
 
α β α β α β α β 
DiGlucose 
(1-1) 
57.05 
(46.58)a 
95.62 
(30.05)b 
11.14 
(15.51) 
4.59 
(1.79) 
29.17 
(36.74)a* 
3.69  
(2.54) 
126.21 
(54.36) 
103.74 
(30.59) 
DiGlucose 
(1-2) 
101.16 
(37.29) 
125.32 
(48.45)b 
5.68 
(8.25) 
6.44 
(1.22) 
4.19 
(9.61)‡ 
19.91 
(32.56) 
120.97 
(64.45) 
149.05 
(78.12) 
DiGlucose 
(1-3) 
105.44 
(67.52) 
86.96 
(44.63)b 
5.39 
(3.37) 
7.25 
(3.11) 
3.51 
(8.37)b 
8.09 
(20.72) 
123.76 
(59.59) 
128.64 
(60.94) 
DiGlucose 
(1-4) 
108.97 
(48.50)b 
110.03 
(80.83)b 
4.30 
(3.53) 
9.13 
(21.09) 
2.75 
(2.60)b* 
26.43 
(35.80) 
118.86 
(51.86) 
98.23 
(78.75) 
DiGlucose 
(1-6) 
125.51 
(43.50)b 
191.47 
(191.09)a 
6.32 
(3.75) 
10.49 
(24.41) 
3.68 
(4.91)b 
15.18 
(13.89) 
134.54 
(55.14) 
165.64 
(67.19) 
Median (IQR) n = 15 for α(1-1), and  β(1-4), n= 9 β(1-1) all other diglucoses n=10. 
Different letters within colums show significant differences. ‡ shows α(1-1) p= 0.057. * indicates 
signifcant differences as a reault of anomer p= 0.035 
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Table 6-4: Ratio of SCFA after 24 hours of diglucose fermentation 
 
Acetate Propionate Butyrate 
 
α β α β α β 
Diglucose 
(1-1) 
61.47 
(21.44)b* 
92.18 
(12.74)b 
9.1   
(9.38) 
5.09 
(4.88) 
26.45 
(32.4)b* 
2.68 
(8.27)+ 
Diglucose 
(1-2) 
90.80 
(18.90)a 
97.14 
(16.74) 
5.51 
(7.90) 
5.47 
(4.72) 
3.98 
(8.45)a 
15.19 
(17.13) 
Diglucose 
(1-3) 
92.20 
(17.52)a 
88.27 
(23.53) 
4.83 
(7.13) 
5.98 
(7.06) 
3.35 
(7.36)a 
6.23 
(18.79) 
Diglucose 
(1-4) 
93.94 
(8.82)a * 
68.56 
(37.89)a 
3.89 
(7.71)† * 
9.29 
(7.22) 
2.86 
(2.63)a* 
19.20 
(28.39) 
Diglucose 
(1-6) 
92.16 
(8.45)a 
85.27 
(10.82)b 
4.68 
(4.37) 
4.47  
(5.07) 
3.51 
(3.66)a 
7.60 
(9.20) 
Median (IQR), α(1-1), β(1-4) n= 15, β(1-1) n=9 all others n=10. Different letters indicate 
significant differences between bond positions.  p<0.05. † indicates p = 0.086 vs α(1-1) + indicates 
p = 0.051 vs. β(1-4). Significant differences as a result of bond anomer are shown as *. 
 
Figure 6-3: 24 hour SCFA production (mmol/g carbohydrate/day at 24 hours). 
Data presented are Median + IQR. α(1-1), β(1-4) n= 15, β(1-1) n=9 all others n=10. * indicate 
differences between the α and β anomer p< 0.05. 
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 Ranked propionate production 
As there were no observed significant differences in the production of propionate, the 
production of propionate by the 10 individuals fermented were ranked (Figure 6-4).  There 
was no substrate that ranked consistantly for propionate production.  A sub-population was 
identified with preference for propionate with diglucoses with beta anomers.  Subgroups of 
individuals are discussed below. 
 
 
 
Figure 6-4: Heat map of ranked propionate production by the diglucoses tested by each 
individual. 
Key: Grey- alpha anomer diglucoses, purple – beta anomer diglucose. Different shades indicate 
different bond positions. P1, P3, P6 β(1-6) not included. P10 β(1-1) not included 
 
 Individual variability in SCFA production 
Figure 6-5 shows the variability for propionate, butyrate and total production between 
individuals with fermentation of α(1-1) and β(1-4).  For propionate and butyrate 
production there was a subset of individuals appearing to have higher propionate (n = 3) 
and butyrate (n =4) producing capabilities.  However, it was not same individual producing 
consistently higher propionate, butyrate, and total production suggesting that this may not 
have occurred due to of issues of the experimental set up.  For example donor number 6 
(green line) produced the most propionate with diglucose α(1-1), but butyrate and total 
production were unremarkable, indicating that the substrate added to the vial was not 
erroneous.  It was also observed for donor number 6 that SCFA production with diglucose 
β(1-4) was also unremarkable indicating that there were no issues with the fermentation 
media/ experimental setup as all fermentations were performed concurrently.  Similar 
effects were also observed with the top producers, with no individual having high 
Rank P1 P2 P3 P4 P5 P6 P7 P8 P9 P10
1
2
3
4
5
6
7
8
9
10
α(1-1) α(1-2) α(1-3) α(1-4) α(1-6)
β(1-1) β(1-2) β(1-3) β(1-4) β(1-6)
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propionate, butyrate or total production on all occasions.  Figure 6-5 shows that although 
some individuals produced high concentrations of propionate and butyrate, there were also 
others who produced low concentrations of propionate and butyrate.  Interestingly, it was 
not always the same individuals yielding high or low propionate/ butyrate concentrations. 
 
 
 
Figure 6-5: Individually plotted absolute SCFA production at 0, 8, and 24 hours.                                             
Diglucose α(1-1): A, Propionate, C, Butyrate, E, Total SCFA. Diglucose β(1-4): B, Propionate, D, 
Butyrate, F, Total SCFA. Each coloured line is an individual 
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 Discussion 
Knowing which fractions of dietary fibres are responsible for driving the production of 
propionate would enable better selection for substrates to increase concentrations of 
propionate in the colon.  As discussed in Chapter 1, selectively increasing the production 
of propionate could enable targeted activation of FFAR2 and FFAR3.  This has been 
shown in principle to confer advantages to metabolic health, including the regulation of the 
appetite (Chambers et al., 2014, Byrne et al., 2016). 
 
Different dietary fibres appear to be associated with increases in propionate production. 
NDC consisting of β-glucans, such as laminarin, and psyllium are associated with 
increased propionate production, whereas starch with α(1-4) and α(1-6) bonding is linked 
with increased butyrate production (Fässler et al., 2006, Deville, 2007, Kaur et al., 2011). 
Due to the lack of mechanistic studies it still remains unclear why these substrates increase 
the generation of these specific SCFA. Currently there are few investigations that have 
assessed the effect of mono/ disaccharide sugars and their linkages on the production of 
propionate (Mortensen et al., 1988, Gietl et al., 2012). The most comprehensive 
investigation consisted of only a single stool sample from one donor (Sanz et al., 2005a).  
This of limited use when there is such variation in different individual’s abilities to 
produce SCFA (Carlson et al., 2016). 
 
The disaccharide sugars tested within this study are unlikely to reach the colon in vivo due 
to digestion and/or absorption.  However, this in vitro analysis has enabled the 
investigation of whether a specific bond linkage leads to the production of propionate.  
This was conducted by utilising all possible glucose-glucose disaccharides, except for β-β-
trehalose β(1-1)β as the cost was too high to include within this experiment (Figure 6-2). 
With limited commercially viable availability of some substrates, and the requirement of a 
high number of replicates, the validated miniaturised method discussed in Chapter 4 was 
utilised with each fermentation vial requiring 50 mg of substrate.  The use of these glucose 
disaccharides also enabled the analysis of the propionate producing capabilities of the 
bonding without confounding effects from the sugar composition, substrate solublity, or 
MW on SCFA production. 
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Although up to 15 different donors provided stool samples only α(1-1) and β(1-4) reached 
statistical power after 24 hours, these substrates along with β(1-2) and β(1-6) were 
sufficiently powered at 8 hours. This indicates that although generally underpowered, 
significant differences or trends would have been identified from the 10/ 15 fermentations. 
To gain sufficient power for some substrates would require more than 100 different 
fermentations, which due to substrate availability and time constraints was not feasible. 
Lack of power likely occurred as a result of the variability in an individual’s ability to 
produce SCFA, which as shown in Figure 6-3 - Figure 6-5 is substantial. This variation in 
an individual’s ability to produce SCFA may be as a result of their habitual diet prior to 
donating a sample, which was not controlled. Different diets are likely to have influenced 
the bacterial diversity in the stool as well as the bacterial enzymes expressed and as a result 
the SCFA produced (Bourriaud et al., 2005, Reichardt et al., 2014, David et al., 2014, 
O'Keefe et al., 2015). 
 
Unexpectedly, there was little effect of bonding position or anomer on propionate 
production, and this was also apparent after ranking the substrates.  All differences in 
SCFA production observed were associated with diglucoses α(1-1) and β(1-4).  The final 
pH for glucose disaccharides with α(1-1) bonding was higher with the alpha anomer than 
all other diglucoses after 8 and 24 hours of fermentation.  Although pH is an indicator of 
fermentation, this difference did not result in differences in SCFA production after 8 hours, 
or total SCFA production after 24 hours.  No differences in total production of SCFA 
between all substrates were observed, but differences in acetate and butyrate were 
identified.  After 24 hours of fermentation α(1-1) generated less acetate as a rate of 
production and as a proportion but had significantly increased butyrate production 
compared to the other diglucoses tested.  This may have occurred as a result of 
interconversion of acetate to butyrate thus increasing butyrate concentrations and 
decreasing acetate concentrations (Morrison et al., 2006). 
 
Differences linked with bond anomer were mostly isolated to (1-1) and (1-4) bond 
positions. The alpha anomer had a significantly reduced decrease in pH compared to the 
beta anomer with the 1-1 bonding position at 8 and 24 hours. Similar effects were also 
observed with the 1-4 bond position with the alpha anomer having a significantly lower pH 
at 8 and 24 hours compared to the beta anomer. This however did not alter the total SCFA 
production at 8 or 24 hours. This was also associated with changes in butyrate production 
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and propionate and butyrate proportion.  Alpha (1-1) generated significantly more butyrate 
as a rate as well as molar proportion than the beta anomer, and the opposite was found with 
alpha (1-4) linkages.  The alpha (1-4) also resulted in significantly less propionate 
proportion than the beta anomer.  This could be associated with the requirement for 
different CAZymes for each different bonding positions and anomers.  For example, α(1-4) 
glucose linkages (which are located in starch) can be utilised by enzymes encoded within 
starch utilisation systems such as the extracellular GH97 from B.thetaoiotaomicron. 
Bonding with β(1-4) glucose linkages can by catabolised by GH3 expressed by B.ovatus 
indicating that different bacterial species were likely required thus leading to different 
SCFA production (Martens et al., 2011, Martens et al., 2014). 
 
An increase in propionate production as a result of the beta anomer within an NDC, has 
been previously reported (Laurentin and Edwards, 2004).  Heat treatment of native starch 
(α[1-4], α[1-6]), resulting in pyrodextrisined starch and the conversion to β(1-4), β(1-6) 
bonds, led to increased in propionate production in vitro.  The effect of this change on the 
bacterial profile was not assessed, however it is likely that the α(1-4) linkages are utilised 
with starch utilising systems such as those present in B.thetaoiotaomicron which use 
interconverstion to produce butyrate (although increased butyrate was not observed here) 
(Martens et al., 2011, Reichardt et al., 2014).  In contrast β(1-4) are utilised by B.ovatus 
which forms propionate via the succinate pathway indicating that a shift from an alpha to a 
beta bond leads to different requirements for bacterial enzymes and as a result, alters the 
SCFA production profile (Martens et al., 2011, Reichardt et al., 2014).  This may partially 
explain the increased proportion of propionate with β(1-4) bonding compared to the alpha 
anomer (Siljestrom et al., 1989, Laurentin and Edwards, 2004).  Increased butyrate 
production from diglucoses with β(1-4) bonding is also supported by lactose which consist 
of this bonding and selectively generate butyrate in vitro (Mortensen et al., 1988, Hughes 
et al., 2008). 
 
Studies assessing the in vitro fermentation capabilities of foods consisting of α(1-1) 
bonding, ie trehalose are scarce.  Within foods these linkages are commonly found in 
mushrooms such as the ‘common’ mushroom (Wannet et al., 1998) and the shiitake 
mushroom (Chen et al., 2015) which also contain β-glucans.  Shiitake mushrooms have 
been used in chinese medicine and have also been demonstrated to reduce body weight 
gain, and fat pad mass when rats were fed up to 6% wt/wt of shiitake mushroom powder 
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for 6 weeks (Handayani et al., 2014).  Therefore it would be advantageous assess the 
propionate producing capabilities of these mushrooms.  Wong et al., (2005) also carried 
out in vitro fermentations of mushroom sclerotia containing β-glucans containing β(1-3) 
and β(1-4) bonding and observed that they selectively increased propionate and butyrate 
proportions. However it was identified that two of the mushrooms tested were not well 
fermented, and that this did not lead to differences in the concentration of propionate. 
Within this investigation and few fermentations were conducted (n=1, with two technical 
repeats), this further makes it difficult extrapolate these findings to SCFA production in the 
wider population (Wong et al., 2005), also within this study the effect of β(1-6) linkages 
commonly identified in mushrooms was not present (Yu et al., 2009).  A selection of 
mushrooms have also been demonstrated to have immunregulatory effects after response to 
an LPS challenge in mouse macrophage cells (RAW 264.7).  Extracts of white button, 
shiitake, crimini and oyster mushrooms were able increase IL-1β, and TNFα expression, as 
well as decrease IL-10 expression which is favourable for immuno-regulation. It was also 
observed within this investigation that after feeding mice a diet which was 2% white 
button mushroom for 4 weeks, the expression of TNFα was increased after DSS mediated 
colitis (Yu et al., 2009). These immuno-regulatory affects have also been observed after 
the activation of FFAR2 by SCFA in mice (Maslowski et al., 2009b), suggesting that the 
benefical roles of fungal β-glucans may be occurring as a result of the colonic SCFA that 
are produced.  Based on this, it would be interesting to assess the differences in propionate 
and butyrate production of different mushrooms, containing β-glucan bonding.  It would 
also be interesting to assess the additional branching with trehalose and assess how that 
would alter propionate and butyrate production. 
 
The results observed within this chapter are also in part supported by other investigations.  
The investigation by Sanz et al., (2005), assessing all of the possible diglucoses, with a 
stool sample from one donor for 12 hours also detected no trends in regards to linkage. It 
was however observed that the beta anomer did lead to selectively reduced acetate, and 
increased propionate and butyrate production.  There were also no changes in the bacterial 
composition observed for all bond positions except for diglucose β(1-6) (gentiobiose) 
which generated decreased bifidobacteria numbers. As the investigation by Sanz et al., 
(2005) only used one donor, there was no inter-individual variability which may have 
made these differences more easily to observe. This investigation by Sanz et al., (2005) 
also did not continue the fermentations for 24 hours, so it is unknown whether these trends 
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are maintained after 24 hours. Within the small investigation by Gietl., 2012 comparing 
maltose (α[1-4]), cellobiose (β[1-4]), isomaltose (α[1-6]) and gentiobiose (β[1-6]) in in 
vitro fermentations with three stool donors for 24 hours no differences in propionate or 
butyrate were identified (Gietl et al., 2012). 
 
This suggests that the specific bonding a glucose disaccharide is not the determining factor 
in propionate production. However this may be different for longer saccharides, which are 
broken down into smaller sugars, which is likely to be more beneficial to some bacteria 
than others (Martens et al., 2011).  This may lead to differences in individual and total 
SCFA production observed as a result of different DP (Stewart et al., 2008). 
 
In conclusion it is unlikely that the bonding alone determines the production of propionate 
and that other physicochemical determinants play role in driving this production. 
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  The propionate producing capacity of 
mycoprotein and extracted mycoprotein fibre. 
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 Introduction 
Mycoprotein is produced from cultures of the microfungus Fusarium venenatum.  
Mycoprotein is marketed in the UK as the meat replacement product Quorn®, and is 
widely consumed in the UK.  Mycoprotein is high in protein and low in fat.  It consists of 
25% (dry weight, and 6% wet weight) dietary fibre.  Chitin makes up 33% of the fibre 
fraction and the other 66% is β-glucan (Denny, 2008).  Mycoprotein has been shown to be 
beneficial to health, with positive effects seen in human feeding trials including improved 
plasma cholesterol, and reduced energy intake (Table 7-1).  A series of human feeding 
trials were conducted by Turnbull et al, in the early 1990s with mycoprotein consumption 
ranging from a single meal to 8 weeks of 80 g to 191 g/day.  The 80 g dose corresponds to 
approximately 1.67 g chitin and 3.33 g β-glucan and the 191 g dose corresponds to 
approximately 3.98 g chitin and 7.96 g β-glucan which is about 1/3rd of current 
recommended intake of dietary fibre (SACN., 2015).  Several advantages were associated 
with the consumption of mycoprotein in these studies, such as reduction in plasma 
cholesterol, glucose and insulin, energy intake, hunger, and desire to eat as well as 
increased fullness. These effects did not always occur and when measured did not lead to 
significant differences in body weight (Turnbull et al., 1990, Turnbull et al., 1991, 
Turnbull et al., 1993b, Turnbull and Ward, 1995)(Table 7-1).  
 
The mechanisms for these effects of mycoprotein on health remain unclear. Mycoprotein is 
11% (wet weight) protein, and the satiety inducing effects compared with other proteins 
have been assessed.  Williamson et al., (2006) compared the effects on satiety of a preload 
of chicken, mycoprotein or tofu (soy protein).  These meals were matched for protein but 
not fibre content.  Tofu and mycoprotein resulted in significantly less food intake than 
chicken (Williamson et al., 2006).  This is in agreement with other investigations 
comparing mycoprotein with chicken (protein content was matched) where subsequent 
energy intake after mycoprotein decreased (Turnbull et al., 1993a).  Mycoprotein has also 
been shown to produce greater reductions in serum glucose and insulin than soy, although 
feelings of satiety were not measured (Turnbull and Ward, 1995).  As the impact of the 
mycoprotein is seen when protein content is matched with other protein sources tested, 
studies have matched for overall protein content, but the amino acid content differed 
(Marlow foods LtD., 2016).  Beef and soy protein have increased concentrations of many 
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amino acids compared to mycoprotein, but in a feeding study of beef and chicken where 
the amino acid composition was similar, no effect on satiety was observed (Uhe et al., 
1992). Soy and beef protein leucine content is approximately double that of mycoprotein 
(Marlow foods LtD., 2016) and leucine in rat studies has been shown to reduce food intake 
(Morrison et al., 2007).  Therefore, it is unlikely that the mycoprotein-induced effects on 
satiety occurred due to the protein content.   
 
However, many of the effects observed with mycoprotein are often associated with 
increased fibre intake and thus the impact of mycoprotein may be due to its fibre, 
especially β-glucan.  
 
Chitosan, which is the soluble fraction of chitin, formed by the deacetylation of chitin, and 
can occur with large scale bioprocessing.  Chitin can be consumed as it is contained within 
the shells of crustaceans and fungi (Ravi Kumar, 2000). Chitosan has also been shown to 
reduce body weight (Mhurchu et al., 2004) and cholesterol (Bokura and Kobayashi, 2003) 
after consumption by overweight women.  Beta glucan, which has a health claim for 
reductions in cholesterol, and glycaemic response ((EFSA Panel on Dietetic Products, 
2011)) and is fermented, forming SCFA promotes the production of propionate (Queenan 
et al., 2007).  These effects have also been seen when an inulin-propionate ester was 
consumed for 24 weeks by overweight individuals and resulted in reduced energy intake as 
well as reduced cholesterol (Chambers et al., 2014). 
 
In Chapter 5, laminarin from seaweed (β[1-3], β[1-6], bonded glucose polymers, [Deville 
et al., 2007]) was the best candidate for propionate production in vitro.  Mushrooms have 
been shown to contain similar bonded β glucans with additional β(1-4) bonds (Wong et al., 
2005).  Thus if mycoprotein fibre has similar bonding, its effects on satiety and plasma 
lipids could be mediated through propionate production and stimulation of FFAR receptor 
mediated gut hormone response.  
 
Mycoprotein is approximately 25% dietary fibre (dry mass) and of that over 65% of the 
fibre is β-glucan with β(1-3), β(1-6) bonding.  The remainder is chitin consisting of N-
acetyl glucosamine monomers bound by β(1-4) linkages (Turnbull et al., 1991, Denny, 
2008). Beta glucans from sources such as oats (Hughes et al., 2008), laminarin (Deville, 
2007), and mushroom (Wong et al., 2005) also contain β(1-3), β(1-6), and β(1-4) linked 
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glucoses and have been associated with increased propionate and butyrate production, not 
only within published literature, but also within previous chapters (Chapter 3, Chapter 5).  
This indicates that these health benefits of mycoprotein may in part be due to increased 
production of SCFA, and more specifically propionate and butyrate. 
 
Therefore in this chapter, the fermentation and propiogenic properties of mycoprotein and 
its extracted fibres was investigated.
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Table 7-1: Effects of mycoprotein consumption assessed by human feeding trials 
Study Dose 
(daily)1 
Form Control Length 
of 
feeding 
2N  Health status Outcome (empirical) Outcome (subjective) 
Single 
meals 
        
(Turnbull et 
al., 1991) 
~140 g Meal Chicken single 
meal 
13 Healthy Decreased  energy intake (18%, vs 
chicken) 
Reduced desire to eat (7%), and 
hunger (6%, vs chicken) 
(Burley et 
al., 1993) 
~ 180 g meal and a 
cake 
Chicken, 
standard 
cake 
single 
meal 
19 Healthy Reduced subsequent energy intake (18%),  
NE on intake after 36 hours 
Decreased hunger at 4 hours (NE 
over time), NE desire to eat, 
prospective fullness. Reduced 
taste (12%) and pleasantness 
(14%)*  
(Turnbull et 
al., 1993b) 
130 g meal Chicken single 
meal 
13 Healthy Decreased energy intake on test day (24%) 
and the next day (16.5%) 
Reduced desire to eat (25%), 
hunger (16%), and increased 
fullness (11%) 
(Turnbull 
and Ward, 
1995)  
 ~80 g 
(20g/dw) 
Milkshake Soy protein  single 
meal 
19 Healthy Decreased serum glucose (13%) and 
insulin (36%) 
 
(Williamson 
et al., 2006) 
44 g Pasta meal Chicken and 
tofu 
single 
meal 
42 Overweight vs chicken: decreased food (12%) and 
energy intake (12%) 
vs tofu: NE on food or energy intake 
NE on hunger or fullness 
Long term studies         
(Turnbull et 
al., 1990) 
19 1 g Pie Equicaloric 
meal 
3 
weeks 
9 Raised 
cholesterol 
(5.2-6.2 mM) 
NE body weight, dietary intake, glycaemic 
control, TAG or insulin. Decreased total 
(13%) and LDL cholesterol (9%), increase 
in HDL cholesterol (12%) 
 
(Udall et al., 
1984) 
  
~80 g  
(20g/dw) 
 
Cookie 
 
Mycoprotein 
free cookies 
 
30 days  
 
100 
 
Healthy 
 
Decreased cholesterol (7%) 
 
(Turnbull et 
al., 1992) 
130 g Cookie Soy protein  8 
weeks 
11 Raised 
cholesterol 
>5.2 mM 
NE body weight, energy intake, TAG, or 
HDL cholesterol.  
Total (16%) and LDL (18%) cholesterol 
decreased   
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(Ruxton 
and 
McMillan, 
2010) 
 88 g   
(21g/dw) 
Meal Standard 
diet 
6 
weeks 
21 50% healthy, 
50% high 
cholesterol 
Overall: NE on BMI, waist 
circumference, blood pressure, or 
cholesterol (total, HDL, LDL).  
High cholesterol: Reduced total 
cholesterol (35%) 
Compliance: Reduced waist 
circumference (2.6%) and cholesterol 
(21%), NE on BMI or blood pressure  
 
1: wet weight, 2: number of individuals consuming mycoprotein.  DW= dry weight, NE= no effect, TAG= triacylglycerol, LDL= low-density lipoprotein, HDL= high-density 
lipoprotein. Dietary fibre content is 6% wet weight, and 25% dw. Percentage in brackets indicate percentage change. * reported that differences in taste and pleasantness were within 
the neutral range 
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 Aim 
To compare the propionate producing capacity of mycoprotein (and its extracted fibre) 
with a selection of ‘propiogenic’ substrates when fermented by gut bacteria in vitro. 
 
 Methods 
 Experimental Controls 
All fermentation runs included a positive control of oligofructose (OF; Beneo P95, 
Mannheim, Germany) and a negative control (no fibre faecal blank).  
 
 Experiment 1: Fermentability and production of propionic acid from 
mycoprotein  
 Substrates fermented were: 
x Mycoprotein, Quorn® (Marlow foods ltd, Yorkshire, UK) 
x Fibersol-2, resistant maltodextrin (Matsutani Chemical Industry Ltd. Co, Hyogo, 
Japan). 
x Oligofructose (OF/FOS) (Beneo p95, Mannheim, Germany) 
Fermentation model used: 100 mg (medium) vessel, pH 6.8 media 
Stool donors: 2 males and 1 female aged 23-25 (mean age 24 years), n = 3 (duplicate 
vials) 
Time points: 0, 6, and 24 hours 
 
 Experiment 2: Comparison of mycoprotein and mycoprotein fibre with other 
propiogenic substrates. 
 Substrates fermented were: 
x Mycoprotein, (Quorn®- Marlow Foods (Stokesley, UK)) 
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x Mycoprotein fibre, - isolated from whole mycoprotein by a proprietary process in 
collaboration with Marlow Foods (Stokesley, UK) and Premier Analytical Services 
(High Wycombe, UK). The substrate was supplied as a dry white powder fibre 
extract containing > 75% fibre. 
x Rhamnose (Sigma, Poole, UK) 
x Laminarin (Sigma, Poole, UK) 
x Oligofructose (OF/FOS) (Beneo p95)  
x Inulin-propionate ester (DE = 0.8, IPE0.8) – provided by Dr Douglas Morrison 
 
Fermentation model used: 100 mg (medium) vessel, pH 6.8 media 
Stool donors: 2 males and 1 female aged 24-25 (mean age 24.7 years), n = 3 (duplicate 
vials) 
Time points: 0, 6, and 24 hours 
 
 pH measurements 
At each sampling time point, the pH of the fermentation fluid was measured using a pH 
meter (HANNA) (Chapter 2- Section  2.1.3).  
 
 SCFA analysis 
SCFA production was analysed by GC: FID of ether extractions. This was conducted as 
described in  Chapter 2 section 2.3  
 
 Statistical Analysis 
Statistical analysis was conducted on IBM SPSS version 22. Tests of normality was analysed 
by the Shapiro Wilks test.  One-way ANOVA with post hoc Bonferroni, or Students t-test 
were used when normally distributed and Kruskall Wallis, with post hoc Dunn Bonferroni 
or Mann Whitney U test when normal distribution was not present as required. 
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 Results 
 Experiment 1: Fermentability and production of propionic acid from 
mycoprotein 
 pH 
Using pH as a marker of fermentation, mycoprotein was less well fermented than fibersol 
and oligofructose, and was similar to the control (Table 7-2).  
Table 7-2: pH changes after fermentation of mycoprotein in comparison to fibersol and 
oligofructose.  
 
0h 6h 24h 
Control 6.70 (0.2) 6.71 (0.18) † 6.76 (0.09) † 
Mycoprotein 6.57 (0.23) 6.44 (0.34) † 6.26 (0.18) † 
Fibersol 6.66 (0.24) 4.62 (0.31) 4.34 (0.1) 
Oligofructose 6.65 (0.25) 3.79 (0.3) 3.42 (0.34) 
Median (IQR), n=3.  
Between substrate, analysis used Kruskal Wallis with pairwise comparison and differences 
vs Oligofructose indicated by †. 
 
 Pattern and amount of SCFA production 
Acetate 
At 6 hours, mycoprotein fermentation resulted in much lower acetate production compared 
with oligofructose and fibersol, producing only 26% of that produced by oligofructose 
(p<0.001; Table 7-3, Figure 7-1, Figure 7-2).  After 24 hours of fermentation, acetate 
production from mycoprotein was 73.5% less than from oligofructose fermentation 
(p<0.001, Table 7-3). 
 
When considered as molar proportions, mycoprotein generated a significantly lower 
percentage of acetate compared with oligofructose (62.9 [6.9] % vs. 88.3 [2.7] %, p<0.01) 
and fibersol (62.9 [6.9] % vs. 73.1 [9.5] %, p<0.05) at 6 hours.  At 24h hours 50.1 [5.5] % 
of SCFA produced by mycoprotein fermentation formed acetate, this was lowest of the all 
substrates tested and was significantly less than acetate proportion with oligofructose 
fermentation (89.9 [1.0] %, p<0.001). 
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Table 7-3:  6 and 24 hour acetate concentration and proportion  
 
Concentration (mmol/l) Molar proportion (%) 
Time 6 hours 24 hours 6 hours 24 hours 
Control  5.28 (1.87)† 6.77 (0.76)† 67.6 (3.8)† 66.7 (19.3) 
Mycoprotein 7.85 (2.80)† 13.36 (1.55)† 62.9 (6.9)† 50.1 (5.5)† 
Fibersol 25.77 (4.0)†* 33.35 (11.04) 73.1 (9.5) 64.3 (11.5) 
Oligofructose 35.05 (1.54)* 50.05 (11.23)* 88.3 (2.7)* 89.9 (1.0)* 
Median (IQR), n=3. * vs mycoprotein, † vs oligofructose. Concentration = ANOVA and post hoc 
Bonferroni, Molar Proportions = Kruskal Wallis and post hoc Dunn Bonferroni  
 
Propionate 
After 6 hours of fermentation, propionate production from mycoprotein and fibersol was 
similar and much higher than from oligofructose, which produced 43% less propionate 
than from mycoprotein (Table 7-4, Figure 7-1, Figure 7-2).  
 
After 24 hours, mycoprotein and fibersol produced the highest amount of propionate (and 
highest molar proportion) of all the substrates tested (7.22 [1.2] mmol/l and 6.41 [2.53] 
mmol/l respectively), which was significantly greater than the control and oligofructose 
(p<0.001).   
 
Proportionally, after 6 hours of fermentation propionate production by the control and 
mycoprotein were similar. This did not occur after 24 hours with propionate proportion 
from mycoprotein (27.2 [3.2] %) was greater than that of the control – albeit not 
significantly so (p = 1.0). Propionate molar proportions with oligofructose did not vary 
over time, leading to ~3.5% propionate; this was significantly less than the propionate 
proportion from mycoprotein (p<0.001, Table 7-4). 
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Table 7-4: 6 and 24 hour propionate concentration and proportion 
 
Concentration (mmol/l) Molar proportion (%) 
Time 6 hours 24 hours 6 hours 24 hours 
Control  1.09 (0.45) 1.85 (1.54)* 16.1 (3.2)† 17.9 (9.1)† 
Mycoprotein 2.68 (0.76) 7.22 (1.20)† 16.2 (7.6)† 27.2 (4.0)† 
Fibersol 3.49 (0.47)† 6.41 (2.53)† 10.1 (0.6) 12.1 (3.2) 
Oligofructose 1.53 (0.19) 1.93 (0.46)* 3.8 (0.3)* 3.4 (0.3)* 
Median (IQR) n=3. * vs mycoprotein, † vs oligofructose. Concentration = ANOVA and 
post hoc Bonferroni Molar Proportions = Kruskal Wallis and post hoc Dunn Bonferroni  
 
 
Butyrate 
The 6 hour butyrate production from mycoprotein was significantly less than production 
by fibersol (2.7 [0.2] mmol/l vs 6.3 [1.6] mmol/l, p<0.022; Table 7-5 , Figure 7-1, Figure 
7-2 ). Fibersol also led to greater production of butyrate compared with oligofructose 
increasing by 47% after 6 hours (p= 0.041) and 91% after 24 hours (p=0.013, Table 7-5). 
Although not significant, mycoprotein fermentation led to the formation of 90% more 
butyrate than oligofructose after 24 hours of fermentation. 
 
Proportionally, oligofructose led to the lowest molar proportion of butyrate, which was 
significantly less than all other substrates after 6 hours of fermentation (Table 7-5). For 
example, mycoprotein formed 20.4 (0.9) % butyrate versus 8.1 (1.0) % produced by 
oligofructose (p<0.05).  After 24 hours mycoprotein and fibersol led to similar proportions 
of butyrate (~23%), which was significantly greater than the butyrate molar proportion 
after oligofructose fermentation (6.8 [1.0] %, p<0.05). 
 
Table 7-5: 6 and 24 hour butyrate concentration and proportion 
 Concentration (mmol/l) Molar proportion (%) 
Time 6 hours 24 hours 6 hours 24 hours 
Control  1.44 (0.86) 3.91 (0.28) 18.3 (2.9)† 15.4 (10.5) 
Mycoprotein 2.72 (0.23) 6.44 (1.32) 20.4 (0.9)† 23.5 (4.8)† 
Fibersol 6.26 (1.59) †* 7.04 (7.43) † 16.6 (10.8)† 22.0 (13.0)† 
Oligofructose 3.32 (0.73) 0.62 (0.66) 8.1 (1.0)* 6.8 (1.0)* 
Median (IQR). * vs mycoprotein, † vs oligofructose. Concentration = ANOVA and post hoc 
Bonferroni, Molar Proportions = Kruskal Wallis and post hoc Dunn Bonferroni test. 
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Figure 7-2: SCFA production after 24 hours of fermentation.  
Mean + SEM. * indicates significant differences against mycoprotein and † 
indicates significant differences against oligofructose, p<0.05. 
Figure 7-1: SCFA production after 6 hours of fermentation. 
Mean + SEM. * indicates significant differences against mycoprotein and † 
indicates significant differences against oligofructose p<0.05. 
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 Experiment 2: Mycoprotein compared with mycoprotein fibre. 
To explore the propiogenic properties of the fibre component of mycoprotein,  SCFA 
production from mycoprotein and mycoprotein fibre was compared with that from the 
‘propiogenic’ substrates; rhamnose and laminarin, as well as oligofructose and the 
synthetic inulin-propionate ester 0.8 (IPE0.8).   
 
 pH 
After 6 hours of fermentation mycoprotein and mycoprotein fibre did not greatly reduce in 
pH, with both decreasing by less than 0.5 pH units, and did not differ from the control.  In 
contrast, the pH for oligofructose reduced by 2.82 pH units and was significantly lower 
than mycoprotein and mycoprotein fibre (p<0.01 for both). 
 
After 24 hours fermentation the pH of the control, mycoprotein and IPE 0.8 did not differ.  
Unlike after 6 hours of fermentation the mycoprotein fibre (4.94 [0.63]) had a significantly 
reduced pH from the control (6.54 [0.24]) after 24 hours of fermentation (p=0.022) 
suggesting that it was slowly, but well fermented (Figure 7-3).  
 
 
Figure 7-3: Change in pH over 24 hours of fermentation 
Mean +/- Standard deviation, N=3. Time points measured are 0, 6, and 24 hours. Significant differences are 
discussed within text.  
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 SCFA production 
Acetate 
 
At 6 hours mycoprotein fibre yielded the second highest concentration of acetate (15.1 
[3.0] mmol/l), although this did not significantly differ from the other substrates tested 
(Figure 7-4, Figure 7-5).  By 24 hours, mycoprotein fibre generated significantly more 
acetate (37.6 [10.3] mmol/l) than the control (6.5 [1.2] mmol/l, p< 0.01), IPE 0.8 (11.3 
[2.4] mmol/l, p=0.035), and mycoprotein (6.4 [0.8] mmol/l, p=0.045).  Oligofructose 
remained the highest producer of acetate generating 46.5 (4.9) mmol/l. 
 
Propionate 
 
As expected, IPE0.8 yielded the highest rate of propionate concentration at both 6 and 24 
hours yielding 36.7 (2.2) and 37.4 (3.1) mmol/l which was significantly higher than all 
other substrates tested (p<0.01).  Propionate production by mycoprotein and its extracted 
fibre was similar after 6 hours of fermentation, yielding ~2.5 mmol/l.  After 24 hours, 
mycoprotein fibre generated approximately double the amount of propionate compared to 
the mycoprotein (12.3 [3.0] vs 6.4 [0.5], Figure 7-4, Figure 7-5).  Rhamnose also generated 
high concentrations of propionate yielding 8.0 (3.0) mmol/l at 6 hours and 23.2 (1.3) 
mmol/l at 24 hours was significantly larger than all substrates except after 24 hours 
p<0.05.  
 
This was not a significant increase in propionate (p=0.848), which may be due to variation 
as ‘participant 2’ did not rank high for SCFA production with mycoprotein fibre (see 
below).  In opposition to findings within Chapter 4, laminarin yielded lower concentrations 
of propionate when tested at 6, and 24 hours, and production was only greater than that of 
the control and oligofructose.  For example, after 6 hours, laminarin generated (2.0 (0.3) 
mmol/l) of propionate which was only greater than the control (1.3 [0.0] mmol/l) and 
oligofructose 1.2 [0.2] mmol/l), although this was not significant.  After 24 hours laminarin 
produced 4.7 (1.64) mmol/l of propionate only surpassing the control (2.2 [0.1] mmol/l) 
and oligofructose (1.3 [0.1] mmol/l), although this was not significant (Figure 7-4, Figure 
7-5). 
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Butyrate 
 
In contrast, laminarin generated the highest rate of butyrate after 6 (6.5 [2.7] mmol/l) and 
24 hours (18.4 [5.5] mmol/l). After 24 hours butyrate production significantly greater than 
all substrates tested (p<0.05) except for mycoprotein (6.3 [0.3] mmol/l, p=0.072) and 
mycoprotein fibre (11.3 [3.0] mmol/l, p=1.0). Butyrate production was the lowest for 
oligofructose (2.29 [0.6] mmol/l, Figure 7-4, Figure 7-5). 
 
Total 
 
All substrates tested were fermented, and all substrates (except for mycoprotein) resulted 
in significant increases in total SCFA production, p<0.05.  Laminarin and mycoprotein 
generated the highest concentrations of total SCFA which was significantly higher than 
mycoprotein (laminarin vs mycoprotein: 64.1 [9.0] mmol/l vs 24.9 [1.7] mmol/l, p=0.044, 
mycoprotein fibre vs mycoprotein: 61.2 [15.7] mmol/l vs 24.9 [1.7] mmol/l, p=0.078). 
 
 
Figure 7-4: Acetate, propionate and butyrate production after 6 hours of fermentation 
(mmol/l) 
Data presented is mean + standard deviation, n= 3. Statistical significant differences are shown by 
* vs mycoprotein fibre and † vs FOS p<0.05. IPE0.8 vs all for propionate p<0.001. IPE0.8 = inulin 
propionate ester 0.8. 
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Figure 7-5: Acetate, propionate and butyrate production after 24 hours of fermentation 
(mmol/l) 
Mean + standard deviation, n= 3. Statistically significant differences are shown by * vs 
mycoprotein fibre and † vs FOS p<0.05. IPE0.8 and rhamnose vs all for propionate p<0.001. 
IPE0.8 = inulin propionate ester 0.8. 
 
 Molar proportions 
The proportions of propionate and butyrate produced with mycoprotein and mycoprotein 
fibre were similar, with mycoprotein producing acetate: propionate: butyrate in the 
approximate ratio 50:25:25 and mycoprotein 61:20:18 (Table 7-6).  The molar proportion 
of acetate at 24h was highest for oligofructose with 92.6 (2.8) % of total SCFA. 
Mycoprotein fibre and laminarin both generated similar proportions of acetate yielding 
approximately 63% acetate, whereas both mycoprotein and rhamnose yielded 
approximately 46% of acetate.  Rhamnose had the highest molar proportion of propionate 
(45.33 [1.95] %, except for the inulin ester IPE 0.8; 71.4 [2.1] %, p<0.001).  Unexpectedly 
laminarin led to a significantly lower proportion of propionate than all other substrates 
except FOS (p<0.01).  Laminarin generated the highest proportion of butyrate (28.0 [10.0] 
%), which was similar to that of the control and mycoprotein.  
p<0.01. 
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 Ranked production 
The ability of the individual stool donors to produce acetate, propionate and butyrate from 
each substrate after 24 hours of fermentation was ranked (Table 7-7).  The rank for acetate 
production varied between stool donors with each participant having different ‘top’ acetate 
substrates.  The bottom three substrates of acetate for all participants were mycoprotein, 
IPE0.8 and the control.  Ranked production of propionate was very similar for all 
individuals with IPE0.8, rhamnose and mycoprotein fibre ranking 1st, 2nd and 3rd for 
production. Mycoprotein, ranked 4th for participant 1 (p1) and participant 2 (p2) and 5th for 
stool donor 3 (p3).  At all time points, oligofructose and the control ranked as the lowest 
producers for both propionate and butyrate.  Laminarin ranked highest for butyrate with all 
participants.  Mycoprotein fibre ranked 2nd for p1 and p3, and ranked 4th for p2.and was 
higher than mycoprotein except for p2.  
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Table 7-6: Molar proportions (%) of acetate, propionate and butyrate after 24 hours of fermentation 
 
Control FOS IPE0.8 Rhamnose Laminarin Mycoprotein Mycoprotein Fibre 
Acetate 56.91 (6.33)c 92.57 (2.82)b 20.94 (4.65)a 44.77 (3.13)c 65.04 (11.51)c 48.31    (6.53)c 61.36   (4.17)c 
Propionate 20.12 (2.57)a 2.57 (0.34)b 71.44 (2.07)d 45.33 (1.95)c 6.95 (2.48)b 25.99   (3.51)a 20.25   (1.28)a 
Butyrate 22.97 (3.88)c 4.86 (2.72)b 7.63 (2.58)b 9.90 (2.70)bc 28.02 (10.04)ac 25.70   (3.11)c 18.39 (5.18)abc 
Mean (standard deviation). FOS = oligofructose, IPE0.8 = inulin propionate ester 0.8.  
Difference letters within rows indicate significant differences. 
Table 7-7: Ranked production of acetate, propionate, and butyrate by each stool donor 
 Acetate Propionate Butyrate 
Rank P1 P3 P3 P1 P3 P3 P1 P2 P3 
1 FOS Laminarin Mycoprotein fibre IPE 0.8 IPE 0.8 IPE 0.8 Laminarin Laminarin Laminarin 
2 Laminarin FOS FOS Rhamnose Rhamnose Rhamnose Mycoprotein fibre Mycoprotein 
Mycoprotein 
fibre 
3 Mycoprotein fibre 
Mycoprotein 
fibre Laminarin 
Mycoprotein 
fibre 
Mycoprotein 
fibre 
Mycoprotein 
fibre Mycoprotein Rhamnose Mycoprotein 
4 Rhamnose Rhamnose Rhamnose Mycoprotein Mycoprotein Laminarin Rhamnose Mycoprotein fibre Rhamnose 
5 Mycoprotein Mycoprotein IPE 0.8 Laminarin Laminarin Mycoprotein IPE 0.8 IPE 0.8 IPE 0.8 
6 IPE 0.8 IPE 0.8 Mycoprotein Control Control Control FOS FOS Control 
7 Control Control Control FOS FOS FOS Control Control FOS 
P1 = stool donor 1, P2 = stool donor 2, P3= stool donor 3. Rank number 1 = top producer, Rank number 7 = bottom producer 
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  Discussion 
It has been demonstrated that mycoprotein, the commercial meat replacement product, 
known commercially as Quorn® and its extracted fibre are both well fermented and 
produce SCFA in vitro.  Initially this was unexpected as the pH for mycoprotein barely 
dropped over the 24-hour duration of the fermentation.  Although mycoprotein did not 
generate high yields of SCFA compared to the other substrates tested, the SCFA appeared 
to lead preferentially to the production of propionate.  This was demonstrated by ~27% of 
total SCFA produced by mycoprotein forming propionate.  Mycoprotein fibre on the other 
hand was highly fermentable and produced similar concentrations of SCFA to laminarin 
(Deville, 2007), and oligofructose (De Preter et al., 2010), which are both considered as 
highly fermentable dietary fibres. 
 
However, it needs to be noted that the mycoprotein did not undergo a pre-digestion step, or 
a freeze-drying step. As a result, the fat and protein, which would not reach the colon after 
consumption were also available for fermentation in the batch culture systems.  As only 
approximately 6% of the mycoprotein (as fibre) would reach the colon for fermentation 
indicating that protein fermentation may have occurred.  
 
Propionate production from mycoprotein fibre was 61.5 μmoles/75.1 mg fibre (production 
in 5 ml, and based on the extracted fibre having >75% fibre; personal communication with 
Premier Analytical Services).  Based on this it was likely that only 4.9 μmoles propionate 
was produced from the 6 mg (6% of 100 mg) of fibre in the mycoprotein.  However when 
considering the propionate production from (whole) mycoprotein, 31 μmoles/ 100 mg 
propionate were produced within fermentation the fermentation vial (5 ml).  This is over 
6x more than that would have been expected from the fibre alone.  
As mycoprotein also consists of 11% protein and 9% carbohydrate, it is likely that these 
are also contributing to the propionate produced.  Mortensen et al., (1990) fermented a 
selection of amino acids and identified that they lead to the production of SCFA, although 
this was to a lesser extent than BCFA.  During the fermentation of the protein within the 
mycoprotein, it is likely that low concentrations of ammonia and hydrogen sulphide, which 
occur as a result of bacterial fermentation of proteins were produced (Walker et al., 2005, 
Magee et al., 2000).  As both of these are alkali, this could have led to buffering the pH in 
the system, preventing a reduction in pH.  
212 
 
 
 
 
High proportions of propionate (and butyrate) as a result of mycoprotein fibre are likely 
due the E(1-3), E(1-4) and E(1-6) glucose linkages within the mycoprotein fibre.  These 
bonds types have previously been associated with the selective increase in the production 
of propionate and butyrate in vitro (Queenan et al., 2007, Hughes et al., 2008, Deville, 
2007).  Although few studies have looked at the fermentability of chitin, SCFA have been 
observed from the fermentation of mushroom sclerotia, this along with the presence of E-
bonding suggests that chitin is also likely to selectively increase propionate and butyrate.  
 
Feeding of chitosan (derived from chitin), and using the ruminal fluid and faeces of sheep 
generated significantly increased proportions of propionate and an increased propionate-
acetate ratio in the rumen (0.17 vs 0.22, p=0.007) and faeces (0.13 vs 0.15, p=0.045). 
Chitosan consumption had no effect of total ruminal SCFA but reduced faecal SCFA (19.4 
to 13.4 mmol/l, p=0.01). In vitro fermentation of starch ruminal fluid from both groups 
also demonstrated similar effects with no effect on total production and increased 
propionate proportion and ratio. Fermentation with cellulose resulted in the control 
yielding more propionate than the chitosan after the fermentation of cellulose but total 
production was significantly reduced (48.98 vs 35.30 mmol/l, p=0.001) (Goiri et al., 2009).  
 
Further indications that these effects discussed in Table 7-1 of mycoprotein may occur via 
SCFA production have been found in other fungi. For example in in vitro batch 
fermentations of Polyporous rhinoceros and Wolfiporia cocos, both consisting of E(1-3) 
linked glucoses have been performed. Fermentation of these fungi resulted in 27% 
propionate production (of total SCFA), This was particularly apparent for W. cocos which 
yielded the most SCFA of the mushrooms tested, as well as the most propionate production 
(Wong et al., 2005).  Similar effects were also observed when a selection of E-glucans, 
including mushroom sclerotia (Pleurotus rhinoceros) consisting of E(1-3), E(1-4) and E(1-
6) bonding were fermented in vitro after the addition of different strains of bifidobacteria.  
Propionate production of the mushroom sclerotia was similar to other E-glucans tested, 
some of which are associated with the increased production of propionate (barley and 
seaweed) and was significantly higher than inulin, when fermented in vitro along with 
Bifidobacterium infantis (Zhao and Cheung, 2011).  
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Other substrates were fermented along with the mycoprotein and mycoprotein fibre, and in 
many cases ‘propiogenic’ substrates were selected.  This enabled the comparison of 
multiple propionate producing fibres.  In the initial fermentations with the mycoprotein 
alone, rate proportions of propionate were similar to that of fibersol, which been 
demonstrated to increase propionate production in vitro (Laurentin and Edwards, 2004). 
Mycoprotein and its extracted fibre were also compared with rhamnose, a monosaccharide 
sugar, and laminarin, a derivative of seaweed both of which lead to the increased 
production of propionate in vitro (Deville, 2007, Gietl et al., 2012). Rhamnose production 
from propionate exceeded that of mycoprotein, and the mycoprotein fibre. In contrast, 
laminarin production favoured butyrate and the mycoprotein produced more propionate.  
The propionate production by these fibres was dwarfed by that of the synthetic substrate 
where propionate is conjugated to inulin (IPE 0.8).  This fibre directly delivers propionate 
to the colon leading to downstream propionate associated effects, including a reduction in 
weight gain (Chambers et al., 2014). Although the IPE 0.8 produces high concentrations of 
propionate, the mycoprotein fibre showed potential in terms of propionate production.  For 
example, the mycoprotein fibre consistently ranked 3rd for propionate production (1st = IPE 
0.8, 2nd rhamnose).  Proportionally, mycoprotein and its extracted fibre generated increased 
amounts of propionate, (mycoprotein; 26.0 [3.5] % and the extracted fibre (20.3 [1.3] %) 
which was only exceeded by IPE 0.8 (71.4 [2.1] %) and rhamnose (45.3 [2.0] %).  It was 
also observed that for mycoprotein and mycoprotein fibre the increased propionate was at 
the cost of acetate, a SCFA profile which has been shown to be beneficial for cholesterol 
regulation (Wolever et al., 1991). 
 
Other advantages of mycoprotein include the fact that it is currently mass-produced within 
the UK, and is easily accessible to the general public.  This therefore may be an effective 
avenue to increase the production of propionate within a standard diet as well as being 
beneficial for regulation of cholesterol and energy intake. The increased propionate 
observed with mycoprotein, and in particular, the extracted fibre may be involved in the 
increased feelings of satiety and energy intake that were also observed in feeding studies 
(Table 7-1) (Turnbull et al., 1990, Turnbull et al., 1993b, Turnbull et al., 1994, Turnbull 
and Ward, 1995).  
 
This likely occurred as 25% of the dry weight of mycoprotein is fibre, and an 80g dose 
provides 5 g of fibre.  The extracted fibre ranked high for propionate production, 
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proportion, and total fibre concentrations were not dissimilar from other highly 
fermentable substrates tested. This, and the observation that consumption of IPE 0.8 
reduced energy intake and weight gain (Chambers et al., 2014) indicates that the effects on 
satiety and energy intake observed with mycoprotein are possibly due to colonic 
propionate production by fermentation of the mycoprotein fibre.  The production of 
propionate by the ester and the mycoprotein could be compared. This is as 10 g IPE, 
produced 2.65 g propionate, which is the equivalent of 36.23 mmoles. Within this 
assessment, 100 mg of mycoprotein fibre yielded 61.25 μmoles of propionate, which is 
612.5 μmoles per gram of fibre.  Based on this, to achieve the same amount of propionate 
as the IPE, approximately 60 g of mycoprotein fibre would be required. Mycoprotein fibre 
yielded approximately 10x the amount of propionate as oligofructose, and based on the 
study by (Pedersen et al., 2013), <10 g of mycoprotein fibre would likely achieve appetite 
regulation.  Indicating that although mycoprotein is beneficial to selectively increase 
propionate production compared to oligofructose, it remains to be seen if it can induce a 
similar effect on appetite regulation as seen IPE, within similar dose ranges. 
 
Although protein was within the mycoprotein it is unlikely that the effects occurred as a 
result of the protein fermentation as when protein content was matched; differences in 
energy intake were observed indicating the effects are likely due to the fibre content 
(Turnbull et al., 1993b).  Based on this it would be interesting to observe the effects of 
consumption of mycoprotein and/or its extracted fibre on the production of propionate.   
In conclusion, it has been demonstrated that mycoprotein and its fibre are propiogenic. 
This capacity to produce propionate as well as butyrate may go to some way to explain the 
ability of mycoprotein to reduce cholesterol. Although further investigations into the 
ability of mycoprotein to increase propionate and butyrate after consumption is required, 
mycoprotein, marketed as Quorn®, is easily available within the UK could be used tool to 
potentially increase propionate within the diet.  
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  General Discussion 
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What is becoming more and more apparent is the importance of the gut microbiota, and 
their metabolites in human health.  Previously, the role of the colon was thought to be 
solely for the absorption of water and salts.  The advent of improved anaerobic and 
molecular techniques has shown that the colon is a diverse microbial ecosystem consisting 
of over 150 different species and has a symbiotic relationship with the human host 
providing selective advantage (Qin et al., 2010).  It has long been known that gut microbial 
fermentation is important for the generation of energy by ruminants (Sunvold et al., 1995), 
but the role of the NDC fermentation in humans and the consequences on SCFA 
production of is much less well understood. 
 
As discussed in the general introduction (Chapter 1), the main SCFA are acetate, 
propionate, and butyrate.  These have a selection of roles in health including in the 
mediation of cancer, gluconeogenesis, cholesterol synthesis and the satiety response.  This 
satiety response, at least in part, likely occurs via the release of the satiety hormones PYY 
and GLP-1 mediated by the receptors FFAR2 and FFAR3. These receptors also have other 
roles including the production of hormones not only for satiety, but also leptin for the 
regulation of adipogenesis which has also been postulated to have regulatory effects in 
inflammation. Leptin also alters signals in the brain as it can cross the blood - brain barrier.  
Propionate, in particular may be an important signalling molecule responsible for many of 
these effects, it is the most potent activator of both FFAR2 and FFAR3 (den Besten et al., 
2013b, Byrne et al., 2015).  
 
The ratio of acetate to propionate is also of importance.  In the recent study by Perry., et al 
(2016) assessing colonic acetate production when feeding rats a high fat diet, identified 
that increasing acetate, led to increased body weight, insulin secretion, and fatty acid 
production (Perry et al., 2016).  In contrast propionate has the opposite effect to acetate, 
where supplementation has been shown to reduce weight gain, reduced glycaemic response 
and reduced adipose tissue (Chambers et al., 2014).  The importance of the role of the 
acetate to propionate ratio was also identified in earlier studies where propionate was 
shown to compete with acetate by preventing acetate mediated FA synthesis in a dose 
dependent manor in vitro (Wright et al., 1990).  Infusion studies have also demonstrated 
the inhibition of HMG-CoA reductase by propionate, thus preventing cholesterol synthesis 
(Wolever et al., 1991).  Therefore, although acetate is consistently the most abundant 
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SCFA produced, reducing the acetate to propionate ratio, by increasing colonic 
concentrations and proportions of propionate is potentially beneficial. 
 
 Functional foods targeting selective SCFA production 
Prebiotics are substrates which are fermented in the colon to selectively stimulate 
beneficial bacteria (Gibson and Roberfroid, 1995).  The prebiotic capability of many 
different substrates have been assessed, but the most commonly assessed are inulin and 
oligofructose (although there are others) (Roberfroid et al., 2010).  In vitro inulin has been 
associated with increased Bifidobacterium spp such as B.longum, B.infantis, B.adolscentis 
but inhibited E.coli and C.perfringens (Wang and Gibson, 1993).  These species along with 
a number of lactobacilli species (along with many others) are also considered to be 
probiotics.  Consumption of these substrates is also associated with a number of positive 
effects.  Bouhnik et al., (1999), identified increased faecal bifidobacteria after consumption 
of oligofructose.  What is also of interest is that oligofructose has other health benefits.  
For example, high doses of oligofructose increase feelings of satiety, and concentrations of 
the appetite hormones PYY and GLP-1 (Pedersen et al., 2013).  The SCFA, and in 
particular propionate, are associated with the release of these hormones (Lin et al., 2012), 
which is one of the beneficial roles of these SCFA. Other roles of propionate also include 
gluconeogenesis, regulation of fatty acid and cholesterol synthesis (Chapter 1) (den Besten 
et al., 2013b).  These SCFA are produced when NDC reach the colon and are utilised by 
the colonic bacteria.  The colon is an ecosystem which has the capacity to metabolise a 
vast array of substrates, providing sustenance for the colonic bacteria, and generating 
SCFA as terminal reduced products. Different species are able to use the substrates to 
produce different SCFA and SCFA production profile can alter depending on the dietary 
source available.  The ability of the colonic bacteria to be modified by diet has been 
demonstrated in a number of studies (David et al., 2014, O'Keefe et al., 2015).  O’Keefe et 
al., (2015), fed African Americans a native African diet (high fibre, low fat), and native 
Africans an American diet (low fibre, high fat). The switch to a high fibre diet increased 
faecal SCFA production, as well as increased the bacterial diversity, compared to the high 
fat diet.  Similar effects were also seen in the study by David et al., (2014) where diet was 
changed from a standard diet to a plant or animal based diet, changes in the bacteria such 
as increases in Roseburia, E.rectale, and R.bromii were associated with increases in SCFA 
production. This ability to adapt can also be used to manipulate the colonic bacteria. A 
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prime example of this is resistant starch, which is fermented by many species such as 
E.rectale, and R.bromii resulting in the production of butyrate.    
 
It is important to consider that fibres are not eaten in isolation but more as a mixture, this 
may influence their impact on the microbiota, and SCFA produced.  For example, 
consuming porridge and an apple for breakfast exposes the colonic bacteria to oat β-glucan 
with β(1-3), β(1-4) linked glucoses from the porridge and pectin with from the apple 
consisting of α(1-4) linked galacturonic acids.  Therefore, for the colonic bacteria to 
survive they need to adapt so that they can utilise these energy sources.  This can be 
demonstrated from in vitro studies where β-glucans are associated with increased 
populations within the clostridia cluster IX group, Bacteroides-prevotella group, and the 
Clostridium histolyticum subgroup, all of which are associated with the production of 
propionate (Hughes et al., 2008).  Pectin on the other hand has also been associated with 
increased populations of B.thetaiotaomicron (Dongowski et al., 2000) which, along with 
previous studies suggests that B.thetaiotaomicron can use many different substrates 
demonstrating the adaptability of the bacteria within the colon (Martens et al., 2011).  
Thus, eating pectin and oat β-glucan may result in different populations of bacteria than 
each eaten on its own. 
 
This is a feature that can be exploited for functional foods.  If the diet could be used to 
optimise the microbiome so that the ecosystem selectively increased the production of 
propionate would be advantageous.  This could occur by manipulating which bacteria are 
present and their functions, or ensuring that the bacteria present have the appropriate 
enzymes to utilise the substrates to produce propionate directly, or by interconversion from 
a different substrate.  
 
 Increasing colonic propionate 
Human feeding trials where propionate is added directly to food have been problematic, 
particularly in the study of appetite regulation. Propionate is absorbed in the small intestine 
and does not reach the colon. Independently of this, addition of propionate to directly 
foods leads to feelings of satiety and effects on glucose tolerance are often attributed to the 
poor organoleptic properties of the food product (Darzi et al., 2012). To date- the one way 
to selectively deliver propionate to the colon is via the recently developed inulin-
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propionate ester, in which propionate is delivered to the colon through conjugation to 
inulin. This inulin-propionate ester has been shown to suppress appetite, reduce weight 
gain, and reduce intra-abdominal adipose tissue in overweight individuals with elevated 
hepatic fat (Chambers et al., 2014).  Although this is beneficial in overweight individuals, 
positive effects in healthy individuals are less clear and may revolve around the prevention 
of obesity-related metabolic phenotypes.  The identification of a natural (non-synthetic) 
food source as a functional food, which might also selectively promote propionate 
production in the colon, would also be advantageous for carrying out long-term feeding 
trials, which could also have very high consumer acceptance.  
 
Identifying ‘propiogenic’ foods or food ingredients has been hindered by the paucity of 
techniques to assess colonic production of SCFA within the literature.  Selecting NDCs for 
feeding trials and mechanistic analysis is difficult due to a lack of systematic assessment of 
the properties which selectively increase the production of propionate.  In order to assess 
the drivers of propionate production a multipronged approach was adopted.  The overall 
aim of this thesis to be a systematic and step-wise approach to identify which factors are 
identifiable that lead to the preferential production of propionate.  
 
During this PhD, the aim was to try to tease out the ideal composition of NDC to 
selectively elevate the production of propionate in vitro. This was carried out in a step-wise 
fashion: 
1. A systematic review of the literature to identify any previously identified 
propiogenic substrates 
2. Screening of selection of potentially propiogenic substrates 
3. Assessing the effect of specific bonding on propionate production 
 
 Assessment of the literature 
The aim of the systematic review of in vitro batch fermentations was to identify NDC 
which could be targeted for further analysis to elucidate why it was propiogenic. 
Unfortunately, many issues became apparent when carrying out this analysis. The lack of 
uniformity of methodologies and units provided made comparisons difficult. Due to this 
limitation, a rate term (mmol/g CHO/day) was developed to enable the comparison of 
these investigations. This somewhat enabled the SCFA producing capabilities of the 
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substrates tested to be evaluated and compared side-by-side.  The rate term was beneficial 
as the ratio is often used for comparisons of different studies, a unit that was identified to 
be misleading, as it does not take into account the amount of propionate produced, just a 
proportion, i.e. 50% of four is the same as 25% of eight.  
 
Within the non-pooled studies, no NDC stood out as being propiogenic (based on rate), for 
example, the top three producers were a monosaccharide or disaccharide sugar. 
Differences were found with the pooled data where β-glucans were identified to be the 
highest propionate producers.  In contrast, pectin and guar gum were seen to produce high 
proportions of propionate, based on ratio.  Differences in the pooled and non-pooled data 
could have occurred for many reasons, for example rhamnose which is deemed as highly 
propiogenic (Vogt et al., 2004b), did not have enough data for analysis within the pooled 
data and was not included.  Pooling may have reduced inter-individual variation which 
could have down-stream effects on propionate production. Although differences did occur 
as a result of pooling and non-pooling data, each group had over 50 studies for 
comparison, providing a good overview of the literature.  These studies where compared 
separately due to potential effects of combining bacteria.  As discussed in Chapter 3, when 
stool samples are pooled the bacteria within the samples are likely to interact with each 
other and a dominant ecosystem is likely to prevail.  This has not only been shown in 
faecal transplantation (Fuentes et al., 2014), but also in vitro where the bacteria of 
individual stool samples and the combined pool were compared (Aguirre et al., 2014). 
Aguirre et al., (2014) identified that the bacterial composition of the individuals was 
different compared to the pool, and that these differences were not uniform for all 
individuals. This was exemplified by the change of Roseburia populations in which one 
individual has a 63.5 fold change, and another had a 2 fold change compared with the pool. 
It was reported that this did not translate to differences in the SCFA production, however 
this was using the TIM-2 models and not batch fermentations. This is also in contrast to 
what was observed when the variability between pooled and non-pooled was assessed 
within this thesis. In Chapter 3, where pooled and non-pooled studies were compared the 
pooled samples had more overall variability, indicating that pooling may mask population 
variation in SCFA production.    
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 In vitro analysis 
A selection of NDC that are generally considered ‘propiogenic’ as well as others which 
seemed to produce propionate but did not fulfil the inclusion criteria for the systematic 
review were screened.  As this was a screening of a selection of different substrates, batch 
in vitro investigations were carried out.  This fermentation system lent itself to high-
throughput screening allowing direct and simultaneous comparison of a range of NDC 
within each individual participant.  We were unable to study all substrates in one huge 
fermentation batch and so this would have meant using different faecal samples for 
different substrates.  We therefore grouped the substrates into related batches with similar 
properties which reduced the variability of faecal samples used for each comparison.   
 
This fermentation system was also effectively ‘miniaturised’ which enabled fermentations 
to be carried out when there was reduced substrate availability, however there was a limit 
to this particularly with the 50 mg system.  For example, it became apparent during the 
validation of the miniaturisation that the smallest fermentation system requiring 50 mg of 
substrate did not lend itself to some soluble fibres which increased supernatant viscosity 
(e.g pectin)  As a result this system was only utilised for the disaccharide substrates which 
were very expensive and completely and freely soluble (discussed below). 
 
An issue with the screening was that due to the relatively small sample size and the 
variability in SCFA production by different stool donors, led to difficulties in identifying 
statistical significances in production (Further discussed below).  In contrast, if a greater 
number of biological replicate fermentations for each substrate were conducted, fewer 
substrates would have been compared due to time restraints, and on occasion (e.g glucose 
disaccharides) thus reducing the ability to screen a variety of different substrates. 
 
Substrates which produced propionate were ranked after screening to examine the nature 
of the top 25% of propionate producing substrates.  The top 10 producers of propionate 
included laminarin, oat and barley β-glucan, guar gum and legumes.  Also within the top 
10 propionate producers was oligofructose, although oligofructose is not generally 
considered as a ‘propionate producer’ (although it does consists of β[2-1] linkages [Khan 
and Edwards., 2005]).  Oligofructose ranked in the top 25% as it produced high total 
SCFA production, which lead to increased propionate production as a consequence.  A 
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common theme of the top 10 producers was the presence of linkages with beta bonding. 
For example laminarin has β(1-3), β(1-6) bonding (Deville, 2007), oat and barley β-glucan 
has β(1-3), β(1-4) bonding (Hughes et al., 2008), guar gum has a β(1-4) backbone (Stewart 
and Slavin, 2006). Legume fibre (although not in the substrates test here) consists of a 
variety of sugars.  The soluble fibre fraction having high proportions of galacturonic acid 
(found in pectin), but also xyloglucan which also consists of β- bonding (Brummer et al., 
2015), both of which have been associated with increased propionate production in vitro 
(Gulfi et al., 2005, Hughes et al., 2008).  Therefore, it would have been interesting to 
assess the sugar structure of the legume fibres tested, however this was not in the scope of 
this thesis.  
 
This also led to the assessment of the commercial mycoprotein product, known as Quorn.  
The polysaccharide within mycoprotein (mycoprotein fibre) also contains β(1-4), β(1-3), 
and β(1-6) bonding.  After fermentation of the mycoprotein, and its extracted fibre it 
became apparent that the SCFA produced preferentially led to the production of 
propionate.  This further supports other observations in this thesis that E-bonding plays an 
important role in the selective production of propionate.  
 
The assessment of the effect that bond linkage had on the production of propionate was 
within the scope of this thesis, although only assessment of glucose-glucose disaccharides 
was possible.  Due to the high cost of the substrates used for this experiment, the 
fermentation system was successfully miniaturised, allowing 10 fermentations in duplicate 
to be conducted initially.  Although the majority of in vitro investigations carry out 
fermentations with stool donors from approximately 3 to 6 donors (Stewart and Slavin, 
2006, Bourquin et al., 1992, Wang and Gibson, 1993), a post hoc power calculation 
indicated that the study was underpowered to assess the production of propionate with 10 
different sample donors.  It did indicate that for α(1-1) and β(1-4) bonding an additional 
five fermentations would provide power for robust statistical assessment.  For the 
remainder of the substrates an unfeasible number of replicates would have been required to 
reach statistical power. 
 
These disaccharide fermentations showed that β(1-4) bonding had an increased proportion 
of propionate compared to the α(1-4) linkage.  However, linkage and bond orientation had 
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no effect on the production of propionate, and minimal effects were seen in differences in 
butyrate production.   
 
These findings were not supported by a similar study by Sanz et al., (2005) who observed 
increased propionate (and butyrate) production with β-bonding when compared to the same 
linkage in the alpha orientation.  However, this investigation differed from the one 
presented within this thesis in a number of different ways.  For example, only 7 mg of 
substrate was used by Sanz et al, (2005) and within their study they validated the reduced 
size fermentation system based on bacterial populations and not SCFA production.  
Differing from this thesis, the system that they validated against was pH controlled, and 
their miniaturised system did not appear to have any form of pH control.  In contrast, 
within this thesis the validation occurred with miniaturisations with identical 
methodologies.  However, total SCFA production was consistently lower for the 50 mg 
system; this difference would likely have been more prevalent if the amount of substrate 
was further reduced.  However, the system was valid for cross-comparison of substrate 
fermentation within and between subjects. 
 
Another difference when compared to Sanz et al., (2005) was that fermentation was only 
carried out for 12 hours, whereas within this thesis 8 and 24 hour time points were used. 
By 12 hours, the substrate would likely have been fully utilised, but this does not take into 
account the interconversion of the SCFA which may have occurred between 12 and 24 
hours of fermentation (although this often occurs within 12 hours ). Interestingly, 
differences in the SCFA production were not associated with differences in the bacterial 
composition, which were not affected by the different bond linkages in the study by Sanz 
et al., (2005).  This either indicates that the functionality of the bacteria did not differ or 
they were able to express different enzymes to utilise the different linkages.  As assessment 
of the bacterial populations or the functionality of the bacteria was not accomplishable 
within this thesis it is difficult to compare the findings of Sanz et al., (2005) with the 
findings within this thesis.  
 
The main difference and possibly the most important was the use of a single stool donor in 
the study by Sanz et al., (2005), negating any effect of inter-individual variability on SCFA 
production.  Variability in the colonic microbiota has been observed on many different 
occasions, with a variety of different methods used to assess the colonic diversity.  For 
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example, the type of food consumed has been previously shown to rapidly alter the 
composition of the colonic bacteria, which would then lead to down-stream effects on 
SCFA production (David et al., 2014).  Similar effects were also observed by Walker et al., 
(2011) where overweight individuals consumed a maintenance diet, a non-starch 
polysaccharide diet, a resistant starch diet, and a weight loss diet, each for three weeks. 
Here it was seen that people had differences in their abilities to digest the individual diets 
but that these differing diets also altered the bacterial profiles.  Within this thesis, the diets 
were not assessed, and no dietary control was instigated prior to stool collection.  This may 
have played a role in the variability of SCFA production that was observed throughout this 
thesis and in particular during the disaccharide analysis. This variation could possibly have 
been reduced with a pre-study diet which may have ‘normalised’ the initial colonic 
bacteria. 
 
Variation in SCFA production capabilities has also been discussed in other in vitro studies 
(Bourriaud et al., 2005, Rosendale et al., 2012, Carlson et al., 2016).  Together this 
indicates the complexities of the diet - bacteria interactions within the colon of the donor, 
as well as the substrate being tested by fermentation. This indicates that SCFA production 
is multifactorial and complex, thus predicting SCFA formation by different NDCs is 
challenging.  The disaccharide model used consisted only of glucose disaccharides, and 
although NDC such as β-glucans consist of β-linked glucoses, not all NDC do.  This is 
exemplified by guar gum which is considered propiogenic and is formed of a β(1-4) 
mannose sugar backbone and α(l-6) linked galactose side chain (Stewart and Slavin, 2006).  
Therefore, saying that substrates such as guar gum is propiogenic is simplistic and does not 
address the fact that NDC are complex and there utilisation and the production of 
propionate is determined by not only the bacteria that are present but also the enzymes 
which they produce.  However, what was identified throughout this thesis was that a 
propiogenic substrate for one individual may not be for another.  This could have been for 
varieties of reasons, such as habitual diet, meal consumed prior to food intake and 
environment which may have, alter the SCFA producing capabilities of the donors.  Based 
on this it would be interesting to assess the bacterial composition of sample donors who 
vastly differed in SCFA production compared to the other donors.   
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 Overarching conclusions 
Within this thesis, it has become increasingly apparent that determining which factors 
drive propionate production is highly complex. Very few studies have assessed the 
propionate producing capabilities of monosaccharides or disaccharides; allowing the 
effects of a particular sugar and/or linkage to be addressed.  This thesis has estimated the 
propionate producing capabilities of all possible glucose-glucose linkages; however, in 
terms of all of the food that is consumed it is more complex than a linear chain of glucose 
bonding.  This linear bonding has been demonstrated within oat and barley β-glucans 
which consist of β(1-3), β(1-4) bonding (Hughes et al., 2008).  Due to a lack of side chains 
these β-glucans likely have a more open structure, thus making the bonding connecting the 
sugars more easily accessible.  However NDC are often more complex that this, they often 
have multiple types of bonding with various branches. An example of this is pectin which 
consists of α(l-4) linked galactuoronic acids but also consists of branches containing a 
selection of sugars such as rhamnose, arabinan, galactan and arabinogalactan, which utilise 
different linkages (Gulfi et al., 2005).  For SCFA production a selection of different 
bacterial enzymes are required, and access may only be possible after a different linkage 
has been catabolised, so if the initial bond is catabolised, even if the correct enzymes for 
the secondary bond are present, breaking the bond to utilise the sugar is not possible.  
 
Another level of complexity is that often these fibres are also encapsulated as part of a 
food. The fibre of mycoprotein is an example of this. Approximately 25% (dry weight) of 
mycoprotein is dietary fibre, and the remainder consists of protein, fat, and a selection of 
different micronutrients (Marlow foods Ltd., 2016).  How this is digested when consumed 
may affect what reaches the colon.  If a substrate has not fully digested once reaching the 
colon the bacteria may utilise the non-digested material which may alter the SCFA that are 
produced but also the bacterial composition.  This could also make it difficult for the 
bacterial enzymes to catabolise the different bonds and as a result release the sugars for 
bacterial utilisation.  This indicates that increasing the overall fermentability of a substrate 
is key to increasing propionate production. 
 
A main observation within the investigations carried out here are that β(1-3), β(1-4), and 
β(1-6) bonding increased propionate production, or at least ranked high for propionate 
production.  Diglucoses with β(1-4) bonding were the only sugars that selectively 
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increased the proportion of propionate when tested.  This bond is present in oat and barley 
β-glucans which have been shown to propiogenic as well as butyrogenic.  What was also 
seen was that many of the more unusual substrates that lend themselves to production of 
propionate seem to have β(1-6) bonding which seem to occur in foods that are less 
common in the British diet.  For example, brown seaweed (laminarin) (Deville, 2007), 
pyrodextrinised starch (Laurentin and Edwards, 2004), mycoprotein fibre (Quorn, 2016), 
and some fungi (Wong et al., 2005) all contain β(1-6) linkages which are all associated 
with increased propionate production.  This was not observed when assessing the 
propionate producing capabilities of β(1-6) linked glucose disaccharides. This may be as 
the β(1-6) linkages are part of a chain in which the other linkages have influenced the 
bacteria that are present.  The accessibility of these bonds may be improved when it is a 
branch point, also the number of branch points may also alter the accessibility of the 
bacterial enzymes.  The ability of fungi to produce propionate and butyrate is also 
interesting as the α(1-1)α bonding (trehalose) has been seen to selectively increase butyrate 
production occurs in a variety of different fungi as well as other sources.  Trehalose is 
present in shiitake mushroom (Chen et al., 2015), and the ‘common’ mushroom (Agaricus 
Bisporus) (Wannet et al., 1998) where it is used as a storage polysaccharide alongside beta 
glucans. It is found in other sources too such as the Arabidopsis plant (Müller et al., 2001). 
This suggests that trehalose could be exploited for the development of functional foods to 
increase butyrate production and that less common types of food, as well as those that are 
yet to have their SCFA producing capabilities measured would be interesting pursuits 
when further investigating the production of propionate.  
 
Within this thesis and the overview of the literature, it has become increasingly clear that 
determining the production of a single SCFA is not simple, and is likely reliant on 
increased overall fermentability of the substrate.  Production of a single SCFA relies on a 
series of different events to come together at the same time. It is likely that it is reliant on 
the sugars that are in the dietary fibre, the bonds that they have, the branching and the 
degree of branching present.  All these effects likely alter the bacterial enzymes expressed 
by the colonic bacteria that are present and the pathways that occur and as a result the 
SCFA produced.  Therefore, a next logical step would have been to assess which pathways 
were used to assess the production of propionate by different dietary fibres.  This could be 
done using stable isotopes to assess which pathways were being utilised.  Within the PhD, 
this was initiated in fermentation using 13C3 lactate, and 2H5-propionate with a number of 
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the propiogenic substrates in vitro.  This, along with possible changes in the bacterial 
composition could have provided more mechanistic information on how propiogenic 
substrates, lead to the production of propionate.  However, due to instrumental issues and 
time constraints these aspects were unable to be completed. 
 
Within this thesis, it was identified that targeting a single substrate solely for increasing 
colonic propionate is unlikely to be achievable by manipulating the diet (without the use of 
IPE).  Many different fibre sources were tested, and a systematic review of the current 
literature performed, and not one substrate was found to consistently increase propionate 
production.  It was also observed within the systematic review that there were not large 
differences in the ability of the substrates to produce each individual SCFA.   
 
It was found that increasing overall SCFA production, also led to increased propionate 
production.  If fermentation of a substrate produced a high proportion of propionate, this 
did not always translate into high concentrations of propionate.  It is important to consider 
not only what is produced but how the SCFA when they enter human tissues interact.  
Thus, the different proportions of each SCFA may affect the overall impact on metabolism. 
Previous infusion studies have showed that in terms of fatty acid and cholesterol 
production propionate can inhibit the effects of acetate (Wolever et al., 1991, Wolever et 
al., 1995).  Recently opposing effects on energy intake of acetate and propionate have also 
been shown. Perry., et al (2016) found acetate increased energy intake, whereas propionate 
has opposing effects and reduces energy intake, however the mechanisms for this are 
unclear (Chambers et al., 2014).  These results also conflict with the effects of acetate 
observed by Frost et al., (2014) suggesting that further work is needed at the whole animal 
level to understand the role of SCFA. 
 
Extrapolating from the published studies on fibre, it would appear that to have a significant 
effect on satiety high intakes of fibre are needed.   A major mechanism for the effects of 
fibre on satiety is now thought to be via the actions of propionate.  The studies in this 
thesis suggest that rather than eating specific foods or fibres the best means to increase 
colonic propionate production within the diet is by increasing overall consumption of 
highly fermentable, non-digestible carbohydrates. 
 
228 
 
 
 
Appendices 
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